
<html lang="en"     class="pb-page"  data-request-id="ce4e6dd6-f1ed-4017-a88a-a49bd2e1f879"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2017.60.issue-4;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.6b01173;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of N-(Pyridin-4-yl)-1,5-naphthyridin-2-amines as Potential Tau Pathology PET Tracers for Alzheimer’s Disease" /></meta><meta name="dc.Creator" content="Frederik J. R.  Rombouts" /></meta><meta name="dc.Creator" content="José-Ignacio  Andrés" /></meta><meta name="dc.Creator" content="Manuela  Ariza" /></meta><meta name="dc.Creator" content="José Manuel  Alonso" /></meta><meta name="dc.Creator" content="Nigel  Austin" /></meta><meta name="dc.Creator" content="Astrid  Bottelbergs" /></meta><meta name="dc.Creator" content="Lu  Chen" /></meta><meta name="dc.Creator" content="Vladimir  Chupakhin" /></meta><meta name="dc.Creator" content="Erna  Cleiren" /></meta><meta name="dc.Creator" content="Katleen  Fierens" /></meta><meta name="dc.Creator" content="Alberto  Fontana" /></meta><meta name="dc.Creator" content="Xavier  Langlois" /></meta><meta name="dc.Creator" content="Joseph E.  Leenaerts" /></meta><meta name="dc.Creator" content="Jonas  Mariën" /></meta><meta name="dc.Creator" content="Carolina  Martínez Lamenca" /></meta><meta name="dc.Creator" content="Rhys  Salter" /></meta><meta name="dc.Creator" content="Mark E.  Schmidt" /></meta><meta name="dc.Creator" content="Paula  Te Riele" /></meta><meta name="dc.Creator" content="Cindy  Wintmolders" /></meta><meta name="dc.Creator" content="Andrés A.  Trabanco" /></meta><meta name="dc.Creator" content="Wei  Zhang" /></meta><meta name="dc.Creator" content="Gregor  Macdonald" /></meta><meta name="dc.Creator" content="Dieder  Moechars" /></meta><meta name="dc.Description" content="A mini-HTS on 4000 compounds selected using 2D fragment-based similarity and 3D pharmacophoric and shape similarity to known selective tau aggregate binders identified N-(6-methylpyridin-2-yl)quino..." /></meta><meta name="Description" content="A mini-HTS on 4000 compounds selected using 2D fragment-based similarity and 3D pharmacophoric and shape similarity to known selective tau aggregate binders identified N-(6-methylpyridin-2-yl)quino..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 10, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01173" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01173" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01173" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01173" /></link>
        
    
    

<title>Discovery of N-(Pyridin-4-yl)-1,5-naphthyridin-2-amines as Potential Tau Pathology PET Tracers for Alzheimer’s Disease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01173" /></meta><meta property="og:title" content="Discovery of N-(Pyridin-4-yl)-1,5-naphthyridin-2-amines as Potential Tau Pathology PET Tracers for Alzheimer’s Disease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0025.jpeg" /></meta><meta property="og:description" content="A mini-HTS on 4000 compounds selected using 2D fragment-based similarity and 3D pharmacophoric and shape similarity to known selective tau aggregate binders identified N-(6-methylpyridin-2-yl)quinolin-2-amine 10 as a novel potent binder to human AD aggregated tau with modest selectivity versus aggregated β-amyloid (Aβ). Initial medicinal chemistry efforts identified key elements for potency and selectivity, as well as suitable positions for radiofluorination, leading to a first generation of fluoroalkyl-substituted quinoline tau binding ligands with suboptimal physicochemical properties. Further optimization toward a more optimal pharmacokinetic profile led to the discovery of 1,5-naphthyridine 75, a potent and selective tau aggregate binder with potential as a tau PET tracer." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01173"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01173">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01173&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01173&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01173&amp;href=/doi/10.1021/acs.jmedchem.6b01173" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 1272-1291</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00990" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01218" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of <i>N</i>-(Pyridin-4-yl)-1,5-naphthyridin-2-amines as Potential Tau Pathology PET Tracers for Alzheimer’s Disease</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frederik+J.+R.++Rombouts">Frederik J. R. Rombouts</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-1986-0476" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9-Ignacio++Andr%C3%A9s">José-Ignacio Andrés</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manuela++Ariza">Manuela Ariza</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9+Manuel++Alonso">José Manuel Alonso</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nigel++Austin">Nigel Austin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Astrid++Bottelbergs">Astrid Bottelbergs</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lu++Chen">Lu Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vladimir++Chupakhin">Vladimir Chupakhin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erna++Cleiren">Erna Cleiren</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katleen++Fierens">Katleen Fierens</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alberto++Fontana">Alberto Fontana</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xavier++Langlois">Xavier Langlois</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+E.++Leenaerts">Joseph E. Leenaerts</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonas++Mari%C3%ABn">Jonas Mariën</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carolina++Mart%C3%ADnez+Lamenca">Carolina Martínez Lamenca</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rhys++Salter">Rhys Salter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+E.++Schmidt">Mark E. Schmidt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paula++Te+Riele">Paula Te Riele</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cindy++Wintmolders">Cindy Wintmolders</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andr%C3%A9s+A.++Trabanco">Andrés A. Trabanco</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-4225-758X" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Zhang">Wei Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregor++Macdonald">Gregor Macdonald</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dieder++Moechars">Dieder Moechars</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Neuroscience Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Discovery Sciences, Janssen Research & Development, Janssen-Cilag S. A., C/Jarama 75A, 45007 Toledo, Spain</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Discovery Sciences, Janssen Research & Development, Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Isotope Chemistry and Biotransformation, Janssen Research & Development, Welsh & McKean Roads, Spring House, Pennsylvania 19477, United States</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Neuroscience Biology, Janssen Research & Development, Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">Neuroscience Experimental Medicine, Janssen Early Development, Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">∇</span> <span class="aff-text">Neuroscience Medicinal Chemistry, Janssen Research & Development, Janssen-Cilag S. A., C/Jarama 75A, 45007 Toledo, Spain</span></div><div class="aff-info" id="aff8"><span class="aff-symbol">○</span> <span class="aff-text">Neuroscience Biomarker Research, Janssen Research & Development, 3210 Merryfield Row, San Diego, California 92121, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: +32-14608216. E-mail: <a href="/cdn-cgi/l/email-protection#85e3f7eae8e7eaf0f1c5ecf1f6abefebefabe6eae8"><span class="__cf_email__" data-cfemail="fc9a8e93919e938988bc95888fd2969296d29f9391">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01173&amp;href=/doi/10.1021%2Facs.jmedchem.6b01173" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 1272–1291</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 20, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 August 2016</li><li><span class="item_label"><b>Published</b> online</span>10 February 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 February 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01173" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01173</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1272%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFrederik%2BJ.%2BR.%2BRombouts%252C%2BJos%25C3%25A9-Ignacio%2BAndr%25C3%25A9s%252C%2BManuela%2BAriza%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D4%26contentID%3Dacs.jmedchem.6b01173%26title%3DDiscovery%2Bof%2BN-%2528Pyridin-4-yl%2529-1%252C5-naphthyridin-2-amines%2Bas%2BPotential%2BTau%2BPathology%2BPET%2BTracers%2Bfor%2BAlzheimer%25E2%2580%2599s%2BDisease%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1291%26publicationDate%3DFebruary%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01173"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2846</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">19</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01173" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of N-(Pyridin-4-yl)-1,5-naphthyridin-2-amines as Potential Tau Pathology PET Tracers for Alzheimer’s Disease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Frederik&quot;,&quot;last_name&quot;:&quot;J. R. Rombouts&quot;},{&quot;first_name&quot;:&quot;José-Ignacio&quot;,&quot;last_name&quot;:&quot;Andrés&quot;},{&quot;first_name&quot;:&quot;Manuela&quot;,&quot;last_name&quot;:&quot;Ariza&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;Manuel Alonso&quot;},{&quot;first_name&quot;:&quot;Nigel&quot;,&quot;last_name&quot;:&quot;Austin&quot;},{&quot;first_name&quot;:&quot;Astrid&quot;,&quot;last_name&quot;:&quot;Bottelbergs&quot;},{&quot;first_name&quot;:&quot;Lu&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Vladimir&quot;,&quot;last_name&quot;:&quot;Chupakhin&quot;},{&quot;first_name&quot;:&quot;Erna&quot;,&quot;last_name&quot;:&quot;Cleiren&quot;},{&quot;first_name&quot;:&quot;Katleen&quot;,&quot;last_name&quot;:&quot;Fierens&quot;},{&quot;first_name&quot;:&quot;Alberto&quot;,&quot;last_name&quot;:&quot;Fontana&quot;},{&quot;first_name&quot;:&quot;Xavier&quot;,&quot;last_name&quot;:&quot;Langlois&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;E. Leenaerts&quot;},{&quot;first_name&quot;:&quot;Jonas&quot;,&quot;last_name&quot;:&quot;Mariën&quot;},{&quot;first_name&quot;:&quot;Carolina&quot;,&quot;last_name&quot;:&quot;Martínez Lamenca&quot;},{&quot;first_name&quot;:&quot;Rhys&quot;,&quot;last_name&quot;:&quot;Salter&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;E. Schmidt&quot;},{&quot;first_name&quot;:&quot;Paula&quot;,&quot;last_name&quot;:&quot;Te Riele&quot;},{&quot;first_name&quot;:&quot;Cindy&quot;,&quot;last_name&quot;:&quot;Wintmolders&quot;},{&quot;first_name&quot;:&quot;Andrés&quot;,&quot;last_name&quot;:&quot;A. Trabanco&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Gregor&quot;,&quot;last_name&quot;:&quot;Macdonald&quot;},{&quot;first_name&quot;:&quot;Dieder&quot;,&quot;last_name&quot;:&quot;Moechars&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;1272-1291&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01173&quot;},&quot;abstract&quot;:&quot;A mini-HTS on 4000 compounds selected using 2D fragment-based similarity and 3D pharmacophoric and shape similarity to known selective tau aggregate binders identified N-(6-methylpyridin-2-yl)quinolin-2-amine 10 as a novel potent binder to human AD aggregated tau with modest selectivity versus aggregated β-amyloid (Aβ). Initial medicinal chemistry efforts identified key elements for potency and selectivity, as well as suitable positions for radiofluorination, leading to a first generation of fluoroalkyl-substituted quinoline tau binding ligands with suboptimal physicochemical properties. Further optimization toward a more optimal pharmacokinetic profile led to the discovery of 1,5-naphthyridine 75, a potent and selective tau aggregate binder with potential as a tau PET tracer.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01173&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01173" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01173&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01173" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01173&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01173" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01173&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01173&amp;href=/doi/10.1021/acs.jmedchem.6b01173" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01173" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01173" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01173%26sid%3Dliteratum%253Aachs%26pmid%3D28106992%26genre%3Darticle%26aulast%3DRombouts%26date%3D2017%26atitle%3DDiscovery%2Bof%2BN-%2528Pyridin-4-yl%2529-1%252C5-naphthyridin-2-amines%2Bas%2BPotential%2BTau%2BPathology%2BPET%2BTracers%2Bfor%2BAlzheimer%25E2%2580%2599s%2BDisease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D4%26spage%3D1272%26epage%3D1291%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=290795" title="Quinolines">Quinolines</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/jmcmar.2017.60.issue-4/20170223/jmcmar.2017.60.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A mini-HTS on 4000 compounds selected using 2D fragment-based similarity and 3D pharmacophoric and shape similarity to known selective tau aggregate binders identified <i>N</i>-(6-methylpyridin-2-yl)quinolin-2-amine <b>10</b> as a novel potent binder to human AD aggregated tau with modest selectivity versus aggregated β-amyloid (Aβ). Initial medicinal chemistry efforts identified key elements for potency and selectivity, as well as suitable positions for radiofluorination, leading to a first generation of fluoroalkyl-substituted quinoline tau binding ligands with suboptimal physicochemical properties. Further optimization toward a more optimal pharmacokinetic profile led to the discovery of 1,5-naphthyridine <b>75</b>, a potent and selective tau aggregate binder with potential as a tau PET tracer.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05007" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05007" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD), a chronic neurodegenerative disorder and the most common cause of dementia among the elderly population, is characterized by progressive cognitive impairment including memory loss, compromised executive function, behavioral symptoms, and loss of ability for self-care.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Presentation can vary, and signs and symptoms of other neurodegenerative diseases overlap with those of AD. As a consequence, the accuracy of clinical diagnosis, when judged by autopsy, varies considerably.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Despite the recent advances in the search for relevant biomarkers to diagnose AD, such as amyloid positron emission tomography (PET) imaging agents, definitive diagnosis of AD can only be made by post-mortem histological analysis of human brain samples.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Post-mortem studies of AD brains have revealed two pathological hallmarks of the disease: (1) extracellular senile plaques (SPs), composed of Aβ peptides, and (2) intracellular neurofibrillary tangles (NFTs), composed of paired helical filaments (PHFs) of hyperphosphorylated tau protein.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Evidence for AD pathology can also be obtained from cerebrospinal fluid (CSF) samples and brain imaging. The latter technique is noninvasive and may be used to identify patients at risk of developing AD prior to the development of indications of cognitive impairment.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> Specifically, PET is a sensitive imaging technique that enables in vivo and in situ noninvasive visualization, characterization, and quantification of physiological processes at the molecular level and has become an extremely powerful diagnostic tool.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">Several PET probes for in vivo imaging of Aβ-plaques have been described, of which four representative examples <b>1</b> ([<sup>11</sup>C]PiB), <b>2</b> ([<sup>18</sup>F]flutemetamol), <b>3a</b> ([<sup>18</sup>F]florbetapir), and <b>3b</b> ([<sup>18</sup>F]florbetaben) are shown in <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14">(10-14)</a> The latter three were approved by regulatory agencies for commercial use. However, the density of amyloid plaques does not correlate well with the levels of neurodegeneration or cognitive impairment in AD.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0001.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Representative Aβ PET Probes Used in the Clinic</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In contrast to the amyloid pathology, the density and neocortical spread of NFTs correlate very well with progressive neuronal degeneration and cognitive decline in AD patients,<a onclick="showRef(event, 'ref14 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref16 ref17">(14, 16, 17)</a> thus making PET imaging of NFTs a desirable biomarker for AD. Indeed, recently published PET imaging studies comparing amyloid PET and tau PET reported that the tau PET signal was highly correlated with cognitive performance and disease severity compared to Aβ imaging.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a> Whereas Aβ imaging may provide an early marker for disease risk, brain amyloid burden does not correlate with disease severity. NFT imaging may allow early detection of neurodegeneration, possibly even before the onset of cognitive symptoms, as well as predict disease progression.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> NFT imaging may also help to delineate the relationship between the accumulation of tau aggregates and their spread as a function of time, cognition, and brain structure across the continuum from normal aging to AD. Tau aggregate imaging may also help researchers to investigate the effect of disease-modifying therapies on tau aggregation and disease progression. In addition to its involvement in AD, tau aggregation is a characteristic of other neurodegenerative diseases known as “tauopathies”,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> which include tangle-only dementia (TD), argyrophilic grain disease (AGD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), Pick’s disease, and frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Therefore, tau aggregate imaging might be useful for the diagnosis and study of these pathologies as well, although interpretation of the in vivo signal in early PET studies of other tauopathies with current generation tau PET ligands is an active topic of debate.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">The development of small molecule PET imaging radiotracers for the in vivo quantification of NFTs has been pursued by numerous academic and industrial groups.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27 ref28">(24-28)</a> Recently, we have reviewed these efforts as well as the multiple challenges inherent to the discovery of suitable tau PET ligands.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Several of these recently discovered radioligands with high binding to NFTs and selectivity over Aβ-plaques have been selected and evaluated in early clinical studies (<a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>). The Tohoku University has described a series of <sup>18</sup>F-labeled “THK compounds”, among which <b>4</b> ([<sup>18</sup>F]THK-5117)<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30-32)</a> and <b>5</b> ([<sup>18</sup>F]THK-5351)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> are being extensively evaluated in the clinic. The Siemens group, now Avid/Lilly, has reported two <sup>18</sup>F-labeled compounds <b>6</b> ([<sup>18</sup>F]AV-1451, previously known as [<sup>18</sup>F]T807),<a onclick="showRef(event, 'ref34 ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36 ref37 ref38">(34-38)</a> and <b>7</b> ([<sup>18</sup>F]AV-680, previously known as [<sup>18</sup>F]T808).<a onclick="showRef(event, 'ref25 ref39'); return false;" href="javascript:void(0);" class="ref ref25 ref39">(25, 39)</a> The National Institute of Radiological Sciences (NIRS) in Chiba has described a new series of <sup>11</sup>C-labeled phenylbutadienylbenzothiazole (PBB) compounds from which <b>8</b> ([<sup>11</sup>C]PBB3)<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40, 41)</a> has also been evaluated in human subjects. Very recently Merck & Co. has reported the discovery of a new tau PET tracer <b>9</b> ([<sup>18</sup>F]MK-6240)<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> which is currently under clinical evaluation. Finally, Hoffmann-La Roche in collaboration with the Johns Hopkins University School of Medicine, reported in vitro and in vivo results with three potential tau tracers, [<sup>11</sup>C]RO6931643, [<sup>11</sup>C]RO6924963, and [<sup>18</sup>F]RO6958948,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> but whose structures were not disclosed at the 2015 Annual Human Amyloid Imaging Conference.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> From all these radiotracers, <b>6</b> has been the most extensively studied in AD patients. However, although <b>6</b> is very selective for tau over Aβ, recent reports suggest that it shows widespread, high affinity off-target binding; hence the signal-to-background ratio in early AD patients may not be optimal.<a onclick="showRef(event, 'ref23 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref23 ref44 ref45">(23, 44, 45)</a> In addition <b>6</b> is reported to have a rather slow washout from the human brain requiring long scanning times of 80–100 min, and thus cortical (but not putamen) time–SUVR curves for <b>6</b> may not subsequently plateau within 100 min for mild cognitive impaired (MCI) or AD subjects.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> These limitations reinforce our belief that more sensitive and selective tau PET tracers are needed. Toward this objective we started a medicinal chemistry program and herein describe our hit identification strategy and subsequent medicinal chemistry optimization that allowed the discovery of a new family of potent and selective 1,5-naphthyridines as promising tau PET tracers with potential for human use, in particular for patient selection and monitoring of disease progression in clinical trials for AD.</div><figure id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0002.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Representative Tau PET Tracers Evaluated in Clinical Studies</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Selection and Screening</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our initial screening set was assembled from the Janssen compound collection applying two different selection strategies: (a) 2D fragment-based (ECFP6) similarity<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> via internally developed software and (b) 3D shape/pharmacophore similarity to reference compounds with known affinity for NFT using FastROCS.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Reference compounds <b>2</b>, <b>4</b>, <b>6</b>, <b>7</b> and astemizole,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> were selected from literature and scientific databases up to January 2013, the moment our search for tau PET tracers started. While being a nonselective binder to tau, we selected astemizole to increase the chemical diversity of our reference set. The FastROCS approach aligns the center of masses of the conformer shapes of the reference with conformer shapes of the database compounds.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Then, a sum of 3D shape similarity and 3D pharmacophore features similarity was calculated giving us a combo score. 3D pharmacophore features include HBA, HBD, anion, cation, hydrophobic and aromatic rings. FastROCS is a good tool for hit diversification, but it is sensitive to the size of the reference compounds compared to the 2D similarity methods. Thus, we have additionally applied 2D fragment-based similarity methods to get more chemically diverse compounds from internal compound database. Extended connectivity fingerprints of a size 6 (ECFP6) were used to encode the compounds and Tanimoto similarity to compare the reference compounds versus database compounds resulting in a score from 0, when no fragments are shared between compounds, to a value of 1, when shared fragments are identical between compounds.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_p">The two ranked lists were combined using the median of individually scaled similarities; compounds with molecular weight of >700 and number of rotatable bonds between aromatic fragments of ≥3 were discarded. Additional manual filtering was applied to the combined list to reach a diverse library of ∼4000 compounds. This compound set was then screened for binding to aggregated tau extracted from human late stage AD brains (Braak V–VI)<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> using a filter binding assay with [<sup>3</sup>H]<b>7</b> as a displacement probe.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Compounds with <i>K</i><sub>i</sub> ≤ 50 nM were subsequently screened for their selectivity versus purified amyloid β in a similar competition assay using [<sup>3</sup>H]<b>3a</b> as a displacement probe.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Following this strategy we identified <i>N</i>-(6-methyl-2-pyridyl)quinolin-2-amine (<b>10</b>, <a class="ref internalNav" href="#cht3" aria-label="Chart 3">Chart 3</a>) as an attractive starting point with good binding affinity for aggregated tau (<i>K</i><sub>i</sub> = 14 nM), moderate selectivity (∼10-fold) versus aggregated Aβ (<i>K</i><sub>i</sub> = 134 nM), and optimal physicochemical properties for achieving brain penetration (MW = 235, PSA = 38 Å<sup>2</sup>, and <i>S</i> + log <i>P</i> = 3.4 calculated with ADMET predictor).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div><figure id="cht3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0003.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. Hit Identified from a Mini-HTS with Selected Compounds with Similarity to Known Selective Tau Binders</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">For the medicinal chemistry optimization of <b>10</b> to potential candidate PET tracers, we defined a target product profile (TPP) with the following criteria: (i) high affinity tau binding (<i>K</i><sub>i</sub> ≤ 15 nM), (ii) over 100-fold selectivity versus Aβ binding, (iii) the presence of fluorine atom that can be easily introduced using standard radiochemistry methods, (iv) fast brain uptake and brain-to-plasma ratio of >1, and (v) fast clearance without formation of radioactive brain penetrant or defluorinated metabolites.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65363" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65363" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis routes for the preparation of compounds <b>10</b> and <b>30</b>–<b>44</b> are outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. While <i>N</i>-(pyridin-2-yl)quinolin-2-amine (<b>11</b>) was commercially available, compounds <b>10</b> and <b>30</b>–<b>43</b> were prepared via Buchwald–Hartwig aminations of (het)aryl halides (<b>12</b>–<b>19</b>) with anilines or aminopyridines (<b>20</b>–<b>27</b>), which were commercially available or obtained by straightforward and/or reported procedures (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route 1). The 2-naphthyl derivative <b>44</b> was prepared via the reverse Buchwald–Hartwig coupling between 2-aminonaphthalene (<b>28</b>) and 2-bromo-6-methylpyridine (<b>29</b>) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, route 2).</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Buchwald–Hartwig Couplings Leading to Compounds <b>10</b> and <b>30</b>–<b>44</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(OAc)<sub>2</sub>, XantPhos, Cs<sub>2</sub>CO<sub>3</sub>, <i>tert</i>-butanol, 90 °C, 10–16 h.</p></p></figure><div class="NLM_p">Compounds <b>50</b>–<b>52</b> were synthesized as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Thus, Buchwald–Hartwig coupling of 2-aminoquinoline (<b>45</b>) with (4-chloro-2-pyridinyl)methanol (<b>46</b>) provided alcohol <b>49</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) which was subsequently treated with DAST to provide the fluoromethyl derivative <b>50</b> with low yield. Hence for the preparation of <b>51</b>–<b>52</b>, fluorination in the last step was avoided and both compounds were synthesized in satisfactory yields via Buchwald–Hartwig coupling of <b>45</b> with the fluorine-containing pyridyl halides <b>47</b> and <b>48</b>. These in turn were conveniently prepared from commercial materials (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis Routes toward 2-Fluoroalkyl(oxy)pyridines <b>50</b>–<b>52</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd<sub>2</sub>(dba)<sub>3</sub>, XantPhos, K<sub>3</sub>PO<sub>4</sub>, THF, 80 °C, 16 h; (b) DAST, DCM, 0 °C, 30 min.</p></p></figure><div class="NLM_p">Compounds <b>58</b>–<b>60</b> were prepared via a two-step procedure (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). First, commercially available 2-chloroquinolin-6-ol (<b>53</b>) or 2-chloroquinolin-7-ol (<b>54</b>) was O-alkylated with the corresponding fluorine-containing primary haloalkane to give fluoroalkyl ethers <b>55</b>–<b>57</b>. Finally, reactions of the 2-chloroquinoline ethers <b>55</b>–<b>57</b> with 4-aminopyridine (<b>23</b>) under Buchwald–Hartwig conditions yielded the desired fluoroalkyloxy-substituted quinolines <b>58</b>–<b>60</b>.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis Route toward Fluoroalkoxy-Substituted Quinolines <b>58</b>–<b>60</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-fluoro-2-iodoethane or 3-bromo-1-fluoropropane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 85 °C, 1–16 h; (b) <b>23</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, XantPhos, K<sub>3</sub>PO<sub>4</sub>, toluene, 80 °C, 16 h.</p></p></figure><div class="NLM_p">Compound <b>63</b> was prepared from the previously reported 2-bromo-4-nitroquinoline (<b>61</b>) following the two-step procedure shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> First, Buchwald–Hartwig coupling of <b>61</b> with <b>23</b> led to the nitro substituted quinoline <b>62</b>. Subsequent nucleophilic aromatic substitution of the nitro group in <b>62</b> with KF in DMSO yielded the 4-fluoroquinoline <b>63</b> in modest yield.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis Route toward 4-Fluoroquinoline <b>63</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>23</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, XantPhos, K<sub>3</sub>PO<sub>3</sub>, THF, 90 °C, 1 h; (b) KF, DMSO, 150 °C (microwave), 5 min.</p></p></figure><div class="NLM_p">The 1,7-naphthyridine derivative <b>68</b> was prepared from 4-bromo-6-fluoropyridin-3-amine (<b>64</b>),<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> as shown in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. Thus, Heck coupling of <b>64</b> with methyl acrylate provided <b>65</b> in moderate yield. Next, sodium methoxide promoted intramolecular cyclization of <b>65</b> led to the bicyclic pyridine <b>66</b> with excellent yield. The 1,7-naphthyridone <b>66</b> was subsequently chlorinated with POCl<sub>3</sub> to give <b>67</b> which was then finally coupled with <b>23</b> to provide the target molecule <b>68</b>.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0012.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis Route toward 1,7-Naphthyridine <b>68</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyl acrylate, Pd(Amphos)Cl<sub>2</sub>, Et<sub>3</sub>N, DMF, 145 °C, 40 min; (b) NaOMe, MeOH, 60 °C, 6 h; (c) POCl<sub>3</sub>, 120 °C (microwave), 20 min; (d) <b>23</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, XantPhos, K<sub>3</sub>PO<sub>4</sub>, THF, 100 °C, 6 h.</p></p></figure><div class="NLM_p">1,5-Naphthyridines <b>74</b> and <b>75</b> were prepared from 2-bromo-6-fluoropyridin-3-amine (<b>69</b>)<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> using a similar procedure as the one outlined for <b>68</b> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>). Thus, Heck reaction of <b>69</b> with methyl acrylate provided <b>70</b> in good yield. Cyclization of <b>70</b> under the previously described NaOMe promoted reaction conditions was unsuccessful and did not afford compound <b>71</b> but the corresponding carboxylic acid of <b>70</b>. On the other hand, a literature procedure using PBu<sub>3</sub> in AcOH proved effective in providing <b>71</b> in 93% yield.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Treatment of <b>71</b> with POCl<sub>3</sub> yielded a mixture and <b>72</b> and <b>73</b> which were not separated but subsequently coupled via Buchwald–Hartwig amination with <b>23</b> or 4-amino-2-methylpyridine (<b>24</b>) providing <b>74</b> and <b>75</b>, respectively, after isolation from the crude reaction mixture.</div><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis Route toward 1,5-Naphthyridines <b>74</b> and <b>75</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyl acrylate, Pd(OAc)<sub>2</sub>, PPh<sub>3</sub>, Et<sub>3</sub>N, DMF, 140 °C, 120 min; (b) Bu<sub>3</sub>P, AcOH, 110 °C, 60 min; (c) POCl<sub>3</sub>, 1,4-dioxane, 110 °C, 60 min; (d) <b>23</b> or <b>24</b>, Pd(OAc)<sub>2</sub>, XantPhos, Cs<sub>2</sub>CO<sub>3</sub>, <i>tert</i>-butanol, 90 °C, 18–24 h.</p></p></figure><div class="NLM_p">In view of a potential future radiofluorination, an alternative route to <b>75</b> in which the fluorine label could be introduced in the last step was also explored (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). Thus, 1,5-naphthyridine (<b>76</b>) was treated with mCPBA to provide the bis-<i>N</i>-oxide derivative <b>77</b>. Next, rearrangement of both <i>N</i>-oxide functions with NMe<sub>3</sub> in the presence of TFAA led to the bistrimethylammonium trifluoroacetate salt <b>78</b> in good yield.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Interestingly, one of both trimethylamine groups could be selectively substituted by treatment with the sodium salt of <b>24</b>, providing after purification by RP-HPLC with 0.1% TFA buffer compound <b>79</b> as a triple TFA salt. Displacement of the remaining trimethylammonium group <b>79</b> with fluorine in DMF at 90 °C using TBAF as fluorine source provided <b>75</b> in a satisfactory 65% yield, demonstrating that intermediate <b>79</b> could be a suitable radiofluorination precursor for the preparation of [<sup>18</sup>F]<b>75</b>.</div><figure id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0014.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Evaluation of Potential Radiofluorination Route for <b>75</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) mCPBA, DCM/MeOH, rt, 75 h; (b) TFAA, Me<sub>3</sub>N, DCM, 0 °C to rt, 30 min; (c) <b>24</b>, NaH, DMF, 0 °C to rt, 20 min; (d) TBAF, DMF, 90 °C, 30 min.</p></p></figure><div class="NLM_p">Radioligand [<sup>3</sup>H]<b>39</b> was prepared as follows. Monobromination of <b>39</b> occurred selectively in the 3-position of the pyridine after treatment with NBS providing <b>80</b>. Next, <b>80</b> was subjected to Pd/C assisted tritio-debromination by reaction with carrier free tritium gas at rt to afford [<sup>3</sup>H]<b>39</b> in high specific activity (23.6 Ci/mmol) after HPLC purification (<a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>).</div><figure id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0015.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Radioligand [<sup>3</sup>H]<b>39</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, CHCl<sub>3</sub>, MeOH, 60 °C, 2 h; (b) <sup>3</sup>H<sub>2</sub>, 10% Pd/C, DIPEA, DMF.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58470" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58470" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Prior to exploring suitable fluorination positions, a focused exploration of <b>10</b> aiming to identify key structural elements for potency and selectivity was carried out. In first instance variations around the quinoline core were explored. The quinoline nitrogen proved to be crucial for good tau binding, as the naphthalene derivative <b>44</b> showed significantly lower affinity for tau (<b>44</b>, <i>K</i><sub>i</sub> = 92.5 nM).<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Variation of the nitrogen position across the quinoline core revealed an interesting and unexpected SAR: while isoquinolines <b>30</b>, <b>33</b>, and <b>34</b> showed potent binding to tau with <i>K</i><sub>i</sub> values lower than 35 nM, the other (iso)quinoline variations <b>31</b>, <b>32</b>, and <b>35</b> had much weaker affinity for tau. The quinazoline derivative <b>36</b>, which can be considered a hybrid of the potent binders <b>10</b> and <b>30</b>, also showed reduced affinity for tau (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Interestingly compounds <b>33</b> and <b>34</b> were the only analogues from this exploration showing increased selectivity for tau versus Aβ aggregates (205- and 33-fold, respectively) when compared to the initial hit <b>10</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Results for Aggregated Tau and Aβ from the Exploration of the Quinoline Moiety in HTS Hit <b>10</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0017.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0018.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub> values are a mean of at least two measurements and are given with standard deviation.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Selectivity ratio calculated as <i>K</i><sub>i</sub>(Aβ)/<i>K</i><sub>i</sub>(tau).</p></div></div><div></div></div><div class="NLM_p">While the similar activity of quinolones <b>10</b> and <b>30</b> can be explained by the rotational freedom around the NH bonds, which allows both molecules to present their acceptor nitrogens in similar positions, further exploration of isomers <b>33</b> and <b>34</b> suggested a distinct binding mode. This was confirmed after an extensive SAR exploration, which will be disclosed in a separate communication.</div><div class="NLM_p">Next, a focused exploration of the 6-methylpyridin-2-yl substituent in hit <b>10</b> was carried out (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). First, the presence of the pyridine nitrogen in <b>10</b> was crucial for activity, as this was lost in the toluene analogue <b>37</b>. The methyl group next to the pyridyl nitrogen in <b>10</b> was not essential for achieving good binding to aggregated tau, as the 2-pyridyl derivative <b>11</b> displayed not only improved binding but also increased selectivity versus Aβ binding (63-fold). While affinity for aggregated tau was lost in the 3-pyridyl regioisomer (<b>38</b>) of <b>11</b>, improved potency and remarkable selectivity versus Aβ (>680-fold) were observed for the 4-pyridyl derivative <b>39</b>. Both potency and selectivity were maintained in the 2-methylpyridin-4-yl derivative <b>40</b>. Interestingly, binding was lost in the pyrimidine isomer <b>41</b>, which displays each of the nitrogens at tolerated positions for activity in compounds <b>11</b> and <b>39</b>. Finally, methylation of the NH linker in <b>10</b> significantly reduced binding affinity to aggregated tau (<b>42</b>, tau <i>K</i><sub>i</sub> = 2,233 nM).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Results for Aggregated Tau and Aβ from the Exploration of the Aminopyridine Moiety in HTS Hit <b>10</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0019.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0020.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub> values are a mean of at least two measurements and are given with standard deviation.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Selectivity ratio calculated as <i>K</i><sub>i</sub>(Aβ)/<i>K</i><sub>i</sub>(tau).</p></div></div><div></div></div><div class="NLM_p">From these initial explorations compounds <b>39</b> and <b>40</b> were the only examples that met the first two criteria of the TPP, i.e., <i>K</i><sub>i</sub> ≤ 15 nM for aggregated tau and >100-fold selectivity versus Aβ. Compound <b>39</b> is a low MW (221) compound with a PSA (38 Å<sup>2</sup>), log <i>D</i> (2.93) and log <i>P</i> (3.29) and p<i>K</i><sub>a</sub> (7.51) well within the ideal boundaries for a CNS penetrant molecule.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> On the basis of these favorable properties, <b>39</b> was further profiled and the results obtained are shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>. Metabolic stability of <b>39</b> was assessed in human (h), rat (r), and mouse liver microsomes (mLM) and was found to be low in all three species. High metabolic turnover is a desired attribute in a PET tracer, provided that the produced radiometabolites are polar and do not enter the brain, as this is likely to lead to more rapid clearance in vivo and therefore a short half-life which will help minimizing scanning time. Compound <b>39</b> was administered subcutaneously (sc) to mice at a dose of 5 mg/kg in a pharmacokinetic (PK) study to assess total brain and plasma concentrations. Compound <b>39</b> showed an excellent exposure (<i>C</i><sub>max</sub> = 5980 ng/g) and a high total brain-to-plasma ratio (<i>K</i><sub>p</sub>) of 8.1.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> On the basis of the AUC values in brain (5024 ng·h/g) and plasma (617 ng·h/mL) and the unbound fractions in brain (<i>f</i><sub>u,b</sub>(rat) = 0.016) and plasma (<i>f</i><sub>u,p</sub>(mouse) = 0.12) determined in vitro, the <i>K</i><sub>p,uu</sub> was estimated to be 1.09 in mouse. This could be expected from the low efflux ratio of 0.95 observed in an MDCK-MDR1 cell line.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Physicochemical and ADME Properties of <b>39</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0021.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW (Da)</td><td class="colsep0 rowsep0" align="left">221</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PSA (Å<sup>2</sup>)</td><td class="colsep0 rowsep0" align="left">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log <i>D</i> (pH 7.4)</td><td class="colsep0 rowsep0" align="left">2.93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log <i>P</i></td><td class="colsep0 rowsep0" align="left">3.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub></td><td class="colsep0 rowsep0" align="left">7.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hLM CL<sub>int</sub> (μL min<sup>–1</sup> mg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">112</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rLM CL<sub>int</sub> (μL min<sup>–1</sup> mg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">>346</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mLM CL<sub>int</sub> (μL min<sup>–1</sup> mg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">258</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>f</i><sub>u,b</sub></td><td class="colsep0 rowsep0" align="left">0.016</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>f</i><sub>u,p</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>f</i><sub>u,p</sub> (m)</td><td class="colsep0 rowsep0" align="left">0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app</sub> A → B (nm/s)</td><td class="colsep0 rowsep0" align="left">187</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B → A/A → B ratio</td><td class="colsep0 rowsep0" align="left">0.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/g)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">5980</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–last</sub>, b/p<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">5024/617</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>p</sub><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">8.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>p,uu</sub><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">1.09</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">PK study in male Swiss mice (<i>n</i> = 2 per time point); dose, 5 mg/kg sc; formulation, 0.5 mg/mL in 20% HP-β-CD at pH 3.6; time points, 0.25, 0.5, 1, 2, 4 h.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">AUC ratio of total drug levels in brain (ng·h/g) and plasma (ng·h/mL).</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Estimated from AUC<sub>0–last</sub> values, <i>f</i><sub>u,b</sub>, and <i>f</i><sub>u,p</sub> (m).</p></div></div></div><div class="NLM_p">Finally, autoradiography studies were performed to assess whether the high in vitro binding of <b>39</b> translated into binding to AD brain tissue sections. To this end a tritiated analog of <b>39</b> was prepared ([<sup>3</sup>H]<b>39</b>, <a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>) and its binding profile compared to that of tritiated analogues of the selective amyloid binder [<sup>3</sup>H]<b>3a</b> and selective tau binder [<sup>3</sup>H]<b>7</b> on human AD brain tissue sections (Braak stage V–VI as indicated by IHC with phospho-tau antibody AT8 and amyloid antibody 4G8 performed on adjacent sections). As can be seen from <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, the binding pattern of [<sup>3</sup>H]<b>39</b> matched that of [<sup>3</sup>H]<b>7</b>, thus confirming it to be a selective tau binder. By use of saturation binding experiments on adjacent sections, <i>K</i><sub>d</sub> and <i>B</i><sub>max</sub> values were determined for [<sup>3</sup>H]<b>7</b> (<i>K</i><sub>d</sub> = 5.3 nM, <i>B</i><sub>max</sub> = 5823) and [<sup>3</sup>H]<b>39</b> (<i>K</i><sub>d</sub> = 8.5 nM, <i>B</i><sub>max</sub> = 3827); see <a href="/doi/suppl/10.1021/acs.jmedchem.6b01173/suppl_file/jm6b01173_si_001.pdf" class="ext-link">Supporting Information</a>.</div><figure id="fig1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0004.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Binding of (A) 3 nM [<sup>3</sup>H]<b>3a</b>, (B) 10 nM [<sup>3</sup>H]<b>7</b>, and (C) 10 nM [<sup>3</sup>H]<b>39</b> to post-mortem human AD brain sections and IHC with phospho-tau antibody AT8 (D) and amyloid antibody 4G8 (E) show <b>39</b> is selective for tau. Zoom regions have been boxed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With the potent and selective tau ligands <b>39</b> and <b>40</b> in hand, an exploration looking for suitable positions to introduce <sup>18</sup>F for PET imaging was initiated. The pyridine ring was first explored by modification with fluoroalkyl (<b>50</b>, <b>51</b>) and fluoroalkyloxy chains (<b>52</b>). The binding results determined for aggregated tau and Aβ are shown in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> and suggest that the basicity of the pyridyl nitrogen is a key factor to obtain good affinity for tau. For instance, the less basic fluoromethyl derivative <b>50</b> presented a much reduced binding to tau (<b>50</b>, tau <i>K</i><sub>i</sub> = 37.7 nM) compared to the methyl analogue <b>40</b> (tau <i>K</i><sub>i</sub> = 6.3 nM). The slightly more basic 2-fluoroethyl homologue <b>51</b> showed somewhat improved binding (<b>51</b>, tau <i>K</i><sub>i</sub> = 13.4 nM) when compared to <b>50</b> but not as good as in the case of <b>40</b>. Compound <b>52</b> bearing a fluoroakyloxy chain also showed reduced affinity for tau compared to <b>40</b>, confirming that the presence of a nitrogen with certain basicity is required for potent tau binding.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Exploration of Fluorine Tails on the Pyridine 2-Position<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0022.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>7</sup></th><th class="colsep0 rowsep0" align="center">tau <i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">Aβ <i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center">selectivity (ratio)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>F</td><td class="colsep0 rowsep0" align="left">37.7 ± 1.7</td><td class="colsep0 rowsep0" align="left">>4400</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub>F</td><td class="colsep0 rowsep0" align="left">13.4 ± 2.0</td><td class="colsep0 rowsep0" align="left">>4400</td><td class="colsep0 rowsep0" align="left">>320</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CH<sub>2</sub>F</td><td class="colsep0 rowsep0" align="left">17.2 ± 4.5</td><td class="colsep0 rowsep0" align="left">>4400</td><td class="colsep0 rowsep0" align="left">>250</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last"><i>K</i><sub>i</sub> values are a mean of at least two measurements and are given with standard deviation.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Selectivity ratio calculated as <i>K</i><sub>i</sub>(Aβ)/<i>K</i><sub>i</sub>(tau).</p></div></div></div><div class="NLM_p">Modifications around the quinoline core proved to be better tolerated for potency and offered good opportunities for the introduction of fluorine containing aliphatic chains. From recognition that the quinoline nitrogen is a key pharmacophoric element, the exploration focused on the distal 6- and 7-positions of the quinoline core (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Thus, the 6-(2-fluoroethoxy) derivative <b>58</b> maintained potency and selectivity (>750-fold) when compared to <b>39</b>. In contrast, the isomeric 7-(2-fluoroethoxy) derivative <b>59</b> did not show any affinity for tau aggregates. The 6-(3-fluoropropyloxy) chain homologue <b>60</b> had similar potency and selectivity to the shorter <b>58</b>. While both <b>58</b> and <b>60</b> met the first three requirements of the TPP, i.e., high affinity for tau with >100-fold selectivity over Aβ and a tolerated position to introduce a [<sup>18</sup>F], they showed high metabolic stability in hLM which, in the absence of other clearance pathways, could result in a slow clearance from plasma and subsequently slow clearance from brain. Moreover significant O-dealkylation was observed for <b>60</b> upon incubation with human liver microsomes, which risks generation of a potentially brain penetrant radiometabolite.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Exploration of Fluorine Substituted Alkyloxy Chains on the Quinoline 6- and 7-Position<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0023.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">compound</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>58</b></th><th class="colsep0 rowsep0" align="center"><b>59</b></th><th class="colsep0 rowsep0" align="center"><b>60</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R<sup>8</sup></td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CH<sub>2</sub>F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>F</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R<sup>9</sup></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CH<sub>2</sub>F</td><td class="colsep0 rowsep0" align="left">H</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tau <i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">5.7 ± 2.5</td><td class="colsep0 rowsep0" align="left">>3900</td><td class="colsep0 rowsep0" align="left">4.7 ± 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aβ <i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>4400</td><td class="colsep0 rowsep0" align="left">>4400</td><td class="colsep0 rowsep0" align="left">>4400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">selectivity (ratio)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">>750</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>900</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW (Da)</td><td class="colsep0 rowsep0" align="left">283</td><td class="colsep0 rowsep0" align="left">283</td><td class="colsep0 rowsep0" align="left">297</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PSA (Å<sup>2</sup>)</td><td class="colsep0 rowsep0" align="left">47</td><td class="colsep0 rowsep0" align="left">47</td><td class="colsep0 rowsep0" align="left">47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log <i>P</i></td><td class="colsep0 rowsep0" align="left">2.82</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">4.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log <i>D</i></td><td class="colsep0 rowsep0" align="left">2.38</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub></td><td class="colsep0 rowsep0" align="left">7.67</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hLM CL<sub>int</sub> (μL min<sup>–1</sup> mg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">8.9</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">10.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mLM CL<sub>int</sub> (μL min<sup>–1</sup> mg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">193</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">147</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>f</i><sub>u,b</sub></td><td class="colsep0 rowsep0" align="left">0.018</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.0049</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>f</i><sub>u,p</sub> m/h</td><td class="colsep0 rowsep0" align="left">0.13/0.22</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.10/0.042</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app</sub> A → B (nm/s)</td><td class="colsep0 rowsep0" align="left">132</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B → A/A → B ratio</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>brain</sub> (15 min, ng/g)<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">792</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">460</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–last</sub> (ng·h/g), b/p<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">789/178</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">853/137</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>p</sub><a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">6.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>p,uu</sub><a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">0.61</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.31</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last"><i>K</i><sub>i</sub> values are a mean of at least two measurements and are given with standard deviation.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Selectivity ratio calculated as <i>K</i><sub>i</sub>(Aβ)/<i>K</i><sub>i</sub>(tau).</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">PK study in Male swiss mice (<i>n</i> = 2 per time point); dose, 1 mg/kg, sc; formulation, 0.1 mg/mL in 10% HP-β-CD at pH > 3.5.</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">AUC ratio of total drug levels in brain (ng·h/g) and plasma (ng·h/mL).</p></div><div class="footnote" id="t5fn6"><sup>f</sup><p class="last">Estimated from AUC<sub>0–last</sub> values, <i>f</i><sub>u,b</sub>, and f<sub>u,p</sub> (m).</p></div></div></div><div class="NLM_p">In view of the challenges due to the low clearance of fluoroalkyl-substitued quinolines the introduction of aromatic fluorines on activated positions of either the pyridyl or quinoline rings was explored. Although the preparation of the <sup>18</sup>F-labeled compounds could present some additional challenges, fluorine substituents in aromatic rings offer the advantage of being more robust against oxidative defluorination which was one of the requirements in an optimal TPP. Furthermore, a similar consideration led to the progression of <b>6</b> instead of <b>7</b>, where the latter suffered from oxidative defluorination issues.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The introduction of a fluorine atom in the 2-position of the pyridyl ring was detrimental for affinity (<b>43</b>, tau <i>K</i><sub>i</sub> > 1000 nM), as could be expected due to its strong electron withdrawing effect making the pyridine nitrogen less basic. Compound <b>63</b> which carries the fluorine substituent on the quinoline 4-position showed a reduced binding affinity to tau compared to <b>39</b> (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>, <b>63</b>, tau <i>K</i><sub>i</sub> = 18.7 nM vs <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, <b>39</b>, tau <i>K</i><sub>i</sub> = 6.3 nM). As no other activated positions to introduce a fluorine atom were available in the quinoline core and from knowledge that the presence of nitrogen atoms in certain positions of the fused phenyl ring was tolerated for activity in compounds such as <b>32</b>–<b>35</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), a small exploration focused on fluoro-substituted naphthyridine cores was initiated. Although the data for the first representative prepared (<b>68</b>), bearing a 1,7-naphthyridine core, were rather disappointing (tau <i>K</i><sub>i</sub> = 263 nM), better results were obtained for the isomeric 1,5-naphthyridines <b>74</b> and <b>75</b> which maintained the good potency and high selectivity of the corresponding quinoline analogues <b>39</b> and <b>40</b>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Exploration of Aromatic Fluorines at Activated Positions<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0024.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub> values are a mean of at least two measurements and are given with standard deviation.</p></div><div class="footnote" id="t6fn2"><sup>Table b</sup><p class="last">Selectivity ratio calculated as <i>K</i><sub>i</sub>(Aβ)/<i>K</i><sub>i</sub>(tau).</p></div></div><div></div></div><div class="NLM_p">Compound <b>75</b> was selected for further evaluation as a potential tau PET radiotracer. The physicochemical properties and ADME profile of <b>75</b> are compared with our internally generated data for <b>6</b> in <a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>. 1,5-Naphthyridine <b>75</b> is a low MW compound with a significantly lower experimental log <i>P</i> value compared to <b>6</b> (<b>75</b>, log <i>P</i> = 3.38 vs <b>6</b>, log <i>P</i> = 4.31) and slightly higher p<i>K</i><sub>a</sub> (<b>75</b>, p<i>K</i><sub>a</sub> = 7.89 vs <b>6</b>, p<i>K</i><sub>a</sub> = 7.61). In line with the lower log <i>P</i>, <b>75</b> had higher free fraction in brain homogenate compared to <b>6</b> (<b>75</b>, <i>f</i><sub>u,b</sub> = 0.045 vs <b>6</b>, <i>f</i><sub>u,b</sub> = 0.015). In addition, <b>75</b> was found to have a high unbound fraction of 0.37, 0.32, and 0.39 in mouse, rat, and human plasma, respectively. Interestingly, <b>75</b> showed consistently high microsomal clearance across species (hLM = 49.9, rLM = 98.6, and mLM = 73.3 μL min<sup>–1</sup> mg<sup>–1</sup>) in contrast to <b>6</b>, which is cleared much faster in mLM and rLM (98.6, 181 μL min<sup>–1</sup> mg<sup>–1</sup>) compared to hLM (16.8 μL min<sup>–1</sup> mg<sup>–1</sup>). This made <b>75</b> a good candidate for microdosing studies, as it was likely to have fast clearance/short half-life in rodent preclinical models and in human.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Comparison between Tau Binders <b>6</b> and <b>75</b><a class="ref internalNav" href="#t7fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">compound</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>6</b></th><th class="colsep0 rowsep0" align="center"><b>75</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tau <i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.1 ± 0.5</td><td class="colsep0 rowsep0" align="left">7.9 ± 2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aβ <i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">258 ± 76</td><td class="colsep0 rowsep0" align="left">>4400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">selectivity (ratio)</td><td class="colsep0 rowsep0" align="left">235</td><td class="colsep0 rowsep0" align="left">>540</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW (Da)</td><td class="colsep0 rowsep0" align="left">263</td><td class="colsep0 rowsep0" align="left">254</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PSA (Å<sup>2</sup>)</td><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="left">51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log <i>D</i> (pH 7.4)</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">2.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log <i>P</i></td><td class="colsep0 rowsep0" align="left">4.31</td><td class="colsep0 rowsep0" align="left">3.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub></td><td class="colsep0 rowsep0" align="left">7.61</td><td class="colsep0 rowsep0" align="left">7.89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>f</i><sub>u,b</sub></td><td class="colsep0 rowsep0" align="left">0.015</td><td class="colsep0 rowsep0" align="left">0.045</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>f</i><sub>u,p</sub> m/r/h</td><td class="colsep0 rowsep0" align="left">0.08/NT/0.11</td><td class="colsep0 rowsep0" align="left">0.37/0.32/0.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hLM CL<sub>int</sub> (μL min<sup>–1</sup> mg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">16.8</td><td class="colsep0 rowsep0" align="left">49.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rLM CL<sub>int</sub> (μL min<sup>–1</sup> mg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">98.6</td><td class="colsep0 rowsep0" align="left">94.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mLM CL<sub>int</sub> (μL min<sup>–1</sup> mg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">181</td><td class="colsep0 rowsep0" align="left">73.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app</sub> A → B (nm/s)</td><td class="colsep0 rowsep0" align="left">73.5</td><td class="colsep0 rowsep0" align="left">376</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B → A/A → B ratio</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">0.68</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">See <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last"><i>K</i><sub>i</sub> values are a mean of at least two measurements and are given with standard deviation.</p></div></div></div><div class="NLM_p">The specific binding of <b>75</b> to tau was assessed by displacement studies with [<sup>3</sup>H]<b>3a</b>, [<sup>3</sup>H]<b>7</b>, and [<sup>3</sup>H]<b>39</b> on human AD sections (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). The binding of selective tau binders [<sup>3</sup>H]<b>39</b> and [<sup>3</sup>H]<b>7</b> could be entirely displaced by treatment with <b>75</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A–D). In contrast the binding of selective amyloid binders [<sup>3</sup>H]<b>3a</b> was not affected by treatment with <b>75</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>E,F). The presence and distribution of aggregated amyloid and tau in these sections were confirmed by IHC (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>G,H). This suggests <b>75</b> is a highly selective binder to aggregated tau.</div><figure id="fig2" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0005.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Total binding of 10 nM [<sup>3</sup>H]<b>39</b>, (B) displacement of 10 nM [<sup>3</sup>H]<b>39</b> with 1 μM <b>75</b>, (C) total binding of 10 nM [<sup>3</sup>H]<b>7</b>, (D) displacement of 10 nM [<sup>3</sup>H]<b>7</b> with 1 μM <b>75</b>, (E) total binding of 3 nM [<sup>3</sup>H]<b>3a</b>, (F) competition of 3 nM [<sup>3</sup>H]<b>3a</b> with 1 μM <b>75</b>, (G) AT8 phospho-tau staining on adjacent section, (H) 4G8 amyloid staining on adjacent section.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The early lead <b>60</b> showed negligible clearance from cortex following iv dosing in mice in an acute microdosing study (0.03 mg/kg). Compounds <b>6</b> and <b>75</b> on the other hand showed significant clearance from brain compared to compound <b>60</b> which was in line with a previous PET tracer study with [<sup>18</sup>F]<b>6</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) and reflects the high in vitro CL<sub>int</sub> in mouse liver microsomes.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Of importance is that <b>75</b> has similar high turnover in hLM, in contrast to <b>6</b>, which is significantly more stable in hLM compared to mLM and rLM (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). This high metabolic stability of <b>6</b> could explain the unfavorable PK reported in human studies. Further allometric modeling confirmed a high predicted clearance for <b>75</b> in man.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><figure id="fig3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0006.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cortex clearance for compounds <b>6</b>, <b>60</b>, and <b>75</b> in an acute microdosing study in NMRI mouse (0.03 mg/kg, iv, <i>n</i> = 3/time point).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of the promising clearance observed for <b>75</b> in the acute microdosing study, the compound was progressed into a more elaborate microdosing study in rat (iv, 0.03 mg/kg), in which cortex, cerebellum, and plasma levels were assessed in a 60 min time course (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). These studies were used to extract relevant PK parameters which are summarized in <a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>.</div><figure id="fig4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0007.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Microdosing study of <b>75</b> in Sprague-Dawley rat (0.03 mg/kg, iv, <i>n</i> = 3/time point) with sampling of cortex, cerebellum, and plasma.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. PK Parameters Extracted from Microdosing of <b>75</b> in Rat (0.03 mg/kg, iv)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">234</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma <i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma AUC<sub>0–1h</sub> (h·ng/mL)</td><td class="colsep0 rowsep0" align="left">1.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cortex AUC<sub>0–1h</sub> (h·ng/g)</td><td class="colsep0 rowsep0" align="left">23.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>d,ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>p</sub> cortex/plasma</td><td class="colsep0 rowsep0" align="left">12</td></tr></tbody></table></div></div><div class="NLM_p">First of all, <b>75</b> showed a fast clearance from plasma of 234 mL min<sup>–1</sup> kg<sup>–1</sup>, resulting in a short half-life of 0.31 h. In addition, <b>75</b> showed good brain exposure given the low administered dose (AUC cortex of 24.9 ng·h/mL) in line with its high <i>V</i><sub>d,ss</sub> (5.2 L/kg), and a high total cortex to plasma ratio (<i>K</i><sub>p</sub> = 12). Finally, levels in cortex and cerebellum correlated well, suggesting comparable distribution of <b>75</b> between these regions.</div><div class="NLM_p">A metabolic pathway study was performed for <b>75</b> in mouse, rat, dog, monkey, and human hepatocytes (<a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>). It was found that the same metabolites were formed in all five species, one being the result of the hydroxylation of the methyl group (<b>81</b>) and the other an oxidation of the 1,5-naphthyridine core (<b>82</b>). No defluorinated metabolites were observed across species in this assay.</div><figure id="sch9" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0016.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Metabolites <b>81</b> and <b>82</b> Observed for <b>75</b> after Incubation with Human, Rat, Mouse, Dog, and Monkey Hepatocytes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Finally, off-target binding for compound <b>75</b> was assessed via single concentration screening on a receptor panel of 52 targets (CEREP, 10 μM)<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> and 400 kinases (KINOMEscan, DiscoverX, 1 μM).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Of the receptor panel only the 5-HT<sub>2B</sub> receptor was found to give a significant interaction of 80% at 10 μM, which resulted in a <i>K</i><sub>i</sub> of 650 nM in concentration-response. This was not considered an issue for the developability of <b>75</b> as a PET tracer, as the 5-HT<sub>2B</sub> receptor is mostly peripherally expressed<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> and a significant 71-fold margin to aggregated tau (<b>75</b>, tau <i>K</i><sub>i</sub> = 7.9 nM) was achieved. Interestingly, while <b>75</b> bears a typical hydrogen bond donor (HBD)–hydrogen bond acceptor (HBA) hinge-binding motif, no binding over 50% at 1 μM was observed to any of the 400 tested kinases. Finally, the inhibition of MAO-A and MAO-B, two targets known to be modestly inhibited by other tau PET tracers,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> was assessed. Compound <b>75</b> showed no inhibition of MAO-A up to 1 mM and a IC<sub>50</sub> of 631 μM for MAO-B.</div><div class="NLM_p last">In conclusion, a mini-HTS of 4000 compounds selected with 3D shape/pharmacophore comparison (FastROCS) and a 2D similarity search (ECFP6) identified <b>10</b> as a potent tau aggregate binder with moderate selectivity versus aggregated Aβ. An initial SAR exploration identified key structural elements for potency and selectivity. Subsequent exploration of suitable fluorination positions identified the 1,5-naphthyridine <b>75</b>. In a radioligand filter binding assay and via displacement studies on human AD sections <b>75</b> was shown to be a potent and selective tau aggregate binder. Compound <b>75</b> additionaly showed a fast clearance in two preclinical species, and in a hepatocyte study it was shown to be consistently metabolized to two major polar metabolites across species. No off-target activity was found for <b>75</b> in a receptor panel and a kinase panel, as well as no MAO-A and MAO-B inhibitory activity. On the basis of these results, compound <b>75</b> has been selected for [<sup>18</sup>F] radiolabeling and PET imaging studies in different preclinical species, the results of which will be reported in due course.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24408" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24408" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All in vivo experimental procedures were performed according to the applicable European Communities Council Directive of November 24, 1986 (86/609/EEC) and approved by the Animal Care and Use Committee of Janssen Pharmaceutical Companies of Johnson & Johnson and by the local ethical committee.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> log <i>D</i></h3><div class="NLM_p last">The log <i>D</i> was determined chromatographically at Sirius Analytical Ltd.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Nonspecific Binding to Brain Tissue and Plasma Protein Binding</h3><div class="NLM_p last">The in vitro nonspecific binding of test compounds to rat brain homogenate and the free fraction in mouse, rat, and human plasma were determined by rapid equilibrium dialysis (RED Device, Thermo Fisher Scientific, Geel, Belgium). The RED device consists of a 48-well plate containing disposable inserts bisected by a semipermeable membrane creating two chambers.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Nonspecific Binding to Brain Tissue</h3><div class="NLM_p last">Each test compound was diluted with rat brain homogenate, prepared following a 1:10 dilution with PBS, to achieve a final concentration of 5 μM. The plate was incubated at approximately 37 °C for 5 h. After 5 h samples were removed from both the brain homogenate and buffer compartment and analyzed for test compound using a specific LCMS/MS method to estimate free and bound concentrations.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Plasma Protein Binding</h3><div class="NLM_p last">A 300 μL aliquot of plasma containing test compound at 5 μM was placed on one side and 500 μL of phosphate buffered saline (PBS) on the other. The plate was sealed and incubated at approximately 37 °C for 4.5 h. After 4.5 h samples were removed and both the plasma and buffer compartment were analyzed for test compound using a specific LCMS/MS method to estimate free and bound concentrations.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> In Vitro Permeability/P-gp Efflux</h3><div class="NLM_p last">The in vitro permeability and potential to be transported by P-glycoprotein (P-gp) were determined using an MDCK cell line transfected with human MDR1 (P-glycoprotein). Each test compound (5 μM) was added to either the apical (A) or basolateral (B) side of a confluent monolayer of MDCK-MDR1 cells and permeability in the A → B and B → A directions measured by monitoring the appearance of the test compound on the opposite side of the membrane using a specific LCMS/MS method. Efflux ratios (B → A/A → B) were calculated to determine if the test compound was subject to efflux by P-gp.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Metabolic Stability in Liver Microsomes (CL<sub>int</sub>)</h3><div class="NLM_p last">To test for metabolic stability, compounds (1 μM) were incubated at 37 °C with mouse, rat, and human liver microsomes at a protein concentration of 0.5 mg protein/mL microsomal protein, 1 mM NADPH, 1 mM MgCl<sub>2</sub>, and 0.1 M phosphate buffer, pH 7.4. DMSO stock solutions (5 mM) of each compound were diluted with CH<sub>3</sub>CN/H<sub>2</sub>O (1:1) to provide a working stock solution at 0.1 mM. The total incubation volume was 0.5 mL with a final total solvent content of 0.01% (v/v) DMSO and 0.5% (v/v) CH<sub>3</sub>CN. The reaction was initiated by the addition of 100 μL of prewarmed NADPH solution. Sequential aliquots of the incubation mixture were removed at 0, 5, 10, 20, 40, and 60 min and quenched with 200 μL of CH<sub>3</sub>CN. Each sample was centrifuged and analyzed using a specific HPLCMS/MS technique, and the percentage of test compound remaining was used to calculate the half-life and subsequent intrinsic clearance (CL<sub>int</sub>).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Metabolite Identification in Hepatocytes</h3><div class="NLM_p last">Compound <b>75</b> was incubated with human, rat, and mouse hepatocytes at a 1 μM compound concentration, 0.02% final DMSO concentration, and 0.24% final CH<sub>3</sub>CN concentration. The study was conducted to identify the main metabolites formed after 120 min of incubation time. The final hepatocyte density was 10<sup>6</sup> cells/mL. 40 μL incubation volume was quenched with two volumes of DMSO. Triplicates were then pooled, centrifuged for 10 min at 4000 rpm, and analyzed by UPLC/HRMS for metabolite identification (<i>n</i> = 1).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> PHF Tau and Aβ Isolation from Human AD Brain</h3><div class="NLM_p last">Enriched PHF tau and Aβ fractions were prepared as described by L. Declercq et al.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> using human AD brain tissue with high tau fibril or high amyloid plaques load, respectively.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> In Vitro Competitive Radioligand Binding Assays</h3><div class="NLM_p last">The competitive radioligand binding assays measure the binding of a fixed amount of [<sup>3</sup>H]<b>7</b> (tau aggregate binder) or [<sup>3</sup>H]<b>3a</b> (amyloid plaques binder) in the presence of a dose response concentration range of test compounds. Experimental assay setup has been described in detail by L. Declercq et al.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Immunohistochemistry</h3><div class="NLM_p last">Human brain samples were snap-frozen, sliced with a cryostat (20 μm thickness), and stored at −80 °C before use. Sections were dried, followed by formalin fixation, blocking of endogenous peroxidase with 3% hydrogen peroxide (DAKO, Glostrup, Denmark), and permeabilization in 1× PBS and 0.05% Triton X-100 during 1 h. Primary antibodies (4G8, Biolegend, San Diego, CA, USA, 2 μg/mL; AT8, in-house, 0.4 μg/mL) were diluted in antibody diluent with background reducing components (DAKO, S3022) and applied to the sections for 1 h. After extensive washing, slides were incubated with HRP-conjugated antimouse secondary antibody (Envision, DAKO), followed by chromogenic DAB labeling (DAKO). Slides were counterstained with hematoxylin, dehydrated, and mounted with organic mounting medium (Vectamount, Vector Laboratories, Burlingame, CA, USA). Imaging was performed with a Zeiss Axio Scan.Z1 (Zeiss, Oberkochen, Germany).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Radioligand Binding Autoradiography</h3><div class="NLM_p last">For [<sup>3</sup>H]<b>3a</b> slices were preincubated 15 min in 1× PBS with 1% BSA at rt. Next they were incubated for 60 min with 3 nM [<sup>3</sup>H]<b>3a</b> in 1× PBS with 0.1% BSA at rt. Finally slices were rinsed 3 × 10 min with 1× PBS followed by a quick dip in demineralized H<sub>2</sub>O at 4 °C. For [<sup>3</sup>H]<b>7</b> and [<sup>3</sup>H]<b>39</b> no preincubation was carried out. The slices were incubated for 60 min with 10 nM [<sup>3</sup>H]<b>39</b> or [<sup>3</sup>H]<b>7</b> in 1× PBS at rt. Next, the slices were rinsed 1 min with 1× PBS, 2 min with 70% EtOH/1× PBS, 1 min with 30% EtOH/1× PBS, and finally 1 min with 1× PBS at rt. After drying, slides were exposed to storage phosphor screens (Fujix plate) for 3 days. Autoradiograms were digitized using a Typhoon FLA-7000 imaging system (GE Healthcare Life Sciences).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Microdosing Combined with LC/MS Detection</h3><div class="NLM_p last">Animals are kept in quarantine upon arrival for at least 4 days, with access to food and water ad libitum. Compounds were formulated with 20% HP-β-CD acidified with 0.01 N HCl until pH ≈ 3 and administered to animals intravenously (iv) at a dose of 0.03 mg/kg. Animals are sacrificed by decapitation at different time points after administration, and immediately the brain is dissected in regions of interest. The wet tissue is weighed and stored at −20 °C. The samples are homogenized in 75% CH<sub>3</sub>CN using a FastPrep homogenizer and subsequently stored at −20 °C prior to bioanalysis using UPLC/MS.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Analytical Methods</h3><div class="NLM_p">All final compounds were characterized by <sup>1</sup>H NMR and HRMS.</div><div class="NLM_p"><sup>1</sup>H nuclear magnetic resonance spectra were recorded on Bruker spectrometers: 360 MHz, DPX-400 MHz, and AV-500 MHz. Purity of all final compounds was ≥95% by <sup>1</sup>H NMR. For the <sup>1</sup>H NMR spectra, all chemical shifts are reported in part per million (δ) units and are relative to the residual signal at 7.26 and 2.50 ppm for CDCl<sub>3</sub> and DMSO, respectively.</div><div class="NLM_p">Low mass resolution LC/MS analyses were performed using a SQD (Waters, Milford, MA, USA) mass spectrometer quadrupole coupled to an Acquity or to an Acquity IClass UPLC system (Waters, Milford, MA, USA) system consisting of a binary pump with degasser, autosampler, thermostated column compartment, and diode array detector. The MS was operated with an API-ESI source. Spectra were acquired in positive and negative switching modes. The capillary voltage was set to 3.0 kV for both polarities. Nitrogen was used as the nebulizer gas. Standard LCMS methods were carried out following LCMS1, LCMS2, LCMS3, and LCMS4 conditions shown below, as described for each compound. The standard injection volume was 2 μL. Data acquisition was performed with MassLynx/OpenLynx 4.1 software (Waters, Milford, MA, USA). High mass resolution analyses were performed using a Xevo G2-S QTOF MS (Waters, Milford, MA, USA) coupled to an IClass UPLC (Waters, Milford, MA, USA) system consisting of a binary pump with degasser, autosampler, thermostated column compartment, and diode array detector. The MS was operated with an API-ESI source. Spectra were acquired in positive mode. The capillary voltage was set to 0.25 kV. The cone voltage was set to 25 V. The source temperature was maintained at 140 °C. Acquisition mass range was <i>m</i>/<i>z</i> 50–1200. Nitrogen was used as the nebulizer gas and argon as collision gas. Standard reversed phase gradients were carried out following LCMS4 conditions detailed below. The standard injection volume was 2 μL. A Lockmass device with leucine-enkephalin as standard substance was used for mass calibration. Data acquisition was performed with MassLynx/OpenLynx 4.1 software (Waters, Milford, MA, USA). Radiochemistry low mass resolution LC/MS analyses for [<sup>3</sup>H]<b>39</b> were performed using a mass spectrometer quadrupole coupled to a 1200 HPLC system (Agilent Santa Clara, CA, USA) consisting of a quaternary pump with degasser, autosampler, thermostated column compartment, and diode array detector. The MS was operated with an API-ESI source. Spectra were acquired in positive mode. The capillary voltage was set to 1 kV, and the fragmentor voltage was 70 V. The source temperature was maintained at 100 °C. Acquisition mass range was <i>m</i>/<i>z</i> 90–1500. Nitrogen was used as the nebulizer gas. Standard reversed phase gradients were carried out following LCMS5 conditions detailed below. The standard injection volume was 2 μL. Data acquisition was performed with Chemstation software (Agilent, Santa Clara, CA, USA).</div><div id="sec5_13_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> LCMS1 Conditions</h4><div class="NLM_p">LC: Reversed phase UPLC was carried out on a HSS T3 column (1.8 μm, 2.1 mm × 100 mm) from Waters, with a flow rate of 0.7 mL/min, at 55 °C. The gradient conditions used are 100% A (NH<sub>4</sub>OAc, 10 mM in H<sub>2</sub>O + 5% CH<sub>3</sub>CN), 0% B (CH<sub>3</sub>CN), to 95% A in 2.1 min, to 0% A in 0.9 min, held for 0.5 min. Acquisition range for the UV-PDA detector was set to 210–400 nm. MS: Cone voltage was 30 V for both polarities. The source temperature was maintained at 150 °C. Acquisition mass range was <i>m</i>/<i>z</i> 120–1000.</div><div class="NLM_p"><i>LCMS2 Conditions.</i> LC: Reversed phase UPLC was carried out on a BEH C18 column (1.7 μm, 2.1 mm × 50 mm) from Waters, with a flow rate of 0.8 mL/min, at 55 °C. The gradient conditions used are 95% A (NH<sub>4</sub>OAc, 10 mM in H<sub>2</sub>O + 5% CH<sub>3</sub>CN), 5% B (CH<sub>3</sub>CN), to 5% A in 1.3 min, held for 0.7 min. Acquisition range for the UV-PDA detector was set to 210–400 nm. MS: Cone voltage was 30 V for both polarities. The source temperature was maintained at 150 °C. Acquisition mass range was <i>m</i>/<i>z</i> 120–1000.</div><div class="NLM_p"><i>LCMS3 Conditions.</i> LC: Reversed phase UPLC was carried out on a CSH C18 column (1.7 μm, 2.1 mm × 50 mm) from Waters, with a flow rate of 1.0 mL/min, at 50 °C. The gradient conditions used are 95% A (NH<sub>4</sub>OAc, 6.5 mM in H<sub>2</sub>O + 5% CH<sub>3</sub>CN), 5% B (CH<sub>3</sub>CN), to 40% A in 1.2 min, to 5% A in 0.6 min, held for 0.2 min. Acquisition range for the UV-PDA detector was set to 200–450 nm. MS (SQD): Cone voltage was 25 V for positive and 30 V for negative modes. The source temperature was maintained at 140 °C. Acquisition mass range was <i>m</i>/<i>z</i> 100–1000.</div><div class="NLM_p"><i>LCMS4 Conditions.</i> Reversed phase UPLC was carried out on a BEH C18 column (1.7 μm, 2.1 mm × 50 mm) from Waters, with a flow rate of 1.0 mL/min, at 50 °C. The gradient conditions used are 95% A (NH<sub>4</sub>OAc, 6.5 mM in H<sub>2</sub>O + 5% CH<sub>3</sub>CN), 5% B (CH<sub>3</sub>CN), to 40% A in 1.2 min, to 5% A in 0.6 min, held for 0.2 min. Acquisition range for the UV-PDA detector was set to 200–450 nm. MS: (SQD) Cone voltage was 25 V for positive and 30 V for negative modes. The source temperature was maintained at 140 °C. Acquisition mass range was <i>m</i>/<i>z</i> 100–1000. MS (QTOF): see general description.</div><div class="NLM_p"><i>LCMS5 Conditions.</i> LC: reversed phase HPLC was carried out on an Agilent Zorbax SB-C18 column (3.5 μm, 2.1 mm × 30 mm) from Agilent, with a flow rate of 0.75 mL/min at 35 °C. The gradient conditions used are 90% A (H<sub>2</sub>O, + 0.1% TFA), 10% B (CH<sub>3</sub>CN + 0.1% TFA), to 0% A in 4 min, held for 2 min and equilibrated to initial conditions in 0.1 min, held for 1.9 min. Acquisition for the UV-DAD detector was set to 210, 254, and 280 nm. MS (6140 quadrupole): see general description.</div><div class="NLM_p">For <b>79</b> H<sub>2</sub>O (% w/w) was determined with a CA-02-moisture meter (Mitsubishi) by coulometric principle applied to Karl Fischer titration.</div><div class="NLM_p">For <b>79</b>, amount of carbon, hydrogen, and nitrogen (CHN) in (% w/w) was determined by dynamic flash combustion on an EA 1108 CHN analyzer from Fisons instruments.</div><div class="NLM_p last">For <b>79</b>, anions were detected with a DX-120 instrument from Dionex. An Ion Pac AS14 was used with eluent (3.5 mM Na<sub>2</sub>CO<sub>3</sub>/1 mM NaHCO<sub>3</sub> in H<sub>2</sub>O).</div></div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Synthetic Protocols</h3><div class="NLM_p last">The following compounds were obtained commercially or prepared using reported procedures: <i>N</i>-(pyridin-2-yl)quinolin-2-amine (<b>11</b>, Chembridge),<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> 2-chloroquinoline (<b>12</b>), 3-chloroisoquinoline (<b>13</b>), 3-bromoquinoline (<b>14</b>), 6-iodoquinoline (<b>15</b>), 6-bromoisoquinoline (<b>16</b>), 7-bromoisoquinoline (<b>17</b>), 7-bromoquinoline (<b>18</b>), 2-chloroquinazoline (<b>19</b>), 6-methylpyridin-2-amine (<b>20</b>), 3-methylaniline (<b>21</b>), 3-aminopyridine (<b>22</b>), 4-aminopyridine (<b>23</b>), 2-methylpyridin-4-amine (<b>24</b>), pyrimidin-4-amine (<b>25</b>), <i>N</i>,6-dimethylpyridin-2-amine (<b>26</b>),<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> 2-fluoropyridin-4-amine (<b>27</b>), naphthalen-2-amine (<b>28</b>), 2-bromo-6-methylpyridine (<b>29</b>), 2-aminoquinoline (<b>45</b>), (4-chloro-2-pyridinyl)methanol (<b>46</b>), 2-chloroquinolin-6-ol (<b>53</b>), 2-chloroquinolin-7-ol (<b>54</b>), 2-bromo-4-nitroquinoline (<b>61</b>),<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> 4-bromo-6-fluoropyridin-3-amine <b>64</b>, 2-bromo-6-fluoro-3-pyridinamine <b>69</b>.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div></div><div id="sec5_14_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-(6-Methylpyridin-2-yl)quinolin-2-amine (<b>10</b>)</h3><div class="NLM_p last">This compound was obtained commercially<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> but was resynthesized because no analytical data were reported in literature: To a solution of 2-chloroquinoline <b>12</b> (300 mg, 1.83 mmol) in <i>tert</i>-butanol (7.2 mL) were added 6-methylpyridin-2-amine <b>20</b> (220 mg, 2.04 mmol), Pd(OAc)<sub>2</sub> (8.2 mg, 0.037 mmol), XantPhos (21 mg, 0.037 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (1.67 g, 5.13 mmol). The mixture was flushed with nitrogen and heated at 90 °C for 10 h under a nitrogen atmosphere. Next, the mixture was concentrated under reduced pressure, taken up in H<sub>2</sub>O, extracted with DCM, dried on MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by flash column chromatography with silica gel (gradient DCM/MeOH from 100/0 to 95/5). The product fractions were evaporated providing <b>10</b> as off-white crystals (211 mg, 49%). Mp: 115.2 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.01 (s, 1 H), 8.42 (d, <i>J</i> = 8.4 Hz, 1 H), 8.12 (d, <i>J</i> = 9.1 Hz, 1 H), 7.71–7.81 (m, 2 H), 7.64–7.70 (m, 1 H), 7.61 (ddd, <i>J</i> = 8.4, 7.0, 1.5 Hz, 1 H), 7.52 (d, <i>J</i> = 9.1 Hz, 1 H), 7.30–7.38 (m, 1 H), 6.84 (d, <i>J</i> = 7.3 Hz, 1 H), 2.42 (s, 3 H). HRMS calcd for C<sub>15</sub>H<sub>14</sub>N<sub>3</sub> [M + H]<sup>+</sup> 236.1182, found 236.1196.</div></div><div id="sec5_14_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-(6-Methylpyridin-2-yl)isoquinolin-3-amine (<b>30</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>10</b> starting from 3-chloroisoquinoline <b>13</b> (300 mg, 1.83 mmol) and 6-methylpyridin-2-amine 2<b>0</b> (218 mg, 2.04 mmol), yielding <b>30</b> as a pale yellow solid (279 mg, 65%). Mp: 91.8 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.72 (s, 1H), 9.06 (s, 1H), 8.49 (s, 1H), 7.96 (d, <i>J</i> = 8.0 Hz, 1H), 7.76 (d, <i>J</i> = 8.4 Hz, 1H), 7.61 (dt, <i>J</i> = 1.3, 7.6 Hz, 1H), 7.52 (dd, <i>J</i> = 7.3, 8.0 Hz, 1H), 7.34–7.41 (m, 1H), 7.17 (d, <i>J</i> = 8.4 Hz, 1H), 6.71 (d, <i>J</i> = 7.3 Hz, 1H), 2.47 (s, 3H). HRMS calcd for C<sub>15</sub>H<sub>14</sub>N<sub>3</sub> [M + H]<sup>+</sup> 236.1182, found 236.1192.</div></div><div id="sec5_14_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-(6-Methylpyridin-2-yl)quinolin-3-amine (<b>31</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>10</b> starting from 3-bromoquinoline <b>14</b> (300 mg, 1.44 mmol) and 6-methylpyridin-2-amine <b>20</b> (171 mg, 1.59 mmol), yielding <b>31</b> as a pale yellow solid (259 mg, 76%). Mp: 131.4 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.50 (s, 1H), 8.95 (d, <i>J</i> = 2.6 Hz, 1H), 8.91 (d, <i>J</i> = 2.6 Hz, 1H), 7.85–7.92 (m, 1H), 7.79–7.85 (m, 1H), 7.46–7.58 (m, 3H), 6.76 (d, <i>J</i> = 8.0 Hz, 1H), 6.72 (d, <i>J</i> = 7.3 Hz, 1H), 2.46 (s, 3H). HRMS calcd for C<sub>15</sub>H<sub>14</sub>N<sub>3</sub> [M + H]<sup>+</sup> 236.1182, found 236.1196.</div></div><div id="sec5_14_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>N</i>-(6-Methylpyridin-2-yl)quinolin-6-amine (<b>32</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>10</b> starting from 6-iodoquinoline <b>15</b> (468 mg, 1.83 mmol) and 6-methylpyridin-2-amine <b>20</b> (218 mg, 2.02 mmol), yielding <b>32</b> as a pale yellow solid (328 mg, 76%). Mp: 172.2 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.37 (s, 1H), 8.67 (dd, <i>J</i> = 1.5, 4.03 Hz, 1H), 8.54 (d, <i>J</i> = 2.2 Hz, 1H), 8.18 (dd, <i>J</i> = 1.1, 8.0 Hz, 1H), 7.88–7.93 (m, 1H), 7.82–7.87 (m, 1H), 7.49–7.56 (m, 1H), 7.42 (dd, <i>J</i> = 4.2, 8.2 Hz, 1H), 6.77 (d, <i>J</i> = 8.4 Hz, 1H), 6.70 (d, <i>J</i> = 7.3 Hz, 1H), 2.46 (s, 3H). HRMS calcd for C<sub>15</sub>H<sub>14</sub>N<sub>3</sub> [M + H]<sup>+</sup> 236.1182, found 236.1196.</div></div><div id="sec5_14_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i>-(6-Methylpyridin-2-yl)isoquinolin-6-amine (<b>33</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>10</b> starting from 6-bromoisoquinoline <b>16</b> (300 mg, 1.44 mmol) and 6-methylpyridin-2-amine <b>20</b> (172 mg, 1.59 mmol), yielding <b>33</b> as a white solid (170 mg, 50%). Mp: 178.9 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.52 (s, 1H), 9.04 (s, 1H), 8.54 (d, <i>J</i> = 1.5 Hz, 1H), 8.32 (d, <i>J</i> = 5.5 Hz, 1H), 7.95 (d, <i>J</i> = 8.8 Hz, 1H), 7.71 (dd, <i>J</i> = 2.0, 9.0 Hz, 1H), 7.60 (d, <i>J</i> = 5.5 Hz, 1H), 7.55 (t, <i>J</i> = 7.9 Hz, 1H), 6.80 (d, <i>J</i> = 8.0 Hz, 1H), 6.74 (d, <i>J</i> = 7.3 Hz, 1H), 2.47 (s, 3H). HRMS calcd for C<sub>15</sub>H<sub>14</sub>N<sub>3</sub> [M + H]<sup>+</sup> 236.1182, found 236.1190.</div></div><div id="sec5_14_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>-(6-Methylpyridin-2-yl)isoquinolin-7-amine (<b>34</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>10</b> starting from 7-bromoisoquinoline <b>17</b> (300 mg, 1.44 mmol) and 6-methylpyridin-2-amine <b>20</b> (172 mg, 1.59 mmol), yielding <b>34</b> as a white solid (168 mg, 50%). Mp: 173.6 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.41 (s, 1H), 9.13 (s, 1H), 8.68 (s, 1H), 8.29 (d, <i>J</i> = 5.5 Hz, 1H), 7.84 (br s, 2H), 7.66 (br d, <i>J</i> = 5.9 Hz, 1H), 7.53 (t, <i>J</i> = 7.9 Hz, 1H), 6.76 (d, <i>J</i> = 8.4 Hz, 1H), 6.70 (d, <i>J</i> = 7.3 Hz, 1H), 2.46 (s, 3H). HRMS calcd for C<sub>15</sub>H<sub>14</sub>N<sub>3</sub> [M + H]<sup>+</sup> 236.1182, found 236.1192.</div></div><div id="sec5_14_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>N</i>-(6-Methylpyridin-2-yl)quinolin-7-amine (<b>35</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>10</b> starting from 7-bromoquinoline <b>18</b> (300 mg, 1.44 mmol) and 6-methylpyridin-2-amine <b>20</b> (172 mg, 1.59 mmol), yielding <b>35</b> as a white solid (138 mg, 41%). Mp: 145.5 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.41 (s, 1H), 8.75 (dd, <i>J</i> = 1.6, 4.2 Hz, 1H), 8.68 (d, <i>J</i> = 1.8 Hz, 1H), 8.16 (dd, <i>J</i> = 1.1, 8.0 Hz, 1H), 7.81 (d, <i>J</i> = 8.8 Hz, 1H), 7.69 (dd, <i>J</i> = 2.0, 9.0 Hz, 1H), 7.49–7.56 (m, 1H), 7.28 (dd, <i>J</i> = 4.0, 8.0 Hz, 1H), 6.77 (d, <i>J</i> = 8.0 Hz, 1H), 6.71 (d, <i>J</i> = 7.3 Hz, 1H), 2.45 (s, 3H). HRMS calcd for C<sub>15</sub>H<sub>14</sub>N<sub>3</sub> [M + H]<sup>+</sup> 236.1182, found 236.1189.</div></div><div id="sec5_14_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>N</i>-(6-Methylpyridin-2-yl)quinazolin-2-amine (<b>36</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>10</b> starting from 1-chloroquinazoline <b>19</b> (300 mg, 1.82 mmol) and 6-methylpyridin-2-amine <b>20</b> (217 mg, 2.01 mmol), yielding <b>36</b> as a white solid (158 mg, 37%). Mp: 231.5 °C. <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ 9.20 (s, 1H), 8.57 (d, <i>J</i> = 8.4 Hz, 1H), 8.22 (br s, 1H), 7.74–7.81 (m, 3H), 7.62–7.70 (m, 1H), 7.39 (ddd, <i>J</i> = 2.2, 5.9, 8.0 Hz, 1H), 6.84 (d, <i>J</i> = 7.3 Hz, 1H), 2.51 (s, 3H). HRMS calcd for C<sub>14</sub>H<sub>13</sub>N<sub>4</sub> [M + H]<sup>+</sup> 237.1135, found 237.1144.</div></div><div id="sec5_14_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N</i>-(3-Methylphenyl)quinolin-2-amine (<b>37</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>10</b> starting from 2-chloroquinoline <b>12</b> (300 mg, 1.83 mmol) and 3-methylaniline <b>21</b> (218 mg, 2.04 mmol) yielding <b>37</b> as a pale yellow solid (85 mg, 20%) after reversed-phase HPLC purification (stationary phase, RP XBridge Prep C18 OBD, 10 μm, 30 mm × 150 mm; mobile phase, 0.25% NH<sub>4</sub>HCO<sub>3</sub> solution in H<sub>2</sub>O, MeOH). Mp: 78.8 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.35 (s, 1H), 8.04 (d, <i>J</i> = 8.8 Hz, 1H), 7.85 (br d, <i>J</i> = 8.1 Hz, 1H), 7.77 (br s, 1H), 7.72 (dd, <i>J</i> = 1.3, 7.87 Hz, 1H), 7.68 (d, <i>J</i> = 8.4 Hz, 1H), 7.57 (ddd, <i>J</i> = 1.5, 6.9, 8.4 Hz, 1H), 7.28 (dt, <i>J</i> = 1.1, 7.3 Hz, 1H), 7.21 (t, <i>J</i> = 7.9 Hz, 1H), 7.05 (d, <i>J</i> = 8.8 Hz, 1H), 6.78 (br d, <i>J</i> = 7.7 Hz, 1H), 2.33 (s, 3H). HRMS calcd for C<sub>16</sub>H<sub>15</sub>N<sub>2</sub> [M + H]<sup>+</sup> 235.1230, found 235.1240.</div></div><div id="sec5_14_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>N</i>-(Pyridin-3-yl)quinolin-2-amine (<b>38</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>10</b> starting from 2-chloroquinoline <b>12</b> (300 mg, 1.83 mmol) and 3-aminopyridine <b>22</b> (218 mg, 2.32 mmol) yielding <b>38</b> as a white solid (298 mg, 73%). Mp: 180.7 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.67 (s, 1H), 9.08 (d, <i>J</i> = 2.6 Hz, 1H), 8.59 (td, <i>J</i> = 2.0, 8.4 Hz, 1H), 8.19 (dd, <i>J</i> = 1.3, 4.6 Hz, 1H), 8.12 (d, <i>J</i> = 8.8 Hz, 1H), 7.71–7.81 (m, 2H), 7.61 (dt, <i>J</i> = 1.1, 7.7 Hz, 1H), 7.29–7.42 (m, 2H), 7.11 (d, <i>J</i> = 8.8 Hz, 1H). HRMS calcd for C<sub>14</sub>H<sub>12</sub>N<sub>3</sub> [M + H]<sup>+</sup> 222.1026, found 222.1037.</div></div><div id="sec5_14_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>N</i>-(Pyridin-4-yl)quinolin-2-amine (<b>39</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>10</b> starting from 2-chloroquinoline <b>12</b> (300 mg, 1.83 mmol) and 4-aminopyridine <b>23</b> (192 mg, 2.04 mmol) yielding <b>39</b> as a white solid (163 mg, 40%). Mp 247.3 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.90 (s, 1H), 8.37–8.45 (m, 2H), 8.18 (d, <i>J</i> = 8.8 Hz, 1H), 7.96–8.02 (m, 2H), 7.78–7.85 (m, 2H), 7.65 (ddd, <i>J</i> = 1.3, 6.9, 8.3 Hz, 1H), 7.36–7.42 (m, 1H), 7.14 (d, <i>J</i> = 8.8 Hz, 1H). HRMS calcd for C<sub>14</sub>H<sub>12</sub>N<sub>3</sub> [M + H]<sup>+</sup> 222.1026, found 222.1034.</div></div><div id="sec5_14_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>N</i>-(2-Methylpyridin-4-yl)quinolin-2-amine (<b>40</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>7</b> starting from 2-chloroquinoline <b>12</b> (300 mg, 1.83 mmol) and 2-methylpyridin-4-amine <b>24</b> (251 mg, 2.32 mmol) yielding <b>40</b> as a white solid (316 mg, 73%). Mp: 158.4 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.80 (s, 1H), 8.26 (d, <i>J</i> = 5.8 Hz, 1H), 8.15 (d, <i>J</i> = 8.8 Hz, 1H), 7.75–7.86 (m, 4H), 7.64 (ddd, <i>J</i> = 1.5, 6.9, 8.4 Hz, 1H), 7.37 (ddd, <i>J</i> = 1.1, 7.0, 8.0 Hz, 1H), 7.12 (d, <i>J</i> = 8.8 Hz, 1H), 2.44 (s, 3H). HRMS calcd for C<sub>15</sub>H<sub>14</sub>N<sub>3</sub> [M + H]<sup>+</sup> 236.1182, found 236.1190.</div></div><div id="sec5_14_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>N</i>-(Pyrimidin-4-yl)quinolin-2-amine (<b>41</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>10</b> starting from 2-chloroquinoline <b>12</b> (86 mg, 0.53 mmol) pyrimidin-4-amine <b>23</b> (50 mg, 0.53 mmol) and yielding <b>41</b> as a white solid (83 mg, 71%). Mp: 201.1 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.59 (s, 1H), 8.78 (d, <i>J</i> = 1.1 Hz, 1H), 8.57 (d, <i>J</i> = 5.8 Hz, 1H), 8.49 (dd, <i>J</i> = 1.3, 6.0 Hz, 1H), 8.26 (d, <i>J</i> = 8.8 Hz, 1H), 7.81–7.88 (m, 2H), 7.69 (ddd, <i>J</i> = 1.5, 6.9, 8.4 Hz, 1H), 7.62 (d, <i>J</i> = 8.8 Hz, 1H), 7.44 (ddd, <i>J</i> = 1.1, 6.9, 8.0 Hz, 1H). HRMS calcd for C<sub>13</sub>H<sub>11</sub>N<sub>4</sub> [M + H]<sup>+</sup> 223.0978, found 223.0989.</div></div><div id="sec5_14_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>N</i>-Methyl-<i>N</i>-(6-methylpyridin-2-yl)quinolin-2-amine (<b>42</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>10</b> starting from 2-chloroquinoline <b>12</b> (223 mg, 1.36 mmol) and <i>N</i>,6-dimethylpyridin-2-amine <b>26</b> (185 mg, 1.51 mmol) yielding <b>42</b>, which was converted to a HCl salt and crystallized from ethanol to yield a white solid (129 mg, 33%). Mp: 209.1 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.46 (d, <i>J</i> = 9.5 Hz, 1H), 8.29–8.41 (m, 1H), 7.97–8.06 (m, 2H), 7.86 (ddd, <i>J</i> = 1.3, 7.1, 8.4 Hz, 1H), 7.55–7.64 (m, 1H), 7.49 (d, <i>J</i> = 8.0 Hz, 1H), 7.38 (d, <i>J</i> = 7.7 Hz, 1H), 7.25–7.33 (m, 1H), 3.85 (s, 3H), 2.57 (s, 3H). HRMS calcd for C<sub>16</sub>H<sub>16</sub>N<sub>3</sub> [M + H]<sup>+</sup> 250.1339, found 250.1345.</div></div><div id="sec5_14_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>N</i>-(2-Fluoropyridin-4-yl)quinolin-2-amine (<b>43</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>10</b> starting from 2-chloroquinoline <b>12</b> (100 mg, 0.611 mmol) and 2-fluoropyridin-4-amine <b>27</b> (75 mg, 0.672 mmol), yielding <b>43</b> as a white solid after crystallization from DIPE (77 mg, 53%). Mp 244.7 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.23 (s, 1H), 8.22 (d, <i>J</i> = 8.8 Hz, 1H), 8.05 (d, <i>J</i> = 1.5 Hz, 1H), 8.04 (d, <i>J</i> = 5.8 Hz, 1H), 7.80–7.86 (m, 2H), 7.67 (dt, <i>J</i> = 1.5, 7.68 Hz, 1H), 7.55 (td, <i>J</i> = 1.6, 5.8 Hz, 1H), 7.38–7.45 (m, 1H), 7.15 (d, <i>J</i> = 8.8 Hz, 1H). HRMS calcd for C<sub>14</sub>H<sub>11</sub>FN<sub>3</sub> [M + H]<sup>+</sup> 240.0932, found 240.0943.</div></div><div id="sec5_14_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 6-Methyl-<i>N</i>-(naphthalen-2-yl)pyridin-2-amine (<b>44</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>10</b> starting from naphthalen-2-amine <b>28</b> (193 mg, 1.35 mmol) and 2-bromo-6-methylpyridine <b>29</b> (225 mg, 1.48 mmol) yielding <b>44</b> as a sticky oil. Treatment with 5 N HCl in 2-propanol resulted in a beige solid, which was filtered and dried in vacuo to yield the hydrochloric acid salt of <b>44</b> (115 mg, 32%). Mp: 206.5 °C. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.62 (br s, 1H), 7.88–8.03 (m, 5H), 7.46–7.58 (m, 3H), 7.16 (d, <i>J</i> = 8.8 Hz, 1H), 6.94 (d, <i>J</i> = 7.3 Hz, 1H), 2.52 (s, 3H). HRMS calcd for C<sub>16</sub>H<sub>15</sub>N<sub>2</sub> [M + H]<sup>+</sup> 235.1230, found 235.1238.</div></div><div id="sec5_14_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 4-Bromo-2-(2-fluoroethyl)pyridine (<b>47</b>)</h3><div class="NLM_p last">DAST (0.259 mL, 2.12 mmol) was added to a solution of 2-(4-bromopyridin-2-yl)ethanol<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> (285 mg, 1.41 mmol) in DCM at 0 °C. The mixture was stirred at 100 °C for 10 min under microwave irradiation. Next the reaction was quenched with aq sat. NaHCO<sub>3</sub> and extracted with DCM. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered and the solvent evaporated in vacuo. The residue was purified by column chromatography (silica; EtOAc in DCM 0/100 to 10/90). The desired fractions were collected and the solvent was evaporated in vacuo to yield <b>47</b> as a yellow oil (162 mg, 56%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.38 (d, <i>J</i> = 5.3 Hz, 1H), 7.43 (d, <i>J</i> = 1.8 Hz, 1H), 7.35 (dd, <i>J</i> = 1.8, 5.3 Hz, 1H), 4.82 (td, <i>J</i> = 6.0, 47 Hz, 2H), 3.16 (td, <i>J</i> = 5.5, 25 Hz, 2H). LCMS (LCMS3 conditions) <i>t</i><sub>R</sub> = 0.85, 93.99% pure, <i>m</i>/<i>z</i> 204 [M + H]<sup>+</sup>.</div></div><div id="sec5_14_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 4-Chloro-2-(2-fluoroethoxy)pyridine (<b>48</b>)</h3><div class="NLM_p last">2-Bromo-1-fluoroethane (0.941 mL, 11.579 mmol) was added to a mixture of 4-chloropyridin-2-ol (1.0 g, 7.72 mmol) and K<sub>2</sub>CO<sub>3</sub> (3.201 g, 23.158 mmol) in 25 mL of CH<sub>3</sub>CN. The reaction mixture was heated at 100 °C for 2 h, after which LCMS showed a 1:4 ratio of desired <b>48</b> and undesired isomeric 4-chloro-1-(2-fluoroethyl)pyridin-2(1<i>H</i>)-one. The mixture was diluted with CH<sub>3</sub>CN, the solid was filtered off, and the filtrate was concentrated in vacuo. The residue was purified by flash chromatography (silica; EtOAc in heptane 0/100 to 20/80). The desired fractions were collected and solvents removed in vacuo to afford <b>48</b> as a white solid (252 mg, 17%). Mp: amorphous. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.16 (d, <i>J</i> = 5.7 Hz, 1H), 7.14 (dd, <i>J</i> = 1.8, 5.5 Hz, 1H), 7.05 (d, <i>J</i> = 1.8 Hz, 1H), 4.77–4.84 (m, 1H), 4.66–4.70 (m, 1H), 4.55–4.59 (m, 1H), 4.47–4.51 (m, 1H). LCMS (LCMS1 conditions) <i>t</i><sub>R</sub> = 1.81, 92.28% pure, <i>m</i>/<i>z</i> 176 [M + H]<sup>+</sup>.</div></div><div id="sec5_14_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> [4-(Quinolin-2-ylamino)pyridin-2-yl]methanol (<b>49</b>)</h3><div class="NLM_p last">XantPhos (56 mg, 0.098 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (51 mg, 0.056 mmol), and K<sub>3</sub>PO<sub>4</sub> (591 mg, 2.79 mmol) were added to a stirred solution of 2-aminoquinoline <b>45</b> (201 mg, 1.39 mmol) and (4-chloro-2-pyridinyl)methanol <b>46</b> (300 mg, 2.09 mmol) in 8.5 mL of THF. Then nitrogen was bubbled, and the reaction mixture was stirred at 80 °C for 16 h. Then H<sub>2</sub>O and EtOAc were added. The organic layer was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and the solvents were evaporated in vacuo. The crude product was triturated with DCM affording [4-(quinolin-2-ylamino)pyridin-2-yl]methanol <b>49</b> as a yellow solid (326 mg, 93%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.88 (s, 1H), 8.30 (d, <i>J</i> = 5.5 Hz, 1H), 8.16 (d, <i>J</i> = 8.8 Hz, 1H), 8.06 (dd, <i>J</i> = 2.2, 5.7 Hz, 1H), 7.91 (d, <i>J</i> = 1.8 Hz, 1H), 7.76–7.82 (m, 2H), 7.64 (ddd, <i>J</i> = 1.5, 6.9, 8.4 Hz, 1H), 7.37 (ddd, <i>J</i> = 1.2, 6.9, 7.9 Hz, 1H), 7.13 (d, <i>J</i> = 8.8 Hz, 1H), 5.40 (t, <i>J</i> = 5.8 Hz, 1H), 4.53 (d, <i>J</i> = 5.8 Hz, 2H). LCMS (LCMS3 conditions) <i>t</i><sub>R</sub> = 0.80, 91.45% pure, <i>m</i>/<i>z</i> 252 [M + H]<sup>+</sup>.</div></div><div id="sec5_14_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>N</i>-[2-(Fluoromethyl)pyridin-4-yl]quinolin-2-amine (<b>50</b>)</h3><div class="NLM_p last">DAST (0.237 mL, 1.79 mmol) was added dropwise to a stirred solution of [4-(quinolin-2-ylamino)pyridin-2-yl]methanol <b>49</b> (150 mg, 0.60 mmol) in 2 mL DCM at 0 °C under nitrogen atmosphere. The reaction mixture was stirred at rt for 30 min. The mixture was again cooled at 0 °C, and sat. NaHCO<sub>3</sub> was added slowly. The resulting mixture was extracted with EtOAc twice. The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The residue was purified by flash column chromatography (EtOAc in heptane 0/100 to 100/0). The desired fractions were collected and concentrated in vacuo yielding <b>50</b> as a pale pink solid (11 mg, 7%). Mp: amorphous. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.18 (br s, 1H), 8.43 (d, <i>J</i> = 5.8 Hz, 1H), 8.23 (d, <i>J</i> = 9.0 Hz, 1H), 8.14 (br s, 1H), 8.07 (br d, <i>J</i> = 3.8 Hz, 1H), 7.81–7.87 (m, 2H), 7.68 (br t, <i>J</i> = 7.7 Hz, 1H), 7.42 (t, <i>J</i> = 7.5 Hz, 1H), 7.18 (d, <i>J</i> = 9.0 Hz, 1H), 5.50 (d, <i>J</i> = 47.1 Hz, 2H). HRMS calcd for C<sub>15</sub>H<sub>13</sub>FN<sub>3</sub> [M + H]<sup>+</sup> 254.1088, found 254.1095.</div></div><div id="sec5_14_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>N</i>-[2-(2-Fluoroethyl)pyridin-4-yl]quinolin-2-amine (<b>51</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>49</b> starting from 2-aminoquinoline <b>45</b> (110 mg, 0.539 mmol) and 4-bromo-2-(2-fluoroethyl)pyridine <b>47</b> (218 mg, 2.32 mmol) yielding <b>51</b> as a white solid (88 mg, 61%). Mp: 158.7 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.43 (d, <i>J</i> = 5.5 Hz, 1H), 8.03 (d, <i>J</i> = 8.8 Hz, 1H), 7.90 (d, <i>J</i> = 8.3 Hz, 1H), 7.59–7.75 (m, 4H), 7.39 (ddd, <i>J</i> = 1.2, 7.0, 8.0 Hz, 1H), 6.95 (d, <i>J</i> = 9.0 Hz, 1H), 6.89 (br s, 1H), 4.87 (td, <i>J</i> = 6.2, 47 Hz, 2H), 3.19 (td, <i>J</i> = 6.2, 25 Hz, 2H). HRMS calcd for C<sub>16</sub>H<sub>15</sub>FN<sub>3</sub> [M + H]<sup>+</sup> 268.1245, found 268.1255.</div></div><div id="sec5_14_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>N</i>-[2-(2-Fluoroethoxy)pyridin-4-yl]quinolin-2-amine (<b>52</b>)</h3><div class="NLM_p last">A mixture of <b>48</b> (100 mg, 0.57 mmol), 2-aminoquinoline <b>45</b> (90.32 mg, 0.626 mmol), Pd(OAc)<sub>2</sub> (12.786 mg, 0.057 mmol), Xantphos (32.954 mg, 0.057 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (519.56 mg, 1.595 mmol) in toluene (2.7 mL) was degassed for a few min with N<sub>2</sub> and sonicated. Then, the mixture was heated to 100 °C for 2 h in a sealed tube, after which the solvent was removed in vacuo. The residue was dissolved in DCM and H<sub>2</sub>O and filtered through Celite. The organic layer was washed with brine, separated, dried (MgSO<sub>4</sub>), filtered and the solvent removed in vacuo. The residue was purified by flash chromatography (silica; EtOAc in heptane 0/100 to 40/60). The desired fractions were collected and solvents removed in vacuo. The resulting compound was triturated with DIPE to yield <b>52</b> as a pale yellow solid (32 mg, 20%). Mp: amorphous. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.87 (s, 1H), 8.17 (d, <i>J</i> = 8.9 Hz, 1H), 7.98 (d, <i>J</i> = 5.6 Hz, 1H), 7.77–7.83 (m, 3H), 7.64 (ddd, <i>J</i> = 1.4, 7.1, 8.5 Hz, 1H), 7.38 (dt, <i>J</i> = 1.2, 7.5 Hz, 1H), 7.29–7.33 (m, 1H), 7.12 (d, <i>J</i> = 8.9 Hz, 1H), 4.68–4.85 (m, 2H), 4.45–4.57 (m, 2H). HRMS calcd for C<sub>16</sub>H<sub>15</sub>FN<sub>3</sub>O [M + H]<sup>+</sup> 284.1194, found 284.1201.</div></div><div id="sec5_14_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 2-Chloro-6-(2-fluoroethoxy)quinoline (<b>55</b>)</h3><div class="NLM_p last">2-Chloroquinolin-6-ol <b>53</b> (800 mg, 4.454 mmol) and 1-fluoro-2-iodoethane (0.435 mL, 5.345 mmol) were dissolved in 18 mL of DMF, and Cs<sub>2</sub>CO<sub>3</sub> (2.177 g, 6.681 mmol) was added under nitrogen atmosphere. The mixture was heated at 85 °C for 16 h. After cooling to ambient temperature, the dark brown suspension was diluted with H<sub>2</sub>O and extracted with DCM. The organic layer was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. Flash column chromatography (80 g silica) using a gradient (0–20% EtOAc in heptane) afforded <b>55</b> as a white solid (954 mg, 95%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.32 (d, <i>J</i> = 8.8 Hz, 1H), 7.85–7.92 (m, 1H), 7.55 (d, <i>J</i> = 8.8 Hz, 1H), 7.48–7.53 (m, 2H), 4.73–4.91 (m, 2H), 4.32–4.45 (m, 2H). LCMS (LCMS1 conditions) <i>t</i><sub>R</sub> = 1.86, 95.71% pure, <i>m</i>/<i>z</i> 226 [M + H]<sup>+</sup>.</div></div><div id="sec5_14_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 2-Chloro-7-(2-fluoroethoxy)quinoline (<b>56</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>55</b> starting from 2-chloroquinolin-7-ol <b>54</b> (300 mg 1.64 mmol) and 1-bromo-2-fluoroethane (0. 137 mL, 1.837 mmol) yielding <b>56</b> as a yellow solid (350 mg, 93%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.37 (d, <i>J</i> = 8.5 Hz, 1H), 7.97 (d, <i>J</i> = 9.0 Hz, 1H), 7.44 (d, <i>J</i> = 8.3 Hz, 1H), 7.41 (d, <i>J</i> = 2.5 Hz, 1H), 7.34 (dd, <i>J</i> = 2.5, 9.0 Hz, 1H), 4.74–4.91 (m, 2H), 4.36–4.49 (m, 2H). LCMS (LCMS3 conditions) <i>t</i><sub>R</sub> = 1.29, 99.09% pure, <i>m</i>/<i>z</i> 226 [M + H]<sup>+</sup>.</div></div><div id="sec5_14_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 2-Chloro-6-(3-fluoropropoxy)quinoline (<b>57</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>55</b> starting from 2-chloroquinolin-6-ol <b>53</b> (300 mg, 1.64 mmol) and 1-bromo-3-fluoropropane (184 mg, 2.00 mmol) yielding <b>57</b> as a pale brown solid (390 mg, 97%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.33 (d, <i>J</i> = 8.7 Hz, 1H), 7.87 (d, <i>J</i> = 9.2 Hz, 1H), 7.55 (d, <i>J</i> = 8.7 Hz, 1H), 7.50 (d, <i>J</i> = 2.9 Hz, 1H), 7.48 (dd, <i>J</i> = 2.9, 9.0 Hz, 1H), 4.66 (td, <i>J</i> = 5.8, 47 Hz, 2H), 4.23 (t, <i>J</i> = 6.4 Hz, 2H), 2.20 (quind, <i>J</i> = 6.1, 25 Hz, 2H). LCMS (LCMS1 conditions) <i>t</i><sub>R</sub> = 2.03, 97.85% pure, <i>m</i>/<i>z</i> 240 [M + H]<sup>+</sup>.</div></div><div id="sec5_14_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 6-(2-Fluoroethoxy)-<i>N</i>-(pyridin-4-yl)quinolin-2-amine (<b>58</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>49</b> starting from <b>55</b> (150 mg, 0.665 mmol) and 4-aminopyridine <b>23</b> (63 mg, 0.665 mmol) yielding <b>58</b> as a white solid (21 mg, 11%). Mp: 256.8 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.77 (s, 1H), 8.33–8.39 (m, 2H), 8.09 (d, <i>J</i> = 8.8 Hz, 1H), 7.90–7.95 (m, 2H), 7.75 (d, <i>J</i> = 8.8 Hz, 1H), 7.29–7.36 (m, 2H), 7.11 (d, <i>J</i> = 8.8 Hz, 1H), 4.72–4.89 (m, 2H), 4.27–4.40 (m, 2H). HRMS calcd for C<sub>16</sub>H<sub>15</sub>FN<sub>3</sub>O [M + H]<sup>+</sup> 284.1194, found 284.1200.</div></div><div id="sec5_14_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 7-(2-Fluoroethoxy)-<i>N</i>-(pyridin-4-yl)quinolin-2-amine (<b>59</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>49</b> starting from <b>56</b> (150 mg, 0.665 mmol) and 4-aminopyridine <b>23</b> (63 mg, 0.665 mmol) yielding <b>59</b> as a white solid (71 mg, 38%). Mp: 176.9 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.83 (s, 1H), 8.34–8.41 (m, 2H), 8.09 (d, <i>J</i> = 8.8 Hz, 1H), 7.94–8.00 (m, 2H), 7.72 (d, <i>J</i> = 8.8 Hz, 1H), 7.26 (d, <i>J</i> = 2.5 Hz, 1H), 7.05 (dd, <i>J</i> = 2.5, 8.8 Hz, 1H), 6.98 (d, <i>J</i> = 8.8 Hz, 1H), 4.74–4.92 (m, 2H), 4.42 (td, <i>J</i> = 3.9, 30 Hz, 2H). HRMS calcd for C<sub>16</sub>H<sub>15</sub>FN<sub>3</sub>O [M + H]<sup>+</sup> 284.1194, found 284.1200.</div></div><div id="sec5_14_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 6-(3-Fluoropropoxy)-<i>N</i>-(pyridin-4-yl)quinolin-2-amine (<b>60</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>49</b> starting from <b>57</b> (166 mg, 0.693 mmol) and 4-aminopyridine <b>23</b> (65 mg, 0.693 mmol) yielding <b>60</b> as a white solid (90 mg, 44%). Mp: 231.1 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.76 (s, 1H), 8.33–8.39 (m, 2H), 8.09 (d, <i>J</i> = 9.0 Hz, 1H), 7.89–7.95 (m, 2H), 7.70–7.77 (m, 1H), 7.28–7.33 (m, 2H), 7.10 (d, <i>J</i> = 9.0 Hz, 1H), 4.65 (td, <i>J</i> = 5.9, 47 Hz, 2H), 4.17 (t, <i>J</i> = 6.2 Hz, 2H), 2.17 (quind, <i>J</i> = 6.1, 25 Hz, 2H). HRMS calcd for C<sub>17</sub>H<sub>17</sub>FN<sub>3</sub>O [M + H]<sup>+</sup> 298.1350, found 298.1357.</div></div><div id="sec5_14_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 4-Nitro-<i>N</i>-(pyridin-4-yl)quinolin-2-amine (<b>62</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>49</b> starting from 2-bromo-4-nitroquinoline <b>61</b> (489 mg, 1.93 mmol)<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> and 4-aminopyridine (182 mg, 1.93 mmol) yielding <b>62</b> as a yellow solid (241 mg, 47%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.34 (s, 1H), 8.44–8.48 (m, 2H), 8.16 (dd, <i>J</i> = 0.8, 8.2 Hz, 1H), 8.00 (d, <i>J</i> = 8.3 Hz, 1H), 7.93–7.97 (m, 2H), 7.84 (dt, <i>J</i> = 1.4, 7.74 Hz, 1H), 7.81 (s, 1H), 7.60 (ddd, <i>J</i> = 1.2, 7.2, 8.3 Hz, 1H). HRMS calcd for C<sub>14</sub>H<sub>11</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 267.0877, found 267.0898.</div></div><div id="sec5_14_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 4-Fluoro-<i>N</i>-(pyridin-4-yl)quinolin-2-amine (<b>63</b>)</h3><div class="NLM_p last">KF (678 mg, 4.53 mmol) was added to a stirred solution of <b>64</b> (241 mg, 0.905 mmol) in 6 mL of DMSO at rt. Then the resulting mixture was stirred at 180 °C for 5 min under microwave irradiation. The reaction mixture was quenched with H<sub>2</sub>O and extracted with DCM twice. The combined organic layer was washed with H<sub>2</sub>O, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and evaporated in vacuo. The residue was purified by ion exchange chromatography using an ISOLUTE SCX2 cartridge eluting with MeOH, then 7 M solution of ammonia and MeOH. The solvent was evaporated in vacuo. The residue was purified by flash column chromatography (silica; (7 N NH<sub>3</sub> in MeOH)/DCM, gradient 0/100 to 10/90). The desired fractions were collected and concentrated in vacuo and further purified via SFC (stationary phase, diethylaminopropyl 5 μm, 150 mm × 21.2 mm; mobile phase, 85% CO<sub>2</sub>, 15% MeOH (0.3% <i>i</i>-PrNH<sub>2</sub>)) yielding <b>63</b> (74 mg, 34%). Mp: 210.9 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.99 (br s, 1H), 8.39–8.44 (m, 2H), 7.91–7.97 (m, 3H), 7.88 (d, <i>J</i> = 8.7 Hz, 1H), 7.76 (ddd, <i>J</i> = 1.4, 7.1, 8.4 Hz, 1H), 7.45–7.50 (m, 1H), 6.94 (d, <i>J</i> = 12 Hz, 1H). HRMS calcd for C<sub>14</sub>H<sub>11</sub>FN<sub>3</sub> [M + H]<sup>+</sup> 240.0932, found 240.0943.</div></div><div id="sec5_14_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Methyl (2<i>E</i>)-3-(5-Amino-2-fluoropyridin-4-yl)prop-2-enoate (<b>65</b>)</h3><div class="NLM_p last">Two glass microwave reaction vessels (10–20 mL) were charged with 4-bromo-6-fluoropyridin-3-amine <b>64</b> (1.54 g, 8.063 mmol) and Pd(Amphos)Cl<sub>2</sub> (171.269 mg, 0.242 mmol). DMF (10 mL) was added, followed by methyl acrylate (2.923 mL, 32.251 mmol) and Et<sub>3</sub>N (2.241 mL, 16.125 mmol). The reaction mixture was sealed under nitrogen and heated at 145 °C under microwave for 40 min. The two reaction mixtures were combined, and the solvent was removed in vacuo. The residue was dissolved in DCM, washed with H<sub>2</sub>O twice, and the two layers were separated. The organic layer was dried over MgSO<sub>4</sub>, filtered, and the solvent was evaporated in vacuo. The residue was purified by flash column chromatography (silica; solid loading; MeOH in DCM (0/100 to 3/97)). The desired fractions were collected and the solvents were evaporated to yield <b>65</b> as a yellow solid (1.78 g, 56%). LCMS (LCMS1 conditions) <i>t</i><sub>R</sub> = 1.34, 92.19% pure, <i>m</i>/<i>z</i> 197 [M + H]<sup>+</sup>.</div></div><div id="sec5_14_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 6-Fluoro-1,7-naphthyridin-2(1<i>H</i>)-one (<b>66</b>)</h3><div class="NLM_p last">To a room temperature solution of <b>65</b> (1.78 g, 9.073 mmol) in MeOH was added sodium methoxide (0.5 M in MeOH, 54.44 mL, 27.22 mmol). The reaction was heated at 60 °C for 6 h. Then, the mixture was cooled to room temperature and the solvent was removed in vacuo to give <b>66</b> as a bright yellow solid, which was used as such in the next step (1.6 g, 98%). LCMS (LCMS1 conditions) <i>t</i><sub>R</sub> = 1.00, 92.62% pure, <i>m</i>/<i>z</i> 165 [M + H]<sup>+</sup>.</div></div><div id="sec5_14_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 2-Chloro-6-fluoro-1,7-naphthyridine (<b>67</b>)</h3><div class="NLM_p last">A mixture of <b>66</b> (280 mg, 1.706 mmol) in POCl<sub>3</sub> (10 mL, 107.61 mmol) was heated at 120 °C for 20 min under microwave irradiation. The mixture was cooled to room temperature and then poured into ice while stirring. NaHCO<sub>3</sub> aq sat. solution was added until pH 7–8. The mixture was extracted with EtOAc and the combined organic layers washed were dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. A yellow solid was obtained which was used as such for the next reaction step (<b>67</b>, 383 mg). LCMS (LCMS1 conditions) <i>t</i><sub>R</sub> = 1.60, 79.76% pure, no ionization achieved.</div></div><div id="sec5_14_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 6-Fluoro-<i>N</i>-(pyridin-4-yl)-1,7-naphthyridin-2-amine (<b>68</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>49</b> starting from <b>67</b> (150 mg, 0.78 mmol) and 4-aminopyridine <b>23</b> (81 mg 0.859 mmol) yielding <b>68</b> as a white fluffy solid (56 mg, 30%, 2 steps). Mp: 276.5 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.15 (s, 1H), 8.87 (s, 1H), 8.40–8.47 (m, 2H), 8.25 (d, <i>J</i> = 9.0 Hz, 1H), 7.95–7.99 (m, 2H), 7.55 (d, <i>J</i> = 2.4 Hz, 1H), 7.39 (d, <i>J</i> = 9.0 Hz, 1H). HRMS calcd for C<sub>13</sub>H<sub>10</sub>FN<sub>4</sub> [M + H]<sup>+</sup> 241.0884, found 241.0893.</div></div><div id="sec5_14_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Methyl (2<i>E</i>)-3-(3-Amino-6-fluoropyridin-2-yl)prop-2-enoate (<b>70</b>)</h3><div class="NLM_p last">A mixture of 2-bromo-6-fluoro-3-pyridinamine <b>69</b> (20 g, 96.33 mmol), methyl acrylate (13.01 mL, 144.50 mmol), Pd(OAc)<sub>2</sub> (2.81 g, 12.52 mmol), PPh<sub>3</sub> (5.81 g, 22.16 mmol), and TEA (30.13 mL, 216.75 mmol) in THF (143 mL) was heated in a sealed tube at 140 °C for 2 h. The reaction was cooled to rt. NaHCO<sub>3</sub> (sat. solution) and EtOAc were 30 added, and the phases were separated. The aqueous phase was extracted twice more with EtOAc. The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by flash column chromatography (silica; dry loading; heptane/EtOAc 100/0 to 60/40). The desired fractions were collected, and the solvents were evaporated to yield <b>70</b> (17.6 g, 93%) as an orange solid. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.10 (s, 1 H), 8.36–8.45 (m, 3 H), 8.12 (d, <i>J</i> = 9.1 Hz, 1 H), 7.94 (d, <i>J</i> = 6.2 Hz, 2 H), 7.49 (dd, <i>J</i> = 9.0, 2.7 Hz, 1 H), 7.40 (d, <i>J</i> = 8.9 Hz, 1 H). LCMS (LCMS1 conditions) <i>t</i><sub>R</sub> = 1.43, 97.21% pure, <i>m</i>/<i>z</i> 197 [M + H]<sup>+</sup>.</div></div><div id="sec5_14_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 6-Fluoro-1,5-naphthyridin-2(1<i>H</i>)-one (<b>71</b>)</h3><div class="NLM_p last">A mixture of <b>70</b> (14.8 g, 75.44 mmol) and tri-<i>n</i>-butylphosphine (18.84 mL, 75.44 mmol) in AcOH (107.87 mL) was heated in a sealed tube at 110 °C for 1 h. The mixture was evaporated and then stirred in DIPE (500 mL). The solids were filtered off and dried under vacuum at 50 °C overnight, yielding intermediate <b>71</b> (11.3 g, 91%) as a yellow solid. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.05 (br s, 1H), 7.85 (dd, <i>J</i> = 6.9, 8.8 Hz, 1H), 7.83 (d, <i>J</i> = 9.9 Hz, 1H), 7.36 (dd, <i>J</i> = 2.9, 8.8 Hz, 1H), 6.79 (d, <i>J</i> = 9.9 Hz, 1H). LCMS (LCMS1 conditions) <i>t</i><sub>R</sub> = 0.98, 88.74% pure, <i>m</i>/<i>z</i> 165 [M + H]<sup>+</sup>.</div></div><div id="sec5_14_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 2-Chloro-6-fluoro-1,5-naphthyridine (<b>72</b>) and 2,6-Dichloro-1,5-naphthyridine (<b>73</b>)</h3><div class="NLM_p last">POCl<sub>3</sub> (1.925 mL, 20.71 mmol) was added to a suspension of <b>73</b> (5 g, 20.71 mmol) in 1,4-dioxane (64.32 mL), and the mixture was heated in a pressure tube at 110 °C for 1 h. The reaction mixture was evaporated, taken up in a sat. aq. NaHCO<sub>3</sub>, extracted with DCM, dried over MgSO<sub>4</sub>, and evaporated. The residue was purified by column chromatography (silica gel; heptane/EtOAc 100/0 to 80/20 (dry loading)). The desired fractions were evaporated, yielding <b>72</b> (3.36 g) as a white solid (the sample was determined to contain 13 mol % <b>73</b>). <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ ppm 8.36–8.45 (m, 1 H), 8.21 (dd, <i>J</i> = 8.8, 0.7 Hz, 1 H), 7.65 (d, <i>J</i> = 9.1 Hz, 1 H), 7.35 (dd, <i>J</i> = 9.1, 2.9 Hz, 1 H). LCMS (LCMS1 conditions) <i>t</i><sub>R</sub> = 1.66, 79.18% pure, <i>m</i>/<i>z</i> 183 [M + H]<sup>+</sup>.</div></div><div id="sec5_14_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 6-Fluoro-<i>N</i>-(pyridin-4-yl)-1,5-naphthyridin-2-amine (<b>74</b>)</h3><div class="NLM_p last">The compound was prepared using the same procedure as <b>10</b> starting from <b>72</b> (200 mg, 1.10 mmol) and 4-aminopyridine (114.43 mg, 1.22 mmol) yielding <b>74</b>, as a yellow solid after trituration with DIPE/H<sub>2</sub>O, filtering, and drying in vacuo (46 mg, 17%, 2 steps). Mp: amorphous. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.10 (s, 1 H), 8.36–8.45 (m, 3 H), 8.12 (d, <i>J</i> = 9.1 Hz, 1 H), 7.94 (d, <i>J</i> = 6.2 Hz, 2 H), 7.49 (dd, <i>J</i> = 9.0, 2.7 Hz, 1 H), 7.40 (d, <i>J</i> = 8.9 Hz, 1 H). HRMS calcd for C<sub>13</sub>H<sub>10</sub>FN<sub>4</sub> [M + H]<sup>+</sup> 241.0884, found 241.0895.</div></div><div id="sec5_14_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 6-Fluoro-<i>N</i>-(2-methylpyridin-4-yl)-1,5-naphthyridin-2-amine (<b>75</b>)</h3><div id="sec5_14_39_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Procedure a</h4><div class="NLM_p last">The compound was prepared using the same procedure as <b>10</b> starting from <b>72</b> (1.66 g, 15.34 mmol) and 2-methyl-4-pyridinamine <b>24</b> (1.66 g, 15.34 mmol) yielding <b>75</b> as a yellow solid after purification via preparative HPLC (stationary phase, RP XBridge Prep C18 OBD, 10 μm, 50 mm × 150 mm; mobile phase, 0.25% NH<sub>4</sub>HCO<sub>3</sub> solution in H<sub>2</sub>O, MeOH) (915 mg, 24%, 2 steps). Mp: 248.0 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.97 (s, 1 H), 8.39 (t, <i>J</i> = 8.0 Hz, 1 H), 8.28 (d, <i>J</i> = 5.7 Hz, 1 H), 8.10 (d, <i>J</i> = 9.0 Hz, 1 H), 7.72–7.85 (m, 2 H), 7.48 (dd, <i>J</i> = 8.9, 2.8 Hz, 1 H), 7.39 (d, <i>J</i> = 9.2 Hz, 1 H), 2.45 (s, 3 H). HRMS calcd for C<sub>14</sub>H<sub>12</sub>FN<sub>4</sub> [M + H]<sup>+</sup> 255.1041, found 255.1047.</div></div><div id="sec5_14_39_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Procedure b</h4><div class="NLM_p last">TBAF (1 M in THF, 0.28 mL, 0.28 mmol) was added to a solution of <b>79</b> (38 mg, 0.093 mmol) in DMF (0.93 mL). The resulting mixture was stirred at 90 °C for 30 min. All volatiles were evaporated. The residue was purified by flash column chromatography over silica gel using a gradient (DCM/7 N NH<sub>3</sub> in MeOH, 1:0 to 9:1). The product fractions were evaporated providing <b>75</b> (15.4 mg, 65%) as yellow crystals.</div></div></div><div id="sec5_14_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 1,5-Naphthyridine 1,5-Dioxide (<b>77</b>)</h3><div class="NLM_p last">3-Chlorobenzoperoxoic acid (164.4 g, 666.9 mmol) was added to a solution of 1,5-naphthyridine <b>76</b> (28.0 g, 215.1 mmol) in DCM (1.4 L) and MeOH (0.7 L). The reaction mixture was stirred at rt for 3 h. More 3-chlorobenzoperoxoic acid (53.0 g, 215.1 mmol) was added, and stirring was continued for 72 h. A solid was formed which was filtered. The filtrate was half concentrated, and more precipitate formed which was filtered and combined with the precipitate obtained before. This solid was triturated with DCM/MeOH (9:1), filtered, and dried in vacuo yielding <b>77</b> (28.0 g, 172.7 mmol, 80%) as a yellow solid. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.73 (d, <i>J</i> = 6.2 Hz, 2H), 8.29 (d, <i>J</i> = 9.1 Hz, 2H), 7.70 (dd, <i>J</i> = 6.0, 9.0 Hz, 2H). LCMS (LCMS1 conditions) <i>t</i><sub>R</sub> = 0.61, 99.09% pure, <i>m</i>/<i>z</i> 163 [M + H]<sup>+</sup>.</div></div><div id="sec5_14_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> <i>N</i>,<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′,<i>N</i>′-Hexamethyl-1,5-naphthyridine-2,6-diaminium Bis(trifluoroacetate) (<b>78</b>)</h3><div class="NLM_p last">Trifluoroacetic anhydride (69.5 mL, 499.5 mmol) was added to a stirred solution of <b>77</b> (27.0 g, 166.5 mmol) and trimethylamine (1 M in THF, 0.85 L, 850 mmol) in DCM (1.35 L) at 0 °C. The mixture was stirred at rt. Upon completion (about 30 min), Et<sub>2</sub>O (1 L) was added and stirring was continued for 1 h. The white salts were isolated by filtration, washed with Et<sub>2</sub>O, and dried in vacuo overnight to yield <b>78</b> (68 g, 144.0 mmol, 86%). LCMS (LCMS1 conditions) <i>t</i><sub>R</sub> = 0.41, <i>m</i>/<i>z</i> 123 [M]<sup>2+</sup>.</div></div><div id="sec5_14_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 2-Methyl-4-{[6-(trimethylammonio)-1,5-naphthyridin-2-yl]ammonio}pyridinium Tris(trifluoroacetate) Monohydrate (<b>79</b>)</h3><div class="NLM_p">NaH (60% dispersion in mineral oil, 4.92 g, 122.98 mmol) was added to a mixture of intermediate <b>78</b> (9.68 g, 20.50 mmol) and 4-amino-2-methylpyridine <b>24</b> (2.22 g, 20.50 mmol) in DMF (dry on molecular sieves, 202.3 mL) at 0 °C. The resulting mixture was stirred for 20 min (red color developed) while slowly warming to rt. The solvent was evaporated to dryness, the residue was dissolved in EtOAc, then H<sub>2</sub>O was added and the mixture was evaporated yielding crude <b>79</b> as a yellow solid that was purified via prep HPLC (stationary phase, Uptisphere C18 ODB, 10 μm, 200 g, 5 cm; mobile phase, 0.1% TFA solution in H<sub>2</sub>O + 5% CH<sub>3</sub>CN, MeOH) to provide a solid that was taken up in Et<sub>2</sub>O, filtered, and then dried in vacuo at 40 °C overnight <b>79</b> (triple TFA salt and monohydrate, 2.4 g, 29%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.56 (s, 1 H), 8.81 (dd, <i>J</i> = 9.2, 0.7 Hz, 1 H), 8.55 (d, <i>J</i> = 7.0 Hz, 1 H), 8.45–8.52 (m, 3 H), 8.19 (br d, <i>J</i> = 5.1 Hz, 1 H), 7.71 (d, <i>J</i> = 9.2 Hz, 1 H), 3.71 (s, 9 H), 2.71 (s, 3 H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 161.13 (s, 1 C), 158.15 (s, 1 C), 155.52 (s, 1 C), 154.79 (s, 1 C), 153.17 (s, 1 C), 150.39 (s, 1 C), 144.98 (s, 1 C), 142.01 (s, 1 C), 139.64 (s, 1 C), 138.24 (s, 1 C), 137.62 (s, 1 C), 135.80 (s, 1 C), 120.28 (s, 1 C), 116.31 (s, 1 C), 112.30 (s, 1 C), 111.06 (s, 1 C), 69.84 (s, 1 C), 54.68 (s, 1 C), 38.30 (s, 1 C), 21.81 (s, 1 C). In addition a quartet at δ ppm 157.99 (<i>J</i> = 33 Hz) and 117.44 (<i>J</i> = 301 Hz) confirmed the presence of trifluoroacetate. H<sub>2</sub>O content (coulometry): 0.8 mol. TFA content (IC): 3 mol. LCMS (LCMS1 conditions) <i>t</i><sub>R</sub> = 1.00, 100.00% pure, <i>m</i>/<i>z</i> 294 [M]<sup>+</sup>.</div><div class="NLM_p last"><i>Note:</i> The double TFA salt and hemihydrate could be obtained as follows. The salt obtained from HPLC purification was triturated overnight in a large volume of Et<sub>2</sub>O, and the resulting fine yellow powder was filtered and washed with ether, dried overnight in vacuo at 55 °C and then for 24 h in a lyophilizer at room temperature. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>, 61 °C) δ ppm 11.68 (br s, 1 H), 8.69 (d, <i>J</i> = 9.2 Hz, 1 H), 8.52 (d, <i>J</i> = 6.7 Hz, 1 H), 8.45 (d, <i>J</i> = 9.2 Hz, 1 H), 8.40 (s,1 H), 8.36 (d, <i>J</i> = 9.1 Hz, 1 H), 8.30 (br d, <i>J</i> = 5.1 Hz, 1 H), 7.82 (d, <i>J</i> = 9.1 Hz, 1 H), 3.71 (s, 9 H), 2.65 (s, 3 H). H<sub>2</sub>O content (coulometry): 0.4 mol. TFA content (IC): 2 mol TFA. Anal. Calcd for C<sub>17</sub>H<sub>20</sub>N<sub>5</sub>·C<sub>2</sub>F<sub>3</sub>O<sub>2</sub>·C<sub>2</sub>HF<sub>3</sub>O<sub>2</sub>·0.4H<sub>2</sub>O: C, 47.71; H, 4.16; N, 13.25. Found: C, 47.18; H, 4.04; N, 13.13. LCMS (LCMS1 conditions) <i>t</i><sub>R</sub> = 0.99, 96.14% pure, <i>m</i>/<i>z</i> 294 [M]<sup>+</sup>.</div></div><div id="sec5_14_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> <i>N</i>-[(3-<sup>3</sup>H)Pyridin-4-yl]quinolin-2-amine ([<sup>3</sup>H]<b>39</b>)</h3><div id="sec5_14_43_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> Synthesis of the Precursor <i>N</i>-(3-Bromopyridin-4-yl)quinolin-2-amine (<b>80</b>)</h4><div class="NLM_p last">NBS (150 mg, 0.843 mmol) was added to a stirred solution of <b>39</b> (170 mg, 0.768 mmol) in 4 mL of CHCl<sub>3</sub> and a few drops of MeOH at rt, and the resulting mixture was heated to 60 °C for 2 h. The reaction mixture was evaporated and the residue purified by flash chromatography (silica; EtOAc in DCM, 0/100 to 10/90). The desired fractions were collected and solvents removed in vacuo to afford <b>80</b> as a white solid (59 mg, 26%). <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.72–8.91 (m, 2 H), 8.64 (s, 1 H), 8.41 (d, <i>J</i> = 5.8 Hz, 1 H), 8.25 (d, <i>J</i> = 8.8 Hz, 1 H), 7.75–7.88 (m, 2 H), 7.67 (ddd, <i>J</i> = 8.4, 6.9, 1.5 Hz, 1 H), 7.56 (d, <i>J</i> = 8.8 Hz, 1 H), 7.43 (ddd, <i>J</i> = 8.0, 6.9, 1.3 Hz, 1 H). LCMS (LCMS1 conditions) <i>t</i><sub>R</sub> = 1.15, 100% pure, <i>m</i>/<i>z</i> 300 [M + H]<sup>+</sup>.</div></div><div id="sec5_14_43_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> Synthesis of <i>N</i>-[(3-<sup>3</sup>H)Pyridin-4-yl]quinolin-2-amine ([<sup>3</sup>H]<b>39</b>)</h4><div class="NLM_p last">A reaction vessel was charged with 3 mg of the bromide precursor <b>80</b>, 5 mg of 10% Pd/C, and 0.3 mL of DMF containing 3 μL of DIPEA. The mixture was cooled in liquid nitrogen, the system was subjected to 3 cycles of degassing in vacuo, then treated with 10 Ci tritium gas with the pressure 760 mmHg. The mixture was stirred at room temperature for 3 h. The crude product was purified on a HPLC Capcell Pak C-18 column using the following instrument parameters. The flow rate was 6.0 mL/min, UV 275 nm, with mobile phase A of 0.1% TFA in H<sub>2</sub>O and mobile phase B of 0.1% TFA in acetonitrile. Elution was completed using an isocratic of 30% B. Retention time was at 30 min. 10 mCi [<sup>3</sup>H]<b>39</b> was isolated in 99.4% radiochemical purity with specific activity of 23.6 Ci/mmol. <sup>3</sup>H NMR (320 MHz, MeOD) δ ppm 8.55 (s, 1 H). LCMS <i>t</i><sub>R</sub> = 12.45 min, 99.4% radiochemical purity, <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 224.43.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01173">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11735" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11735" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01173" class="ext-link">10.1021/acs.jmedchem.6b01173</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Metabolic pathways for <b>60</b> in human and mouse liver microsomes, <i>K</i><sub>d</sub> and <i>B</i><sub>max</sub> determination for [<sup>3</sup>H]<b>7</b> and [<sup>3</sup>H]<b>39</b>, and CEREP and KINOMEscan data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01173/suppl_file/jm6b01173_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01173/suppl_file/jm6b01173_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01173/suppl_file/jm6b01173_si_001.pdf">jm6b01173_si_001.pdf (696.22 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01173/suppl_file/jm6b01173_si_002.csv">jm6b01173_si_002.csv (1.44 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b01173" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05355" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05355" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederik J. R. Rombouts</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research &
Development, Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1986-0476" title="Orcid link">http://orcid.org/0000-0003-1986-0476</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9dfbeff2f0fff2e8e9ddf4e9eeb3f7f3f7b3fef2f0"><span class="__cf_email__" data-cfemail="0462766b69666b7170446d70772a6e6a6e2a676b69">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José-Ignacio Andrés</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, Janssen Research & Development,
Janssen-Cilag S. A., C/Jarama 75A, 45007 Toledo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manuela Ariza</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research &
Development, Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José Manuel Alonso</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, Janssen Research & Development,
Janssen-Cilag S. A., C/Jarama 75A, 45007 Toledo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nigel Austin</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, Janssen Research & Development,
Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Astrid Bottelbergs</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, Janssen Research & Development,
Janssen-Cilag S. A., C/Jarama 75A, 45007 Toledo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lu Chen</span> - <span class="hlFld-Affiliation affiliation">Isotope
Chemistry and Biotransformation, Janssen
Research & Development, Welsh & McKean Roads, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vladimir Chupakhin</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, Janssen Research & Development,
Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erna Cleiren</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, Janssen Research & Development,
Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katleen Fierens</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, Janssen Research & Development,
Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alberto Fontana</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, Janssen Research & Development,
Janssen-Cilag S. A., C/Jarama 75A, 45007 Toledo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xavier Langlois</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Biology, Janssen Research & Development,
Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph E. Leenaerts</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research &
Development, Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonas Mariën</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Biology, Janssen Research & Development,
Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carolina Martínez Lamenca</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research &
Development, Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rhys Salter</span> - <span class="hlFld-Affiliation affiliation">Isotope
Chemistry and Biotransformation, Janssen
Research & Development, Welsh & McKean Roads, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark E. Schmidt</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Experimental Medicine, Janssen Early Development, Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paula Te Riele</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Biology, Janssen Research & Development,
Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cindy Wintmolders</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Biology, Janssen Research & Development,
Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrés A. Trabanco</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research &
Development, Janssen-Cilag S. A., C/Jarama 75A, 45007 Toledo, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4225-758X" title="Orcid link">http://orcid.org/0000-0002-4225-758X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Zhang</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Biomarker Research, Janssen Research &
Development, 3210 Merryfield
Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregor Macdonald</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research &
Development, Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dieder Moechars</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Biology, Janssen Research & Development,
Janssen Pharmaceutica N. V., Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d92e7131-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45572" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45572" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to Lieve Heylen for the planning and data management. We thank Geert Pille for the p<i>K</i><sub>a</sub> and log <i>P</i> measurements. We thank Ilse Lenaerts for performing the autoradiography experiments with [<sup>3</sup>H]<b>39</b>. We thank Dr. Yong Gong for coordinating the tritiation of <b>39</b> with Moravek Biochemicals (<a href="http://www.moravek.com/" class="extLink">http://www.moravek.com/</a>, accessed August 3, 2016). We thank Lieven Declercq and Dr. Guy Bormans from the University of Leuven for their input and guidance during the project. Finally, we also thank Dr. Hartmuth Kolb for his input and guidance during the project. This work was supported by Flanders Innovation and Entrepreneurship (formerly called IWT), <a href="http://www.vlaio.be/english" class="extLink">http://www.vlaio.be/english</a> (accessed August 01, 2016).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i91" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i91"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i92" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i92"> Abbreviations Used</h2><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">Amphos</td><td class="NLM_def"><p class="first last">di-<i>tert</i>-butyl(4-dimethylaminophenyl)phosphine</p></td></tr><tr><td class="NLM_term">AUC<sub>0–last</sub></td><td class="NLM_def"><p class="first last">area under the curve until last time point sampled</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid β</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum plasma concentration</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">DAST</td><td class="NLM_def"><p class="first last">diethylaminosulfur trifluoride</p></td></tr><tr><td class="NLM_term">dba</td><td class="NLM_def"><p class="first last">dibenzylideneacetone</p></td></tr><tr><td class="NLM_term">DIPE</td><td class="NLM_def"><p class="first last">diisopropyl ether</p></td></tr><tr><td class="NLM_term"><i>f</i><sub>u</sub></td><td class="NLM_def"><p class="first last">free (unbound) fraction</p></td></tr><tr><td class="NLM_term">HBA</td><td class="NLM_def"><p class="first last">hydrogen bond acceptor</p></td></tr><tr><td class="NLM_term">HBD</td><td class="NLM_def"><p class="first last">hydrogen bond donor</p></td></tr><tr><td class="NLM_term">hLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">HP-β-CD</td><td class="NLM_def"><p class="first last">(2-hydroxypropyl)-β-cyclodextrin [CAS no. 128446-35-5]</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high throughput screening</p></td></tr><tr><td class="NLM_term">IC</td><td class="NLM_def"><p class="first last">ion chromatography</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>p</sub></td><td class="NLM_def"><p class="first last">brain-to-plasma ratio</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>p,uu</sub></td><td class="NLM_def"><p class="first last">ratio between unbound concentrations in brain and plasma</p></td></tr><tr><td class="NLM_term">MAO</td><td class="NLM_def"><p class="first last">monoamine oxidase</p></td></tr><tr><td class="NLM_term">NFT</td><td class="NLM_def"><p class="first last">neurofibrillary tangle</p></td></tr><tr><td class="NLM_term">NT</td><td class="NLM_def"><p class="first last">not tested</p></td></tr><tr><td class="NLM_term">mLM</td><td class="NLM_def"><p class="first last">mouse liver microsome</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent permeability</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">PHF</td><td class="NLM_def"><p class="first last">paired helical filaments</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">polar surface area</p></td></tr><tr><td class="NLM_term">rLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">sc</td><td class="NLM_def"><p class="first last">subcutaneous</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">Sprague-Dawley</p></td></tr><tr><td class="NLM_term">SP</td><td class="NLM_def"><p class="first last">senile plaque</p></td></tr><tr><td class="NLM_term">SUVR</td><td class="NLM_def"><p class="first last">standardized uptake value between region of interest and reference region</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term">TBAT</td><td class="NLM_def"><p class="first last">tetrabutylammonium difluorotriphenylsilicate</p></td></tr><tr><td class="NLM_term">TPP</td><td class="NLM_def"><p class="first last">target product profile</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>d,ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution at steady state</p></td></tr><tr><td class="NLM_term">Xantphos</td><td class="NLM_def"><p class="first last">4,5-bis(diphenylphosphino)-9,9-dimethylxanthene</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i93">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33323" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33323" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 72 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Khachaturian, Z. S.</span><span> </span><span class="NLM_article-title">Diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1097</span><span class="NLM_x">–</span> <span class="NLM_lpage">1105</span><span class="refDoi"> DOI: 10.1001/archneur.1985.04060100083029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1001%2Farchneur.1985.04060100083029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=2864910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADyaL28%252FisV2kug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1985&pages=1097-1105&author=Z.+S.+Khachaturian&title=Diagnosis+of+Alzheimer%E2%80%99s+disease&doi=10.1001%2Farchneur.1985.04060100083029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Diagnosis of Alzheimer's disease</span></div><div class="casAuthors">Khachaturian Z S</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1097-105</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTc9SvEChaSAWGmni0r9GoKfW6udTcc2ebiikET93PlG7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL28%252FisV2kug%253D%253D&md5=a47cb19684c6e17f83431a1aadd57cde</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1001%2Farchneur.1985.04060100083029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.1985.04060100083029%26sid%3Dliteratum%253Aachs%26aulast%3DKhachaturian%26aufirst%3DZ.%2BS.%26atitle%3DDiagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D1985%26volume%3D42%26spage%3D1097%26epage%3D1105%26doi%3D10.1001%2Farchneur.1985.04060100083029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: strategies for disease modification</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span><span class="refDoi"> DOI: 10.1038/nrd2896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1038%2Fnrd2896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=20431570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVWjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=387-398&author=M.+Citron&title=Alzheimer%E2%80%99s+disease%3A+strategies+for+disease+modification&doi=10.1038%2Fnrd2896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: strategies for disease modification</span></div><div class="casAuthors">Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">387-398</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is the largest unmet medical need in neurol.  Current drugs improve symptoms, but do not have profound disease-modifying effects.  However, in recent years, several approaches aimed at inhibiting disease progression have advanced to clin. trials.  Among these, strategies targeting the prodn. and clearance of the amyloid-β peptide - a cardinal feature of Alzheimer's disease that is thought to be important in disease pathogenesis - are the most advanced.  Approaches aimed at modulating the abnormal aggregation of tau filaments (another key feature of the disease), and those targeting metabolic dysfunction, are also being evaluated in the clinic.  This article discusses recent progress with each of these strategies, with a focus on anti-amyloid strategies, highlighting the lessons learned and the challenges that remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeM0fsdJQ-z7Vg90H21EOLACvtfcHk0lh_tpoCktT4kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVWjsrw%253D&md5=281ba27137d2a1fa173d5dde1dcbe772</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd2896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2896%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520strategies%2520for%2520disease%2520modification%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D387%26epage%3D398%26doi%3D10.1038%2Fnrd2896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Nelson, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alafuzoff, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigio, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouras, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellani, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crain, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Tredici, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duyckaerts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frosch, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haroutunian, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulette, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jellinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jicha, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukull, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverenz, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackenzie, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonnen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troncoso, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woltjer, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beach, T. G.</span><span> </span><span class="NLM_article-title">Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature</span> <span class="citation_source-journal">J. Neuropathol. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span><span class="refDoi"> DOI: 10.1097/NEN.0b013e31825018f7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1097%2FNEN.0b013e31825018f7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=22487856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADC%252BC38rjsFaitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=362-381&author=P.+T.+Nelsonauthor=I.+Alafuzoffauthor=E.+H.+Bigioauthor=C.+Bourasauthor=H.+Braakauthor=N.+J.+Cairnsauthor=R.+J.+Castellaniauthor=B.+J.+Crainauthor=P.+Daviesauthor=K.+Del+Trediciauthor=C.+Duyckaertsauthor=M.+P.+Froschauthor=V.+Haroutunianauthor=P.+R.+Hofauthor=C.+M.+Huletteauthor=B.+T.+Hymanauthor=T.+Iwatsuboauthor=K.+A.+Jellingerauthor=G.+A.+Jichaauthor=E.+Kovariauthor=W.+A.+Kukullauthor=J.+B.+Leverenzauthor=S.+Loveauthor=I.+R.+Mackenzieauthor=D.+M.+Mannauthor=E.+Masliahauthor=A.+C.+McKeeauthor=T.+J.+Montineauthor=J.+C.+Morrisauthor=J.+A.+Schneiderauthor=J.+A.+Sonnenauthor=D.+R.+Thalauthor=J.+Q.+Trojanowskiauthor=J.+C.+Troncosoauthor=T.+Wisniewskiauthor=R.+L.+Woltjerauthor=T.+G.+Beach&title=Correlation+of+Alzheimer+disease+neuropathologic+changes+with+cognitive+status%3A+a+review+of+the+literature&doi=10.1097%2FNEN.0b013e31825018f7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of Alzheimer disease neuropathologic changes with cognitive status:  a review of the literature</span></div><div class="casAuthors">Nelson Peter T; Alafuzoff Irina; Bigio Eileen H; Bouras Constantin; Braak Heiko; Cairns Nigel J; Castellani Rudolph J; Crain Barbara J; Davies Peter; Del Tredici Kelly; Duyckaerts Charles; Frosch Matthew P; Haroutunian Vahram; Hof Patrick R; Hulette Christine M; Hyman Bradley T; Iwatsubo Takeshi; Jellinger Kurt A; Jicha Gregory A; Kovari Eniko; Kukull Walter A; Leverenz James B; Love Seth; Mackenzie Ian R; Mann David M; Masliah Eliezer; McKee Ann C; Montine Thomas J; Morris John C; Schneider Julie A; Sonnen Joshua A; Thal Dietmar R; Trojanowski John Q; Troncoso Juan C; Wisniewski Thomas; Woltjer Randall L; Beach Thomas G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuropathology and experimental neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">362-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Clinicopathologic correlation studies are critically important for the field of Alzheimer disease (AD) research.  Studies on human subjects with autopsy confirmation entail numerous potential biases that affect both their general applicability and the validity of the correlations.  Many sources of data variability can weaken the apparent correlation between cognitive status and AD neuropathologic changes.  Indeed, most persons in advanced old age have significant non-AD brain lesions that may alter cognition independently of AD.  Worldwide research efforts have evaluated thousands of human subjects to assess the causes of cognitive impairment in the elderly, and these studies have been interpreted in different ways.  We review the literature focusing on the correlation of AD neuropathologic changes (i.e. β-amyloid plaques and neurofibrillary tangles) with cognitive impairment.  We discuss the various patterns of brain changes that have been observed in elderly individuals to provide a perspective for understanding AD clinicopathologic correlation and conclude that evidence from many independent research centers strongly supports the existence of a specific disease, as defined by the presence of Aβ plaques and neurofibrillary tangles.  Although Aβ plaques may play a key role in AD pathogenesis, the severity of cognitive impairment correlates best with the burden of neocortical neurofibrillary tangles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfBiLIW6MJ0v9pSBfyDvp7fW6udTcc2ebiikET93PlG7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rjsFaitg%253D%253D&md5=172e31ea54410212b1d60f7ff6f1d4d6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2FNEN.0b013e31825018f7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FNEN.0b013e31825018f7%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DP.%2BT.%26aulast%3DAlafuzoff%26aufirst%3DI.%26aulast%3DBigio%26aufirst%3DE.%2BH.%26aulast%3DBouras%26aufirst%3DC.%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DCairns%26aufirst%3DN.%2BJ.%26aulast%3DCastellani%26aufirst%3DR.%2BJ.%26aulast%3DCrain%26aufirst%3DB.%2BJ.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DDel%2BTredici%26aufirst%3DK.%26aulast%3DDuyckaerts%26aufirst%3DC.%26aulast%3DFrosch%26aufirst%3DM.%2BP.%26aulast%3DHaroutunian%26aufirst%3DV.%26aulast%3DHof%26aufirst%3DP.%2BR.%26aulast%3DHulette%26aufirst%3DC.%2BM.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DJellinger%26aufirst%3DK.%2BA.%26aulast%3DJicha%26aufirst%3DG.%2BA.%26aulast%3DKovari%26aufirst%3DE.%26aulast%3DKukull%26aufirst%3DW.%2BA.%26aulast%3DLeverenz%26aufirst%3DJ.%2BB.%26aulast%3DLove%26aufirst%3DS.%26aulast%3DMackenzie%26aufirst%3DI.%2BR.%26aulast%3DMann%26aufirst%3DD.%2BM.%26aulast%3DMasliah%26aufirst%3DE.%26aulast%3DMcKee%26aufirst%3DA.%2BC.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DSchneider%26aufirst%3DJ.%2BA.%26aulast%3DSonnen%26aufirst%3DJ.%2BA.%26aulast%3DThal%26aufirst%3DD.%2BR.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DTroncoso%26aufirst%3DJ.%2BC.%26aulast%3DWisniewski%26aufirst%3DT.%26aulast%3DWoltjer%26aufirst%3DR.%2BL.%26aulast%3DBeach%26aufirst%3DT.%2BG.%26atitle%3DCorrelation%2520of%2520Alzheimer%2520disease%2520neuropathologic%2520changes%2520with%2520cognitive%2520status%253A%2520a%2520review%2520of%2520the%2520literature%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2012%26volume%3D71%26spage%3D362%26epage%3D381%26doi%3D10.1097%2FNEN.0b013e31825018f7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Delacourte, A.</span><span> </span><span class="NLM_article-title">Diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">Ann. Biol. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=9754238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADyaK1cvis1yntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1998&pages=133-142&author=A.+Delacourte&title=Diagnosis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Diagnosis of Alzheimer's disease</span></div><div class="casAuthors">Delacourte A</div><div class="citationInfo"><span class="NLM_cas:title">Annales de biologie clinique</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-42</span>
        ISSN:<span class="NLM_cas:issn">0003-3898</span>.
    </div><div class="casAbstract">Alzheimer's disease is a neurodegenerative disorder leading to cognitive impairment (amnesia, aphasia, apraxia and agnosia).  The prevalence of this age related disabling illness is increasing.  During the course of the disease, the clinical diagnosis will be that of "possible Alzheimer's disease", then "probable Alzheimer's disease".  But the diagnosis of "definite Alzheimer's disease" requires a post-mortem brain examination and the demonstration of numerous senile plaques and neurofibrillary tangles in hippocampal and association cortical areas.  The neuropathological examination confirms probable Alzheimer's disease clinical diagnosis in 85% of the cases examined in medical schools.  However, with much more than 15% errors, the early diagnosis of Alzheimer's disease must be improved since it is a key factor for the therapeutic approach, and more especially for the efficiency of drug trials.  At the present time, there are new leads for a biological diagnosis in the blood or the CSF.  However, the natural (and molecular) history of Alzheimer's disease points out that all biochemical dysfunctions remain in the CNS, and more particularly in association brain areas.  This is demonstrated using reliable biochemical markers such as A beta and pathological Tau proteins, which are the basic components of amyloid deposits and neurofibrillary tangles, respectively.  Also, a genetic diagnosis can be performed in half of familial autosomic dominant Alzheimer's disease, which represents less than 1% of all Alzheimer's disease cases.  Together, this shows that there is a lack of reliable Alzheimer's disease markers.  The search for new specific markers (clinical, epidemiological, genetic, biochemical, biological) must go on.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1f1PBUrz3XdyzdcP07UmufW6udTcc2eaRgFBWT3Dkybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1cvis1yntA%253D%253D&md5=3c95236af3100e692fad9515b72cfbdd</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelacourte%26aufirst%3DA.%26atitle%3DDiagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520Biol.%2520Clin.%26date%3D1998%26volume%3D56%26spage%3D133%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Strategies for improving the postmortem neuropathological diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">S75</span><span class="NLM_x">–</span> <span class="NLM_lpage">S79</span><span class="refDoi"> DOI: 10.1016/S0197-4580(97)00075-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2FS0197-4580%2897%2900075-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=9330990" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=S75-S79&author=J.+Q.+Trojanowskiauthor=C.+M.+Clarkauthor=M.+L.+Schmidtauthor=S.+E.+Arnoldauthor=V.+M.+Lee&title=Strategies+for+improving+the+postmortem+neuropathological+diagnosis+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0197-4580%2897%2900075-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2897%2900075-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252897%252900075-4%26sid%3Dliteratum%253Aachs%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DClark%26aufirst%3DC.%2BM.%26aulast%3DSchmidt%26aufirst%3DM.%2BL.%26aulast%3DArnold%26aufirst%3DS.%2BE.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DStrategies%2520for%2520improving%2520the%2520postmortem%2520neuropathological%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D1997%26volume%3D18%26spage%3DS75%26epage%3DS79%26doi%3D10.1016%2FS0197-4580%2897%2900075-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">DeKosky, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marek, K.</span><span> </span><span class="NLM_article-title">Looking backward to move forward: early detection of neurodegenerative disorders</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">830</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span><span class="refDoi"> DOI: 10.1126/science.1090349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1126%2Fscience.1090349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=14593169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Cmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=830-834&author=S.+T.+DeKoskyauthor=K.+Marek&title=Looking+backward+to+move+forward%3A+early+detection+of+neurodegenerative+disorders&doi=10.1126%2Fscience.1090349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Looking backward to move forward: Early detection of neurodegenerative disorders</span></div><div class="casAuthors">DeKosky, Steven T.; Marek, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5646</span>),
    <span class="NLM_cas:pages">830-834</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Early detection of neurodegenerative disorders would provide clues to the underlying pathobiol. of these diseases and would enable more effective diagnosis and treatment of patients.  Recent advances in mol. neuroscience have begun to provide the tools to detect diseases like Alzheimer's disease, Parkinson's disease, and others early in their course and potentially even before the development of clin. manifestations of disease.  These genetic, imaging, clin., and biochem. tools are being validated in a no. of studies.  Early detection of these slowly progressive diseases offers the promise of presymptomatic diagnosis and, ultimately, of disease-modifying medications for use early in disease and during the presymptomatic period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsFocomYIAdbVg90H21EOLACvtfcHk0ljzkccI0S6yNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Cmt7s%253D&md5=2f286b23ca55deeca5990ad6f1bfed53</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.1090349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1090349%26sid%3Dliteratum%253Aachs%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26aulast%3DMarek%26aufirst%3DK.%26atitle%3DLooking%2520backward%2520to%2520move%2520forward%253A%2520early%2520detection%2520of%2520neurodegenerative%2520disorders%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D830%26epage%3D834%26doi%3D10.1126%2Fscience.1090349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Reiman, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagust, W. J.</span><span> </span><span class="NLM_article-title">Brain imaging in the study of Alzheimer’s disease</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span><span class="refDoi"> DOI: 10.1016/j.neuroimage.2011.11.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.neuroimage.2011.11.075" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=505-516&author=E.+M.+Reimanauthor=W.+J.+Jagust&title=Brain+imaging+in+the+study+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neuroimage.2011.11.075"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2011.11.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2011.11.075%26sid%3Dliteratum%253Aachs%26aulast%3DReiman%26aufirst%3DE.%2BM.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26atitle%3DBrain%2520imaging%2520in%2520the%2520study%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuroImage%26date%3D2012%26volume%3D61%26spage%3D505%26epage%3D516%26doi%3D10.1016%2Fj.neuroimage.2011.11.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, W.</span><span> </span><span class="NLM_article-title">Advances of molecular imaging probes for the diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span><span class="refDoi"> DOI: 10.2174/1567205011666140131121259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2174%2F1567205011666140131121259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=24484277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1eru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=221-231&author=M.+Zhouauthor=X.+Wangauthor=Z.+Liuauthor=L.+Yuauthor=S.+Huauthor=L.+Chenauthor=W.+Zeng&title=Advances+of+molecular+imaging+probes+for+the+diagnosis+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F1567205011666140131121259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Advances of Molecular Imaging Probes for the Diagnosis of Alzheimer's Disease</span></div><div class="casAuthors">Zhou, Ming; Wang, Xiaobo; Liu, Zhiguo; Yu, Lun; Hu, Shuo; Chen, Lizhang; Zeng, Wenbin</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-231</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive decline in multiple cognitive domains and it becomes the most common cause of dementia in the elderly.  There is an urgent need for the early diagnosis and treatment of AD to ease caregiver burden and medical costs, as well as improve patients' living activities assocd. with the dramatic increasing no. of affected individuals.  Mol. imaging with target-specific probes is contributing to identify the underlying biol. in AD, which benefits to the early diagnosis of AD and the evaluation of anti-AD therapy.  Mol. imaging probes, such as 11C-PIB, 11C-MP4A, 18F-AV-45, and 18F-FDG, can selectively bind to special bimol. of AD or accurately accumulate at the location of damage areas, thus become an edge tool for a better management of the diseases in the clin. practice and new drug development.  In the past decades, a large variety of probes is being developed and tested to be useful for the early and accurate diagnosis of Alzheimer's disease, patient selection for disease-modifying therapeutic trials and monitoring the effect of anti-amyloid therapy.  Since imaging probes may also help to guide physicians to identify those patients that could best benefit from a given therapeutic regimen, dose, or duration of drug, this paper is to present a perspective of the available imaging probes for AD, classified on different modalities.  Meanwhile, recent advances of those probes that have been selected for clin. trials and are at the different stages of the US Food and Drugs Administration (FDA) approval are outlined.  Addnl., future directions and specific application of imaging strategies designed for both diagnosis and treatment for AD are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLa6ITw42ws7Vg90H21EOLACvtfcHk0lgY5c0bPaEMQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1eru7k%253D&md5=d919e86d68e5ba2243d1715db76c3d4d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F1567205011666140131121259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205011666140131121259%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DW.%26atitle%3DAdvances%2520of%2520molecular%2520imaging%2520probes%2520for%2520the%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2014%26volume%3D11%26spage%3D221%26epage%3D231%26doi%3D10.2174%2F1567205011666140131121259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Valk, P. E.; Bailey, D. L.; Townsend, D. W.; Maisey, M. N.</span> <span class="citation_source-book">Positron Emission Tomography: Basic Science</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=P.+E.+Valk&author=D.+L.+Bailey&author=D.+W.+Townsend&author=M.+N.+Maisey&title=Positron+Emission+Tomography%3A+Basic+Science"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DValk%26aufirst%3DP.%2BE.%26btitle%3DPositron%2520Emission%2520Tomography%253A%2520Basic%2520Science%26pub%3DSpringer%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Kung, H. F.</span><span> </span><span class="NLM_article-title">The β-amyloid hypothesis in Alzheimer’s disease: seeing is believing</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span><span class="refDoi"> DOI: 10.1021/ml300058m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300058m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFehs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=265-267&author=H.+F.+Kung&title=The+%CE%B2-amyloid+hypothesis+in+Alzheimer%E2%80%99s+disease%3A+seeing+is+believing&doi=10.1021%2Fml300058m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The β-Amyloid Hypothesis in Alzheimer's Disease: Seeing Is Believing</span></div><div class="casAuthors">Kung, Hank F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">265-267</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, discussing amyloid precursor protein degrdn. by proteases and the imbalance of prodn. and clearance of Aβ40-42 fragments in the brain in Alzheimer's disease and the PET imaging agents being approved by the FDA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2d1v-xf_5IrVg90H21EOLACvtfcHk0lgY5c0bPaEMQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFehs78%253D&md5=729086c7a759fc5d22f84d300289a44a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fml300058m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300058m%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DH.%2BF.%26atitle%3DThe%2520%25CE%25B2-amyloid%2520hypothesis%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520seeing%2520is%2520believing%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D265%26epage%3D267%26doi%3D10.1021%2Fml300058m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Mason, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span> </span><span class="NLM_article-title">Positron emission tomography radioligands for in vivo imaging of Aβ plaques</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span><span class="refDoi"> DOI: 10.1002/jlcr.2989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1002%2Fjlcr.2989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=24285314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtlejtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=89-95&author=N.+S.+Masonauthor=C.+A.+Mathisauthor=W.+E.+Klunk&title=Positron+emission+tomography+radioligands+for+in+vivo+imaging+of+A%CE%B2+plaques&doi=10.1002%2Fjlcr.2989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography radioligands for in vivo imaging of Aβ plaques</span></div><div class="casAuthors">Mason, N. Scott; Mathis, Chester A.; Klunk, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">89-95</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  The development of positron emission tomog. (PET) radioligands for the non-invasive imaging of amyloid-β plaque burden has been the focus of intense research efforts over the last decade.  A variety of structural backbones have been investigated and several radiolabeled mols. have been evaluated in phase I (and later) clin. studies.  These efforts have been driven by the desire not only to develop a suitable diagnostic imaging agent but also to develop a means to evaluate potential therapies for Alzheimer's disease.  This review focuses on the development of these ligands, as well as the radiochem. and current regulatory status of these PET radioligands.  Particular attention is given to those ligands that have progressed to the later stages of drug development (phase II/III clin. trial studies) or approved New Drug Application status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFhPmau7iHILVg90H21EOLACvtfcHk0lgY5c0bPaEMQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtlejtbs%253D&md5=423e02bcc2709e718d7a32adb552f81f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.2989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.2989%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DN.%2BS.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DPositron%2520emission%2520tomography%2520radioligands%2520for%2520in%2520vivo%2520imaging%2520of%2520A%25CE%25B2%2520plaques%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2013%26volume%3D56%26spage%3D89%26epage%3D95%26doi%3D10.1002%2Fjlcr.2989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Noël, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gras, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hureau, C.</span><span> </span><span class="NLM_article-title">The benzazole scaffold: a SWAT to combat Alzheimer’s disease</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">7747</span><span class="NLM_x">–</span> <span class="NLM_lpage">7762</span><span class="refDoi"> DOI: 10.1039/c3cs60086f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1039%2Fc3cs60086f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=23793644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSit7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=7747-7762&author=S.+No%C3%ABlauthor=S.+Cadetauthor=E.+Grasauthor=C.+Hureau&title=The+benzazole+scaffold%3A+a+SWAT+to+combat+Alzheimer%E2%80%99s+disease&doi=10.1039%2Fc3cs60086f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The benzazole scaffold: a SWAT to combat Alzheimer's disease</span></div><div class="casAuthors">Noel, Sabrina; Cadet, Sarah; Gras, Emmanuel; Hureau, Christelle</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7747-7762</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative disorders including Alzheimer's disease (AD) are drawing scientists' attention within various fields, being one of the most serious diseases mankind will have to fight against in the very near future.  AD is multi-factorial and is characterized by two histopathol. hallmarks: the senile plaques made of amyloid-β (Aβ) peptide fibrils which also contain high levels of transition metal ions and the neurofibrillary tangles of Tau protein.  Aβ aggregation, possibly modulated by metal ions, is now considered as an important factor in AD etiol.  Hence, chemists are studying the details of mol. features at the origin of the disease with special interest in Aβ aggregation and in the design of new mols. for the early diagnosis of AD or with curative properties.  In this context, the benzazole mol. scaffold, included for instance in Thioflavin-T, an Aβ fibril specific dye, or the PIB imaging agent, appears to be very attractive and exhibits multiple uses.  In the present review, the authors have thus focused the authors' interest on the applications of benzazole derivs. for understanding, diagnosing and curing AD.  After having analyzed the synthetic access to 2-arylbenzazoles, the authors have described a selection of recent applications of such compds. aiming to combat AD.  They include the use of Thioflavin-T for the monitoring of Aβ aggregation, the investigations of new PET and SPECT imaging agents for the detection of the senile plaques, the development of bi-functional mols., encompassing the 2-arylbenzazole moiety for Aβ binding and a chelating unit for metal ions coordination for instance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHZz8Ue4nXT7Vg90H21EOLACvtfcHk0liueiAU8cC4jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSit7bJ&md5=2e45c81f4fdc6d9edd3a7d452971a701</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1039%2Fc3cs60086f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cs60086f%26sid%3Dliteratum%253Aachs%26aulast%3DNo%25C3%25ABl%26aufirst%3DS.%26aulast%3DCadet%26aufirst%3DS.%26aulast%3DGras%26aufirst%3DE.%26aulast%3DHureau%26aufirst%3DC.%26atitle%3DThe%2520benzazole%2520scaffold%253A%2520a%2520SWAT%2520to%2520combat%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2013%26volume%3D42%26spage%3D7747%26epage%3D7762%26doi%3D10.1039%2Fc3cs60086f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span> </span><span class="NLM_article-title">Amyloid imaging with PET in early Alzheimer disease diagnosis</span> <span class="citation_source-journal">Med. Clin. North Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span><span class="refDoi"> DOI: 10.1016/j.mcna.2012.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.mcna.2012.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=23642577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADC%252BC3sngvFCrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2013&pages=377-398&author=C.+C.+Roweauthor=V.+L.+Villemagne&title=Amyloid+imaging+with+PET+in+early+Alzheimer+disease+diagnosis&doi=10.1016%2Fj.mcna.2012.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid imaging with PET in early Alzheimer disease diagnosis</span></div><div class="casAuthors">Rowe Christopher C; Villemagne Victor L</div><div class="citationInfo"><span class="NLM_cas:title">The Medical clinics of North America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">377-98</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In vivo imaging of amyloid-β (Aβ) with positron emission tomography has moved from the research arena into clinical practice.  Clinicians working with cognitive decline and dementia must become familiar with its benefits and limitations.  Amyloid imaging allows earlier diagnosis of Alzheimer disease and better differential diagnosis of dementia and provides prognostic information for mild cognitive impairment.  It also has an increasingly important role in therapeutic trial recruitment and for evaluation of anti-Aβ treatments.  Longitudinal observations are required to elucidate the role of Aβ deposition in the course of Alzheimer disease and provide information needed to fully use the prognostic power of this investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ6G2K_LCaW1QHqQV89nF-2fW6udTcc2eb9GkelFnwZ27ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sngvFCrug%253D%253D&md5=46ec97a002c90bbd2b1f14303b243fa3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.mcna.2012.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcna.2012.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26atitle%3DAmyloid%2520imaging%2520with%2520PET%2520in%2520early%2520Alzheimer%2520disease%2520diagnosis%26jtitle%3DMed.%2520Clin.%2520North%2520Am.%26date%3D2013%26volume%3D97%26spage%3D377%26epage%3D398%26doi%3D10.1016%2Fj.mcna.2012.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Holland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotstein, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greguric, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasdev, N.</span><span> </span><span class="NLM_article-title">Alternative approaches for PET radiotracer development in Alzheimers disease: imaging beyond plaque</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span><span class="refDoi"> DOI: 10.1002/jlcr.3158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1002%2Fjlcr.3158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=24327420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFakur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=323-331&author=J.+P.+Hollandauthor=S.+H.+Liangauthor=B.+H.+Rotsteinauthor=T.+L.+Collierauthor=N.+A.+Stephensonauthor=I.+Greguricauthor=N.+Vasdev&title=Alternative+approaches+for+PET+radiotracer+development+in+Alzheimers+disease%3A+imaging+beyond+plaque&doi=10.1002%2Fjlcr.3158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative approaches for PET radiotracer development in Alzheimers disease: imaging beyond plaque</span></div><div class="casAuthors">Holland, Jason P.; Liang, Steven H.; Rotstein, Benjamin H.; Collier, Thomas L.; Stephenson, Nickeisha A.; Greguric, Ivan; Vasdev, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">323-331</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) and related dementias show increasing clin. prevalence, yet our understanding of the etiol. and pathobiol. of disease-related neurodegeneration remains limited.  In this regard, noninvasive imaging with radiotracers for positron emission tomog. (PET) presents a unique tool for quantifying spatial and temporal changes in characteristic biol. markers of brain disease and for assessing potential drug efficacy.  PET radiotracers targeting different protein markers are being developed to address questions pertaining to the mol. and/or genetic heterogeneity of AD and related dementias.  For example, radiotracers including [11C]-PiB and [18F]-AV-45 (Florbetapir) are being used to measure the d. of Aβ-plaques in AD patients and to interrogate the biol. mechanisms of disease initiation and progression.  Our focus is on the development of novel PET imaging agents, targeting proteins beyond Aβ-plaques, which can be used to investigate the broader mechanism of AD pathogenesis.  Here, we present the chem. basis of various radiotracers which show promise in preclin. or clin. studies for use in evaluating the phenotypic or biochem. characteristics of AD.  Radiotracers for PET imaging neuroinflammation, metal ion assocn. with Aβ-plaques, tau protein, cholinergic and cannabinoid receptors, and enzymes including glycogen-synthase kinase-3β and monoamine oxidase B amongst others, and their connection to AD are highlighted.  Copyright © 2013 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAGqOOrpGlyrVg90H21EOLACvtfcHk0liueiAU8cC4jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFakur%252FL&md5=d908d7a016b475367ebe86cb8693f01f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3158%26sid%3Dliteratum%253Aachs%26aulast%3DHolland%26aufirst%3DJ.%2BP.%26aulast%3DLiang%26aufirst%3DS.%2BH.%26aulast%3DRotstein%26aufirst%3DB.%2BH.%26aulast%3DCollier%26aufirst%3DT.%2BL.%26aulast%3DStephenson%26aufirst%3DN.%2BA.%26aulast%3DGreguric%26aufirst%3DI.%26aulast%3DVasdev%26aufirst%3DN.%26atitle%3DAlternative%2520approaches%2520for%2520PET%2520radiotracer%2520development%2520in%2520Alzheimers%2520disease%253A%2520imaging%2520beyond%2520plaque%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2014%26volume%3D57%26spage%3D323%26epage%3D331%26doi%3D10.1002%2Fjlcr.3158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span> </span><span class="NLM_article-title">The challenges of tau imaging</span> <span class="citation_source-journal">Future Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span><span class="refDoi"> DOI: 10.2217/fnl.12.34</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2217%2Ffnl.12.34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSgs7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=409-421&author=V.+L.+Villemagneauthor=S.+Furumotoauthor=M.+Fodero-Tavolettiauthor=R.+Haradaauthor=R.+S.+Mulliganauthor=Y.+Kudoauthor=C.+L.+Mastersauthor=K.+Yanaiauthor=C.+C.+Roweauthor=N.+Okamura&title=The+challenges+of+tau+imaging&doi=10.2217%2Ffnl.12.34"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The challenges of tau imaging</span></div><div class="casAuthors">Villemagne, Victor L.; Furumoto, Shozo; Fodero-Tavoletti, Michelle; Harada, Ryuichi; Mulligan, Rachel S.; Kudo, Yukitsuka; Masters, Colin L.; Yanai, Kazuhiko; Rowe, Chistopher C.; Okamura, Nobuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Future Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">409-421</span>CODEN:
                <span class="NLM_cas:coden">FNUEAM</span>;
        ISSN:<span class="NLM_cas:issn">1479-6708</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  In vivo imaging of tau pathol. will provide new insights into tau deposition in the human brain, thus facilitating research into causes, diagnosis and treatment of major dementias, such as Alzheimer's disease, or some variants of frontotemporal lobar degeneration, in which tau plays a role.  Tau imaging poses several challenges, some related to the singularities of tau aggregation, and others related to radiotracer design.  Several groups around the world are working on the development of imaging agents that will allow the in vivo assessment of tau deposition in aging and in neurodegeneration.  Development of a tau imaging tracer will enable researchers to noninvasively examine the degree and extent of tau pathol. in the brain, quantify changes in tau deposition over time, evaluate its relation to cognition and assess the efficacy of anti-tau therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfIVpSOSew27Vg90H21EOLACvtfcHk0liueiAU8cC4jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSgs7nE&md5=bc3d8d6579bc07a7ab7065948bdfaa73</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2217%2Ffnl.12.34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffnl.12.34%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DOkamura%26aufirst%3DN.%26atitle%3DThe%2520challenges%2520of%2520tau%2520imaging%26jtitle%3DFuture%2520Neurol.%26date%3D2012%26volume%3D7%26spage%3D409%26epage%3D421%26doi%3D10.2217%2Ffnl.12.34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Maccioni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farías, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarrete, L.</span><span> </span><span class="NLM_article-title">The revitalized tau hypothesis on Alzheimer’s disease</span> <span class="citation_source-journal">Arch. Med. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">226</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span><span class="refDoi"> DOI: 10.1016/j.arcmed.2010.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.arcmed.2010.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=20682182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVemt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2010&pages=226-231&author=R.+B.+Maccioniauthor=G.+Far%C3%ADasauthor=I.+Moralesauthor=L.+Navarrete&title=The+revitalized+tau+hypothesis+on+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.arcmed.2010.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The Revitalized Tau Hypothesis on Alzheimer's Disease</span></div><div class="casAuthors">Maccioni, Ricardo B.; Farias, Gonzalo; Morales, Inelia; Navarrete, Leonardo</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Medical Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">226-231</span>CODEN:
                <span class="NLM_cas:coden">AEDEER</span>;
        ISSN:<span class="NLM_cas:issn">0188-4409</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Many hypotheses have been raised regarding the pathophysiol. of Alzheimer's disease (AD).  Because amyloid beta peptide (Aβ) deposition in senile plaques appears as a late, nonspecific event, recent evidence points to tau phosphorylation and aggregation as the final common pathway in this multifactorial disease.  Current approaches that provide evidence in favor of neuroimmunomodulation in AD and the roles of tau pathol. modifications and aggregation into oligomers and filamentous forms are presented.  We propose an integrative model on the pathogenesis of AD that includes several damage signals such as Aβ oligomers, oxygen free radicals, iron overload, homocysteine, cholesterol and LDL species.  These activate microglia cells, releasing proinflammatory cytokines and producing neuronal degeneration and tau pathol. modifications.  Altered and aggregated forms of tau appear to act as a toxic stimuli contributing to neurodegeneration.  Recent findings provide further support to the central role of tau in the pathogenesis of AD, so this protein has turned into a diagnostic and therapeutic target for this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos_mQZP6_GRrVg90H21EOLACvtfcHk0lidDJEW3k1r0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVemt7o%253D&md5=b8d948914ce470f13a3e8b36f0bb563d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.arcmed.2010.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arcmed.2010.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DMaccioni%26aufirst%3DR.%2BB.%26aulast%3DFar%25C3%25ADas%26aufirst%3DG.%26aulast%3DMorales%26aufirst%3DI.%26aulast%3DNavarrete%26aufirst%3DL.%26atitle%3DThe%2520revitalized%2520tau%2520hypothesis%2520on%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DArch.%2520Med.%2520Res.%26date%3D2010%26volume%3D41%26spage%3D226%26epage%3D231%26doi%3D10.1016%2Fj.arcmed.2010.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Arriagada, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Growdon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedley-Whyte, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span> </span><span class="NLM_article-title">Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span><span class="refDoi"> DOI: 10.1212/WNL.42.3.631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1212%2FWNL.42.3.631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1549228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADyaK387psFCktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1992&pages=631-639&author=P.+V.+Arriagadaauthor=J.+H.+Growdonauthor=E.+T.+Hedley-Whyteauthor=B.+T.+Hyman&title=Neurofibrillary+tangles+but+not+senile+plaques+parallel+duration+and+severity+of+Alzheimer%E2%80%99s+disease&doi=10.1212%2FWNL.42.3.631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease</span></div><div class="casAuthors">Arriagada P V; Growdon J H; Hedley-Whyte E T; Hyman B T</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3 Pt 1</span>),
    <span class="NLM_cas:pages">631-9</span>
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    </div><div class="casAbstract">We studied the accumulation of neurofibrillary tangles (NFTs) and senile plaques (SPs) in 10 Alzheimer's disease patients who had been examined during life.  We counted NFTs and SPs in 13 cytoarchitectural regions representing limbic, primary sensory, and association cortices, and in subcortical neurotransmitter-specific areas.  The degree of neuropathologic change was compared with the severity of dementia, as assessed by the Blessed Dementia Scale and duration of illness.  We found that (1) the severity of dementia was positively related to the number of NFTs in neocortex, but not to the degree of SP deposition; (2) NFTs accumulate in a consistent pattern reflecting hierarchic vulnerability of individual cytoarchitectural fields; (3) NFTs appeared in the entorhinal cortex, CA1/subiculum field of the hippocampal formation, and the amygdala early in the disease process; and (4) the degree of SP deposition was also related to a hierarchic vulnerability of certain brain areas to accumulate SPs, but the pattern of SP distribution was different from that of NFT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQV0H_j78dSAoFEOhA_Im3cfW6udTcc2ebVutERGNQ0nbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387psFCktw%253D%253D&md5=76ed8992e3ad9bfe7070d4f83c12b7f8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1212%2FWNL.42.3.631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.42.3.631%26sid%3Dliteratum%253Aachs%26aulast%3DArriagada%26aufirst%3DP.%2BV.%26aulast%3DGrowdon%26aufirst%3DJ.%2BH.%26aulast%3DHedley-Whyte%26aufirst%3DE.%2BT.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26atitle%3DNeurofibrillary%2520tangles%2520but%2520not%2520senile%2520plaques%2520parallel%2520duration%2520and%2520severity%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1992%26volume%3D42%26spage%3D631%26epage%3D639%26doi%3D10.1212%2FWNL.42.3.631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Brier, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrichsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldea, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassenstab, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzinger, T. L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ances, B. M.</span><span> </span><span class="NLM_article-title">Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">338ra66</span><span class="refDoi"> DOI: 10.1126/scitranslmed.aaf2362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1126%2Fscitranslmed.aaf2362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=27169802" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=338ra66&author=M.+R.+Brierauthor=B.+Gordonauthor=K.+Friedrichsenauthor=J.+McCarthyauthor=A.+Sternauthor=J.+Christensenauthor=C.+Owenauthor=P.+Aldeaauthor=Y.+Suauthor=J.+Hassenstabauthor=N.+J.+Cairnsauthor=D.+M.+Holtzmanauthor=A.+M.+Faganauthor=J.+C.+Morrisauthor=T.+L.+S.+Benzingerauthor=B.+M.+Ances&title=Tau+and+A%CE%B2+imaging%2C+CSF+measures%2C+and+cognition+in+Alzheimer%E2%80%99s+disease&doi=10.1126%2Fscitranslmed.aaf2362"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaf2362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaf2362%26sid%3Dliteratum%253Aachs%26aulast%3DBrier%26aufirst%3DM.%2BR.%26aulast%3DGordon%26aufirst%3DB.%26aulast%3DFriedrichsen%26aufirst%3DK.%26aulast%3DMcCarthy%26aufirst%3DJ.%26aulast%3DStern%26aufirst%3DA.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DOwen%26aufirst%3DC.%26aulast%3DAldea%26aufirst%3DP.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DHassenstab%26aufirst%3DJ.%26aulast%3DCairns%26aufirst%3DN.%2BJ.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DFagan%26aufirst%3DA.%2BM.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DBenzinger%26aufirst%3DT.%2BL.%2BS.%26aulast%3DAnces%26aufirst%3DB.%2BM.%26atitle%3DTau%2520and%2520A%25CE%25B2%2520imaging%252C%2520CSF%2520measures%252C%2520and%2520cognition%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D338ra66%26doi%3D10.1126%2Fscitranslmed.aaf2362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Johnson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betensky, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepulcre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rentz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mormino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chhatwal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amariglio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alverio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judge, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philiossaint, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoup, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Isla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasdev, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperling, R.</span><span> </span><span class="NLM_article-title">Tau positron emission tomographic imaging in aging and early Alzheimer disease</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span><span class="refDoi"> DOI: 10.1002/ana.24546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1002%2Fana.24546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=26505746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADC%252BC28zlsVOjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=110-119&author=K.+A.+Johnsonauthor=A.+Schultzauthor=R.+A.+Betenskyauthor=J.+A.+Beckerauthor=J.+Sepulcreauthor=D.+Rentzauthor=E.+Morminoauthor=J.+Chhatwalauthor=R.+Amariglioauthor=K.+Pappauthor=G.+Marshallauthor=M.+Albersauthor=S.+Mauroauthor=L.+Pepinauthor=J.+Alverioauthor=K.+Judgeauthor=M.+Philiossaintauthor=T.+Shoupauthor=D.+Yokellauthor=B.+Dickersonauthor=T.+Gomez-Islaauthor=B.+Hymanauthor=N.+Vasdevauthor=R.+Sperling&title=Tau+positron+emission+tomographic+imaging+in+aging+and+early+Alzheimer+disease&doi=10.1002%2Fana.24546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Tau positron emission tomographic imaging in aging and early Alzheimer disease</span></div><div class="casAuthors">Johnson Keith A; Schultz Aaron; Becker J Alex; Sepulcre Jorge; Mauro Samantha; Pepin Lesley; Alverio Jonathan; Judge Kelly; Philiossaint Marlie; Shoup Timothy; Yokell Daniel; Dickerson Bradford; Vasdev Neil; Johnson Keith A; Rentz Dorene; Mormino Elizabeth; Chhatwal Jasmeer; Amariglio Rebecca; Papp Kate; Marshall Gad; Albers Mark; Dickerson Bradford; Gomez-Isla Teresa; Hyman Bradley; Sperling Reisa; Johnson Keith A; Becker J Alex; Sepulcre Jorge; Mauro Samantha; Pepin Lesley; Alverio Jonathan; Judge Kelly; Philiossaint Marlie; Shoup Timothy; Yokell Daniel; Vasdev Neil; Johnson Keith A; Schultz Aaron; Rentz Dorene; Mormino Elizabeth; Chhatwal Jasmeer; Amariglio Rebecca; Papp Kate; Marshall Gad; Sperling Reisa; Johnson Keith A; Sepulcre Jorge; Rentz Dorene; Chhatwal Jasmeer; Amariglio Rebecca; Papp Kate; Marshall Gad; Albers Mark; Yokell Daniel; Dickerson Bradford; Gomez-Isla Teresa; Hyman Bradley; Vasdev Neil; Sperling Reisa; Schultz Aaron; Sepulcre Jorge; Dickerson Bradford; Sperling Reisa; Betensky Rebecca A; Betensky Rebecca A</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">110-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Detection of focal brain tau deposition during life could greatly facilitate accurate diagnosis of Alzheimer disease (AD), staging and monitoring of disease progression, and development of disease-modifying therapies.  METHODS:  We acquired tau positron emission tomography (PET) using (18)F T807 (AV1451), and amyloid-β PET using (11)C Pittsburgh compound B (PiB) in older clinically normal individuals, and symptomatic patients with mild cognitive impairment or mild AD dementia.  RESULTS:  We found abnormally high cortical (18)F T807 binding in patients with mild cognitive impairment and AD dementia compared to clinically normal controls.  Consistent with the neuropathology literature, the presence of elevated neocortical (18)F T807 binding particularly in the inferior temporal gyrus was associated with clinical impairment.  The association of cognitive impairment was stronger with inferior temporal (18)F T807 than with mean cortical (11)C PIB.  Regional (18)F T807 was correlated with mean cortical (11)C PiB among both impaired and control subjects.  INTERPRETATION:  These findings suggest that (18)F T807 PET could have value as a biomarker that reflects both the progression of AD tauopathy and the emergence of clinical impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0_YW8WOtWAu98rul4nhSdfW6udTcc2eY7PTBd-fUFebntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zlsVOjsA%253D%253D&md5=6f00800f28f2503e0ed2f428973c1502</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fana.24546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24546%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DK.%2BA.%26aulast%3DSchultz%26aufirst%3DA.%26aulast%3DBetensky%26aufirst%3DR.%2BA.%26aulast%3DBecker%26aufirst%3DJ.%2BA.%26aulast%3DSepulcre%26aufirst%3DJ.%26aulast%3DRentz%26aufirst%3DD.%26aulast%3DMormino%26aufirst%3DE.%26aulast%3DChhatwal%26aufirst%3DJ.%26aulast%3DAmariglio%26aufirst%3DR.%26aulast%3DPapp%26aufirst%3DK.%26aulast%3DMarshall%26aufirst%3DG.%26aulast%3DAlbers%26aufirst%3DM.%26aulast%3DMauro%26aufirst%3DS.%26aulast%3DPepin%26aufirst%3DL.%26aulast%3DAlverio%26aufirst%3DJ.%26aulast%3DJudge%26aufirst%3DK.%26aulast%3DPhiliossaint%26aufirst%3DM.%26aulast%3DShoup%26aufirst%3DT.%26aulast%3DYokell%26aufirst%3DD.%26aulast%3DDickerson%26aufirst%3DB.%26aulast%3DGomez-Isla%26aufirst%3DT.%26aulast%3DHyman%26aufirst%3DB.%26aulast%3DVasdev%26aufirst%3DN.%26aulast%3DSperling%26aufirst%3DR.%26atitle%3DTau%2520positron%2520emission%2520tomographic%2520imaging%2520in%2520aging%2520and%2520early%2520Alzheimer%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2016%26volume%3D79%26spage%3D110%26epage%3D119%26doi%3D10.1002%2Fana.24546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Scholl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonhaut, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neil, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janabi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ossenkoppele, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faria, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwimmer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabinovici, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagust, W. J.</span><span> </span><span class="NLM_article-title">PET imaging of tau deposition in the aging human brain</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span><span class="refDoi"> DOI: 10.1016/j.neuron.2016.01.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.neuron.2016.01.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=26938442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1yjsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2016&pages=971-982&author=M.+Schollauthor=S.+N.+Lockhartauthor=D.+R.+Schonhautauthor=J.+P.+O%E2%80%99Neilauthor=M.+Janabiauthor=R.+Ossenkoppeleauthor=S.+L.+Bakerauthor=J.+W.+Vogelauthor=J.+Fariaauthor=H.+D.+Schwimmerauthor=G.+D.+Rabinoviciauthor=W.+J.+Jagust&title=PET+imaging+of+tau+deposition+in+the+aging+human+brain&doi=10.1016%2Fj.neuron.2016.01.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">PET Imaging of Tau Deposition in the Aging Human Brain</span></div><div class="casAuthors">Scholl, Michael; Lockhart, Samuel N.; Schonhaut, Daniel R.; O'Neil, James P.; Janabi, Mustafa; Ossenkoppele, Rik; Baker, Suzanne L.; Vogel, Jacob W.; Faria, Jamie; Schwimmer, Henry D.; Rabinovici, Gil D.; Jagust, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">971-982</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Tau pathol. is a hallmark of Alzheimer's disease (AD) but also occurs in normal cognitive aging.  Using the tau PET agent 18F-AV-1451, we examd. retention patterns in cognitively normal older people in relation to young controls and AD patients.  Age and β-amyloid (measured using PiB PET) were differentially assocd. with tau tracer retention in healthy aging.  Older age was related to increased tracer retention in regions of the medial temporal lobe, which predicted worse episodic memory performance.  PET detection of tau in other isocortical regions required the presence of cortical β-amyloid and was assocd. with decline in global cognition.  Furthermore, patterns of tracer retention corresponded well with Braak staging of neurofibrillary tau pathol.  The present study defined patterns of tau tracer retention in normal aging in relation to age, cognition, and β-amyloid deposition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKrXse2TGfw7Vg90H21EOLACvtfcHk0lgoG96sl482BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1yjsbc%253D&md5=ffa860231cdfc89a91659b2c4a16e335</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2016.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2016.01.028%26sid%3Dliteratum%253Aachs%26aulast%3DScholl%26aufirst%3DM.%26aulast%3DLockhart%26aufirst%3DS.%2BN.%26aulast%3DSchonhaut%26aufirst%3DD.%2BR.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DJ.%2BP.%26aulast%3DJanabi%26aufirst%3DM.%26aulast%3DOssenkoppele%26aufirst%3DR.%26aulast%3DBaker%26aufirst%3DS.%2BL.%26aulast%3DVogel%26aufirst%3DJ.%2BW.%26aulast%3DFaria%26aufirst%3DJ.%26aulast%3DSchwimmer%26aufirst%3DH.%2BD.%26aulast%3DRabinovici%26aufirst%3DG.%2BD.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26atitle%3DPET%2520imaging%2520of%2520tau%2520deposition%2520in%2520the%2520aging%2520human%2520brain%26jtitle%3DNeuron%26date%3D2016%26volume%3D89%26spage%3D971%26epage%3D982%26doi%3D10.1016%2Fj.neuron.2016.01.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Cho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyoo, C. H.</span><span> </span><span class="NLM_article-title">In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span><span class="refDoi"> DOI: 10.1002/ana.24711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1002%2Fana.24711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=27323247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlajurbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2016&pages=247-258&author=H.+Choauthor=J.+Y.+Choiauthor=M.+S.+Hwangauthor=Y.+J.+Kimauthor=H.+M.+Leeauthor=H.+S.+Leeauthor=J.+H.+Leeauthor=Y.+H.+Ryuauthor=M.+S.+Leeauthor=C.+H.+Lyoo&title=In+vivo+cortical+spreading+pattern+of+tau+and+amyloid+in+the+Alzheimer+disease+spectrum&doi=10.1002%2Fana.24711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum</span></div><div class="casAuthors">Cho, Hanna; Choi, Jae Yong; Hwang, Mi Song; Kim, You Jin; Lee, Hye Mi; Lee, Hye Sun; Lee, Jae Hoon; Ryu, Young Hoon; Lee, Myung Sik; Lyoo, Chul Hyoung</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-258</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : To det. the in vivo cortical spreading pattern of tau and amyloid and to establish positron emission tomog. (PET) image-based tau staging in the Alzheimer disease (AD) spectrum.  Methods : We included 195 participants (53 AD, 52 amnestic mild cognitive impairment [MCI], 23 nonamnestic MCI, and 67 healthy controls) who underwent 2 PET scans (18F-florbetaben for amyloid-β and 18F-AV-1451 for tau).  We assumed that regions with earlier appearances of pathol. may show increased binding in a greater no. of participants and acquired spreading order of tau accumulation by sorting the regional frequencies of involvement.  We classified each participant into image-based tau stage based on the Z score of the composite region for each stage.  Results : Tau accumulation was most frequently obsd. in the medial temporal regions and spread stepwise to the basal and lateral temporal, inferior parietal, posterior cingulate, and other assocn. cortices, and then ultimately to the primary cortical regions.  In contrast, amyloid accumulation was found with similar frequency in the diffuse neocortical areas and then finally spread to the medial temporal regions.  The image-based tau stage correlated with the general cognitive status, whereas cortical thinning was found only in the advanced tau stages: medial temporal region in stage V and widespread cortex in stage VI.  Interpretation : Our PET study replicated postmortem spreading patterns of tau and amyloid-β pathologies.  Unlike the diffuse accumulation of amyloid throughout the neocortex, tau spreading occurred in a stepwise fashion through the networks.  Image-based tau staging may be useful for the objective assessment of AD progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbcDR6pbnnUbVg90H21EOLACvtfcHk0lgtmk9Wv1uGHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlajurbP&md5=615324ea961aff5dff1713f69e9ed028</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fana.24711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24711%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DJ.%2BY.%26aulast%3DHwang%26aufirst%3DM.%2BS.%26aulast%3DKim%26aufirst%3DY.%2BJ.%26aulast%3DLee%26aufirst%3DH.%2BM.%26aulast%3DLee%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DRyu%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DLyoo%26aufirst%3DC.%2BH.%26atitle%3DIn%2520vivo%2520cortical%2520spreading%2520pattern%2520of%2520tau%2520and%2520amyloid%2520in%2520the%2520Alzheimer%2520disease%2520spectrum%26jtitle%3DAnn.%2520Neurol.%26date%3D2016%26volume%3D80%26spage%3D247%26epage%3D258%26doi%3D10.1002%2Fana.24711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Spillantini, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedert, M.</span><span> </span><span class="NLM_article-title">Tau pathology and neurodegeneration</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span><span class="refDoi"> DOI: 10.1016/S1474-4422(13)70090-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2FS1474-4422%2813%2970090-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=23684085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVGkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=609-622&author=M.+G.+Spillantiniauthor=M.+Goedert&title=Tau+pathology+and+neurodegeneration&doi=10.1016%2FS1474-4422%2813%2970090-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Tau pathology and neurodegeneration</span></div><div class="casAuthors">Spillantini, Maria Grazia; Goedert, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">609-622</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The pathway leading from sol. and monomeric to hyperphosphorylated, insol. and filamentous tau protein is at the center of many human neurodegenerative diseases, collectively referred to as tauopathies.  Dominantly inherited mutations in MAPT, the gene that encodes tau, cause forms of frontotemporal dementia and parkinsonism, proving that dysfunction of tau is sufficient to cause neurodegeneration and dementia.  However, most cases of tauopathy are not inherited in a dominant manner.  The first tau aggregates form in a few nerve cells in discrete brain areas.  These become self propagating and spread to distant brain regions in a prion-like manner.  The prevention of tau aggregation and propagation is the focus of attempts to develop mechanism-based treatments for tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL-Mr15hi3grVg90H21EOLACvtfcHk0lgtmk9Wv1uGHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVGkur0%253D&md5=532220e2bfffdb228277e80868bdde65</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970090-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970090-5%26sid%3Dliteratum%253Aachs%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26aulast%3DGoedert%26aufirst%3DM.%26atitle%3DTau%2520pathology%2520and%2520neurodegeneration%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D609%26epage%3D622%26doi%3D10.1016%2FS1474-4422%2813%2970090-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Lowe, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liesinger, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josephs, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parisi, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarci, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeve, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruinsma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graff-Radford, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jack, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, M. E.</span><span> </span><span class="NLM_article-title">An autoradiographic evaluation of AV-1451 Tau PET in dementia</span> <span class="citation_source-journal">Acta Neuropathol. Comm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="refDoi"> DOI: 10.1186/s40478-016-0315-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1186%2Fs40478-016-0315-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=27296779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FpvFCjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=58&author=V.+J.+Loweauthor=G.+Curranauthor=P.+Fangauthor=A.+M.+Liesingerauthor=K.+A.+Josephsauthor=J.+E.+Parisiauthor=K.+Kantarciauthor=B.+F.+Boeveauthor=M.+K.+Pandeyauthor=T.+Bruinsmaauthor=D.+S.+Knopmanauthor=D.+T.+Jonesauthor=L.+Petrucelliauthor=C.+N.+Cookauthor=N.+R.+Graff-Radfordauthor=D.+W.+Dicksonauthor=R.+C.+Petersenauthor=C.+R.+Jackauthor=M.+E.+Murray&title=An+autoradiographic+evaluation+of+AV-1451+Tau+PET+in+dementia&doi=10.1186%2Fs40478-016-0315-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">An autoradiographic evaluation of AV-1451 Tau PET in dementia</span></div><div class="casAuthors">Lowe Val J; Curran Geoffry; Fang Ping; Kantarci Kejal; Pandey Mukesh K; Bruinsma Tyler; Jack Clifford R Jr; Liesinger Amanda M; Petrucelli Leonard; Cook Casey N; Dickson Dennis W; Murray Melissa E; Josephs Keith A; Parisi Joseph E; Boeve Bradley F; Knopman David S; Jones David T; Petersen Ronald C; Parisi Joseph E; Graff-Radford Neill R</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  It is essential to determine the specificity of AV-1451 PET for tau in brain imaging by using pathological comparisons.  We performed autoradiography in autopsy-confirmed Alzheimer disease and other neurodegenerative disorders to evaluate the specificity of AV-1451 binding for tau aggregates.  METHODS:  Tissue samples were selected that had a variety of dementia-related neuropathologies including Alzheimer disease, primary age-related tauopathy, tangle predominant dementia, non-Alzheimer disease tauopathies, frontotemporal dementia, parkinsonism, Lewy body disease and multiple system atrophy (n = 38).  Brain tissue sections were stained for tau, TAR DNA-binding protein-43, and α-synuclein and compared to AV-1451 autoradiography on adjacent sections.  RESULTS:  AV-1451 preferentially localized to neurofibrillary tangles, with less binding to areas enriched in neuritic pathology and less mature tau.  The strength of AV-1451 binding with respect to tau isoforms in various neurodegenerative disorders was: 3R + 4R tau (e.g., AD) > 3R tau (e.g., Pick disease) or 4R tau.  Only minimal binding of AV-1451 to TAR DNA-binding protein-43 positive regions was detected.  No binding of AV-1451 to α-synuclein was detected. "Off-target" binding was seen in vessels, iron-associated regions, substantia nigra, calcifications in the choroid plexus, and leptomeningeal melanin.  CONCLUSIONS:  Reduced AV-1451 binding in neuritic pathology compared to neurofibrillary tangles suggests that the maturity of tau pathology may affect AV-1451 binding and suggests complexity in AV-1451 binding.  Poor association of AV-1451 with tauopathies that have preferential accumulation of either 4R tau or 3R tau suggests limited clinical utility in detecting these pathologies.  In contrast, for disorders associated with 3R + 4R tau, such as Alzheimer disease, AV-1451 binds tau avidly but does not completely reflect the early stage tau progression suggested by Braak neurofibrillary tangle staging.  AV-1451 binding to TAR DNA-binding protein-43 or TAR DNA-binding protein-43 positive regions can be weakly positive.  Clinical use of AV-1451 will require a familiarity with distinct types of "off-target" binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRs_4DPJCBHN-qrn-c4Of3KfW6udTcc2ea-Qa1DWiZOgLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FpvFCjtg%253D%253D&md5=a7cb46ea5a1a57447570b780568abb3f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1186%2Fs40478-016-0315-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40478-016-0315-6%26sid%3Dliteratum%253Aachs%26aulast%3DLowe%26aufirst%3DV.%2BJ.%26aulast%3DCurran%26aufirst%3DG.%26aulast%3DFang%26aufirst%3DP.%26aulast%3DLiesinger%26aufirst%3DA.%2BM.%26aulast%3DJosephs%26aufirst%3DK.%2BA.%26aulast%3DParisi%26aufirst%3DJ.%2BE.%26aulast%3DKantarci%26aufirst%3DK.%26aulast%3DBoeve%26aufirst%3DB.%2BF.%26aulast%3DPandey%26aufirst%3DM.%2BK.%26aulast%3DBruinsma%26aufirst%3DT.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DJones%26aufirst%3DD.%2BT.%26aulast%3DPetrucelli%26aufirst%3DL.%26aulast%3DCook%26aufirst%3DC.%2BN.%26aulast%3DGraff-Radford%26aufirst%3DN.%2BR.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DMurray%26aufirst%3DM.%2BE.%26atitle%3DAn%2520autoradiographic%2520evaluation%2520of%2520AV-1451%2520Tau%2520PET%2520in%2520dementia%26jtitle%3DActa%2520Neuropathol.%2520Comm.%26date%3D2016%26volume%3D4%26spage%3D58%26doi%3D10.1186%2Fs40478-016-0315-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span> </span><span class="NLM_article-title">In vivo tau imaging: obstacles and progress</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">S254</span><span class="NLM_x">–</span> <span class="NLM_lpage">S264</span><span class="refDoi"> DOI: 10.1016/j.jalz.2014.04.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.jalz.2014.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=24924676" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=S254-S264&author=V.+L.+Villemagneauthor=N.+Okamura&title=In+vivo+tau+imaging%3A+obstacles+and+progress&doi=10.1016%2Fj.jalz.2014.04.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2014.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2014.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DOkamura%26aufirst%3DN.%26atitle%3DIn%2520vivo%2520tau%2520imaging%253A%2520obstacles%2520and%2520progress%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2014%26volume%3D10%26spage%3DS254%26epage%3DS264%26doi%3D10.1016%2Fj.jalz.2014.04.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Shah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catafau, A. M.</span><span> </span><span class="NLM_article-title">Molecular imaging insights into neurodegeneration: focus on tau PET radiotracers</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">874</span><span class="refDoi"> DOI: 10.2967/jnumed.113.136069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2967%2Fjnumed.113.136069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=871-874&author=M.+Shahauthor=A.+M.+Catafau&title=Molecular+imaging+insights+into+neurodegeneration%3A+focus+on+tau+PET+radiotracers&doi=10.2967%2Fjnumed.113.136069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.113.136069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.113.136069%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DM.%26aulast%3DCatafau%26aufirst%3DA.%2BM.%26atitle%3DMolecular%2520imaging%2520insights%2520into%2520neurodegeneration%253A%2520focus%2520on%2520tau%2520PET%2520radiotracers%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D871%26epage%3D874%26doi%3D10.2967%2Fjnumed.113.136069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">New targets for the development of PET tracers for imaging neurodegeneration in Alzheimer disease</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1221</span><span class="NLM_x">–</span> <span class="NLM_lpage">1224</span><span class="refDoi"> DOI: 10.2967/jnumed.114.127811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2967%2Fjnumed.114.127811" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1221-1224&author=R.+H.+Mach&title=New+targets+for+the+development+of+PET+tracers+for+imaging+neurodegeneration+in+Alzheimer+disease&doi=10.2967%2Fjnumed.114.127811"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.114.127811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.114.127811%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DNew%2520targets%2520for%2520the%2520development%2520of%2520PET%2520tracers%2520for%2520imaging%2520neurodegeneration%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D1221%26epage%3D1224%26doi%3D10.2967%2Fjnumed.114.127811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span> </span><span class="NLM_article-title">Tau imaging: early progress and future directions</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1016/S1474-4422(14)70252-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2FS1474-4422%2814%2970252-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=25496902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADC%252BC2MritFertg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=114-124&author=V.+L.+Villemagneauthor=M.+T.+Fodero-Tavolettiauthor=C.+L.+Mastersauthor=C.+C.+Rowe&title=Tau+imaging%3A+early+progress+and+future+directions&doi=10.1016%2FS1474-4422%2814%2970252-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Tau imaging: early progress and future directions</span></div><div class="casAuthors">Villemagne Victor L; Fodero-Tavoletti Michelle T; Masters Colin L; Rowe Christopher C</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Use of selective in-vivo tau imaging will enable improved understanding of tau aggregation in the brain, facilitating research into causes, diagnosis, and treatment of major tauopathies such as Alzheimer's disease, progressive supranuclear palsy, corticobasal syndrome, chronic traumatic encephalopathy, and some variants of frontotemporal lobar degeneration.  Neuropathological studies of Alzheimer's disease show a strong association between tau deposits, decreased cognitive function, and neurodegenerative changes.  Selective tau imaging will allow the in-vivo exploration of such associations and measure the global and regional changes in tau deposits over time.  Such imaging studies will comprise non-invasive assessment of the spatial and temporal pattern of tau deposition over time, providing insight into the role tau plays in ageing and helping to establish the relation between cognition, genotype, neurodegeneration, and other biomarkers.  Once validated, selective tau imaging might be useful as a diagnostic, prognostic, and progression biomarker, and a surrogate marker for the monitoring of efficacy and patient recruitment for anti-tau therapeutic trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIuS1EFOTTc50d-O_J5C0AfW6udTcc2ebGiQP1-_jA3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MritFertg%253D%253D&md5=95eb0f9b98711e30caaf4a7c67bd46e0</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2814%2970252-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252814%252970252-2%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%2BT.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26atitle%3DTau%2520imaging%253A%2520early%2520progress%2520and%2520future%2520directions%26jtitle%3DLancet%2520Neurol.%26date%3D2015%26volume%3D14%26spage%3D114%26epage%3D124%26doi%3D10.1016%2FS1474-4422%2814%2970252-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Tau PET imaging in Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Neurol. Neurosci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="refDoi"> DOI: 10.1007/s11910-014-0500-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1007%2Fs11910-014-0500-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=25239654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADC%252BC2M7jsFSrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=500&author=N.+Okamuraauthor=R.+Haradaauthor=S.+Furumotoauthor=H.+Araiauthor=K.+Yanaiauthor=Y.+Kudo&title=Tau+PET+imaging+in+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs11910-014-0500-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Tau PET imaging in Alzheimer's disease</span></div><div class="casAuthors">Okamura Nobuyuki; Harada Ryuichi; Furumoto Shozo; Arai Hiroyuki; Yanai Kazuhiko; Kudo Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Current neurology and neuroscience reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">500</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In several neurodegenerative diseases that are collectively called tauopathies, progressive accumulation of tau in the brain is closely associated with neurodegeneration and cognitive impairment.  Noninvasive detection of tau protein deposits in the brain would be useful to diagnose tauopathies as well as to track and predict disease progression.  Recently, several tau PET tracers including T807, THK-5117, and PBB3 have been developed and succeeded in imaging neurofibrillary pathology in vivo.  For use of tau PET as a biomarker of tau pathology in Alzheimer's disease, PET tracers should have high affinity to PHF-tau and high selectivity for tau over amyloid-β and other protein deposits.  PET tau imaging enables the longitudinal assessment of the spatial pattern of tau deposition and its relation to amyloid-β pathology and neurodegeneration.  This technology could also be applied to the pharmacological assessment of anti-tau therapy, thereby allowing preventive interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTy6LVoglwXzIqdXsLcGTEUfW6udTcc2ebGiQP1-_jA3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7jsFSrtA%253D%253D&md5=343715c63553be883942f9829da91648</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs11910-014-0500-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11910-014-0500-6%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DTau%2520PET%2520imaging%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Neurol.%2520Neurosci.%2520Rep.%26date%3D2014%26volume%3D14%26spage%3D500%26doi%3D10.1007%2Fs11910-014-0500-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Ariza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span> </span><span class="NLM_article-title">Tau positron emission tomography (PET) imaging: past, present and future</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4365</span><span class="NLM_x">–</span> <span class="NLM_lpage">4382</span><span class="refDoi"> DOI: 10.1021/jm5017544</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5017544" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4365-4382&author=M.+Arizaauthor=H.+C.+Kolbauthor=D.+Moecharsauthor=F.+Romboutsauthor=J.+I.+Andr%C3%A9s&title=Tau+positron+emission+tomography+%28PET%29+imaging%3A+past%2C+present+and+future&doi=10.1021%2Fjm5017544"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm5017544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5017544%26sid%3Dliteratum%253Aachs%26aulast%3DAriza%26aufirst%3DM.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26atitle%3DTau%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%253A%2520past%252C%2520present%2520and%2520future%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4365%26epage%3D4382%26doi%3D10.1021%2Fjm5017544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Novel <sup>18</sup>F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1420</span><span class="NLM_x">–</span> <span class="NLM_lpage">1427</span><span class="refDoi"> DOI: 10.2967/jnumed.112.117341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2967%2Fjnumed.112.117341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=23857514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVejsr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=1420-1427&author=N.+Okamuraauthor=S.+Furumotoauthor=R.+Haradaauthor=T.+Tagoauthor=T.+Yoshikawaauthor=M.+Fodero-Tavolettiauthor=R.+S.+Mulliganauthor=V.+L.+Villemagneauthor=H.+Akatsuauthor=T.+Yamamotoauthor=H.+Araiauthor=R.+Iwataauthor=K.+Yanaiauthor=Y.+Kudo&title=Novel+18F-labeled+arylquinoline+derivatives+for+noninvasive+imaging+of+tau+pathology+in+Alzheimer+disease&doi=10.2967%2Fjnumed.112.117341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease</span></div><div class="casAuthors">Okamura, Nobuyuki; Furumoto, Shozo; Harada, Ryuichi; Tago, Tetsuro; Yoshikawa, Takeo; Fodero-Tavoletti, Michelle; Mulligan, Rachel S.; Villemagne, Victor L.; Akatsu, Hiroyasu; Yamamoto, Takayuki; Arai, Hiroyuki; Iwata, Ren; Yanai, Kazuhiko; Kudo, Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1420-1427</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">Neurofibrillary tangles in Alzheimer disease (AD) brains are composed of the microtubule-assocd. protein tau.  Noninvasive monitoring of tau protein aggregates in the living brain will provide useful information regarding tau pathophysiol. in AD.  However, no PET probes are currently available for selective detection of tau pathol. in AD.  We have previously reported 18F-labeled THK-523 (18F-6-(2-fluoroethoxy)-2-(4-aminophenyl)quinoline) as a tau imaging radiotracer candidate for PET.  After compd. optimization, we developed novel 18F-labeled arylquinoline derivs., 18F-THK-5105 and 18F-THK-5117, for use as tau imaging PET tracers.  Methods: 18F-labeled compds. were prepd. from the corresponding tosylated precursors.  The binding affinity of compds. to synthetic tau aggregates and tau-rich AD brain homogenates was detd. by satn. and competition binding assays.  The binding selectivity of compds. to tau pathol. was evaluated by autoradiog. of AD brain sections.  The pharmacokinetics of compds. were assessed in biodistribution studies in normal mice.  A 14-d toxicity study with i.v. administration of compds. was performed using rats and mice.  Results: In vitro binding assays demonstrated higher binding affinity of THK-5105 and THK-5117 than THK-523 to tau protein aggregates and tau-rich AD brain homogenates.  Autoradiog. analyses of AD brain sections showed that these radiotracers preferentially bound to neurofibrillary tangles and neuropil threads, which colocalized with Gallyas-pos. and immunoreactive tau protein deposits.  The distribution of this radiotracer binding in AD brain sections was completely different from that of 11C-Pittsburgh compd. B, showing preferential binding to amyloid plaques.  Furthermore, these derivs. demonstrated abundant initial brain uptake and faster clearance in normal mice than 18F-THK-523 and other reported 18F-labeled radiotracers.  THK-5105 and THK-5117 showed no toxic effects related to the administration of these compds. in mice and rats and no significant binding for various neuroreceptors, ion channels, and transporters at 1-μM concns.  Conclusion: 18F-labeled THK-5105 and THK-5117 are promising candidates as PET tau imaging radiotracers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLmleWUvjowbVg90H21EOLACvtfcHk0liYb10_U9oajA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVejsr7L&md5=58ac191b3581c5e4896b999343b6a193</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.112.117341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.112.117341%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DAkatsu%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DNovel%252018F-labeled%2520arylquinoline%2520derivatives%2520for%2520noninvasive%2520imaging%2520of%2520tau%2520pathology%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D1420%26epage%3D1427%26doi%3D10.2967%2Fjnumed.112.117341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shidahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">[<sup>18</sup>F]-THK-5117 PET for assessing neurofibrillary pathology in Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1052</span><span class="NLM_x">–</span> <span class="NLM_lpage">1061</span><span class="refDoi"> DOI: 10.1007/s00259-015-3035-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1007%2Fs00259-015-3035-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=25792456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVKhs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=1052-1061&author=R.+Haradaauthor=N.+Okamuraauthor=S.+Furumotoauthor=K.+Furukawaauthor=A.+Ishikiauthor=N.+Tomitaauthor=K.+Hiraokaauthor=S.+Watanukiauthor=M.+Shidaharaauthor=M.+Miyakeauthor=Y.+Ishikawaauthor=R.+Matsudaauthor=A.+Inamiauthor=T.+Yoshikawaauthor=T.+Tagoauthor=Y.+Funakiauthor=R.+Iwataauthor=M.+Tashiroauthor=K.+Yanaiauthor=H.+Araiauthor=Y.+Kudo&title=%5B18F%5D-THK-5117+PET+for+assessing+neurofibrillary+pathology+in+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00259-015-3035-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">[18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease</span></div><div class="casAuthors">Harada, Ryuichi; Okamura, Nobuyuki; Furumoto, Shozo; Furukawa, Katsutoshi; Ishiki, Aiko; Tomita, Naoki; Hiraoka, Kotaro; Watanuki, Shoichi; Shidahara, Miho; Miyake, Masayasu; Ishikawa, Yoichi; Matsuda, Rin; Inami, Akie; Yoshikawa, Takeo; Tago, Tetsuro; Funaki, Yoshihito; Iwata, Ren; Tashiro, Manabu; Yanai, Kazuhiko; Arai, Hiroyuki; Kudo, Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1052-1061</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Visualization of the spatial distribution of neurofibrillary tangles would help in the diagnosis, prevention and treatment of dementia.  The purpose of the study was to evaluate the clin. utility of [18F]THK-5117 as a highly selective tau imaging radiotracer.  Methods: We initially evaluated in vitro binding of [3H]THK-5117 in post-mortem brain tissues from patients with Alzheimer's disease (AD).  In clin. PET studies, [18F]THK-5117 retention in eight patients with AD was compared with that in six healthy elderly controls.  Ten subjects underwent an addnl. [11C]PiB PET scan within 2 wk.  Results: In post-mortem brain samples, THK-5117 bound selectively to neurofibrillary deposits, which differed from the binding target of PiB.  In clin. PET studies, [18F]THK-5117 binding in the temporal lobe clearly distinguished patients with AD from healthy elderly subjects.  Compared with [11C]PiB, [18F]THK-5117 retention was higher in the medial temporal cortex.  Conclusion: These findings suggest that [18F]THK-5117 provides regional information on neurofibrillary pathol. in living subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotZcAg2f1webVg90H21EOLACvtfcHk0liYb10_U9oajA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVKhs7Y%253D&md5=4c35d238f7026cb33833f28549e760d5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs00259-015-3035-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-015-3035-4%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DIshiki%26aufirst%3DA.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DHiraoka%26aufirst%3DK.%26aulast%3DWatanuki%26aufirst%3DS.%26aulast%3DShidahara%26aufirst%3DM.%26aulast%3DMiyake%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DR.%26aulast%3DInami%26aufirst%3DA.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DFunaki%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DTashiro%26aufirst%3DM.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3D%255B18F%255D-THK-5117%2520PET%2520for%2520assessing%2520neurofibrillary%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2015%26volume%3D42%26spage%3D1052%26epage%3D1061%26doi%3D10.1007%2Fs00259-015-3035-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Ishiki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span> </span><span class="NLM_article-title">Longitudinal assessment of tau pathology in patients with Alzheimer’s disease using [<sup>18</sup>F]-THK-5117 Positron Emission Tomography</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1371/journal.pone.0140311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1371%2Fjournal.pone.0140311" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1-9&author=A.+Ishikiauthor=N.+Okamuraauthor=K.+Furukawaauthor=S.+Furumotoauthor=R.+Haradaauthor=N.+Tomitaauthor=K.+Hiraokaauthor=S.+Watanukiauthor=Y.+Ishikawaauthor=T.+Tagoauthor=Y.+Funakiauthor=R.+Iwataauthor=M.+Tashiroauthor=K.+Yanaiauthor=Y.+Kudoauthor=H.+Arai&title=Longitudinal+assessment+of+tau+pathology+in+patients+with+Alzheimer%E2%80%99s+disease+using+%5B18F%5D-THK-5117+Positron+Emission+Tomography&doi=10.1371%2Fjournal.pone.0140311"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0140311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0140311%26sid%3Dliteratum%253Aachs%26aulast%3DIshiki%26aufirst%3DA.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DHiraoka%26aufirst%3DK.%26aulast%3DWatanuki%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DFunaki%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DTashiro%26aufirst%3DM.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DArai%26aufirst%3DH.%26atitle%3DLongitudinal%2520assessment%2520of%2520tau%2520pathology%2520in%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520using%2520%255B18F%255D-THK-5117%2520Positron%2520Emission%2520Tomography%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3D1%26epage%3D9%26doi%3D10.1371%2Fjournal.pone.0140311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shidahara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F-THK-5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer’s disease</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span><span class="refDoi"> DOI: 10.2967/jnumed.115.164848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2967%2Fjnumed.115.164848" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=208-214&author=R.+Haradaauthor=N.+Okamuraauthor=S.+Furumotoauthor=K.+Furukawaauthor=A.+Ishikiauthor=N.+Tomitaauthor=T.+Tagoauthor=K.+Hiraokaauthor=S.+Watanukiauthor=S.+Shidaharaauthor=M.+Miyakeauthor=Y.+Ishikawaauthor=R.+Matsudaauthor=A.+Inamiauthor=T.+Yoshikawaauthor=Y.+Funakiauthor=R.+Iwataauthor=M.+Tashiroauthor=K.+Yanaiauthor=H.+Araiauthor=Y.+Kudo&title=18F-THK-5351%3A+a+novel+PET+radiotracer+for+imaging+neurofibrillary+pathology+in+Alzheimer%E2%80%99s+disease&doi=10.2967%2Fjnumed.115.164848"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.164848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.164848%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DIshiki%26aufirst%3DA.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DHiraoka%26aufirst%3DK.%26aulast%3DWatanuki%26aufirst%3DS.%26aulast%3DShidahara%26aufirst%3DS.%26aulast%3DMiyake%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DR.%26aulast%3DInami%26aufirst%3DA.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DFunaki%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DTashiro%26aufirst%3DM.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3D18F-THK-5351%253A%2520a%2520novel%2520PET%2520radiotracer%2520for%2520imaging%2520neurofibrillary%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D208%26epage%3D214%26doi%3D10.2967%2Fjnumed.115.164848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Xia, C.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharmath, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocharla, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">[<sup>18</sup>F]-T807, a novel tau positron emission tomography imaging agent for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span><span class="refDoi"> DOI: 10.1016/j.jalz.2012.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.jalz.2012.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=23411393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=666-676&author=C.-F.+Xiaauthor=J.+Arteagaauthor=G.+Chenauthor=U.+Gangadharmathauthor=L.+F.+Gomezauthor=D.+Kasiauthor=C.+Lamauthor=Q.+Liangauthor=C.+Liuauthor=V.+P.+Mocharlaauthor=F.+Muauthor=A.+Sinhaauthor=H.+Suauthor=A.+K.+Szardeningsauthor=J.+C.+Walshauthor=E.+Wangauthor=C.+Yuauthor=W.+Zhangauthor=T.+Zhaoauthor=H.+C.+Kolb&title=%5B18F%5D-T807%2C+a+novel+tau+positron+emission+tomography+imaging+agent+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.jalz.2012.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease</span></div><div class="casAuthors">Xia Chun-Fang; Arteaga Janna; Chen Gang; Gangadharmath Umesh; Gomez Luis F; Kasi Dhanalakshmi; Lam Chung; Liang Qianwa; Liu Changhui; Mocharla Vani P; Mu Fanrong; Sinha Anjana; Su Helen; Szardenings A Katrin; Walsh Joseph C; Wang Eric; Yu Chul; Zhang Wei; Zhao Tieming; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">666-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  We wished to develop a highly selective positron emission tomography (PET) imaging agent targeting PHF-tau in human Alzheimer's disease (AD) brains.  METHODS:  To screen potential tau binders, human AD brain sections were used as a source of native paired helical filament (PHF)-tau and Aβ rather than synthetic tau aggregates or Aβ fibrils generated in vitro to measure the affinity and selectivity of [(18)F]T807 to tau and Aβ.  Brain uptake and biodistribution of [(18)F]T807 in mice were also tested.  RESULTS:  In vitro autoradiography results show that [(18)F]T807 exhibits strong binding to PHF-tau-positive human brain sections.  A dissociation constant (Kd) of [(18)F]T807 (14.6 nM) was measured using brain sections from the frontal lobe of AD patients.  A comparison of autoradiography and double immunohistochemical staining of PHF-tau and Aβ on adjacent sections demonstrated that [(18)F]T807 binding colocalized with immunoreactive PHF-tau pathology, but did not highlight Aβ plaques.  In vivo studies in mice demonstrated that [(18)F]T807 was able to cross the blood-brain barrier and washed out quickly.  CONCLUSIONS:  [(18)F]T807 demonstrates high affinity and selectivity to PHF-tau as well as favorable in vivo properties, making this a promising candidate as an imaging agent for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2ZgjLtot9A50d-O_J5C0AfW6udTcc2eZioukpJt4blbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D&md5=1fccbc6c3ffe8e57fdd6f64ec450b1d7</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DC.-F.%26aulast%3DArteaga%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGangadharmath%26aufirst%3DU.%26aulast%3DGomez%26aufirst%3DL.%2BF.%26aulast%3DKasi%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3D%255B18F%255D-T807%252C%2520a%2520novel%2520tau%2520positron%2520emission%2520tomography%2520imaging%2520agent%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3D666%26epage%3D676%26doi%3D10.1016%2Fj.jalz.2012.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Chien, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Early clinical PET imaging results with the novel PHF-tau radioligand [<sup>18</sup>F]-T807</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.3233/JAD-122059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.3233%2FJAD-122059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=23234879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlWlsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=457-468&author=D.+T.+Chienauthor=S.+Bahriauthor=A.+K.+Szardeningsauthor=J.+C.+Walshauthor=F.+Muauthor=M.-Y.+Suauthor=W.+R.+Shankleauthor=A.+Elizarovauthor=H.+C.+Kolb&title=Early+clinical+PET+imaging+results+with+the+novel+PHF-tau+radioligand+%5B18F%5D-T807&doi=10.3233%2FJAD-122059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807</span></div><div class="casAuthors">Chien, David T.; Bahri, Shadfar; Szardenings, A. Katrin; Walsh, Joseph C.; Mu, Fanrong; Su, Min-Ying; Shankle, William R.; Elizarov, Arkadij; Kolb, Hartmuth C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-468</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease.  We have developed a novel PHF-tau targeting positron emission tomog. imaging agent, [F-18]-T807, which may be useful for imaging Alzheimer's disease and other tauopathies.  Here in, we describe the first human brain images with [F-18]-T807.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofLFkBPeoi47Vg90H21EOLACvtfcHk0ljygZKoCKwbPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlWlsbk%253D&md5=578173de3104c8e470381f0812ce6356</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3233%2FJAD-122059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-122059%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DD.%2BT.%26aulast%3DBahri%26aufirst%3DS.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSu%26aufirst%3DM.-Y.%26aulast%3DShankle%26aufirst%3DW.%2BR.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DEarly%2520clinical%2520PET%2520imaging%2520results%2520with%2520the%2520novel%2520PHF-tau%2520radioligand%2520%255B18F%255D-T807%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D34%26spage%3D457%26epage%3D468%26doi%3D10.3233%2FJAD-122059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Mintun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shcherbinin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontecorvo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skovronsky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Exploratory analyses of regional human brain distribution of the PET tau tracer F18-labeled T807 (AV-1541) in subjects with normal cognitive function or cognitive impairment thought to be due to AD</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">P842</span><span class="refDoi"> DOI: 10.1016/j.jalz.2013.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.jalz.2013.08.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=P842&author=M.+Mintunauthor=A.+Schwarzauthor=A.+Joshiauthor=S.+Shcherbininauthor=D.+Chienauthor=A.+Elizarovauthor=M.-Y.+Suauthor=W.+Shankleauthor=M.+Pontecorvoauthor=J.+Tauscherauthor=D.+Skovronskyauthor=H.+C.+Kolb&title=Exploratory+analyses+of+regional+human+brain+distribution+of+the+PET+tau+tracer+F18-labeled+T807+%28AV-1541%29+in+subjects+with+normal+cognitive+function+or+cognitive+impairment+thought+to+be+due+to+AD&doi=10.1016%2Fj.jalz.2013.08.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2013.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2013.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DMintun%26aufirst%3DM.%26aulast%3DSchwarz%26aufirst%3DA.%26aulast%3DJoshi%26aufirst%3DA.%26aulast%3DShcherbinin%26aufirst%3DS.%26aulast%3DChien%26aufirst%3DD.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DM.-Y.%26aulast%3DShankle%26aufirst%3DW.%26aulast%3DPontecorvo%26aufirst%3DM.%26aulast%3DTauscher%26aufirst%3DJ.%26aulast%3DSkovronsky%26aufirst%3DD.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DExploratory%2520analyses%2520of%2520regional%2520human%2520brain%2520distribution%2520of%2520the%2520PET%2520tau%2520tracer%2520F18-labeled%2520T807%2520%2528AV-1541%2529%2520in%2520subjects%2520with%2520normal%2520cognitive%2520function%2520or%2520cognitive%2520impairment%2520thought%2520to%2520be%2520due%2520to%2520AD%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3DP842%26doi%3D10.1016%2Fj.jalz.2013.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Mintun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devous, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shcherbinin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siderowf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontecorvo, M.</span><span> </span><span class="NLM_article-title">Potential utility of the tau deposit tracer [<sup>18</sup>F]T807 (aka [<sup>18</sup>F]AV-1451) as a PET biomarker for neurodegeneration in clinical trials</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">S207</span><span class="NLM_x">–</span> <span class="NLM_lpage">S208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=S207-S208&author=M.+Mintunauthor=M.+Devousauthor=G.+Attardoauthor=A.+Joshiauthor=A.+Schwarzauthor=S.+Shcherbininauthor=A.+Siderowfauthor=Y.+G.+Linauthor=Q.+W.+Liangauthor=K.+Conwayauthor=F.+Gomezauthor=M.+Pontecorvo&title=Potential+utility+of+the+tau+deposit+tracer+%5B18F%5DT807+%28aka+%5B18F%5DAV-1451%29+as+a+PET+biomarker+for+neurodegeneration+in+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMintun%26aufirst%3DM.%26aulast%3DDevous%26aufirst%3DM.%26aulast%3DAttardo%26aufirst%3DG.%26aulast%3DJoshi%26aufirst%3DA.%26aulast%3DSchwarz%26aufirst%3DA.%26aulast%3DShcherbinin%26aufirst%3DS.%26aulast%3DSiderowf%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DY.%2BG.%26aulast%3DLiang%26aufirst%3DQ.%2BW.%26aulast%3DConway%26aufirst%3DK.%26aulast%3DGomez%26aufirst%3DF.%26aulast%3DPontecorvo%26aufirst%3DM.%26atitle%3DPotential%2520utility%2520of%2520the%2520tau%2520deposit%2520tracer%2520%255B18F%255DT807%2520%2528aka%2520%255B18F%255DAV-1451%2529%2520as%2520a%2520PET%2520biomarker%2520for%2520neurodegeneration%2520in%2520clinical%2520trials%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3DS207%26epage%3DS208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span>9th Annual Human Amyloid Imaging (HAI) Conference, Miami Beach, Florida, January 14–16, 2015. Alzforum News. <a href="http://www.alzforum.org/news/conference-coverage/human-amyloid-imaging-meeting-was-abuzz-talk-tau" class="extLink">http://www.alzforum.org/news/conference-coverage/human-amyloid-imaging-meeting-was-abuzz-talk-tau</a> (accessed August 3,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=9th+Annual+Human+Amyloid+Imaging+%28HAI%29+Conference%2C+Miami+Beach%2C+Florida%2C+January+14%E2%80%9316%2C+2015.+Alzforum+News.+http%3A%2F%2Fwww.alzforum.org%2Fnews%2Fconference-coverage%2Fhuman-amyloid-imaging-meeting-was-abuzz-talk-tau+%28accessed+August+3%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Chien, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katrin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span><span class="refDoi"> DOI: 10.3233/JAD-130098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.3233%2FJAD-130098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=23948934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADC%252BC3sbgsVyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=171-184&author=D.+T.+Chienauthor=A.+Katrinauthor=S.+Bahriauthor=J.+C.+Walshauthor=F.+Muauthor=C.+Xiaauthor=W.+R.+Shankleauthor=A.+J.+Lernerauthor=M.-Y.+Suauthor=A.+Elizarovauthor=H.+C.+Kolb&title=Early+clinical+PET+imaging+results+with+the+novel+PHF-tau+radioligand+%5BF18%5D-T808&doi=10.3233%2FJAD-130098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808</span></div><div class="casAuthors">Chien David T; Szardenings A Katrin; Bahri Shadfar; Walsh Joseph C; Mu Fanrong; Xia Chunfang; Shankle William R; Lerner Alan J; Su Min-Ying; Elizarov Arkadij; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">171-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease.  We have recently reported early clinical results of a novel PHF-tau targeting PET imaging agent, [F18]-T807.  Since then, we have investigated a second novel PHF-tau targeting PET imaging agent, [F18]-T808, with different pharmacokinetic characteristics, which may be favorable for imaging Alzheimer's disease and other tauopathies.  Here, we describe the first human brain images with [F18]-T808.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvVIddGtbpMLqxQ2mb9Pu8fW6udTcc2eauB9kpQn1oPLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbgsVyjtQ%253D%253D&md5=757aaefcfe18524fdd4404c0cb351850</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3233%2FJAD-130098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-130098%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DD.%2BT.%26aulast%3DKatrin%26aufirst%3DA.%26aulast%3DBahri%26aufirst%3DS.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DShankle%26aufirst%3DW.%2BR.%26aulast%3DLerner%26aufirst%3DA.%2BJ.%26aulast%3DSu%26aufirst%3DM.-Y.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DEarly%2520clinical%2520PET%2520imaging%2520results%2520with%2520the%2520novel%2520PHF-tau%2520radioligand%2520%255BF18%255D-T808%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2014%26volume%3D38%26spage%3D171%26epage%3D184%26doi%3D10.3233%2FJAD-130098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Kimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichise, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikoma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinotoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higuchi, M.</span><span> </span><span class="NLM_article-title">PET quantification of tau pathology in human brain with <sup>11</sup>C-PBB3</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1365</span><span class="refDoi"> DOI: 10.2967/jnumed.115.160127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2967%2Fjnumed.115.160127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=26182966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSmsbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=1359-1365&author=Y.+Kimuraauthor=M.+Ichiseauthor=H.+Itoauthor=H.+Shimadaauthor=Y.+Ikomaauthor=C.+Sekiauthor=H.+Takanoauthor=S.+Kitamuraauthor=H.+Shinotohauthor=K.+Kawamuraauthor=M.-R.+Zhangauthor=N.+Saharaauthor=T.+Suharaauthor=M.+Higuchi&title=PET+quantification+of+tau+pathology+in+human+brain+with+11C-PBB3&doi=10.2967%2Fjnumed.115.160127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">PET quantification of tau pathology in human brain with 11C-PBB3</span></div><div class="casAuthors">Kimura, Yasuyuki; Ichise, Masanori; Ito, Hiroshi; Shimada, Hitoshi; Ikoma, Yoko; Seki, Chie; Takano, Harumasa; Kitamura, Soichiro; Shinotoh, Hitoshi; Kawamura, Kazunori; Zhang, Ming-Rong; Sahara, Naruhiko; Suhara, Tetsuya; Higuchi, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1359-1365</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">Tau accumulation in the brain is a pathol. hallmark of Alzheimer disease and other tauopathies.  Quant. visualization of tau pathol. in humans can be a powerful method as a diagnostic aid and for monitoring potential therapeutic interventions.  We established methods of PET quantification of tau pathol. with 11C-PBB3 (2-((1E,3E)-4-(6-(11C-methylamino)pyridin-3-yl)buta-1,3-dienyl) benzo[d]thiazol-6-ol), considering its radiometabolite entering the brain.  Methods: Seven Alzheimer disease patients and 7 healthy subjects underwent dynamic 11C-PBB3 PET scanning.  Arterial blood was sampled to obtain the parent and metabolite input functions.  Quantification of 11C-PBB3 binding was performed using dual-input models that take the brain metabolite activity into consideration, traditional single-input models without such considerations, and the ref. tissue model (MRTMO) and standardized uptake value ratio (SUVR).  The cerebellar cortex was used as the ref. tissue for all methods.  Results: The dual-input graphical models estd. binding parameter (BP*ND)stably (∼0.36 in high-binding regions).  The MRTMO BP*ND matched the corresponding BP*ND by the dual-input graphical model (r2 = 1.00).  SUVR minus 1 correlated well with MRTMO BP*ND (r2 > 0.97).  However, BPND by the single-input models did not correlate with BP*ND by the dual-input graphical model (r2 = 0.04).  Conclusion: The dual-input graphical model BP*ND is consistent with the ref. tissue BP*ND and SUVR-1, suggesting that these parameters can accurately quantify binding of 11C-PBB3 despite the entry of its radiometabolites into the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrePH11hC48FLVg90H21EOLACvtfcHk0limRoG3mpH4Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSmsbfL&md5=72358922f07ecea6110ad217202c039c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.160127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.160127%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DIchise%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DIkoma%26aufirst%3DY.%26aulast%3DSeki%26aufirst%3DC.%26aulast%3DTakano%26aufirst%3DH.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DShinotoh%26aufirst%3DH.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DM.-R.%26aulast%3DSahara%26aufirst%3DN.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DHiguchi%26aufirst%3DM.%26atitle%3DPET%2520quantification%2520of%2520tau%2520pathology%2520in%2520human%2520brain%2520with%252011C-PBB3%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2015%26volume%3D56%26spage%3D1359%26epage%3D1365%26doi%3D10.2967%2Fjnumed.115.160127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Q.-H.</span><span> </span><span class="NLM_article-title">Synthesis of a PET tau tracer [<sup>11</sup>C]PBB3 for imaging of Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4587</span><span class="NLM_x">–</span> <span class="NLM_lpage">4592</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.08.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.bmcl.2015.08.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4587-4592&author=M.+Wangauthor=M.+Gaoauthor=Z.+Xuauthor=Q.-H.+Zheng&title=Synthesis+of+a+PET+tau+tracer+%5B11C%5DPBB3+for+imaging+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2015.08.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.08.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.08.053%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DQ.-H.%26atitle%3DSynthesis%2520of%2520a%2520PET%2520tau%2520tracer%2520%255B11C%255DPBB3%2520for%2520imaging%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4587%26epage%3D4592%26doi%3D10.1016%2Fj.bmcl.2015.08.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Walji, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostetler, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennacef, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salinas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gantert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purcell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riffel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balsells, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OBrien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melquist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Della Rocca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schachter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Struyk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babaoglu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohith, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evelhoch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of 6-(fluoro-<sup>18</sup>F)-3-(1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-1-yl)isoquinolin-5-amine ([<sup>18</sup>F]-MK-6240): a positron emission tomography (PET) imaging agent for quantification of neurofibrillary tangles (NFTs)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4778</span><span class="NLM_x">–</span> <span class="NLM_lpage">4789</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00166</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00166" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtF2ls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4778-4789&author=A.+M.+Waljiauthor=E.+D.+Hostetlerauthor=H.+Selnickauthor=Z.+Zengauthor=P.+Millerauthor=I.+Bennacefauthor=C.+Salinasauthor=B.+Connollyauthor=L.+Gantertauthor=M.+Holahanauthor=S.+O%E2%80%99Malleyauthor=M.+Purcellauthor=K.+Riffelauthor=J.+Liauthor=J.+Balsellsauthor=J.+A.+OBrienauthor=S.+Melquistauthor=A.+Sorianoauthor=X.+Zhangauthor=A.+Ogawaauthor=S.+Xuauthor=E.+Joshiauthor=J.+Della+Roccaauthor=F.+J.+Hessauthor=J.+Schachterauthor=D.+Heskauthor=D.+Schenkauthor=A.+Struykauthor=K.+Babaogluauthor=T.+G.+Lohithauthor=Y.+Wangauthor=K.+Yangauthor=J.+Fuauthor=J.+L.+Evelhochauthor=P.+J.+Coleman&title=Discovery+of+6-%28fluoro-18F%29-3-%281H-pyrrolo%5B2%2C3-c%5Dpyridin-1-yl%29isoquinolin-5-amine+%28%5B18F%5D-MK-6240%29%3A+a+positron+emission+tomography+%28PET%29+imaging+agent+for+quantification+of+neurofibrillary+tangles+%28NFTs%29&doi=10.1021%2Facs.jmedchem.6b00166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)</span></div><div class="casAuthors">Walji, Abbas M.; Hostetler, Eric D.; Selnick, Harold; Zeng, Zhizhen; Miller, Patricia; Bennacef, Idriss; Salinas, Cristian; Connolly, Brett; Gantert, Liza; Holahan, Marie; O'Malley, Stacey; Purcell, Mona; Riffel, Kerry; Li, Jing; Balsells, Jaume; OBrien, Julie A.; Melquist, Stacey; Soriano, Aileen; Zhang, Xiaoping; Ogawa, Aimie; Xu, Serena; Joshi, Elizabeth; Della Rocca, Joseph; Hess, Fred J.; Schachter, Joel; Hesk, David; Schenk, David; Struyk, Arie; Babaoglu, Kerim; Lohith, Talakad G.; Wang, Yaode; Yang, Kun; Fu, Jianmin; Evelhoch, Jeffrey L.; Coleman, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4778-4789</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurofibrillary tangles (NFTs) made up of aggregated tau protein have been identified as the pathol. hallmark of several neurodegenerative diseases including Alzheimer's disease.  In vivo detection of NFTs using PET imaging represents a unique opportunity to develop a pharmacodynamic tool to accelerate the discovery of new disease modifying therapeutics targeting tau pathol.  Herein, we present the discovery of 6-(fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine, 6 ([18F]-MK-6240), as a novel PET tracer for detecting NFTs. 6 exhibits high specificity and selectivity for binding to NFTs, with suitable physicochem. properties and in vivo pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTkJBwXYLQ4LVg90H21EOLACvtfcHk0lj5epMHq0tg_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtF2ls70%253D&md5=7155752a95bc279765280108b794a758</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00166%26sid%3Dliteratum%253Aachs%26aulast%3DWalji%26aufirst%3DA.%2BM.%26aulast%3DHostetler%26aufirst%3DE.%2BD.%26aulast%3DSelnick%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DMiller%26aufirst%3DP.%26aulast%3DBennacef%26aufirst%3DI.%26aulast%3DSalinas%26aufirst%3DC.%26aulast%3DConnolly%26aufirst%3DB.%26aulast%3DGantert%26aufirst%3DL.%26aulast%3DHolahan%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%26aulast%3DPurcell%26aufirst%3DM.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBalsells%26aufirst%3DJ.%26aulast%3DOBrien%26aufirst%3DJ.%2BA.%26aulast%3DMelquist%26aufirst%3DS.%26aulast%3DSoriano%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DOgawa%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DE.%26aulast%3DDella%2BRocca%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DF.%2BJ.%26aulast%3DSchachter%26aufirst%3DJ.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DStruyk%26aufirst%3DA.%26aulast%3DBabaoglu%26aufirst%3DK.%26aulast%3DLohith%26aufirst%3DT.%2BG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DEvelhoch%26aufirst%3DJ.%2BL.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%25206-%2528fluoro-18F%2529-3-%25281H-pyrrolo%255B2%252C3-c%255Dpyridin-1-yl%2529isoquinolin-5-amine%2520%2528%255B18F%255D-MK-6240%2529%253A%2520a%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%2520agent%2520for%2520quantification%2520of%2520neurofibrillary%2520tangles%2520%2528NFTs%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4778%26epage%3D4789%26doi%3D10.1021%2Facs.jmedchem.6b00166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span>Alzheimer’s Association International Conference (AAIC), Washington, D.C., July 18–23, 2015. Alzforum News. <a href="http://www.alzforum.org/news/conference-coverage/new-imaging-data-tells-story-travelling-tau" class="extLink">http://www.alzforum.org/news/conference-coverage/new-imaging-data-tells-story-travelling-tau</a> (accessed August 3,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%E2%80%99s+Association+International+Conference+%28AAIC%29%2C+Washington%2C+D.C.%2C+July+18%E2%80%9323%2C+2015.+Alzforum+News.+http%3A%2F%2Fwww.alzforum.org%2Fnews%2Fconference-coverage%2Fnew-imaging-data-tells-story-travelling-tau+%28accessed+August+3%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Marquie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normandin, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderburg, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costantino, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bien, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rycyna, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikonomovic, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasdev, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomperts, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Growdon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frosch, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Isla, T.</span><span> </span><span class="NLM_article-title">Validating novel tau positron emission tomography tracer [<sup>18</sup>F]-AV-1451 (T807) on postmortem brain tissue</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span><span class="refDoi"> DOI: 10.1002/ana.24517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1002%2Fana.24517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=26344059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKlt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2015&pages=787-800&author=M.+Marquieauthor=M.+D.+Normandinauthor=C.+R.+Vanderburgauthor=I.+M.+Costantinoauthor=E.+A.+Bienauthor=L.+G.+Rycynaauthor=W.+E.+Klunkauthor=C.+A.+Mathisauthor=M.+D.+Ikonomovicauthor=M.+L.+Debnathauthor=N.+Vasdevauthor=B.+C.+Dickersonauthor=S.+N.+Gompertsauthor=J.+H.+Growdonauthor=K.+A.+Johnsonauthor=M.+P.+Froschauthor=B.+T.+Hymanauthor=T.+Gomez-Isla&title=Validating+novel+tau+positron+emission+tomography+tracer+%5B18F%5D-AV-1451+%28T807%29+on+postmortem+brain+tissue&doi=10.1002%2Fana.24517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue</span></div><div class="casAuthors">Marquie, Marta; Normandin, Marc D.; Vanderburg, Charles R.; Costantino, Isabel M.; Bien, Elizabeth A.; Rycyna, Lisa G.; Klunk, William E.; Mathis, Chester A.; Ikonomovic, Milos D.; Debnath, Manik L.; Vasdev, Neil; Dickerson, Bradford C.; Gomperts, Stephen N.; Growdon, John H.; Johnson, Keith A.; Frosch, Matthew P.; Hyman, Bradley T.; Gomez-Isla, Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">787-800</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : To examine region- and substrate-specific autoradiog. and in vitro binding patterns of positron emission tomog. tracer [F-18]-AV-1451 (previously known as T807), tailored to allow in vivo detection of paired helical filament-tau-contg. lesions, and to det. whether there is off-target binding to other amyloid/non-amyloid proteins.  Methods : We applied [F-18]-AV-1451 phosphor screen autoradiog., [F-18]-AV-1451 nuclear emulsion autoradiog., and [H-3]-AV-1451 in vitro binding assays to the study of postmortem samples from patients with a definite pathol. diagnosis of Alzheimer disease, frontotemporal lobar degeneration-tau, frontotemporal lobar degeneration-transactive response DNA binding protein 43 (TDP-43), progressive supranuclear palsy, corticobasal degeneration, dementia with Lewy bodies, multiple system atrophy, cerebral amyloid angiopathy and elderly controls free of pathol.  Results : Our data suggest that [F-18]-AV-1451 strongly binds to tau lesions primarily made of paired helical filaments in Alzheimer brains (eg, intraneuronal and extraneuronal tangles and dystrophic neurites), but does not seem to bind to a significant extent to neuronal and glial inclusions mainly composed of straight tau filaments in non-Alzheimer tauopathy brains or to lesions contg. β-amyloid, α-synuclein, or TDP-43.  [F-18]-AV-1451 off-target binding to neuromelanin- and melanin-contg. cells and, to a lesser extent, to brain hemorrhagic lesions was identified.  Interpretation : Our data suggest that [F-18]-AV-1451 holds promise as a surrogate marker for the detection of brain tau pathol. in the form of tangles and paired helical filament-tau-contg. neurites in Alzheimer brains but also point to its relatively lower affinity for lesions primarily made of straight tau filaments in non-Alzheimer tauopathy cases and to the existence of some [F-18]-AV-1451 off-target binding.  These findings provide important insights for interpreting in vivo patterns of [F-18]-AV-1451 retention.  Ann Neurol 2015 Ann Neurol 2015;78:Ann Neurol 2015;78:679-696.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgyGhMPNpa_bVg90H21EOLACvtfcHk0liL3mG0q7v9FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKlt73P&md5=a913e3c291117ad0a6020939d9cb8f80</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fana.24517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24517%26sid%3Dliteratum%253Aachs%26aulast%3DMarquie%26aufirst%3DM.%26aulast%3DNormandin%26aufirst%3DM.%2BD.%26aulast%3DVanderburg%26aufirst%3DC.%2BR.%26aulast%3DCostantino%26aufirst%3DI.%2BM.%26aulast%3DBien%26aufirst%3DE.%2BA.%26aulast%3DRycyna%26aufirst%3DL.%2BG.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DIkonomovic%26aufirst%3DM.%2BD.%26aulast%3DDebnath%26aufirst%3DM.%2BL.%26aulast%3DVasdev%26aufirst%3DN.%26aulast%3DDickerson%26aufirst%3DB.%2BC.%26aulast%3DGomperts%26aufirst%3DS.%2BN.%26aulast%3DGrowdon%26aufirst%3DJ.%2BH.%26aulast%3DJohnson%26aufirst%3DK.%2BA.%26aulast%3DFrosch%26aufirst%3DM.%2BP.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DGomez-Isla%26aufirst%3DT.%26atitle%3DValidating%2520novel%2520tau%2520positron%2520emission%2520tomography%2520tracer%2520%255B18F%255D-AV-1451%2520%2528T807%2529%2520on%2520postmortem%2520brain%2520tissue%26jtitle%3DAnn.%2520Neurol.%26date%3D2015%26volume%3D78%26spage%3D787%26epage%3D800%26doi%3D10.1002%2Fana.24517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Vermeiren, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mairet-Coello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannestad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courade, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, M.</span><span> </span><span class="NLM_article-title">T807, a reported selective tau tracer, binds with nanomolar affinity to monoamine oxidase A</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="refDoi"> DOI: 10.1016/j.jalz.2015.07.381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.jalz.2015.07.381" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=283&author=C.+Vermeirenauthor=J.+Mercierauthor=D.+Viotauthor=G.+Mairet-Coelloauthor=J.+Hannestadauthor=J.-P.+Couradeauthor=M.+Citronauthor=M.+Gillard&title=T807%2C+a+reported+selective+tau+tracer%2C+binds+with+nanomolar+affinity+to+monoamine+oxidase+A&doi=10.1016%2Fj.jalz.2015.07.381"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2015.07.381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2015.07.381%26sid%3Dliteratum%253Aachs%26aulast%3DVermeiren%26aufirst%3DC.%26aulast%3DMercier%26aufirst%3DJ.%26aulast%3DViot%26aufirst%3DD.%26aulast%3DMairet-Coello%26aufirst%3DG.%26aulast%3DHannestad%26aufirst%3DJ.%26aulast%3DCourade%26aufirst%3DJ.-P.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DGillard%26aufirst%3DM.%26atitle%3DT807%252C%2520a%2520reported%2520selective%2520tau%2520tracer%252C%2520binds%2520with%2520nanomolar%2520affinity%2520to%2520monoamine%2520oxidase%2520A%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2015%26volume%3D11%26spage%3D283%26doi%3D10.1016%2Fj.jalz.2015.07.381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Shcherbinin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navitsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flitter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devous, M. D.,  Sr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintun, M. A.</span><span> </span><span class="NLM_article-title">Kinetics of the tau PET tracer <sup>18</sup>F-AV-1451 (T807) in subjects with normal cognitive function, mild cognitive impairment and Alzheimer’s disease</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1535</span><span class="NLM_x">–</span> <span class="NLM_lpage">1542</span><span class="refDoi"> DOI: 10.2967/jnumed.115.170027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2967%2Fjnumed.115.170027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=1535-1542&author=S.+Shcherbininauthor=A.+J.+Schwarzauthor=A.+D.+Joshiauthor=M.+Navitskyauthor=M.+Flitterauthor=W.+R.+Shankleauthor=M.+D.+Devousauthor=M.+A.+Mintun&title=Kinetics+of+the+tau+PET+tracer+18F-AV-1451+%28T807%29+in+subjects+with+normal+cognitive+function%2C+mild+cognitive+impairment+and+Alzheimer%E2%80%99s+disease&doi=10.2967%2Fjnumed.115.170027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.170027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.170027%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbinin%26aufirst%3DS.%26aulast%3DSchwarz%26aufirst%3DA.%2BJ.%26aulast%3DJoshi%26aufirst%3DA.%2BD.%26aulast%3DNavitsky%26aufirst%3DM.%26aulast%3DFlitter%26aufirst%3DM.%26aulast%3DShankle%26aufirst%3DW.%2BR.%26aulast%3DDevous%26aufirst%3DM.%2BD.%26aulast%3DMintun%26aufirst%3DM.%2BA.%26atitle%3DKinetics%2520of%2520the%2520tau%2520PET%2520tracer%252018F-AV-1451%2520%2528T807%2529%2520in%2520subjects%2520with%2520normal%2520cognitive%2520function%252C%2520mild%2520cognitive%2520impairment%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D1535%26epage%3D1542%26doi%3D10.2967%2Fjnumed.115.170027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Rogers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, M.</span><span> </span><span class="NLM_article-title">Extended-connectivity fingerprints</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span><span class="refDoi"> DOI: 10.1021/ci100050t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci100050t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=742-754&author=D.+Rogersauthor=M.+Hahn&title=Extended-connectivity+fingerprints&doi=10.1021%2Fci100050t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Extended-Connectivity Fingerprints</span></div><div class="casAuthors">Rogers, David; Hahn, Mathew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">742-754</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Extended-connectivity fingerprints (ECFPs) are a novel class of topol. fingerprints for mol. characterization.  Historically, topol. fingerprints were developed for substructure and similarity searching.  ECFPs were developed specifically for structure-activity modeling.  ECFPs are circular fingerprints with a no. of useful qualities: they can be very rapidly calcd.; they are not predefined and can represent an essentially infinite no. of different mol. features (including stereochem. information); their features represent the presence of particular substructures, allowing easier interpretation of anal. results; and the ECFP algorithm can be tailored to generate different types of circular fingerprints, optimized for different uses.  While the use of ECFPs has been widely adopted and validated, a description of their implementation has not previously been presented in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra43orI-Y7lbVg90H21EOLACvtfcHk0lgs5YsOxNb4Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D&md5=cd6c736cd7a3d280b67f5316acce8006</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fci100050t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100050t%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DD.%26aulast%3DHahn%26aufirst%3DM.%26atitle%3DExtended-connectivity%2520fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D742%26epage%3D754%26doi%3D10.1021%2Fci100050t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span>FastROCS, version <span class="NLM_edition">1.4</span>; <span class="NLM_publisher-name">OpenEye Scientific Software Inc.</span> (<span class="NLM_publisher-loc">9 Bisbee Court, Suite D, Santa Fe, NM 87508, U.S.</span>); <a href="http://www.eyesopen.com" class="extLink">www.eyesopen.com</a> (accessed August 1,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FastROCS%2C+version+1.4%3B+OpenEye+Scientific+Software+Inc.+%289+Bisbee+Court%2C+Suite+D%2C+Santa+Fe%2C+NM+87508%2C+U.S.%29%3B+www.eyesopen.com+%28accessed+August+1%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DFastROCS%26pub%3DOpenEye%2520Scientific%2520Software%2520Inc%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rojo, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alzate-Morales, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccioni, R. B.</span><span> </span><span class="NLM_article-title">Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span><span class="refDoi"> DOI: 10.3233/JAD-2010-1262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.3233%2FJAD-2010-1262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=20110603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Slt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=573-589&author=L.+E.+Rojoauthor=J.+Alzate-Moralesauthor=I.+N.+Saavedraauthor=P.+Daviesauthor=R.+B.+Maccioni&title=Selective+interaction+of+lansoprazole+and+astemizole+with+tau+polymers%3A+potential+new+clinical+use+in+diagnosis+of+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-2010-1262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49aR"><div class="casContent"><span class="casTitleNuber">49a</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Interaction of Lansoprazole and Astemizole with Tau Polymers: Potential New Clinical Use in Diagnosis of Alzheimer's Disease</span></div><div class="casAuthors">Rojo, Leonel E.; Alzate-Morales, Jans; Saavedra, Ivan N.; Davies, Peter; Maccioni, Ricardo B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">573-589</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">We describe the interactions of two benzimidazole derivs., astemizole (AST) and lansoprazole (LNS), with anomalous aggregates of tau protein (neurofibrillary tangles).  Interestingly, these compds., with important medical applications in the treatment of allergies and gastrointestinal disorders resp., specifically bind to aggregated variants of tau protein and to paired helical filaments isolated from brains of Alzheimer's disease (AD) patients.  These ligands appear to be a powerful tool to tag brain-isolated tau-aggregates and heparin-induced polymers of recombinant tau.  The interactions of AST and LNS with tau aggregates were assessed by classical radioligand assays, surface plasmon resonance, and bioinformatic approaches.  The affinity of AST and LNS for tau aggregates was comparatively higher than that for amyloid-β polymers according to our data.  This is relevant since senile plaques are also abundant but are not pathognomonic in AD patients.  Immunochem. studies on paired helical filaments from brains of AD patients and surface plasmon resonance studies confirm these findings.  The capacity of these drugs to penetrate the blood-brain barrier was evaluated: (i) in vitro by parallel artificial membrane permeability assay followed by exptl. Log P detns.; and (ii) in vivo by pharmacokinetic studies comparing distribution profiles in blood and brain of mice using HPLC/UV.  Importantly, our studies indicate that the brain/blood concn. ratios for these compds. were suitable for their use as PET radiotracers.  Since neurofibrillary tangles are pos. correlated with cognitive impairment, we concluded that LNS and AST have a great potential in PET neuroimaing for in vivo early detection of AD and in reducing the formation of neurofibrillary tangles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJZHJBdFsZE7Vg90H21EOLACvtfcHk0lgs5YsOxNb4Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Slt7s%253D&md5=db44a10a6d6cf5665e71e10537aaf12f</span></div><a href="/servlet/linkout?suffix=cit49a&amp;dbid=16384&amp;doi=10.3233%2FJAD-2010-1262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2010-1262%26sid%3Dliteratum%253Aachs%26aulast%3DRojo%26aufirst%3DL.%2BE.%26aulast%3DAlzate-Morales%26aufirst%3DJ.%26aulast%3DSaavedra%26aufirst%3DI.%2BN.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DMaccioni%26aufirst%3DR.%2BB.%26atitle%3DSelective%2520interaction%2520of%2520lansoprazole%2520and%2520astemizole%2520with%2520tau%2520polymers%253A%2520potential%2520new%2520clinical%2520use%2520in%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2010%26volume%3D19%26spage%3D573%26epage%3D589%26doi%3D10.3233%2FJAD-2010-1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit49b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Riss, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brichard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aigbirhio, F. I.</span><span> </span><span class="NLM_article-title">Radiosynthesis and characterization of astemizole derivatives as lead compounds toward PET imaging of τ-pathology</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">852</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span><span class="refDoi"> DOI: 10.1039/c3md00017f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1039%2Fc3md00017f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=852-855&author=P.+J.+Rissauthor=L.+Brichardauthor=V.+Ferrariauthor=D.+J.+Williamsonauthor=T.+D.+Fryerauthor=Y.+T.+Hongauthor=J.-C.+Baronauthor=F.+I.+Aigbirhio&title=Radiosynthesis+and+characterization+of+astemizole+derivatives+as+lead+compounds+toward+PET+imaging+of+%CF%84-pathology&doi=10.1039%2Fc3md00017f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49b&amp;dbid=16384&amp;doi=10.1039%2Fc3md00017f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00017f%26sid%3Dliteratum%253Aachs%26aulast%3DRiss%26aufirst%3DP.%2BJ.%26aulast%3DBrichard%26aufirst%3DL.%26aulast%3DFerrari%26aufirst%3DV.%26aulast%3DWilliamson%26aufirst%3DD.%2BJ.%26aulast%3DFryer%26aufirst%3DT.%2BD.%26aulast%3DHong%26aufirst%3DY.%2BT.%26aulast%3DBaron%26aufirst%3DJ.-C.%26aulast%3DAigbirhio%26aufirst%3DF.%2BI.%26atitle%3DRadiosynthesis%2520and%2520characterization%2520of%2520astemizole%2520derivatives%2520as%2520lead%2520compounds%2520toward%2520PET%2520imaging%2520of%2520%25CF%2584-pathology%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D852%26epage%3D855%26doi%3D10.1039%2Fc3md00017f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Hawkins, P. C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skillman, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, A.</span><span> </span><span class="NLM_article-title">Comparison of shape-matching and docking as virtual screening tools</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1021/jm0603365</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0603365" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlansb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=74-82&author=P.+C.+D.+Hawkinsauthor=A.+G.+Skillmanauthor=A.+Nicholls&title=Comparison+of+shape-matching+and+docking+as+virtual+screening+tools&doi=10.1021%2Fjm0603365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Shape-Matching and Docking as Virtual Screening Tools</span></div><div class="casAuthors">Hawkins, Paul C. D.; Skillman, A. Geoffrey; Nicholls, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-82</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ligand docking is a widely used approach in virtual screening.  In recent years a large no. of publications have appeared in which docking tools are compared and evaluated for their effectiveness in virtual screening against a wide variety of protein targets.  These studies have shown that the effectiveness of docking in virtual screening is highly variable due to a large no. of possible confounding factors.  Another class of method that has shown promise in virtual screening is the shape-based, ligand-centric approach.  Several direct comparisons of docking with the shape-based tool ROCS have been conducted using data sets from some of these recent docking publications.  The results show that a shape-based, ligand-centric approach is more consistent than, and often superior to, the protein-centric approach taken by docking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe0IKOly7zibVg90H21EOLACvtfcHk0lhtBcafcKuO2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlansb%252FF&md5=6f97f5c0cc092b4e225f7c2656c1bcf6</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm0603365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603365%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DP.%2BC.%2BD.%26aulast%3DSkillman%26aufirst%3DA.%2BG.%26aulast%3DNicholls%26aufirst%3DA.%26atitle%3DComparison%2520of%2520shape-matching%2520and%2520docking%2520as%2520virtual%2520screening%2520tools%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D74%26epage%3D82%26doi%3D10.1021%2Fjm0603365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, E.</span><span> </span><span class="NLM_article-title">Neuropathological stageing of Alzheimer-related changes</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span><span class="refDoi"> DOI: 10.1007/BF00308809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1007%2FBF00308809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1759558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1991&pages=239-259&author=H.+Braakauthor=E.+Braak&title=Neuropathological+stageing+of+Alzheimer-related+changes&doi=10.1007%2FBF00308809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathological stageing of Alzheimer-related changes</span></div><div class="casAuthors">Braak H; Braak E</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">239-59</span>
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    </div><div class="casAbstract">Eighty-three brains obtained at autopsy from nondemented and demented individuals were examined for extracellular amyloid deposits and intraneuronal neurofibrillary changes.  The distribution pattern and packing density of amyloid deposits turned out to be of limited significance for differentiation of neuropathological stages.  Neurofibrillary changes occurred in the form of neuritic plaques, neurofibrillary tangles and neuropil threads.  The distribution of neuritic plaques varied widely not only within architectonic units but also from one individual to another.  Neurofibrillary tangles and neuropil threads, in contrast, exhibited a characteristic distribution pattern permitting the differentiation of six stages.  The first two stages were characterized by an either mild or severe alteration of the transentorhinal layer Pre-alpha (transentorhinal stages I-II).  The two forms of limbic stages (stages III-IV) were marked by a conspicuous affection of layer Pre-alpha in both transentorhinal region and proper entorhinal cortex.  In addition, there was mild involvement of the first Ammon's horn sector.  The hallmark of the two isocortical stages (stages V-VI) was the destruction of virtually all isocortical association areas.  The investigation showed that recognition of the six stages required qualitative evaluation of only a few key preparations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIZP19xbDelK_dlEzl_fBafW6udTcc2eYWVLYdMcJgmbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D&md5=b3e2663c943c202f121efeb65527a280</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1007%2FBF00308809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00308809%26sid%3Dliteratum%253Aachs%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DBraak%26aufirst%3DE.%26atitle%3DNeuropathological%2520stageing%2520of%2520Alzheimer-related%2520changes%26jtitle%3DActa%2520Neuropathol.%26date%3D1991%26volume%3D82%26spage%3D239%26epage%3D259%26doi%3D10.1007%2FBF00308809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><div class="note"><p class="first last">Online early access:</p></div><span class="NLM_contrib-group">Declercq, L.; Celen, S.; Lecina, J.; Ahamed, M.; Tousseyn, T.; Moechars, D.; Alcazar, J.; Ariza, M.; Fierens, K.; Bottelbergs, A.; Marien, J.; Vandenberghe, R.; Andres, I. J.; Van Laere, K.; Verbruggen, A.; Bormans, G.</span><span> </span><span class="NLM_article-title">Preclinical evaluation of 18F-JNJ64349311, a novel PET tracer for tau imaging</span>.  <span class="citation_source-journal">J. Nucl. Med.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.2967/jnumed.116.185199</span> . Published Online: February 16, 2017.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2967%2Fjnumed.116.185199" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Online+early+access%3ADeclercq%2C+L.%3B+Celen%2C+S.%3B+Lecina%2C+J.%3B+Ahamed%2C+M.%3B+Tousseyn%2C+T.%3B+Moechars%2C+D.%3B+Alcazar%2C+J.%3B+Ariza%2C+M.%3B+Fierens%2C+K.%3B+Bottelbergs%2C+A.%3B+Marien%2C+J.%3B+Vandenberghe%2C+R.%3B+Andres%2C+I.+J.%3B+Van+Laere%2C+K.%3B+Verbruggen%2C+A.%3B+Bormans%2C+G.+Preclinical+evaluation+of+18F-JNJ64349311%2C+a+novel+PET+tracer+for+tau+imaging.+J.+Nucl.+Med.+%5BOnline+early+access%5D.+DOI%3A+10.2967%2Fjnumed.116.185199.+Published+Online%3A+February+16%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.116.185199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.116.185199%26sid%3Dliteratum%253Aachs%26aulast%3DDeclercq%26aufirst%3DL.%26atitle%3DPreclinical%2520evaluation%2520of%252018F-JNJ64349311%252C%2520a%2520novel%2520PET%2520tracer%2520for%2520tau%2520imaging%26jtitle%3DJ.%2520Nucl.%2520Med.%26doi%3D10.2967%2Fjnumed.116.185199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span>ADMET Predictor, version <span class="NLM_edition">7</span>; <span class="NLM_publisher-name">Simulations Plus, Inc.</span> (<span class="NLM_publisher-loc">42505 10th Street West, Lancaster, CA 93534-7059, U.S.</span>); <a href="http://www.simulations-plus.com/" class="extLink">http://www.simulations-plus.com/</a> (accessed August 3,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ADMET+Predictor%2C+version+7%3B+Simulations+Plus%2C+Inc.+%2842505+10th+Street+West%2C+Lancaster%2C+CA+93534-7059%2C+U.S.%29%3B+http%3A%2F%2Fwww.simulations-plus.com%2F+%28accessed+August+3%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DADMET%2520Predictor%26pub%3DSimulations%2520Plus%252C%2520Inc%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Bleickardt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazdoba, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R. A.</span><span> </span><span class="NLM_article-title">Antagonism of the adenosine A2A receptor attenuates akathisia-like behavior induced with MP-10 or aripiprazole in a novel non-human primate model</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.1016/j.pbb.2013.10.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.pbb.2013.10.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2014&pages=36-45&author=C.+J.+Bleickardtauthor=T.+M.+Kazdobaauthor=N.+T.+Jonesauthor=J.+C.+Hunterauthor=R.+A.+Hodgson&title=Antagonism+of+the+adenosine+A2A+receptor+attenuates+akathisia-like+behavior+induced+with+MP-10+or+aripiprazole+in+a+novel+non-human+primate+model&doi=10.1016%2Fj.pbb.2013.10.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2013.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2013.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DBleickardt%26aufirst%3DC.%2BJ.%26aulast%3DKazdoba%26aufirst%3DT.%2BM.%26aulast%3DJones%26aufirst%3DN.%2BT.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26atitle%3DAntagonism%2520of%2520the%2520adenosine%2520A2A%2520receptor%2520attenuates%2520akathisia-like%2520behavior%2520induced%2520with%2520MP-10%2520or%2520aripiprazole%2520in%2520a%2520novel%2520non-human%2520primate%2520model%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2014%26volume%3D118%26spage%3D36%26epage%3D45%26doi%3D10.1016%2Fj.pbb.2013.10.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Dounay, A. B.; Tuttle, J. B.; Verhoest, P. R.</span><span> </span><span class="NLM_article-title">Preparation of tricyclic compds. as KAT II inhibitors for treatment of neurol. disorders and other diseases</span>, WO2013186666, Dec 19,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+B.+Dounay&author=J.+B.+Tuttle&author=P.+R.+Verhoest&title=Preparation+of+tricyclic+compds.+as+KAT+II+inhibitors+for+treatment+of+neurol.+disorders+and+other+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDounay%26aufirst%3DA.%2BB.%26atitle%3DPreparation%2520of%2520tricyclic%2520compds.%2520as%2520KAT%2520II%2520inhibitors%2520for%2520treatment%2520of%2520neurol.%2520disorders%2520and%2520other%2520diseases%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Aldous, S. C.; Fennie, M. W.; Jiang, J. Z.; Lan Mu, S. J.; Pedgrift, B.; Pribish, J. R.; Rauckman, B.; Sabol, J. S.; Stoklosa, G. T.; Thurairatnam, S.; Vandeusen, C. L.</span><span> </span><span class="NLM_article-title">Pyrimidine hydrazide compounds as PGDS inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases</span>, WO2008121670, Oct 9,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+C.+Aldous&author=M.+W.+Fennie&author=J.+Z.+Jiang&author=S.+J.+Lan+Mu&author=B.+Pedgrift&author=J.+R.+Pribish&author=B.+Rauckman&author=J.+S.+Sabol&author=G.+T.+Stoklosa&author=S.+Thurairatnam&author=C.+L.+Vandeusen&title=Pyrimidine+hydrazide+compounds+as+PGDS+inhibitors+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAldous%26aufirst%3DS.%2BC.%26atitle%3DPyrimidine%2520hydrazide%2520compounds%2520as%2520PGDS%2520inhibitors%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span> </span><span class="NLM_article-title">A One-pot diazotation-fluorodediazoniation reaction and fluorine gas for the production of fluoronaphthyridines</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">1001</span><span class="refDoi"> DOI: 10.1021/op500100b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op500100b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=993-1001&author=S.+Abeleauthor=G.+Schmidtauthor=M.+J.+Flemingauthor=H.+Steiner&title=A+One-pot+diazotation-fluorodediazoniation+reaction+and+fluorine+gas+for+the+production+of+fluoronaphthyridines&doi=10.1021%2Fop500100b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fop500100b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop500100b%26sid%3Dliteratum%253Aachs%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DFleming%26aufirst%3DM.%2BJ.%26aulast%3DSteiner%26aufirst%3DH.%26atitle%3DA%2520One-pot%2520diazotation-fluorodediazoniation%2520reaction%2520and%2520fluorine%2520gas%2520for%2520the%2520production%2520of%2520fluoronaphthyridines%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2014%26volume%3D18%26spage%3D993%26epage%3D1001%26doi%3D10.1021%2Fop500100b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Xiong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoye, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horchler, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attardo, G.</span><span> </span><span class="NLM_article-title">Facile route to 2-fluoropyridines via 2-pyridyltrialkylammonium salts prepared from pyridine N-oxides and application to <sup>18</sup>F-labeling</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3726</span><span class="NLM_x">–</span> <span class="NLM_lpage">3729</span><span class="refDoi"> DOI: 10.1021/acs.orglett.5b01703</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.5b01703" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2ltrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=3726-3729&author=H.+Xiongauthor=A.+T.+Hoyeauthor=K.+H.+Fanauthor=X.+Liauthor=J.+Clemensauthor=C.+L.+Horchlerauthor=N.+C.+Limauthor=G.+Attardo&title=Facile+route+to+2-fluoropyridines+via+2-pyridyltrialkylammonium+salts+prepared+from+pyridine+N-oxides+and+application+to+18F-labeling&doi=10.1021%2Facs.orglett.5b01703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Facile Route to 2-Fluoropyridines via 2-Pyridyltrialkylammonium Salts Prepared from Pyridine N-Oxides and Application to 18F-Labeling</span></div><div class="casAuthors">Xiong, Hui; Hoye, Adam T.; Fan, Kuo-Hsien; Li, Ximin; Clemens, Jennifer; Horchler, Carey L.; Lim, Nathaniel C.; Attardo, Giorgio</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3726-3729</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Among known precursors for 2-[18F]fluoropyridines, pyridyltrialkylammonium salts have shown excellent reactivity; however, their broader utility has been limited because synthetic methods for their prepn. suffer from poor functional group compatibility.  In this paper, we demonstrate the regioselective conversion of readily available pyridine N-oxides into 2-pyridyltrialkylammonium salts under mild and metal-free conditions.  These isolable intermediates serve as effective precursors to structurally diverse 2-fluoropyridines, including mols. relevant to PET imaging.  In addn. to providing access to nonradioactive analogs, this method has been successfully applied to 18F-labeling in the radiosynthesis of [18F]AV-1451 ([18F]T807), a PET tracer currently under development for imaging tau.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVTE6KPqgCdLVg90H21EOLACvtfcHk0lggnncd8rVehw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2ltrbM&md5=ee36c30d7305c50722e912ad257cd90e</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.5b01703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.5b01703%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DH.%26aulast%3DHoye%26aufirst%3DA.%2BT.%26aulast%3DFan%26aufirst%3DK.%2BH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DClemens%26aufirst%3DJ.%26aulast%3DHorchler%26aufirst%3DC.%2BL.%26aulast%3DLim%26aufirst%3DN.%2BC.%26aulast%3DAttardo%26aufirst%3DG.%26atitle%3DFacile%2520route%2520to%25202-fluoropyridines%2520via%25202-pyridyltrialkylammonium%2520salts%2520prepared%2520from%2520pyridine%2520N-oxides%2520and%2520application%2520to%252018F-labeling%26jtitle%3DOrg.%2520Lett.%26date%3D2015%26volume%3D17%26spage%3D3726%26epage%3D3729%26doi%3D10.1021%2Facs.orglett.5b01703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="note"><p class="first last">Please note that in the SAR discussion tau and Aβ denote specifically the aggregated form of these proteins.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">CNS drug design: balancing physicochemical properties for optimal brain exposure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2584</span><span class="NLM_x">–</span> <span class="NLM_lpage">2608</span><span class="refDoi"> DOI: 10.1021/jm501535r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501535r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2584-2608&author=Z.+Rankovic&title=CNS+drug+design%3A+balancing+physicochemical+properties+for+optimal+brain+exposure&doi=10.1021%2Fjm501535r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure</span></div><div class="casAuthors">Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2584-2608</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins.  Designing mols. that can overcome this protection system and achieve optimal concn. at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery.  Analogous to the now widely accepted rule of 5 in the design of oral drugs, the physicochem. properties required for optimal brain exposure have been extensively studied in an attempt to similarly define the attributes of successful CNS drugs and drug candidates.  This body of work is systematically reviewed here, with a particular emphasis on the interplay between the most crit. physicochem. and pharmacokinetic parameters of CNS drugs as well as their impact on medicinal chem. strategies toward mols. with optimal brain exposure.  A summary of modern CNS pharmacokinetic concepts and methods is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8V0N1j49uuLVg90H21EOLACvtfcHk0lggnncd8rVehw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP&md5=f01e3f2dc4e2eff7b0618124277a5cf8</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501535r%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DCNS%2520drug%2520design%253A%2520balancing%2520physicochemical%2520properties%2520for%2520optimal%2520brain%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2584%26epage%3D2608%26doi%3D10.1021%2Fjm501535r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span>All in vivo experimental procedures were performed according to the applicable European Communities Council Directive of November 24,<span class="NLM_x"> </span><span class="NLM_year">1986</span><span class="NLM_x">, </span>(86/609/EEC) and approved by the Animal Care and Use Committee of Janssen Pharmaceutical Companies of Johnson & Johnson and by the local ethical committee.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=All+in+vivo+experimental+procedures+were+performed+according+to+the+applicable+European+Communities+Council+Directive+of+November+24%2C+1986%2C+%2886%2F609%2FEEC%29+and+approved+by+the+Animal+Care+and+Use+Committee+of+Janssen+Pharmaceutical+Companies+of+Johnson+%26+Johnson+and+by+the+local+ethical+committee."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D1986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span>Eurofins Cerep SA, Le Bois l’Evêque, 86600 Celle L’Evescault, France. <a href="http://www.cerep.fr/" class="extLink">http://www.cerep.fr/</a> (accessed August 3,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Eurofins+Cerep+SA%2C+Le+Bois+l%E2%80%99Ev%C3%AAque%2C+86600+Celle+L%E2%80%99Evescault%2C+France.+http%3A%2F%2Fwww.cerep.fr%2F+%28accessed+August+3%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span>This is a competition binding assay:  <span class="citation_source-book">KINOMEscan Assay Platform</span>; <span class="NLM_publisher-name">KINOMEscan, a Division of DiscoverX</span> (<span class="NLM_publisher-loc">1180 Roselle Street, Suite D, San Diego, CA 92121, U.S.</span>); <a href="https://www.discoverx.com" class="extLink">https://www.discoverx.com</a> (accessed August 3,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=This+is+a+competition+binding+assay%3A+KINOMEscan+Assay+Platform%3B+KINOMEscan%2C+a+Division+of+DiscoverX+%281180+Roselle+Street%2C+Suite+D%2C+San+Diego%2C+CA+92121%2C+U.S.%29%3B+https%3A%2F%2Fwww.discoverx.com+%28accessed+August+3%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DKINOMEscan%2520Assay%2520Platform%26pub%3DKINOMEscan%252C%2520a%2520Division%2520of%2520DiscoverX%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Bonhaus, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeSouza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salazar, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuppan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eglen, R. M.</span><span> </span><span class="NLM_article-title">The pharmacology and distribution of human 5-hydroxytryptamine<sub>2B</sub> (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">622</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.1995.tb14977.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1111%2Fj.1476-5381.1995.tb14977.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=7582481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADyaK2MXmtlOht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1995&pages=622-628&author=D.+W.+Bonhausauthor=C.+Bachauthor=A.+DeSouzaauthor=F.+H.+Salazarauthor=B.+D.+Matsuokaauthor=P.+Zuppanauthor=H.+W.+Chanauthor=R.+M.+Eglen&title=The+pharmacology+and+distribution+of+human+5-hydroxytryptamine2B+%285-HT2B%29+receptor+gene+products%3A+comparison+with+5-HT2A+and+5-HT2C+receptors&doi=10.1111%2Fj.1476-5381.1995.tb14977.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors</span></div><div class="casAuthors">Bonhaus, Douglas W.; Bach, Chinh; DeSouza, Andrea; Salazar, R. H. Rick; Matsuoka, Barbara D.; Zuppan, Patricia; Chan, Hardy W.; Eglen, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">622-8</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Scientific & Medical Division</span>)
        </div><div class="casAbstract">Full length clones of the human 5-HT2B receptor were isolated from human liver, kidney and pancreas.  The cloned human 5-HT2B receptors had a high degree of homol. (∼80%) with the rat and mouse 5-HT2B receptors.  PCR amplification was used to det. the tissue distribution of human 5-HT2B receptor mRNA.  MRNA encoding the 5-HT2B receptor was expressed with greatest abundance in human liver and kidney.  Lower levels of expression were detected in cerebral cortex, whole brain, pancreas and spleen.  Expression was not detected in heart.  Northern blot anal. confirmed the presence of 5-HT2B receptor mRNA (a 2.4 kB sized band) in pancreas, liver and kidney.  An addnl. 3.2 kB sized band of hybridization was detected in liver and kidney.  This raises the possibility of a splice variant of the receptor or the presence of an addnl. homologous receptor.  The human 5-HT2B receptor was expressed in Cos-7 cells and its ligand binding characteristics were compared to similarly expressed human 5-HT2A and 5-HT2C receptors.  The ligand specificity of the human 5-HT2B receptor (5-HT > ritanserin > SB 204741 > spiperone) was distinct from that of the human 5-HT2A (ritanserin > spiperone > 5-HT > SB 204741) and 5-HT2C (ritanserin > 5-HT > spiperone = SB 204741) receptors.  On the basis of a higher affinity for ketanserin and a lower affinity for yohimbine the human 5-HT2B receptor also appeared to differ from the rat 5-HT2B receptor.  These findings confirm the sequence of the human 5-HT2B receptor and they demonstrate that the receptor has a widespread tissue distribution.  In addn., these data suggest that there are differences in ligand affinities between different species homologues of the receptor.  Finally, the finding of two distinct bands on the Northern blots of liver and kidney raises the possibility of splice variants or subtypes of 5-HT2B receptors, within these tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo79mR3s8H2nLVg90H21EOLACvtfcHk0lhrR--AO0Oakg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtlOht7k%253D&md5=55752ff530149d3ac96e5d9082c3e5d6</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1995.tb14977.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1995.tb14977.x%26sid%3Dliteratum%253Aachs%26aulast%3DBonhaus%26aufirst%3DD.%2BW.%26aulast%3DBach%26aufirst%3DC.%26aulast%3DDeSouza%26aufirst%3DA.%26aulast%3DSalazar%26aufirst%3DF.%2BH.%26aulast%3DMatsuoka%26aufirst%3DB.%2BD.%26aulast%3DZuppan%26aufirst%3DP.%26aulast%3DChan%26aufirst%3DH.%2BW.%26aulast%3DEglen%26aufirst%3DR.%2BM.%26atitle%3DThe%2520pharmacology%2520and%2520distribution%2520of%2520human%25205-hydroxytryptamine2B%2520%25285-HT2B%2529%2520receptor%2520gene%2520products%253A%2520comparison%2520with%25205-HT2A%2520and%25205-HT2C%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D115%26spage%3D622%26epage%3D628%26doi%3D10.1111%2Fj.1476-5381.1995.tb14977.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Declercq, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koole, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fierens, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariën, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanduffel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tousseyn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberghe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span> </span><span class="NLM_article-title">Preclinical evaluation of <sup>18</sup>F-JNJ64349311, a novel PET tracer for tau imaging</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_fpage">in press</span><span class="refDoi"> DOI: 10.2967/jnumed.116.185199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2967%2Fjnumed.116.185199" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=in+press&author=L.+Declercqauthor=F.+Romboutsauthor=M.+Kooleauthor=K.+Fierensauthor=J.+Mari%C3%ABnauthor=X.+Langloisauthor=J.-I.+Andr%C3%A9sauthor=M.+Schmidtauthor=G.+Macdonaldauthor=D.+Moecharsauthor=W.+Vanduffelauthor=T.+Tousseynauthor=R.+Vandenbergheauthor=K.+Van+Laereauthor=A.+Verbruggenauthor=G.+Bormans&title=Preclinical+evaluation+of+18F-JNJ64349311%2C+a+novel+PET+tracer+for+tau+imaging&doi=10.2967%2Fjnumed.116.185199"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.116.185199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.116.185199%26sid%3Dliteratum%253Aachs%26aulast%3DDeclercq%26aufirst%3DL.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DFierens%26aufirst%3DK.%26aulast%3DMari%25C3%25ABn%26aufirst%3DJ.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.-I.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DVanduffel%26aufirst%3DW.%26aulast%3DTousseyn%26aufirst%3DT.%26aulast%3DVandenberghe%26aufirst%3DR.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DPreclinical%2520evaluation%2520of%252018F-JNJ64349311%252C%2520a%2520novel%2520PET%2520tracer%2520for%2520tau%2520imaging%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2017%26spage%3Din%2520press%26doi%3D10.2967%2Fjnumed.116.185199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span>Sirius Analytical Ltd., Forest Row Business Park, Station Road, Forest Row, East Sussex. RH18 5DW, U.K. <a href="http://www.sirius-analytical.com/" class="extLink">http://www.sirius-analytical.com/</a> (accessed August 3,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sirius+Analytical+Ltd.%2C+Forest+Row+Business+Park%2C+Station+Road%2C+Forest+Row%2C+East+Sussex.+RH18+5DW%2C+U.K.+http%3A%2F%2Fwww.sirius-analytical.com%2F+%28accessed+August+3%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Hoaq, B. P.; Kondakov, D. Y.; Conley, S. R.; Owczarczyk, Z. R.; Brown, C. T.</span><span> </span><span class="NLM_article-title">Organic element for electroluminescent devices</span>. EP 2003-75445, Nov 30,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=B.+P.+Hoaq&author=D.+Y.+Kondakov&author=S.+R.+Conley&author=Z.+R.+Owczarczyk&author=C.+T.+Brown&title=Organic+element+for+electroluminescent+devices"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHoaq%26aufirst%3DB.%2BP.%26atitle%3DOrganic%2520element%2520for%2520electroluminescent%2520devices%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Barlaam, B.; Ducray, R.</span><span> </span><span class="NLM_article-title">2,4-Diaminopyrimidine derivatives as EphB4 kinase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of proliferative diseases</span>, WO2009010794, Jan 22,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=B.+Barlaam&author=R.+Ducray&title=2%2C4-Diaminopyrimidine+derivatives+as+EphB4+kinase+inhibitors+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+proliferative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarlaam%26aufirst%3DB.%26atitle%3D2%252C4-Diaminopyrimidine%2520derivatives%2520as%2520EphB4%2520kinase%2520inhibitors%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520proliferative%2520diseases%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Heitman, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goblyos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweemer, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder-Krieger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Veldhoven, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vries, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brussee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">A series of 2,4-disubstituted quinolines as a new class of allosteric enhancers of the adenosine A3 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">926</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span><span class="refDoi"> DOI: 10.1021/jm8014052</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8014052" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=926-931&author=L.+H.+Heitmanauthor=A.+Goblyosauthor=A.+M.+Zweemerauthor=R.+Bakkerauthor=T.+Mulder-Kriegerauthor=J.+P.+van+Veldhovenauthor=H.+de+Vriesauthor=J.+Brusseeauthor=A.+P.+Ijzerman&title=A+series+of+2%2C4-disubstituted+quinolines+as+a+new+class+of+allosteric+enhancers+of+the+adenosine+A3+receptor&doi=10.1021%2Fjm8014052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm8014052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014052%26sid%3Dliteratum%253Aachs%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DGoblyos%26aufirst%3DA.%26aulast%3DZweemer%26aufirst%3DA.%2BM.%26aulast%3DBakker%26aufirst%3DR.%26aulast%3DMulder-Krieger%26aufirst%3DT.%26aulast%3Dvan%2BVeldhoven%26aufirst%3DJ.%2BP.%26aulast%3Dde%2BVries%26aufirst%3DH.%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DA%2520series%2520of%25202%252C4-disubstituted%2520quinolines%2520as%2520a%2520new%2520class%2520of%2520allosteric%2520enhancers%2520of%2520the%2520adenosine%2520A3%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D926%26epage%3D931%26doi%3D10.1021%2Fjm8014052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Aldous, S. C.; Fennie, M. W.; Jiang, J. Z.; John, S.; Mu, L.; Pedgrift, B.; Pribish, J. R.; Rauckman, B.; Sabol, J. S.; Stoklosa, G. T.; Thurairatnam, S.; Vandeusen, C. L.</span><span> </span><span class="NLM_article-title">Pyrimidine hydrazide compounds as PGDS inhibitors</span>. WO 2008121670, Oct 9,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+C.+Aldous&author=M.+W.+Fennie&author=J.+Z.+Jiang&author=S.+John&author=L.+Mu&author=B.+Pedgrift&author=J.+R.+Pribish&author=B.+Rauckman&author=J.+S.+Sabol&author=G.+T.+Stoklosa&author=S.+Thurairatnam&author=C.+L.+Vandeusen&title=Pyrimidine+hydrazide+compounds+as+PGDS+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAldous%26aufirst%3DS.%2BC.%26atitle%3DPyrimidine%2520hydrazide%2520compounds%2520as%2520PGDS%2520inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span>Specs and Biospecs, Bleiswijkseweg 55, 2712 PB, Zoetermeer, The Netherlands. <a href="http://www.specs.net/" class="extLink">http://www.specs.net/</a> (accessed August 3,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Specs+and+Biospecs%2C+Bleiswijkseweg+55%2C+2712+PB%2C+Zoetermeer%2C+The+Netherlands.+http%3A%2F%2Fwww.specs.net%2F+%28accessed+August+3%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Profft, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, H.</span><span> </span><span class="NLM_article-title">Addition of formaldehyde to 4-bromo-2-picoline</span> <span class="citation_source-journal">Wiss. Z. Tech. Hochsch. Chem. "Carl Schorlemmer" Leuna-Merseburg</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADyaF3cXls1Cltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1960&pages=85&author=E.+Profftauthor=H.+Richter&title=Addition+of+formaldehyde+to+4-bromo-2-picoline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Addition of formaldehyde to 4-bromo-2-picoline</span></div><div class="casAuthors">Profft, Elmar; Richter, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Wissenschaftliche Zeitschrift der Technischen Hochschule fuer Chemie "Carl Schorlemmer" Leuna-Merseburg</span>
        (<span class="NLM_cas:date">1960</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85</span>CODEN:
                <span class="NLM_cas:coden">WZTLA3</span>;
        ISSN:<span class="NLM_cas:issn">0043-6909</span>.
    </div><div class="casAbstract">4-Bromo-2-picoline (I) (43 g.), 25 ml. 30% HCHO, and 3-5 drops AcOH heated in a glass autoclave 15 hrs. at 120°, the resulting black mixt. treated with 5 ml. 10% NaOH, extd. with CHCl3, and distd. yielded 15% I, b14 74-80°, and 9% 2-(4-bromo-2-pyridyl)ethanol (II), b14 95-8°, m. 54.5° (ligroine).  The aq. phase acidified with HCl, evapd. to dryness, and digested with 100 ml. of EtOH yielded a soln. that with 150 ml. C6H6 gave a ppt.(black gum); an addnl. 100 ml. C6H6 pptd. 0.6 g. (1%) 2-(4-hydroxy-2-pyridyl)ethanol-HCl, m. 128°.  Picrate of II m. 157°; II reineckate m. 148°.  4-Bromo-2(β-hydroxyethyl)-1-methylpyridinium iodide, from II and MeI in C6H6, m. 242° (HCONMe2-Et2O).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7iDwcNICBgbVg90H21EOLACvtfcHk0lhLh3cMkFXTaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3cXls1Cltw%253D%253D&md5=f5727e46f35801f726368ec9c2008a5f</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DProfft%26aufirst%3DE.%26aulast%3DRichter%26aufirst%3DH.%26atitle%3DAddition%2520of%2520formaldehyde%2520to%25204-bromo-2-picoline%26jtitle%3DWiss.%2520Z.%2520Tech.%2520Hochsch.%2520Chem.%2520%2522Carl%2520Schorlemmer%2522%2520Leuna-Merseburg%26date%3D1960%26volume%3D2%26spage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49a','cit49b'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':[],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 19 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kaixiang Zhou, Fan Yang, Yuying Li, Yimin Chen, Xiaojun Zhang, Jinming Zhang, Junfeng Wang, Jiapei Dai, Lisheng Cai, <span class="NLM_string-name hlFld-ContribAuthor">Mengchao Cui</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of Fluorine-18 Labeled 2-Phenylquinoxaline Derivatives as Potential Tau Imaging Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2021,</strong> <em>18 </em>
                                    (3)
                                     , 1176-1195. <a href="https://doi.org/10.1021/acs.molpharmaceut.0c01078" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.0c01078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.0c01078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.0c01078%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BFluorine-18%252BLabeled%252B2-Phenylquinoxaline%252BDerivatives%252Bas%252BPotential%252BTau%252BImaging%252BAgents%26aulast%3DZhou%26aufirst%3DKaixiang%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01112020%26date%3D28122020%26date%3D27122020%26date%3D21012021%26volume%3D18%26issue%3D3%26spage%3D1176%26epage%3D1195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hiroyuki Watanabe, Haruka Tatsumi, Sho Kaide, Yoichi Shimizu, Shimpei Iikuni, <span class="NLM_string-name hlFld-ContribAuthor">Masahiro Ono</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships of Radioiodinated 6,5,6-Tricyclic Compounds for the Development of Tau Imaging Probes. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (2)
                                     , 120-126. <a href="https://doi.org/10.1021/acsmedchemlett.9b00456" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00456</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00456&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00456%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%252Bof%252BRadioiodinated%252B6%25252C5%25252C6-Tricyclic%252BCompounds%252Bfor%252Bthe%252BDevelopment%252Bof%252BTau%252BImaging%252BProbes%26aulast%3DWatanabe%26aufirst%3DHiroyuki%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D01102019%26date%3D06012020%26date%3D09012020%26volume%3D11%26issue%3D2%26spage%3D120%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Frederik J. R. Rombouts, Lieven Declercq, José-Ignacio Andrés, Astrid Bottelbergs, Lu Chen, Laura Iturrino, Joseph E. Leenaerts, Jonas Mariën, Fengbin Song, Cindy Wintmolders, Stijn Wuyts, Chunfang A. Xia, Paula te Riele, Guy Bormans, Rik Vandenberghe, Hartmuth Kolb, <span class="NLM_string-name hlFld-ContribAuthor">Diederik Moechars</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-(4-[18F]Fluoro-5-methylpyridin-2-yl)isoquinolin-6-amine (JNJ-64326067), a New Promising Tau Positron Emission Tomography Imaging Tracer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (6)
                                     , 2974-2987. <a href="https://doi.org/10.1021/acs.jmedchem.8b01759" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01759</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01759%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-%2525284-%25255B18F%25255DFluoro-5-methylpyridin-2-yl%252529isoquinolin-6-amine%252B%252528JNJ-64326067%252529%25252C%252Ba%252BNew%252BPromising%252BTau%252BPositron%252BEmission%252BTomography%252BImaging%252BTracer%26aulast%3DRombouts%26aufirst%3DFrederik%2BJ.%2BR.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D12112018%26date%3D19032019%26date%3D27022019%26volume%3D62%26issue%3D6%26spage%3D2974%26epage%3D2987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Subhajit  Bhunia</span>, <span class="hlFld-ContribAuthor ">S. Vijay  Kumar</span>, and <span class="hlFld-ContribAuthor ">Dawei  Ma</span>  . </span><span class="cited-content_cbyCitation_article-title">N,N′-Bisoxalamides Enhance the Catalytic Activity in Cu-Catalyzed Coupling of (Hetero)Aryl Bromides with Anilines and Secondary Amines. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (23)
                                     , 12603-12612. <a href="https://doi.org/10.1021/acs.joc.7b02363" title="DOI URL">https://doi.org/10.1021/acs.joc.7b02363</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b02363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b02363%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DN%25252CN%2525E2%252580%2525B2-Bisoxalamides%252BEnhance%252Bthe%252BCatalytic%252BActivity%252Bin%252BCu-Catalyzed%252BCoupling%252Bof%252B%252528Hetero%252529Aryl%252BBromides%252Bwith%252BAnilines%252Band%252BSecondary%252BAmines%26aulast%3DBhunia%26aufirst%3DSubhajit%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D18092017%26date%3D16112017%26date%3D01122017%26date%3D08112017%26volume%3D82%26issue%3D23%26spage%3D12603%26epage%3D12612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca C.  Gobbi</span>, <span class="hlFld-ContribAuthor ">Henner  Knust</span>, <span class="hlFld-ContribAuthor ">Matthias  Körner</span>, <span class="hlFld-ContribAuthor ">Michael  Honer</span>, <span class="hlFld-ContribAuthor ">Christian  Czech</span>, <span class="hlFld-ContribAuthor ">Sara  Belli</span>, <span class="hlFld-ContribAuthor ">Dieter  Muri</span>, <span class="hlFld-ContribAuthor ">Martin R.  Edelmann</span>, <span class="hlFld-ContribAuthor ">Thomas  Hartung</span>, <span class="hlFld-ContribAuthor ">Isabella  Erbsmehl</span>, <span class="hlFld-ContribAuthor ">Sandra  Grall-Ulsemer</span>, <span class="hlFld-ContribAuthor ">Andreas  Koblet</span>, <span class="hlFld-ContribAuthor ">Marianne  Rueher</span>, <span class="hlFld-ContribAuthor ">Sandra  Steiner</span>, <span class="hlFld-ContribAuthor ">Hayden T.  Ravert</span>, <span class="hlFld-ContribAuthor ">William B.  Mathews</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Holt</span>, <span class="hlFld-ContribAuthor ">Hiroto  Kuwabara</span>, <span class="hlFld-ContribAuthor ">Heather  Valentine</span>, <span class="hlFld-ContribAuthor ">Robert F.  Dannals</span>, <span class="hlFld-ContribAuthor ">Dean F.  Wong</span>, and <span class="hlFld-ContribAuthor ">Edilio  Borroni</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimer’s Disease with Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (17)
                                     , 7350-7370. <a href="https://doi.org/10.1021/acs.jmedchem.7b00632" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00632</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00632%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BThree%252BNovel%252BRadiotracers%252Bfor%252BImaging%252BAggregated%252BTau%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Bwith%252BPositron%252BEmission%252BTomography%26aulast%3DGobbi%26aufirst%3DLuca%2BC.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D27042017%26date%3D12072017%26date%3D14092017%26date%3D27062017%26volume%3D60%26issue%3D17%26spage%3D7350%26epage%3D7370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yiyun Henry  Huang</span>, <span class="hlFld-ContribAuthor ">Hongmei  Jia</span>, <span class="hlFld-ContribAuthor ">Weiqi  Bao</span>. </span><span class="cited-content_cbyCitation_article-title">Positron emission tomography imaging agents for evaluating the pathologic features of Alzheimer's disease and drug development. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 367-412. <a href="https://doi.org/10.1016/B978-0-12-816475-4.00013-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-816475-4.00013-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816475-4.00013-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816475-4.00013-6%26sid%3Dliteratum%253Aachs%26atitle%3DPositron%252Bemission%252Btomography%252Bimaging%252Bagents%252Bfor%252Bevaluating%252Bthe%252Bpathologic%252Bfeatures%252Bof%252BAlzheimer%252527s%252Bdisease%252Band%252Bdrug%252Bdevelopment%26aulast%3DHuang%26aufirst%3DYiyun%2BHenry%26date%3D2021%26spage%3D367%26epage%3D412%26pub%3DElsevier%26atitle%3DNeurotherapeutics%252Bin%252Bthe%252BEra%252Bof%252BTranslational%252BMedicine%26date%3D2021%26volume%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark E.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Luc  Janssens</span>, <span class="hlFld-ContribAuthor ">Diederik  Moechars</span>, <span class="hlFld-ContribAuthor ">Frederik J. R.  Rombouts</span>, <span class="hlFld-ContribAuthor ">Maarten  Timmers</span>, <span class="hlFld-ContribAuthor ">Olivier  Barret</span>, <span class="hlFld-ContribAuthor ">Cristian C.  Constantinescu</span>, <span class="hlFld-ContribAuthor ">Jennifer  Madonia</span>, <span class="hlFld-ContribAuthor ">David S.  Russell</span>, <span class="hlFld-ContribAuthor ">Christine M.  Sandiego</span>, <span class="hlFld-ContribAuthor ">Hartmuth  Kolb</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical evaluation of [18F] JNJ-64326067, a novel candidate PET tracer for the detection of tau pathology in Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2020,</strong> <em>47 </em>
                                    (13)
                                     , 3176-3185. <a href="https://doi.org/10.1007/s00259-020-04880-1" title="DOI URL">https://doi.org/10.1007/s00259-020-04880-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-020-04880-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-020-04880-1%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DClinical%252Bevaluation%252Bof%252B%25255B18F%25255D%252BJNJ-64326067%25252C%252Ba%252Bnovel%252Bcandidate%252BPET%252Btracer%252Bfor%252Bthe%252Bdetection%252Bof%252Btau%252Bpathology%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSchmidt%26aufirst%3DMark%2BE.%26date%3D2020%26date%3D2020%26volume%3D47%26issue%3D13%26spage%3D3176%26epage%3D3185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Fuertes</span>, <span class="hlFld-ContribAuthor ">Carme  Masdeu</span>, <span class="hlFld-ContribAuthor ">Endika  Martin-Encinas</span>, <span class="hlFld-ContribAuthor ">Asier  Selas</span>, <span class="hlFld-ContribAuthor ">Gloria  Rubiales</span>, <span class="hlFld-ContribAuthor ">Francisco  Palacios</span>, <span class="hlFld-ContribAuthor ">Concepcion  Alonso</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Strategies, Reactivity and Applications of 1,5-Naphthyridines. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (14)
                                     , 3252. <a href="https://doi.org/10.3390/molecules25143252" title="DOI URL">https://doi.org/10.3390/molecules25143252</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25143252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25143252%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthetic%252BStrategies%25252C%252BReactivity%252Band%252BApplications%252Bof%252B1%25252C5-Naphthyridines%26aulast%3DFuertes%26aufirst%3DMaria%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D14%26spage%3D3252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alberto  Fontana</span>, <span class="hlFld-ContribAuthor ">Laura  Iturrino</span>, <span class="hlFld-ContribAuthor ">David  Corens</span>, <span class="hlFld-ContribAuthor ">Antonio L.  Crego</span>. </span><span class="cited-content_cbyCitation_article-title">Automated open-access liquid chromatography high resolution mass spectrometry to support drug discovery projects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical and Biomedical Analysis</span><span> <strong>2020,</strong> <em>178 </em>, 112908. <a href="https://doi.org/10.1016/j.jpba.2019.112908" title="DOI URL">https://doi.org/10.1016/j.jpba.2019.112908</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpba.2019.112908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpba.2019.112908%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520and%2520Biomedical%2520Analysis%26atitle%3DAutomated%252Bopen-access%252Bliquid%252Bchromatography%252Bhigh%252Bresolution%252Bmass%252Bspectrometry%252Bto%252Bsupport%252Bdrug%252Bdiscovery%252Bprojects%26aulast%3DFontana%26aufirst%3DAlberto%26date%3D2020%26volume%3D178%26spage%3D112908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Endika  Martín-Encinas</span>, <span class="hlFld-ContribAuthor ">Gloria  Rubiales</span>, <span class="hlFld-ContribAuthor ">Birgitta R.  Knudssen</span>, <span class="hlFld-ContribAuthor ">Francisco  Palacios</span>, <span class="hlFld-ContribAuthor ">Concepción  Alonso</span>. </span><span class="cited-content_cbyCitation_article-title">Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>178 </em>, 752-766. <a href="https://doi.org/10.1016/j.ejmech.2019.06.032" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.032%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStraightforward%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bas%252Btopoisomerase%252BI%252Binhibitors%252Band%252Bantiproliferative%252Bagents%252Bof%252Bhybrid%252BChromeno%25255B4%25252C3-b%25255D%25255B1%25252C5%25255DNaphthyridines%252Band%252BChromeno%25255B4%25252C3-b%25255D%25255B1%25252C5%25255DNaphthyridin-6-ones%26aulast%3DMart%25C3%25ADn-Encinas%26aufirst%3DEndika%26date%3D2019%26volume%3D178%26spage%3D752%26epage%3D766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Meng</span>, <span class="hlFld-ContribAuthor ">Shuwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Jia</span>, <span class="hlFld-ContribAuthor ">Liangzhong  Lv</span>, <span class="hlFld-ContribAuthor ">Yu  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">Transition-metal-free sp3 C–H activation of 2-methylquinoline with terminal alkynes for synthesis of 3-(quinolin-2-yl)isoxazoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (21)
                                     , 1443-1447. <a href="https://doi.org/10.1016/j.tetlet.2019.04.047" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.04.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.04.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.04.047%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DTransition-metal-free%252Bsp3%252BC%2525E2%252580%252593H%252Bactivation%252Bof%252B2-methylquinoline%252Bwith%252Bterminal%252Balkynes%252Bfor%252Bsynthesis%252Bof%252B3-%252528quinolin-2-yl%252529isoxazoles%26aulast%3DMeng%26aufirst%3DLei%26date%3D2019%26volume%3D60%26issue%3D21%26spage%3D1443%26epage%3D1447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">JuanJuan  Li</span>, <span class="hlFld-ContribAuthor ">Zhenzhen  Tian</span>, <span class="hlFld-ContribAuthor ">Xingxing  Ge</span>, <span class="hlFld-ContribAuthor ">Zhishan  Xu</span>, <span class="hlFld-ContribAuthor ">Yaqian  Feng</span>, <span class="hlFld-ContribAuthor ">Zhe  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of fluorine and Naphthyridine–Based half-sandwich organoiridium/ruthenium complexes with bioimaging and anticancer activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>163 </em>, 830-839. <a href="https://doi.org/10.1016/j.ejmech.2018.12.021" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.021%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252Bfluorine%252Band%252BNaphthyridine%2525E2%252580%252593Based%252Bhalf-sandwich%252Borganoiridium%25252Fruthenium%252Bcomplexes%252Bwith%252Bbioimaging%252Band%252Banticancer%252Bactivity%26aulast%3DLi%26aufirst%3DJuanJuan%26date%3D2019%26volume%3D163%26spage%3D830%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tobey J.  Betthauser</span>. </span><span class="cited-content_cbyCitation_article-title">AD molecular: Imaging tau aggregates with positron emissions tomography. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 107-138. <a href="https://doi.org/10.1016/bs.pmbts.2019.07.007" title="DOI URL">https://doi.org/10.1016/bs.pmbts.2019.07.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmbts.2019.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmbts.2019.07.007%26sid%3Dliteratum%253Aachs%26atitle%3DAD%252Bmolecular%25253A%252BImaging%252Btau%252Baggregates%252Bwith%252Bpositron%252Bemissions%252Btomography%26aulast%3DBetthauser%26aufirst%3DTobey%2BJ.%26date%3D2019%26spage%3D107%26epage%3D138%26pub%3DElsevier%26atitle%3DBrain%252BImaging%26date%3D2019%26volume%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Hwey  Nai</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Watabe</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of the Feasibility of Screening Tau Radiotracers Using an Amyloid Biomathematical Screening Methodology. </span><span class="cited-content_cbyCitation_journal-name">Computational and Mathematical Methods in Medicine</span><span> <strong>2018,</strong> <em>2018 </em>, 1-13. <a href="https://doi.org/10.1155/2018/6287913" title="DOI URL">https://doi.org/10.1155/2018/6287913</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2018/6287913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2018%2F6287913%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Mathematical%2520Methods%2520in%2520Medicine%26atitle%3DEvaluation%252Bof%252Bthe%252BFeasibility%252Bof%252BScreening%252BTau%252BRadiotracers%252BUsing%252Ban%252BAmyloid%252BBiomathematical%252BScreening%252BMethodology%26aulast%3DNai%26aufirst%3DYing-Hwey%26date%3D2018%26volume%3D2018%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bjoern  Bartels</span>, <span class="hlFld-ContribAuthor ">Philipp  Cueni</span>, <span class="hlFld-ContribAuthor ">Dieter  Muri</span>, <span class="hlFld-ContribAuthor ">Matthias  Koerner</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a safe and scalable route towards a tau PET tracer precursor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (4)
                                     , 970-976. <a href="https://doi.org/10.1016/j.bmc.2017.10.007" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.10.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.10.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Ba%252Bsafe%252Band%252Bscalable%252Broute%252Btowards%252Ba%252Btau%252BPET%252Btracer%252Bprecursor%26aulast%3DBartels%26aufirst%3DBjoern%26date%3D2018%26volume%3D26%26issue%3D4%26spage%3D970%26epage%3D976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José Ignacio  Andrés</span>, <span class="hlFld-ContribAuthor ">Mark  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry strategies for PET tracer discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2017,</strong> <em>25 </em>, 11-17. <a href="https://doi.org/10.1016/j.ddtec.2017.10.002" title="DOI URL">https://doi.org/10.1016/j.ddtec.2017.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2017.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2017.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DMedicinal%252BChemistry%252Bstrategies%252Bfor%252BPET%252Btracer%252Bdiscovery%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJos%25C3%25A9%2BIgnacio%26date%3D2017%26volume%3D25%26spage%3D11%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moritz  Balkenhohl</span>, <span class="hlFld-ContribAuthor ">Robert  Greiner</span>, <span class="hlFld-ContribAuthor ">Ilya S.  Makarov</span>, <span class="hlFld-ContribAuthor ">Benjamin  Heinz</span>, <span class="hlFld-ContribAuthor ">Konstantin  Karaghiosoff</span>, <span class="hlFld-ContribAuthor ">Hendrik  Zipse</span>, <span class="hlFld-ContribAuthor ">Paul  Knochel</span>. </span><span class="cited-content_cbyCitation_article-title">Zn-, Mg-, and Li-TMP Bases for the Successive Regioselective Metalations of the 1,5-Naphthyridine Scaffold (TMP=2,2,6,6-Tetramethylpiperidyl). </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2017,</strong> <em>23 </em>
                                    (53)
                                     , 13046-13050. <a href="https://doi.org/10.1002/chem.201703638" title="DOI URL">https://doi.org/10.1002/chem.201703638</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201703638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201703638%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DZn-%25252C%252BMg-%25252C%252Band%252BLi-TMP%252BBases%252Bfor%252Bthe%252BSuccessive%252BRegioselective%252BMetalations%252Bof%252Bthe%252B1%25252C5-Naphthyridine%252BScaffold%252B%252528TMP%25253D2%25252C2%25252C6%25252C6-Tetramethylpiperidyl%252529%26aulast%3DBalkenhohl%26aufirst%3DMoritz%26date%3D2017%26date%3D2017%26volume%3D23%26issue%3D53%26spage%3D13046%26epage%3D13050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lieven  Declercq</span>, <span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Michel  Koole</span>, <span class="hlFld-ContribAuthor ">Katleen  Fierens</span>, <span class="hlFld-ContribAuthor ">Jonas  Mariën</span>, <span class="hlFld-ContribAuthor ">Xavier  Langlois</span>, <span class="hlFld-ContribAuthor ">José Ignacio  Andrés</span>, <span class="hlFld-ContribAuthor ">Mark  Schmidt</span>, <span class="hlFld-ContribAuthor ">Gregor  Macdonald</span>, <span class="hlFld-ContribAuthor ">Diederik  Moechars</span>, <span class="hlFld-ContribAuthor ">Wim  Vanduffel</span>, <span class="hlFld-ContribAuthor ">Thomas  Tousseyn</span>, <span class="hlFld-ContribAuthor ">Rik  Vandenberghe</span>, <span class="hlFld-ContribAuthor ">Koen  Van Laere</span>, <span class="hlFld-ContribAuthor ">Alfons  Verbruggen</span>, <span class="hlFld-ContribAuthor ">Guy  Bormans</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Evaluation of
              18
              F-JNJ64349311, a Novel PET Tracer for Tau Imaging. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2017,</strong> <em>58 </em>
                                    (6)
                                     , 975-981. <a href="https://doi.org/10.2967/jnumed.116.185199" title="DOI URL">https://doi.org/10.2967/jnumed.116.185199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.116.185199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.116.185199%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DPreclinical%252BEvaluation%252Bof%252B18%252BF-JNJ64349311%25252C%252Ba%252BNovel%252BPET%252BTracer%252Bfor%252BTau%252BImaging%26aulast%3DDeclercq%26aufirst%3DLieven%26date%3D2017%26date%3D2017%26volume%3D58%26issue%3D6%26spage%3D975%26epage%3D981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asha  Hiremathad</span>, <span class="hlFld-ContribAuthor ">Luca  Piemontese</span>. </span><span class="cited-content_cbyCitation_article-title">Heterocyclic compounds as key structures for the interaction with old and new targets in Alzheimer's disease therapy. </span><span class="cited-content_cbyCitation_journal-name">Neural Regeneration Research</span><span> <strong>2017,</strong> <em>12 </em>
                                    (8)
                                     , 1256. <a href="https://doi.org/10.4103/1673-5374.213541" title="DOI URL">https://doi.org/10.4103/1673-5374.213541</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4103/1673-5374.213541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4103%2F1673-5374.213541%26sid%3Dliteratum%253Aachs%26jtitle%3DNeural%2520Regeneration%2520Research%26atitle%3DHeterocyclic%252Bcompounds%252Bas%252Bkey%252Bstructures%252Bfor%252Bthe%252Binteraction%252Bwith%252Bold%252Band%252Bnew%252Btargets%252Bin%252BAlzheimer%252527s%252Bdisease%252Btherapy%26aulast%3DHiremathad%26aufirst%3DAsha%26date%3D2017%26volume%3D12%26issue%3D8%26spage%3D1256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0001.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Representative Aβ PET Probes Used in the Clinic</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0002.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. Representative Tau PET Tracers Evaluated in Clinical Studies</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0003.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. Hit Identified from a Mini-HTS with Selected Compounds with Similarity to Known Selective Tau Binders</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Buchwald–Hartwig Couplings Leading to Compounds <b>10</b> and <b>30</b>–<b>44</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(OAc)<sub>2</sub>, XantPhos, Cs<sub>2</sub>CO<sub>3</sub>, <i>tert</i>-butanol, 90 °C, 10–16 h.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis Routes toward 2-Fluoroalkyl(oxy)pyridines <b>50</b>–<b>52</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd<sub>2</sub>(dba)<sub>3</sub>, XantPhos, K<sub>3</sub>PO<sub>4</sub>, THF, 80 °C, 16 h; (b) DAST, DCM, 0 °C, 30 min.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis Route toward Fluoroalkoxy-Substituted Quinolines <b>58</b>–<b>60</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1-fluoro-2-iodoethane or 3-bromo-1-fluoropropane, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 85 °C, 1–16 h; (b) <b>23</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, XantPhos, K<sub>3</sub>PO<sub>4</sub>, toluene, 80 °C, 16 h.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis Route toward 4-Fluoroquinoline <b>63</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>23</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, XantPhos, K<sub>3</sub>PO<sub>3</sub>, THF, 90 °C, 1 h; (b) KF, DMSO, 150 °C (microwave), 5 min.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0012.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis Route toward 1,7-Naphthyridine <b>68</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyl acrylate, Pd(Amphos)Cl<sub>2</sub>, Et<sub>3</sub>N, DMF, 145 °C, 40 min; (b) NaOMe, MeOH, 60 °C, 6 h; (c) POCl<sub>3</sub>, 120 °C (microwave), 20 min; (d) <b>23</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, XantPhos, K<sub>3</sub>PO<sub>4</sub>, THF, 100 °C, 6 h.</p></p></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis Route toward 1,5-Naphthyridines <b>74</b> and <b>75</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyl acrylate, Pd(OAc)<sub>2</sub>, PPh<sub>3</sub>, Et<sub>3</sub>N, DMF, 140 °C, 120 min; (b) Bu<sub>3</sub>P, AcOH, 110 °C, 60 min; (c) POCl<sub>3</sub>, 1,4-dioxane, 110 °C, 60 min; (d) <b>23</b> or <b>24</b>, Pd(OAc)<sub>2</sub>, XantPhos, Cs<sub>2</sub>CO<sub>3</sub>, <i>tert</i>-butanol, 90 °C, 18–24 h.</p></p></figure><figure data-id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0014.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Evaluation of Potential Radiofluorination Route for <b>75</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) mCPBA, DCM/MeOH, rt, 75 h; (b) TFAA, Me<sub>3</sub>N, DCM, 0 °C to rt, 30 min; (c) <b>24</b>, NaH, DMF, 0 °C to rt, 20 min; (d) TBAF, DMF, 90 °C, 30 min.</p></p></figure><figure data-id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0015.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Radioligand [<sup>3</sup>H]<b>39</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, CHCl<sub>3</sub>, MeOH, 60 °C, 2 h; (b) <sup>3</sup>H<sub>2</sub>, 10% Pd/C, DIPEA, DMF.</p></p></figure><figure data-id="fig1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0004.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Binding of (A) 3 nM [<sup>3</sup>H]<b>3a</b>, (B) 10 nM [<sup>3</sup>H]<b>7</b>, and (C) 10 nM [<sup>3</sup>H]<b>39</b> to post-mortem human AD brain sections and IHC with phospho-tau antibody AT8 (D) and amyloid antibody 4G8 (E) show <b>39</b> is selective for tau. Zoom regions have been boxed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0005.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Total binding of 10 nM [<sup>3</sup>H]<b>39</b>, (B) displacement of 10 nM [<sup>3</sup>H]<b>39</b> with 1 μM <b>75</b>, (C) total binding of 10 nM [<sup>3</sup>H]<b>7</b>, (D) displacement of 10 nM [<sup>3</sup>H]<b>7</b> with 1 μM <b>75</b>, (E) total binding of 3 nM [<sup>3</sup>H]<b>3a</b>, (F) competition of 3 nM [<sup>3</sup>H]<b>3a</b> with 1 μM <b>75</b>, (G) AT8 phospho-tau staining on adjacent section, (H) 4G8 amyloid staining on adjacent section.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0006.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cortex clearance for compounds <b>6</b>, <b>60</b>, and <b>75</b> in an acute microdosing study in NMRI mouse (0.03 mg/kg, iv, <i>n</i> = 3/time point).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0007.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Microdosing study of <b>75</b> in Sprague-Dawley rat (0.03 mg/kg, iv, <i>n</i> = 3/time point) with sampling of cortex, cerebellum, and plasma.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch9" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/medium/jm-2016-01173d_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0016.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Metabolites <b>81</b> and <b>82</b> Observed for <b>75</b> after Incubation with Human, Rat, Mouse, Dog, and Monkey Hepatocytes</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-4/acs.jmedchem.6b01173/20170216/images/large/jm-2016-01173d_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01173&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i93">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55710" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55710" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 72 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Khachaturian, Z. S.</span><span> </span><span class="NLM_article-title">Diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1097</span><span class="NLM_x">–</span> <span class="NLM_lpage">1105</span><span class="refDoi"> DOI: 10.1001/archneur.1985.04060100083029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1001%2Farchneur.1985.04060100083029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=2864910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADyaL28%252FisV2kug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1985&pages=1097-1105&author=Z.+S.+Khachaturian&title=Diagnosis+of+Alzheimer%E2%80%99s+disease&doi=10.1001%2Farchneur.1985.04060100083029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Diagnosis of Alzheimer's disease</span></div><div class="casAuthors">Khachaturian Z S</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1097-105</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTc9SvEChaSAWGmni0r9GoKfW6udTcc2eZCu8918eppr7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL28%252FisV2kug%253D%253D&md5=a47cb19684c6e17f83431a1aadd57cde</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1001%2Farchneur.1985.04060100083029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.1985.04060100083029%26sid%3Dliteratum%253Aachs%26aulast%3DKhachaturian%26aufirst%3DZ.%2BS.%26atitle%3DDiagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D1985%26volume%3D42%26spage%3D1097%26epage%3D1105%26doi%3D10.1001%2Farchneur.1985.04060100083029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: strategies for disease modification</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span><span class="refDoi"> DOI: 10.1038/nrd2896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1038%2Fnrd2896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=20431570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVWjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=387-398&author=M.+Citron&title=Alzheimer%E2%80%99s+disease%3A+strategies+for+disease+modification&doi=10.1038%2Fnrd2896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: strategies for disease modification</span></div><div class="casAuthors">Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">387-398</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease is the largest unmet medical need in neurol.  Current drugs improve symptoms, but do not have profound disease-modifying effects.  However, in recent years, several approaches aimed at inhibiting disease progression have advanced to clin. trials.  Among these, strategies targeting the prodn. and clearance of the amyloid-β peptide - a cardinal feature of Alzheimer's disease that is thought to be important in disease pathogenesis - are the most advanced.  Approaches aimed at modulating the abnormal aggregation of tau filaments (another key feature of the disease), and those targeting metabolic dysfunction, are also being evaluated in the clinic.  This article discusses recent progress with each of these strategies, with a focus on anti-amyloid strategies, highlighting the lessons learned and the challenges that remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeM0fsdJQ-z7Vg90H21EOLACvtfcHk0li6IoxLsg9SUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVWjsrw%253D&md5=281ba27137d2a1fa173d5dde1dcbe772</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd2896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2896%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520strategies%2520for%2520disease%2520modification%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D387%26epage%3D398%26doi%3D10.1038%2Fnrd2896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Nelson, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alafuzoff, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigio, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouras, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellani, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crain, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Tredici, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duyckaerts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frosch, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haroutunian, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulette, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jellinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jicha, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukull, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverenz, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Love, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackenzie, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masliah, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKee, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonnen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troncoso, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisniewski, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woltjer, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beach, T. G.</span><span> </span><span class="NLM_article-title">Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature</span> <span class="citation_source-journal">J. Neuropathol. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span><span class="refDoi"> DOI: 10.1097/NEN.0b013e31825018f7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1097%2FNEN.0b013e31825018f7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=22487856" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADC%252BC38rjsFaitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=362-381&author=P.+T.+Nelsonauthor=I.+Alafuzoffauthor=E.+H.+Bigioauthor=C.+Bourasauthor=H.+Braakauthor=N.+J.+Cairnsauthor=R.+J.+Castellaniauthor=B.+J.+Crainauthor=P.+Daviesauthor=K.+Del+Trediciauthor=C.+Duyckaertsauthor=M.+P.+Froschauthor=V.+Haroutunianauthor=P.+R.+Hofauthor=C.+M.+Huletteauthor=B.+T.+Hymanauthor=T.+Iwatsuboauthor=K.+A.+Jellingerauthor=G.+A.+Jichaauthor=E.+Kovariauthor=W.+A.+Kukullauthor=J.+B.+Leverenzauthor=S.+Loveauthor=I.+R.+Mackenzieauthor=D.+M.+Mannauthor=E.+Masliahauthor=A.+C.+McKeeauthor=T.+J.+Montineauthor=J.+C.+Morrisauthor=J.+A.+Schneiderauthor=J.+A.+Sonnenauthor=D.+R.+Thalauthor=J.+Q.+Trojanowskiauthor=J.+C.+Troncosoauthor=T.+Wisniewskiauthor=R.+L.+Woltjerauthor=T.+G.+Beach&title=Correlation+of+Alzheimer+disease+neuropathologic+changes+with+cognitive+status%3A+a+review+of+the+literature&doi=10.1097%2FNEN.0b013e31825018f7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of Alzheimer disease neuropathologic changes with cognitive status:  a review of the literature</span></div><div class="casAuthors">Nelson Peter T; Alafuzoff Irina; Bigio Eileen H; Bouras Constantin; Braak Heiko; Cairns Nigel J; Castellani Rudolph J; Crain Barbara J; Davies Peter; Del Tredici Kelly; Duyckaerts Charles; Frosch Matthew P; Haroutunian Vahram; Hof Patrick R; Hulette Christine M; Hyman Bradley T; Iwatsubo Takeshi; Jellinger Kurt A; Jicha Gregory A; Kovari Eniko; Kukull Walter A; Leverenz James B; Love Seth; Mackenzie Ian R; Mann David M; Masliah Eliezer; McKee Ann C; Montine Thomas J; Morris John C; Schneider Julie A; Sonnen Joshua A; Thal Dietmar R; Trojanowski John Q; Troncoso Juan C; Wisniewski Thomas; Woltjer Randall L; Beach Thomas G</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuropathology and experimental neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">362-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Clinicopathologic correlation studies are critically important for the field of Alzheimer disease (AD) research.  Studies on human subjects with autopsy confirmation entail numerous potential biases that affect both their general applicability and the validity of the correlations.  Many sources of data variability can weaken the apparent correlation between cognitive status and AD neuropathologic changes.  Indeed, most persons in advanced old age have significant non-AD brain lesions that may alter cognition independently of AD.  Worldwide research efforts have evaluated thousands of human subjects to assess the causes of cognitive impairment in the elderly, and these studies have been interpreted in different ways.  We review the literature focusing on the correlation of AD neuropathologic changes (i.e. β-amyloid plaques and neurofibrillary tangles) with cognitive impairment.  We discuss the various patterns of brain changes that have been observed in elderly individuals to provide a perspective for understanding AD clinicopathologic correlation and conclude that evidence from many independent research centers strongly supports the existence of a specific disease, as defined by the presence of Aβ plaques and neurofibrillary tangles.  Although Aβ plaques may play a key role in AD pathogenesis, the severity of cognitive impairment correlates best with the burden of neocortical neurofibrillary tangles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfBiLIW6MJ0v9pSBfyDvp7fW6udTcc2eZCu8918eppr7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rjsFaitg%253D%253D&md5=172e31ea54410212b1d60f7ff6f1d4d6</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2FNEN.0b013e31825018f7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FNEN.0b013e31825018f7%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DP.%2BT.%26aulast%3DAlafuzoff%26aufirst%3DI.%26aulast%3DBigio%26aufirst%3DE.%2BH.%26aulast%3DBouras%26aufirst%3DC.%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DCairns%26aufirst%3DN.%2BJ.%26aulast%3DCastellani%26aufirst%3DR.%2BJ.%26aulast%3DCrain%26aufirst%3DB.%2BJ.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DDel%2BTredici%26aufirst%3DK.%26aulast%3DDuyckaerts%26aufirst%3DC.%26aulast%3DFrosch%26aufirst%3DM.%2BP.%26aulast%3DHaroutunian%26aufirst%3DV.%26aulast%3DHof%26aufirst%3DP.%2BR.%26aulast%3DHulette%26aufirst%3DC.%2BM.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DJellinger%26aufirst%3DK.%2BA.%26aulast%3DJicha%26aufirst%3DG.%2BA.%26aulast%3DKovari%26aufirst%3DE.%26aulast%3DKukull%26aufirst%3DW.%2BA.%26aulast%3DLeverenz%26aufirst%3DJ.%2BB.%26aulast%3DLove%26aufirst%3DS.%26aulast%3DMackenzie%26aufirst%3DI.%2BR.%26aulast%3DMann%26aufirst%3DD.%2BM.%26aulast%3DMasliah%26aufirst%3DE.%26aulast%3DMcKee%26aufirst%3DA.%2BC.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DSchneider%26aufirst%3DJ.%2BA.%26aulast%3DSonnen%26aufirst%3DJ.%2BA.%26aulast%3DThal%26aufirst%3DD.%2BR.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DTroncoso%26aufirst%3DJ.%2BC.%26aulast%3DWisniewski%26aufirst%3DT.%26aulast%3DWoltjer%26aufirst%3DR.%2BL.%26aulast%3DBeach%26aufirst%3DT.%2BG.%26atitle%3DCorrelation%2520of%2520Alzheimer%2520disease%2520neuropathologic%2520changes%2520with%2520cognitive%2520status%253A%2520a%2520review%2520of%2520the%2520literature%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2012%26volume%3D71%26spage%3D362%26epage%3D381%26doi%3D10.1097%2FNEN.0b013e31825018f7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Delacourte, A.</span><span> </span><span class="NLM_article-title">Diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">Ann. Biol. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=9754238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADyaK1cvis1yntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1998&pages=133-142&author=A.+Delacourte&title=Diagnosis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Diagnosis of Alzheimer's disease</span></div><div class="casAuthors">Delacourte A</div><div class="citationInfo"><span class="NLM_cas:title">Annales de biologie clinique</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-42</span>
        ISSN:<span class="NLM_cas:issn">0003-3898</span>.
    </div><div class="casAbstract">Alzheimer's disease is a neurodegenerative disorder leading to cognitive impairment (amnesia, aphasia, apraxia and agnosia).  The prevalence of this age related disabling illness is increasing.  During the course of the disease, the clinical diagnosis will be that of "possible Alzheimer's disease", then "probable Alzheimer's disease".  But the diagnosis of "definite Alzheimer's disease" requires a post-mortem brain examination and the demonstration of numerous senile plaques and neurofibrillary tangles in hippocampal and association cortical areas.  The neuropathological examination confirms probable Alzheimer's disease clinical diagnosis in 85% of the cases examined in medical schools.  However, with much more than 15% errors, the early diagnosis of Alzheimer's disease must be improved since it is a key factor for the therapeutic approach, and more especially for the efficiency of drug trials.  At the present time, there are new leads for a biological diagnosis in the blood or the CSF.  However, the natural (and molecular) history of Alzheimer's disease points out that all biochemical dysfunctions remain in the CNS, and more particularly in association brain areas.  This is demonstrated using reliable biochemical markers such as A beta and pathological Tau proteins, which are the basic components of amyloid deposits and neurofibrillary tangles, respectively.  Also, a genetic diagnosis can be performed in half of familial autosomic dominant Alzheimer's disease, which represents less than 1% of all Alzheimer's disease cases.  Together, this shows that there is a lack of reliable Alzheimer's disease markers.  The search for new specific markers (clinical, epidemiological, genetic, biochemical, biological) must go on.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1f1PBUrz3XdyzdcP07UmufW6udTcc2eYAcYtqAG9OSLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1cvis1yntA%253D%253D&md5=3c95236af3100e692fad9515b72cfbdd</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelacourte%26aufirst%3DA.%26atitle%3DDiagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520Biol.%2520Clin.%26date%3D1998%26volume%3D56%26spage%3D133%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Strategies for improving the postmortem neuropathological diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">S75</span><span class="NLM_x">–</span> <span class="NLM_lpage">S79</span><span class="refDoi"> DOI: 10.1016/S0197-4580(97)00075-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2FS0197-4580%2897%2900075-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=9330990" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=S75-S79&author=J.+Q.+Trojanowskiauthor=C.+M.+Clarkauthor=M.+L.+Schmidtauthor=S.+E.+Arnoldauthor=V.+M.+Lee&title=Strategies+for+improving+the+postmortem+neuropathological+diagnosis+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0197-4580%2897%2900075-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2897%2900075-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252897%252900075-4%26sid%3Dliteratum%253Aachs%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DClark%26aufirst%3DC.%2BM.%26aulast%3DSchmidt%26aufirst%3DM.%2BL.%26aulast%3DArnold%26aufirst%3DS.%2BE.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DStrategies%2520for%2520improving%2520the%2520postmortem%2520neuropathological%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D1997%26volume%3D18%26spage%3DS75%26epage%3DS79%26doi%3D10.1016%2FS0197-4580%2897%2900075-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">DeKosky, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marek, K.</span><span> </span><span class="NLM_article-title">Looking backward to move forward: early detection of neurodegenerative disorders</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">830</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span><span class="refDoi"> DOI: 10.1126/science.1090349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1126%2Fscience.1090349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=14593169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Cmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=830-834&author=S.+T.+DeKoskyauthor=K.+Marek&title=Looking+backward+to+move+forward%3A+early+detection+of+neurodegenerative+disorders&doi=10.1126%2Fscience.1090349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Looking backward to move forward: Early detection of neurodegenerative disorders</span></div><div class="casAuthors">DeKosky, Steven T.; Marek, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5646</span>),
    <span class="NLM_cas:pages">830-834</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Early detection of neurodegenerative disorders would provide clues to the underlying pathobiol. of these diseases and would enable more effective diagnosis and treatment of patients.  Recent advances in mol. neuroscience have begun to provide the tools to detect diseases like Alzheimer's disease, Parkinson's disease, and others early in their course and potentially even before the development of clin. manifestations of disease.  These genetic, imaging, clin., and biochem. tools are being validated in a no. of studies.  Early detection of these slowly progressive diseases offers the promise of presymptomatic diagnosis and, ultimately, of disease-modifying medications for use early in disease and during the presymptomatic period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsFocomYIAdbVg90H21EOLACvtfcHk0lgRf9NTEPeUTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Cmt7s%253D&md5=2f286b23ca55deeca5990ad6f1bfed53</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1126%2Fscience.1090349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1090349%26sid%3Dliteratum%253Aachs%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26aulast%3DMarek%26aufirst%3DK.%26atitle%3DLooking%2520backward%2520to%2520move%2520forward%253A%2520early%2520detection%2520of%2520neurodegenerative%2520disorders%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D830%26epage%3D834%26doi%3D10.1126%2Fscience.1090349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Reiman, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagust, W. J.</span><span> </span><span class="NLM_article-title">Brain imaging in the study of Alzheimer’s disease</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span><span class="refDoi"> DOI: 10.1016/j.neuroimage.2011.11.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.neuroimage.2011.11.075" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=505-516&author=E.+M.+Reimanauthor=W.+J.+Jagust&title=Brain+imaging+in+the+study+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neuroimage.2011.11.075"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2011.11.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2011.11.075%26sid%3Dliteratum%253Aachs%26aulast%3DReiman%26aufirst%3DE.%2BM.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26atitle%3DBrain%2520imaging%2520in%2520the%2520study%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuroImage%26date%3D2012%26volume%3D61%26spage%3D505%26epage%3D516%26doi%3D10.1016%2Fj.neuroimage.2011.11.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, W.</span><span> </span><span class="NLM_article-title">Advances of molecular imaging probes for the diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span><span class="refDoi"> DOI: 10.2174/1567205011666140131121259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2174%2F1567205011666140131121259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=24484277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1eru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=221-231&author=M.+Zhouauthor=X.+Wangauthor=Z.+Liuauthor=L.+Yuauthor=S.+Huauthor=L.+Chenauthor=W.+Zeng&title=Advances+of+molecular+imaging+probes+for+the+diagnosis+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F1567205011666140131121259"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Advances of Molecular Imaging Probes for the Diagnosis of Alzheimer's Disease</span></div><div class="casAuthors">Zhou, Ming; Wang, Xiaobo; Liu, Zhiguo; Yu, Lun; Hu, Shuo; Chen, Lizhang; Zeng, Wenbin</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-231</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive decline in multiple cognitive domains and it becomes the most common cause of dementia in the elderly.  There is an urgent need for the early diagnosis and treatment of AD to ease caregiver burden and medical costs, as well as improve patients' living activities assocd. with the dramatic increasing no. of affected individuals.  Mol. imaging with target-specific probes is contributing to identify the underlying biol. in AD, which benefits to the early diagnosis of AD and the evaluation of anti-AD therapy.  Mol. imaging probes, such as 11C-PIB, 11C-MP4A, 18F-AV-45, and 18F-FDG, can selectively bind to special bimol. of AD or accurately accumulate at the location of damage areas, thus become an edge tool for a better management of the diseases in the clin. practice and new drug development.  In the past decades, a large variety of probes is being developed and tested to be useful for the early and accurate diagnosis of Alzheimer's disease, patient selection for disease-modifying therapeutic trials and monitoring the effect of anti-amyloid therapy.  Since imaging probes may also help to guide physicians to identify those patients that could best benefit from a given therapeutic regimen, dose, or duration of drug, this paper is to present a perspective of the available imaging probes for AD, classified on different modalities.  Meanwhile, recent advances of those probes that have been selected for clin. trials and are at the different stages of the US Food and Drugs Administration (FDA) approval are outlined.  Addnl., future directions and specific application of imaging strategies designed for both diagnosis and treatment for AD are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLa6ITw42ws7Vg90H21EOLACvtfcHk0lgRf9NTEPeUTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1eru7k%253D&md5=d919e86d68e5ba2243d1715db76c3d4d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F1567205011666140131121259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205011666140131121259%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DW.%26atitle%3DAdvances%2520of%2520molecular%2520imaging%2520probes%2520for%2520the%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2014%26volume%3D11%26spage%3D221%26epage%3D231%26doi%3D10.2174%2F1567205011666140131121259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Valk, P. E.; Bailey, D. L.; Townsend, D. W.; Maisey, M. N.</span> <span class="citation_source-book">Positron Emission Tomography: Basic Science</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=P.+E.+Valk&author=D.+L.+Bailey&author=D.+W.+Townsend&author=M.+N.+Maisey&title=Positron+Emission+Tomography%3A+Basic+Science"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DValk%26aufirst%3DP.%2BE.%26btitle%3DPositron%2520Emission%2520Tomography%253A%2520Basic%2520Science%26pub%3DSpringer%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Kung, H. F.</span><span> </span><span class="NLM_article-title">The β-amyloid hypothesis in Alzheimer’s disease: seeing is believing</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span><span class="refDoi"> DOI: 10.1021/ml300058m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300058m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFehs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=265-267&author=H.+F.+Kung&title=The+%CE%B2-amyloid+hypothesis+in+Alzheimer%E2%80%99s+disease%3A+seeing+is+believing&doi=10.1021%2Fml300058m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The β-Amyloid Hypothesis in Alzheimer's Disease: Seeing Is Believing</span></div><div class="casAuthors">Kung, Hank F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">265-267</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, discussing amyloid precursor protein degrdn. by proteases and the imbalance of prodn. and clearance of Aβ40-42 fragments in the brain in Alzheimer's disease and the PET imaging agents being approved by the FDA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2d1v-xf_5IrVg90H21EOLACvtfcHk0lgOC3vcCRd64Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFehs78%253D&md5=729086c7a759fc5d22f84d300289a44a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fml300058m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300058m%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DH.%2BF.%26atitle%3DThe%2520%25CE%25B2-amyloid%2520hypothesis%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520seeing%2520is%2520believing%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D265%26epage%3D267%26doi%3D10.1021%2Fml300058m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Mason, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span> </span><span class="NLM_article-title">Positron emission tomography radioligands for in vivo imaging of Aβ plaques</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span><span class="refDoi"> DOI: 10.1002/jlcr.2989</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1002%2Fjlcr.2989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=24285314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtlejtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=89-95&author=N.+S.+Masonauthor=C.+A.+Mathisauthor=W.+E.+Klunk&title=Positron+emission+tomography+radioligands+for+in+vivo+imaging+of+A%CE%B2+plaques&doi=10.1002%2Fjlcr.2989"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography radioligands for in vivo imaging of Aβ plaques</span></div><div class="casAuthors">Mason, N. Scott; Mathis, Chester A.; Klunk, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">89-95</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  The development of positron emission tomog. (PET) radioligands for the non-invasive imaging of amyloid-β plaque burden has been the focus of intense research efforts over the last decade.  A variety of structural backbones have been investigated and several radiolabeled mols. have been evaluated in phase I (and later) clin. studies.  These efforts have been driven by the desire not only to develop a suitable diagnostic imaging agent but also to develop a means to evaluate potential therapies for Alzheimer's disease.  This review focuses on the development of these ligands, as well as the radiochem. and current regulatory status of these PET radioligands.  Particular attention is given to those ligands that have progressed to the later stages of drug development (phase II/III clin. trial studies) or approved New Drug Application status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFhPmau7iHILVg90H21EOLACvtfcHk0lgOC3vcCRd64Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtlejtbs%253D&md5=423e02bcc2709e718d7a32adb552f81f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.2989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.2989%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DN.%2BS.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DPositron%2520emission%2520tomography%2520radioligands%2520for%2520in%2520vivo%2520imaging%2520of%2520A%25CE%25B2%2520plaques%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2013%26volume%3D56%26spage%3D89%26epage%3D95%26doi%3D10.1002%2Fjlcr.2989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Noël, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gras, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hureau, C.</span><span> </span><span class="NLM_article-title">The benzazole scaffold: a SWAT to combat Alzheimer’s disease</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">7747</span><span class="NLM_x">–</span> <span class="NLM_lpage">7762</span><span class="refDoi"> DOI: 10.1039/c3cs60086f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1039%2Fc3cs60086f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=23793644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSit7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=7747-7762&author=S.+No%C3%ABlauthor=S.+Cadetauthor=E.+Grasauthor=C.+Hureau&title=The+benzazole+scaffold%3A+a+SWAT+to+combat+Alzheimer%E2%80%99s+disease&doi=10.1039%2Fc3cs60086f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The benzazole scaffold: a SWAT to combat Alzheimer's disease</span></div><div class="casAuthors">Noel, Sabrina; Cadet, Sarah; Gras, Emmanuel; Hureau, Christelle</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7747-7762</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative disorders including Alzheimer's disease (AD) are drawing scientists' attention within various fields, being one of the most serious diseases mankind will have to fight against in the very near future.  AD is multi-factorial and is characterized by two histopathol. hallmarks: the senile plaques made of amyloid-β (Aβ) peptide fibrils which also contain high levels of transition metal ions and the neurofibrillary tangles of Tau protein.  Aβ aggregation, possibly modulated by metal ions, is now considered as an important factor in AD etiol.  Hence, chemists are studying the details of mol. features at the origin of the disease with special interest in Aβ aggregation and in the design of new mols. for the early diagnosis of AD or with curative properties.  In this context, the benzazole mol. scaffold, included for instance in Thioflavin-T, an Aβ fibril specific dye, or the PIB imaging agent, appears to be very attractive and exhibits multiple uses.  In the present review, the authors have thus focused the authors' interest on the applications of benzazole derivs. for understanding, diagnosing and curing AD.  After having analyzed the synthetic access to 2-arylbenzazoles, the authors have described a selection of recent applications of such compds. aiming to combat AD.  They include the use of Thioflavin-T for the monitoring of Aβ aggregation, the investigations of new PET and SPECT imaging agents for the detection of the senile plaques, the development of bi-functional mols., encompassing the 2-arylbenzazole moiety for Aβ binding and a chelating unit for metal ions coordination for instance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHZz8Ue4nXT7Vg90H21EOLACvtfcHk0lgOC3vcCRd64Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSit7bJ&md5=2e45c81f4fdc6d9edd3a7d452971a701</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1039%2Fc3cs60086f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3cs60086f%26sid%3Dliteratum%253Aachs%26aulast%3DNo%25C3%25ABl%26aufirst%3DS.%26aulast%3DCadet%26aufirst%3DS.%26aulast%3DGras%26aufirst%3DE.%26aulast%3DHureau%26aufirst%3DC.%26atitle%3DThe%2520benzazole%2520scaffold%253A%2520a%2520SWAT%2520to%2520combat%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2013%26volume%3D42%26spage%3D7747%26epage%3D7762%26doi%3D10.1039%2Fc3cs60086f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span> </span><span class="NLM_article-title">Amyloid imaging with PET in early Alzheimer disease diagnosis</span> <span class="citation_source-journal">Med. Clin. North Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span><span class="refDoi"> DOI: 10.1016/j.mcna.2012.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.mcna.2012.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=23642577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADC%252BC3sngvFCrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2013&pages=377-398&author=C.+C.+Roweauthor=V.+L.+Villemagne&title=Amyloid+imaging+with+PET+in+early+Alzheimer+disease+diagnosis&doi=10.1016%2Fj.mcna.2012.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid imaging with PET in early Alzheimer disease diagnosis</span></div><div class="casAuthors">Rowe Christopher C; Villemagne Victor L</div><div class="citationInfo"><span class="NLM_cas:title">The Medical clinics of North America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">377-98</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In vivo imaging of amyloid-β (Aβ) with positron emission tomography has moved from the research arena into clinical practice.  Clinicians working with cognitive decline and dementia must become familiar with its benefits and limitations.  Amyloid imaging allows earlier diagnosis of Alzheimer disease and better differential diagnosis of dementia and provides prognostic information for mild cognitive impairment.  It also has an increasingly important role in therapeutic trial recruitment and for evaluation of anti-Aβ treatments.  Longitudinal observations are required to elucidate the role of Aβ deposition in the course of Alzheimer disease and provide information needed to fully use the prognostic power of this investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ6G2K_LCaW1QHqQV89nF-2fW6udTcc2ea6VLo-zwDTb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sngvFCrug%253D%253D&md5=46ec97a002c90bbd2b1f14303b243fa3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.mcna.2012.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcna.2012.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26atitle%3DAmyloid%2520imaging%2520with%2520PET%2520in%2520early%2520Alzheimer%2520disease%2520diagnosis%26jtitle%3DMed.%2520Clin.%2520North%2520Am.%26date%3D2013%26volume%3D97%26spage%3D377%26epage%3D398%26doi%3D10.1016%2Fj.mcna.2012.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Holland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotstein, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greguric, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasdev, N.</span><span> </span><span class="NLM_article-title">Alternative approaches for PET radiotracer development in Alzheimers disease: imaging beyond plaque</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span><span class="refDoi"> DOI: 10.1002/jlcr.3158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1002%2Fjlcr.3158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=24327420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFakur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=323-331&author=J.+P.+Hollandauthor=S.+H.+Liangauthor=B.+H.+Rotsteinauthor=T.+L.+Collierauthor=N.+A.+Stephensonauthor=I.+Greguricauthor=N.+Vasdev&title=Alternative+approaches+for+PET+radiotracer+development+in+Alzheimers+disease%3A+imaging+beyond+plaque&doi=10.1002%2Fjlcr.3158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative approaches for PET radiotracer development in Alzheimers disease: imaging beyond plaque</span></div><div class="casAuthors">Holland, Jason P.; Liang, Steven H.; Rotstein, Benjamin H.; Collier, Thomas L.; Stephenson, Nickeisha A.; Greguric, Ivan; Vasdev, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">323-331</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) and related dementias show increasing clin. prevalence, yet our understanding of the etiol. and pathobiol. of disease-related neurodegeneration remains limited.  In this regard, noninvasive imaging with radiotracers for positron emission tomog. (PET) presents a unique tool for quantifying spatial and temporal changes in characteristic biol. markers of brain disease and for assessing potential drug efficacy.  PET radiotracers targeting different protein markers are being developed to address questions pertaining to the mol. and/or genetic heterogeneity of AD and related dementias.  For example, radiotracers including [11C]-PiB and [18F]-AV-45 (Florbetapir) are being used to measure the d. of Aβ-plaques in AD patients and to interrogate the biol. mechanisms of disease initiation and progression.  Our focus is on the development of novel PET imaging agents, targeting proteins beyond Aβ-plaques, which can be used to investigate the broader mechanism of AD pathogenesis.  Here, we present the chem. basis of various radiotracers which show promise in preclin. or clin. studies for use in evaluating the phenotypic or biochem. characteristics of AD.  Radiotracers for PET imaging neuroinflammation, metal ion assocn. with Aβ-plaques, tau protein, cholinergic and cannabinoid receptors, and enzymes including glycogen-synthase kinase-3β and monoamine oxidase B amongst others, and their connection to AD are highlighted.  Copyright © 2013 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAGqOOrpGlyrVg90H21EOLACvtfcHk0lgJUiZZ1oZAbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFakur%252FL&md5=d908d7a016b475367ebe86cb8693f01f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3158%26sid%3Dliteratum%253Aachs%26aulast%3DHolland%26aufirst%3DJ.%2BP.%26aulast%3DLiang%26aufirst%3DS.%2BH.%26aulast%3DRotstein%26aufirst%3DB.%2BH.%26aulast%3DCollier%26aufirst%3DT.%2BL.%26aulast%3DStephenson%26aufirst%3DN.%2BA.%26aulast%3DGreguric%26aufirst%3DI.%26aulast%3DVasdev%26aufirst%3DN.%26atitle%3DAlternative%2520approaches%2520for%2520PET%2520radiotracer%2520development%2520in%2520Alzheimers%2520disease%253A%2520imaging%2520beyond%2520plaque%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2014%26volume%3D57%26spage%3D323%26epage%3D331%26doi%3D10.1002%2Fjlcr.3158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span> </span><span class="NLM_article-title">The challenges of tau imaging</span> <span class="citation_source-journal">Future Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span><span class="refDoi"> DOI: 10.2217/fnl.12.34</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2217%2Ffnl.12.34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSgs7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=409-421&author=V.+L.+Villemagneauthor=S.+Furumotoauthor=M.+Fodero-Tavolettiauthor=R.+Haradaauthor=R.+S.+Mulliganauthor=Y.+Kudoauthor=C.+L.+Mastersauthor=K.+Yanaiauthor=C.+C.+Roweauthor=N.+Okamura&title=The+challenges+of+tau+imaging&doi=10.2217%2Ffnl.12.34"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The challenges of tau imaging</span></div><div class="casAuthors">Villemagne, Victor L.; Furumoto, Shozo; Fodero-Tavoletti, Michelle; Harada, Ryuichi; Mulligan, Rachel S.; Kudo, Yukitsuka; Masters, Colin L.; Yanai, Kazuhiko; Rowe, Chistopher C.; Okamura, Nobuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Future Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">409-421</span>CODEN:
                <span class="NLM_cas:coden">FNUEAM</span>;
        ISSN:<span class="NLM_cas:issn">1479-6708</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  In vivo imaging of tau pathol. will provide new insights into tau deposition in the human brain, thus facilitating research into causes, diagnosis and treatment of major dementias, such as Alzheimer's disease, or some variants of frontotemporal lobar degeneration, in which tau plays a role.  Tau imaging poses several challenges, some related to the singularities of tau aggregation, and others related to radiotracer design.  Several groups around the world are working on the development of imaging agents that will allow the in vivo assessment of tau deposition in aging and in neurodegeneration.  Development of a tau imaging tracer will enable researchers to noninvasively examine the degree and extent of tau pathol. in the brain, quantify changes in tau deposition over time, evaluate its relation to cognition and assess the efficacy of anti-tau therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfIVpSOSew27Vg90H21EOLACvtfcHk0lgJUiZZ1oZAbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSgs7nE&md5=bc3d8d6579bc07a7ab7065948bdfaa73</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2217%2Ffnl.12.34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffnl.12.34%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DOkamura%26aufirst%3DN.%26atitle%3DThe%2520challenges%2520of%2520tau%2520imaging%26jtitle%3DFuture%2520Neurol.%26date%3D2012%26volume%3D7%26spage%3D409%26epage%3D421%26doi%3D10.2217%2Ffnl.12.34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Maccioni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farías, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarrete, L.</span><span> </span><span class="NLM_article-title">The revitalized tau hypothesis on Alzheimer’s disease</span> <span class="citation_source-journal">Arch. Med. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">226</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span><span class="refDoi"> DOI: 10.1016/j.arcmed.2010.03.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.arcmed.2010.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=20682182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVemt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2010&pages=226-231&author=R.+B.+Maccioniauthor=G.+Far%C3%ADasauthor=I.+Moralesauthor=L.+Navarrete&title=The+revitalized+tau+hypothesis+on+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.arcmed.2010.03.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The Revitalized Tau Hypothesis on Alzheimer's Disease</span></div><div class="casAuthors">Maccioni, Ricardo B.; Farias, Gonzalo; Morales, Inelia; Navarrete, Leonardo</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Medical Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">226-231</span>CODEN:
                <span class="NLM_cas:coden">AEDEER</span>;
        ISSN:<span class="NLM_cas:issn">0188-4409</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Many hypotheses have been raised regarding the pathophysiol. of Alzheimer's disease (AD).  Because amyloid beta peptide (Aβ) deposition in senile plaques appears as a late, nonspecific event, recent evidence points to tau phosphorylation and aggregation as the final common pathway in this multifactorial disease.  Current approaches that provide evidence in favor of neuroimmunomodulation in AD and the roles of tau pathol. modifications and aggregation into oligomers and filamentous forms are presented.  We propose an integrative model on the pathogenesis of AD that includes several damage signals such as Aβ oligomers, oxygen free radicals, iron overload, homocysteine, cholesterol and LDL species.  These activate microglia cells, releasing proinflammatory cytokines and producing neuronal degeneration and tau pathol. modifications.  Altered and aggregated forms of tau appear to act as a toxic stimuli contributing to neurodegeneration.  Recent findings provide further support to the central role of tau in the pathogenesis of AD, so this protein has turned into a diagnostic and therapeutic target for this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos_mQZP6_GRrVg90H21EOLACvtfcHk0lifsgpMSmuKTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVemt7o%253D&md5=b8d948914ce470f13a3e8b36f0bb563d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.arcmed.2010.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arcmed.2010.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DMaccioni%26aufirst%3DR.%2BB.%26aulast%3DFar%25C3%25ADas%26aufirst%3DG.%26aulast%3DMorales%26aufirst%3DI.%26aulast%3DNavarrete%26aufirst%3DL.%26atitle%3DThe%2520revitalized%2520tau%2520hypothesis%2520on%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DArch.%2520Med.%2520Res.%26date%3D2010%26volume%3D41%26spage%3D226%26epage%3D231%26doi%3D10.1016%2Fj.arcmed.2010.03.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Arriagada, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Growdon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedley-Whyte, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span> </span><span class="NLM_article-title">Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span><span class="refDoi"> DOI: 10.1212/WNL.42.3.631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1212%2FWNL.42.3.631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1549228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADyaK387psFCktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1992&pages=631-639&author=P.+V.+Arriagadaauthor=J.+H.+Growdonauthor=E.+T.+Hedley-Whyteauthor=B.+T.+Hyman&title=Neurofibrillary+tangles+but+not+senile+plaques+parallel+duration+and+severity+of+Alzheimer%E2%80%99s+disease&doi=10.1212%2FWNL.42.3.631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease</span></div><div class="casAuthors">Arriagada P V; Growdon J H; Hedley-Whyte E T; Hyman B T</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3 Pt 1</span>),
    <span class="NLM_cas:pages">631-9</span>
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    </div><div class="casAbstract">We studied the accumulation of neurofibrillary tangles (NFTs) and senile plaques (SPs) in 10 Alzheimer's disease patients who had been examined during life.  We counted NFTs and SPs in 13 cytoarchitectural regions representing limbic, primary sensory, and association cortices, and in subcortical neurotransmitter-specific areas.  The degree of neuropathologic change was compared with the severity of dementia, as assessed by the Blessed Dementia Scale and duration of illness.  We found that (1) the severity of dementia was positively related to the number of NFTs in neocortex, but not to the degree of SP deposition; (2) NFTs accumulate in a consistent pattern reflecting hierarchic vulnerability of individual cytoarchitectural fields; (3) NFTs appeared in the entorhinal cortex, CA1/subiculum field of the hippocampal formation, and the amygdala early in the disease process; and (4) the degree of SP deposition was also related to a hierarchic vulnerability of certain brain areas to accumulate SPs, but the pattern of SP distribution was different from that of NFT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQV0H_j78dSAoFEOhA_Im3cfW6udTcc2eYOSRb7dKb4-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387psFCktw%253D%253D&md5=76ed8992e3ad9bfe7070d4f83c12b7f8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1212%2FWNL.42.3.631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.42.3.631%26sid%3Dliteratum%253Aachs%26aulast%3DArriagada%26aufirst%3DP.%2BV.%26aulast%3DGrowdon%26aufirst%3DJ.%2BH.%26aulast%3DHedley-Whyte%26aufirst%3DE.%2BT.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26atitle%3DNeurofibrillary%2520tangles%2520but%2520not%2520senile%2520plaques%2520parallel%2520duration%2520and%2520severity%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1992%26volume%3D42%26spage%3D631%26epage%3D639%26doi%3D10.1212%2FWNL.42.3.631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Brier, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrichsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldea, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassenstab, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzinger, T. L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ances, B. M.</span><span> </span><span class="NLM_article-title">Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">338ra66</span><span class="refDoi"> DOI: 10.1126/scitranslmed.aaf2362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1126%2Fscitranslmed.aaf2362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=27169802" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=338ra66&author=M.+R.+Brierauthor=B.+Gordonauthor=K.+Friedrichsenauthor=J.+McCarthyauthor=A.+Sternauthor=J.+Christensenauthor=C.+Owenauthor=P.+Aldeaauthor=Y.+Suauthor=J.+Hassenstabauthor=N.+J.+Cairnsauthor=D.+M.+Holtzmanauthor=A.+M.+Faganauthor=J.+C.+Morrisauthor=T.+L.+S.+Benzingerauthor=B.+M.+Ances&title=Tau+and+A%CE%B2+imaging%2C+CSF+measures%2C+and+cognition+in+Alzheimer%E2%80%99s+disease&doi=10.1126%2Fscitranslmed.aaf2362"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aaf2362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aaf2362%26sid%3Dliteratum%253Aachs%26aulast%3DBrier%26aufirst%3DM.%2BR.%26aulast%3DGordon%26aufirst%3DB.%26aulast%3DFriedrichsen%26aufirst%3DK.%26aulast%3DMcCarthy%26aufirst%3DJ.%26aulast%3DStern%26aufirst%3DA.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DOwen%26aufirst%3DC.%26aulast%3DAldea%26aufirst%3DP.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DHassenstab%26aufirst%3DJ.%26aulast%3DCairns%26aufirst%3DN.%2BJ.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DFagan%26aufirst%3DA.%2BM.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DBenzinger%26aufirst%3DT.%2BL.%2BS.%26aulast%3DAnces%26aufirst%3DB.%2BM.%26atitle%3DTau%2520and%2520A%25CE%25B2%2520imaging%252C%2520CSF%2520measures%252C%2520and%2520cognition%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D338ra66%26doi%3D10.1126%2Fscitranslmed.aaf2362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Johnson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betensky, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepulcre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rentz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mormino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chhatwal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amariglio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pepin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alverio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judge, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philiossaint, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoup, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Isla, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasdev, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperling, R.</span><span> </span><span class="NLM_article-title">Tau positron emission tomographic imaging in aging and early Alzheimer disease</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">119</span><span class="refDoi"> DOI: 10.1002/ana.24546</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1002%2Fana.24546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=26505746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADC%252BC28zlsVOjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=110-119&author=K.+A.+Johnsonauthor=A.+Schultzauthor=R.+A.+Betenskyauthor=J.+A.+Beckerauthor=J.+Sepulcreauthor=D.+Rentzauthor=E.+Morminoauthor=J.+Chhatwalauthor=R.+Amariglioauthor=K.+Pappauthor=G.+Marshallauthor=M.+Albersauthor=S.+Mauroauthor=L.+Pepinauthor=J.+Alverioauthor=K.+Judgeauthor=M.+Philiossaintauthor=T.+Shoupauthor=D.+Yokellauthor=B.+Dickersonauthor=T.+Gomez-Islaauthor=B.+Hymanauthor=N.+Vasdevauthor=R.+Sperling&title=Tau+positron+emission+tomographic+imaging+in+aging+and+early+Alzheimer+disease&doi=10.1002%2Fana.24546"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Tau positron emission tomographic imaging in aging and early Alzheimer disease</span></div><div class="casAuthors">Johnson Keith A; Schultz Aaron; Becker J Alex; Sepulcre Jorge; Mauro Samantha; Pepin Lesley; Alverio Jonathan; Judge Kelly; Philiossaint Marlie; Shoup Timothy; Yokell Daniel; Dickerson Bradford; Vasdev Neil; Johnson Keith A; Rentz Dorene; Mormino Elizabeth; Chhatwal Jasmeer; Amariglio Rebecca; Papp Kate; Marshall Gad; Albers Mark; Dickerson Bradford; Gomez-Isla Teresa; Hyman Bradley; Sperling Reisa; Johnson Keith A; Becker J Alex; Sepulcre Jorge; Mauro Samantha; Pepin Lesley; Alverio Jonathan; Judge Kelly; Philiossaint Marlie; Shoup Timothy; Yokell Daniel; Vasdev Neil; Johnson Keith A; Schultz Aaron; Rentz Dorene; Mormino Elizabeth; Chhatwal Jasmeer; Amariglio Rebecca; Papp Kate; Marshall Gad; Sperling Reisa; Johnson Keith A; Sepulcre Jorge; Rentz Dorene; Chhatwal Jasmeer; Amariglio Rebecca; Papp Kate; Marshall Gad; Albers Mark; Yokell Daniel; Dickerson Bradford; Gomez-Isla Teresa; Hyman Bradley; Vasdev Neil; Sperling Reisa; Schultz Aaron; Sepulcre Jorge; Dickerson Bradford; Sperling Reisa; Betensky Rebecca A; Betensky Rebecca A</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">110-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Detection of focal brain tau deposition during life could greatly facilitate accurate diagnosis of Alzheimer disease (AD), staging and monitoring of disease progression, and development of disease-modifying therapies.  METHODS:  We acquired tau positron emission tomography (PET) using (18)F T807 (AV1451), and amyloid-β PET using (11)C Pittsburgh compound B (PiB) in older clinically normal individuals, and symptomatic patients with mild cognitive impairment or mild AD dementia.  RESULTS:  We found abnormally high cortical (18)F T807 binding in patients with mild cognitive impairment and AD dementia compared to clinically normal controls.  Consistent with the neuropathology literature, the presence of elevated neocortical (18)F T807 binding particularly in the inferior temporal gyrus was associated with clinical impairment.  The association of cognitive impairment was stronger with inferior temporal (18)F T807 than with mean cortical (11)C PIB.  Regional (18)F T807 was correlated with mean cortical (11)C PiB among both impaired and control subjects.  INTERPRETATION:  These findings suggest that (18)F T807 PET could have value as a biomarker that reflects both the progression of AD tauopathy and the emergence of clinical impairment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ0_YW8WOtWAu98rul4nhSdfW6udTcc2ebdVlZWbob3Lbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zlsVOjsA%253D%253D&md5=6f00800f28f2503e0ed2f428973c1502</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fana.24546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24546%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DK.%2BA.%26aulast%3DSchultz%26aufirst%3DA.%26aulast%3DBetensky%26aufirst%3DR.%2BA.%26aulast%3DBecker%26aufirst%3DJ.%2BA.%26aulast%3DSepulcre%26aufirst%3DJ.%26aulast%3DRentz%26aufirst%3DD.%26aulast%3DMormino%26aufirst%3DE.%26aulast%3DChhatwal%26aufirst%3DJ.%26aulast%3DAmariglio%26aufirst%3DR.%26aulast%3DPapp%26aufirst%3DK.%26aulast%3DMarshall%26aufirst%3DG.%26aulast%3DAlbers%26aufirst%3DM.%26aulast%3DMauro%26aufirst%3DS.%26aulast%3DPepin%26aufirst%3DL.%26aulast%3DAlverio%26aufirst%3DJ.%26aulast%3DJudge%26aufirst%3DK.%26aulast%3DPhiliossaint%26aufirst%3DM.%26aulast%3DShoup%26aufirst%3DT.%26aulast%3DYokell%26aufirst%3DD.%26aulast%3DDickerson%26aufirst%3DB.%26aulast%3DGomez-Isla%26aufirst%3DT.%26aulast%3DHyman%26aufirst%3DB.%26aulast%3DVasdev%26aufirst%3DN.%26aulast%3DSperling%26aufirst%3DR.%26atitle%3DTau%2520positron%2520emission%2520tomographic%2520imaging%2520in%2520aging%2520and%2520early%2520Alzheimer%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2016%26volume%3D79%26spage%3D110%26epage%3D119%26doi%3D10.1002%2Fana.24546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Scholl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schonhaut, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neil, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janabi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ossenkoppele, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faria, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwimmer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabinovici, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagust, W. J.</span><span> </span><span class="NLM_article-title">PET imaging of tau deposition in the aging human brain</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">982</span><span class="refDoi"> DOI: 10.1016/j.neuron.2016.01.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.neuron.2016.01.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=26938442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1yjsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2016&pages=971-982&author=M.+Schollauthor=S.+N.+Lockhartauthor=D.+R.+Schonhautauthor=J.+P.+O%E2%80%99Neilauthor=M.+Janabiauthor=R.+Ossenkoppeleauthor=S.+L.+Bakerauthor=J.+W.+Vogelauthor=J.+Fariaauthor=H.+D.+Schwimmerauthor=G.+D.+Rabinoviciauthor=W.+J.+Jagust&title=PET+imaging+of+tau+deposition+in+the+aging+human+brain&doi=10.1016%2Fj.neuron.2016.01.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">PET Imaging of Tau Deposition in the Aging Human Brain</span></div><div class="casAuthors">Scholl, Michael; Lockhart, Samuel N.; Schonhaut, Daniel R.; O'Neil, James P.; Janabi, Mustafa; Ossenkoppele, Rik; Baker, Suzanne L.; Vogel, Jacob W.; Faria, Jamie; Schwimmer, Henry D.; Rabinovici, Gil D.; Jagust, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">971-982</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Tau pathol. is a hallmark of Alzheimer's disease (AD) but also occurs in normal cognitive aging.  Using the tau PET agent 18F-AV-1451, we examd. retention patterns in cognitively normal older people in relation to young controls and AD patients.  Age and β-amyloid (measured using PiB PET) were differentially assocd. with tau tracer retention in healthy aging.  Older age was related to increased tracer retention in regions of the medial temporal lobe, which predicted worse episodic memory performance.  PET detection of tau in other isocortical regions required the presence of cortical β-amyloid and was assocd. with decline in global cognition.  Furthermore, patterns of tracer retention corresponded well with Braak staging of neurofibrillary tau pathol.  The present study defined patterns of tau tracer retention in normal aging in relation to age, cognition, and β-amyloid deposition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKrXse2TGfw7Vg90H21EOLACvtfcHk0liw87Ad-xDGbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1yjsbc%253D&md5=ffa860231cdfc89a91659b2c4a16e335</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2016.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2016.01.028%26sid%3Dliteratum%253Aachs%26aulast%3DScholl%26aufirst%3DM.%26aulast%3DLockhart%26aufirst%3DS.%2BN.%26aulast%3DSchonhaut%26aufirst%3DD.%2BR.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DJ.%2BP.%26aulast%3DJanabi%26aufirst%3DM.%26aulast%3DOssenkoppele%26aufirst%3DR.%26aulast%3DBaker%26aufirst%3DS.%2BL.%26aulast%3DVogel%26aufirst%3DJ.%2BW.%26aulast%3DFaria%26aufirst%3DJ.%26aulast%3DSchwimmer%26aufirst%3DH.%2BD.%26aulast%3DRabinovici%26aufirst%3DG.%2BD.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26atitle%3DPET%2520imaging%2520of%2520tau%2520deposition%2520in%2520the%2520aging%2520human%2520brain%26jtitle%3DNeuron%26date%3D2016%26volume%3D89%26spage%3D971%26epage%3D982%26doi%3D10.1016%2Fj.neuron.2016.01.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Cho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyoo, C. H.</span><span> </span><span class="NLM_article-title">In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">258</span><span class="refDoi"> DOI: 10.1002/ana.24711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1002%2Fana.24711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=27323247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlajurbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2016&pages=247-258&author=H.+Choauthor=J.+Y.+Choiauthor=M.+S.+Hwangauthor=Y.+J.+Kimauthor=H.+M.+Leeauthor=H.+S.+Leeauthor=J.+H.+Leeauthor=Y.+H.+Ryuauthor=M.+S.+Leeauthor=C.+H.+Lyoo&title=In+vivo+cortical+spreading+pattern+of+tau+and+amyloid+in+the+Alzheimer+disease+spectrum&doi=10.1002%2Fana.24711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum</span></div><div class="casAuthors">Cho, Hanna; Choi, Jae Yong; Hwang, Mi Song; Kim, You Jin; Lee, Hye Mi; Lee, Hye Sun; Lee, Jae Hoon; Ryu, Young Hoon; Lee, Myung Sik; Lyoo, Chul Hyoung</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-258</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : To det. the in vivo cortical spreading pattern of tau and amyloid and to establish positron emission tomog. (PET) image-based tau staging in the Alzheimer disease (AD) spectrum.  Methods : We included 195 participants (53 AD, 52 amnestic mild cognitive impairment [MCI], 23 nonamnestic MCI, and 67 healthy controls) who underwent 2 PET scans (18F-florbetaben for amyloid-β and 18F-AV-1451 for tau).  We assumed that regions with earlier appearances of pathol. may show increased binding in a greater no. of participants and acquired spreading order of tau accumulation by sorting the regional frequencies of involvement.  We classified each participant into image-based tau stage based on the Z score of the composite region for each stage.  Results : Tau accumulation was most frequently obsd. in the medial temporal regions and spread stepwise to the basal and lateral temporal, inferior parietal, posterior cingulate, and other assocn. cortices, and then ultimately to the primary cortical regions.  In contrast, amyloid accumulation was found with similar frequency in the diffuse neocortical areas and then finally spread to the medial temporal regions.  The image-based tau stage correlated with the general cognitive status, whereas cortical thinning was found only in the advanced tau stages: medial temporal region in stage V and widespread cortex in stage VI.  Interpretation : Our PET study replicated postmortem spreading patterns of tau and amyloid-β pathologies.  Unlike the diffuse accumulation of amyloid throughout the neocortex, tau spreading occurred in a stepwise fashion through the networks.  Image-based tau staging may be useful for the objective assessment of AD progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbcDR6pbnnUbVg90H21EOLACvtfcHk0liw87Ad-xDGbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlajurbP&md5=615324ea961aff5dff1713f69e9ed028</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fana.24711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24711%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DJ.%2BY.%26aulast%3DHwang%26aufirst%3DM.%2BS.%26aulast%3DKim%26aufirst%3DY.%2BJ.%26aulast%3DLee%26aufirst%3DH.%2BM.%26aulast%3DLee%26aufirst%3DH.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DRyu%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DM.%2BS.%26aulast%3DLyoo%26aufirst%3DC.%2BH.%26atitle%3DIn%2520vivo%2520cortical%2520spreading%2520pattern%2520of%2520tau%2520and%2520amyloid%2520in%2520the%2520Alzheimer%2520disease%2520spectrum%26jtitle%3DAnn.%2520Neurol.%26date%3D2016%26volume%3D80%26spage%3D247%26epage%3D258%26doi%3D10.1002%2Fana.24711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Spillantini, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedert, M.</span><span> </span><span class="NLM_article-title">Tau pathology and neurodegeneration</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span><span class="refDoi"> DOI: 10.1016/S1474-4422(13)70090-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2FS1474-4422%2813%2970090-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=23684085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVGkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=609-622&author=M.+G.+Spillantiniauthor=M.+Goedert&title=Tau+pathology+and+neurodegeneration&doi=10.1016%2FS1474-4422%2813%2970090-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Tau pathology and neurodegeneration</span></div><div class="casAuthors">Spillantini, Maria Grazia; Goedert, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">609-622</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The pathway leading from sol. and monomeric to hyperphosphorylated, insol. and filamentous tau protein is at the center of many human neurodegenerative diseases, collectively referred to as tauopathies.  Dominantly inherited mutations in MAPT, the gene that encodes tau, cause forms of frontotemporal dementia and parkinsonism, proving that dysfunction of tau is sufficient to cause neurodegeneration and dementia.  However, most cases of tauopathy are not inherited in a dominant manner.  The first tau aggregates form in a few nerve cells in discrete brain areas.  These become self propagating and spread to distant brain regions in a prion-like manner.  The prevention of tau aggregation and propagation is the focus of attempts to develop mechanism-based treatments for tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL-Mr15hi3grVg90H21EOLACvtfcHk0lhiQnOxNXb9jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVGkur0%253D&md5=532220e2bfffdb228277e80868bdde65</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970090-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970090-5%26sid%3Dliteratum%253Aachs%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26aulast%3DGoedert%26aufirst%3DM.%26atitle%3DTau%2520pathology%2520and%2520neurodegeneration%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D609%26epage%3D622%26doi%3D10.1016%2FS1474-4422%2813%2970090-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Lowe, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liesinger, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josephs, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parisi, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarci, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeve, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruinsma, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrucelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graff-Radford, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jack, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, M. E.</span><span> </span><span class="NLM_article-title">An autoradiographic evaluation of AV-1451 Tau PET in dementia</span> <span class="citation_source-journal">Acta Neuropathol. Comm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="refDoi"> DOI: 10.1186/s40478-016-0315-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1186%2Fs40478-016-0315-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=27296779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADC%252BC2s%252FpvFCjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=58&author=V.+J.+Loweauthor=G.+Curranauthor=P.+Fangauthor=A.+M.+Liesingerauthor=K.+A.+Josephsauthor=J.+E.+Parisiauthor=K.+Kantarciauthor=B.+F.+Boeveauthor=M.+K.+Pandeyauthor=T.+Bruinsmaauthor=D.+S.+Knopmanauthor=D.+T.+Jonesauthor=L.+Petrucelliauthor=C.+N.+Cookauthor=N.+R.+Graff-Radfordauthor=D.+W.+Dicksonauthor=R.+C.+Petersenauthor=C.+R.+Jackauthor=M.+E.+Murray&title=An+autoradiographic+evaluation+of+AV-1451+Tau+PET+in+dementia&doi=10.1186%2Fs40478-016-0315-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">An autoradiographic evaluation of AV-1451 Tau PET in dementia</span></div><div class="casAuthors">Lowe Val J; Curran Geoffry; Fang Ping; Kantarci Kejal; Pandey Mukesh K; Bruinsma Tyler; Jack Clifford R Jr; Liesinger Amanda M; Petrucelli Leonard; Cook Casey N; Dickson Dennis W; Murray Melissa E; Josephs Keith A; Parisi Joseph E; Boeve Bradley F; Knopman David S; Jones David T; Petersen Ronald C; Parisi Joseph E; Graff-Radford Neill R</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  It is essential to determine the specificity of AV-1451 PET for tau in brain imaging by using pathological comparisons.  We performed autoradiography in autopsy-confirmed Alzheimer disease and other neurodegenerative disorders to evaluate the specificity of AV-1451 binding for tau aggregates.  METHODS:  Tissue samples were selected that had a variety of dementia-related neuropathologies including Alzheimer disease, primary age-related tauopathy, tangle predominant dementia, non-Alzheimer disease tauopathies, frontotemporal dementia, parkinsonism, Lewy body disease and multiple system atrophy (n = 38).  Brain tissue sections were stained for tau, TAR DNA-binding protein-43, and α-synuclein and compared to AV-1451 autoradiography on adjacent sections.  RESULTS:  AV-1451 preferentially localized to neurofibrillary tangles, with less binding to areas enriched in neuritic pathology and less mature tau.  The strength of AV-1451 binding with respect to tau isoforms in various neurodegenerative disorders was: 3R + 4R tau (e.g., AD) > 3R tau (e.g., Pick disease) or 4R tau.  Only minimal binding of AV-1451 to TAR DNA-binding protein-43 positive regions was detected.  No binding of AV-1451 to α-synuclein was detected. "Off-target" binding was seen in vessels, iron-associated regions, substantia nigra, calcifications in the choroid plexus, and leptomeningeal melanin.  CONCLUSIONS:  Reduced AV-1451 binding in neuritic pathology compared to neurofibrillary tangles suggests that the maturity of tau pathology may affect AV-1451 binding and suggests complexity in AV-1451 binding.  Poor association of AV-1451 with tauopathies that have preferential accumulation of either 4R tau or 3R tau suggests limited clinical utility in detecting these pathologies.  In contrast, for disorders associated with 3R + 4R tau, such as Alzheimer disease, AV-1451 binds tau avidly but does not completely reflect the early stage tau progression suggested by Braak neurofibrillary tangle staging.  AV-1451 binding to TAR DNA-binding protein-43 or TAR DNA-binding protein-43 positive regions can be weakly positive.  Clinical use of AV-1451 will require a familiarity with distinct types of "off-target" binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRs_4DPJCBHN-qrn-c4Of3KfW6udTcc2eaxph-yCcEkQLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s%252FpvFCjtg%253D%253D&md5=a7cb46ea5a1a57447570b780568abb3f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1186%2Fs40478-016-0315-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40478-016-0315-6%26sid%3Dliteratum%253Aachs%26aulast%3DLowe%26aufirst%3DV.%2BJ.%26aulast%3DCurran%26aufirst%3DG.%26aulast%3DFang%26aufirst%3DP.%26aulast%3DLiesinger%26aufirst%3DA.%2BM.%26aulast%3DJosephs%26aufirst%3DK.%2BA.%26aulast%3DParisi%26aufirst%3DJ.%2BE.%26aulast%3DKantarci%26aufirst%3DK.%26aulast%3DBoeve%26aufirst%3DB.%2BF.%26aulast%3DPandey%26aufirst%3DM.%2BK.%26aulast%3DBruinsma%26aufirst%3DT.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DJones%26aufirst%3DD.%2BT.%26aulast%3DPetrucelli%26aufirst%3DL.%26aulast%3DCook%26aufirst%3DC.%2BN.%26aulast%3DGraff-Radford%26aufirst%3DN.%2BR.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DMurray%26aufirst%3DM.%2BE.%26atitle%3DAn%2520autoradiographic%2520evaluation%2520of%2520AV-1451%2520Tau%2520PET%2520in%2520dementia%26jtitle%3DActa%2520Neuropathol.%2520Comm.%26date%3D2016%26volume%3D4%26spage%3D58%26doi%3D10.1186%2Fs40478-016-0315-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span> </span><span class="NLM_article-title">In vivo tau imaging: obstacles and progress</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">S254</span><span class="NLM_x">–</span> <span class="NLM_lpage">S264</span><span class="refDoi"> DOI: 10.1016/j.jalz.2014.04.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.jalz.2014.04.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=24924676" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=S254-S264&author=V.+L.+Villemagneauthor=N.+Okamura&title=In+vivo+tau+imaging%3A+obstacles+and+progress&doi=10.1016%2Fj.jalz.2014.04.013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2014.04.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2014.04.013%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DOkamura%26aufirst%3DN.%26atitle%3DIn%2520vivo%2520tau%2520imaging%253A%2520obstacles%2520and%2520progress%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2014%26volume%3D10%26spage%3DS254%26epage%3DS264%26doi%3D10.1016%2Fj.jalz.2014.04.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Shah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catafau, A. M.</span><span> </span><span class="NLM_article-title">Molecular imaging insights into neurodegeneration: focus on tau PET radiotracers</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">874</span><span class="refDoi"> DOI: 10.2967/jnumed.113.136069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2967%2Fjnumed.113.136069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=871-874&author=M.+Shahauthor=A.+M.+Catafau&title=Molecular+imaging+insights+into+neurodegeneration%3A+focus+on+tau+PET+radiotracers&doi=10.2967%2Fjnumed.113.136069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.113.136069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.113.136069%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DM.%26aulast%3DCatafau%26aufirst%3DA.%2BM.%26atitle%3DMolecular%2520imaging%2520insights%2520into%2520neurodegeneration%253A%2520focus%2520on%2520tau%2520PET%2520radiotracers%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D871%26epage%3D874%26doi%3D10.2967%2Fjnumed.113.136069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">New targets for the development of PET tracers for imaging neurodegeneration in Alzheimer disease</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1221</span><span class="NLM_x">–</span> <span class="NLM_lpage">1224</span><span class="refDoi"> DOI: 10.2967/jnumed.114.127811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2967%2Fjnumed.114.127811" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1221-1224&author=R.+H.+Mach&title=New+targets+for+the+development+of+PET+tracers+for+imaging+neurodegeneration+in+Alzheimer+disease&doi=10.2967%2Fjnumed.114.127811"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.114.127811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.114.127811%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DNew%2520targets%2520for%2520the%2520development%2520of%2520PET%2520tracers%2520for%2520imaging%2520neurodegeneration%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D1221%26epage%3D1224%26doi%3D10.2967%2Fjnumed.114.127811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span> </span><span class="NLM_article-title">Tau imaging: early progress and future directions</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span><span class="refDoi"> DOI: 10.1016/S1474-4422(14)70252-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2FS1474-4422%2814%2970252-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=25496902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADC%252BC2MritFertg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=114-124&author=V.+L.+Villemagneauthor=M.+T.+Fodero-Tavolettiauthor=C.+L.+Mastersauthor=C.+C.+Rowe&title=Tau+imaging%3A+early+progress+and+future+directions&doi=10.1016%2FS1474-4422%2814%2970252-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Tau imaging: early progress and future directions</span></div><div class="casAuthors">Villemagne Victor L; Fodero-Tavoletti Michelle T; Masters Colin L; Rowe Christopher C</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Use of selective in-vivo tau imaging will enable improved understanding of tau aggregation in the brain, facilitating research into causes, diagnosis, and treatment of major tauopathies such as Alzheimer's disease, progressive supranuclear palsy, corticobasal syndrome, chronic traumatic encephalopathy, and some variants of frontotemporal lobar degeneration.  Neuropathological studies of Alzheimer's disease show a strong association between tau deposits, decreased cognitive function, and neurodegenerative changes.  Selective tau imaging will allow the in-vivo exploration of such associations and measure the global and regional changes in tau deposits over time.  Such imaging studies will comprise non-invasive assessment of the spatial and temporal pattern of tau deposition over time, providing insight into the role tau plays in ageing and helping to establish the relation between cognition, genotype, neurodegeneration, and other biomarkers.  Once validated, selective tau imaging might be useful as a diagnostic, prognostic, and progression biomarker, and a surrogate marker for the monitoring of efficacy and patient recruitment for anti-tau therapeutic trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIuS1EFOTTc50d-O_J5C0AfW6udTcc2ea48jdKFRx0Erntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MritFertg%253D%253D&md5=95eb0f9b98711e30caaf4a7c67bd46e0</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2814%2970252-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252814%252970252-2%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%2BT.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26atitle%3DTau%2520imaging%253A%2520early%2520progress%2520and%2520future%2520directions%26jtitle%3DLancet%2520Neurol.%26date%3D2015%26volume%3D14%26spage%3D114%26epage%3D124%26doi%3D10.1016%2FS1474-4422%2814%2970252-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Tau PET imaging in Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Neurol. Neurosci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="refDoi"> DOI: 10.1007/s11910-014-0500-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1007%2Fs11910-014-0500-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=25239654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADC%252BC2M7jsFSrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=500&author=N.+Okamuraauthor=R.+Haradaauthor=S.+Furumotoauthor=H.+Araiauthor=K.+Yanaiauthor=Y.+Kudo&title=Tau+PET+imaging+in+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs11910-014-0500-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Tau PET imaging in Alzheimer's disease</span></div><div class="casAuthors">Okamura Nobuyuki; Harada Ryuichi; Furumoto Shozo; Arai Hiroyuki; Yanai Kazuhiko; Kudo Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Current neurology and neuroscience reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">500</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In several neurodegenerative diseases that are collectively called tauopathies, progressive accumulation of tau in the brain is closely associated with neurodegeneration and cognitive impairment.  Noninvasive detection of tau protein deposits in the brain would be useful to diagnose tauopathies as well as to track and predict disease progression.  Recently, several tau PET tracers including T807, THK-5117, and PBB3 have been developed and succeeded in imaging neurofibrillary pathology in vivo.  For use of tau PET as a biomarker of tau pathology in Alzheimer's disease, PET tracers should have high affinity to PHF-tau and high selectivity for tau over amyloid-β and other protein deposits.  PET tau imaging enables the longitudinal assessment of the spatial pattern of tau deposition and its relation to amyloid-β pathology and neurodegeneration.  This technology could also be applied to the pharmacological assessment of anti-tau therapy, thereby allowing preventive interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTy6LVoglwXzIqdXsLcGTEUfW6udTcc2ea48jdKFRx0Erntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7jsFSrtA%253D%253D&md5=343715c63553be883942f9829da91648</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs11910-014-0500-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11910-014-0500-6%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DTau%2520PET%2520imaging%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Neurol.%2520Neurosci.%2520Rep.%26date%3D2014%26volume%3D14%26spage%3D500%26doi%3D10.1007%2Fs11910-014-0500-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Ariza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span> </span><span class="NLM_article-title">Tau positron emission tomography (PET) imaging: past, present and future</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">4365</span><span class="NLM_x">–</span> <span class="NLM_lpage">4382</span><span class="refDoi"> DOI: 10.1021/jm5017544</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5017544" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=4365-4382&author=M.+Arizaauthor=H.+C.+Kolbauthor=D.+Moecharsauthor=F.+Romboutsauthor=J.+I.+Andr%C3%A9s&title=Tau+positron+emission+tomography+%28PET%29+imaging%3A+past%2C+present+and+future&doi=10.1021%2Fjm5017544"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm5017544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5017544%26sid%3Dliteratum%253Aachs%26aulast%3DAriza%26aufirst%3DM.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26atitle%3DTau%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%253A%2520past%252C%2520present%2520and%2520future%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D4365%26epage%3D4382%26doi%3D10.1021%2Fjm5017544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Novel <sup>18</sup>F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1420</span><span class="NLM_x">–</span> <span class="NLM_lpage">1427</span><span class="refDoi"> DOI: 10.2967/jnumed.112.117341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2967%2Fjnumed.112.117341" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=23857514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVejsr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=1420-1427&author=N.+Okamuraauthor=S.+Furumotoauthor=R.+Haradaauthor=T.+Tagoauthor=T.+Yoshikawaauthor=M.+Fodero-Tavolettiauthor=R.+S.+Mulliganauthor=V.+L.+Villemagneauthor=H.+Akatsuauthor=T.+Yamamotoauthor=H.+Araiauthor=R.+Iwataauthor=K.+Yanaiauthor=Y.+Kudo&title=Novel+18F-labeled+arylquinoline+derivatives+for+noninvasive+imaging+of+tau+pathology+in+Alzheimer+disease&doi=10.2967%2Fjnumed.112.117341"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease</span></div><div class="casAuthors">Okamura, Nobuyuki; Furumoto, Shozo; Harada, Ryuichi; Tago, Tetsuro; Yoshikawa, Takeo; Fodero-Tavoletti, Michelle; Mulligan, Rachel S.; Villemagne, Victor L.; Akatsu, Hiroyasu; Yamamoto, Takayuki; Arai, Hiroyuki; Iwata, Ren; Yanai, Kazuhiko; Kudo, Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1420-1427</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">Neurofibrillary tangles in Alzheimer disease (AD) brains are composed of the microtubule-assocd. protein tau.  Noninvasive monitoring of tau protein aggregates in the living brain will provide useful information regarding tau pathophysiol. in AD.  However, no PET probes are currently available for selective detection of tau pathol. in AD.  We have previously reported 18F-labeled THK-523 (18F-6-(2-fluoroethoxy)-2-(4-aminophenyl)quinoline) as a tau imaging radiotracer candidate for PET.  After compd. optimization, we developed novel 18F-labeled arylquinoline derivs., 18F-THK-5105 and 18F-THK-5117, for use as tau imaging PET tracers.  Methods: 18F-labeled compds. were prepd. from the corresponding tosylated precursors.  The binding affinity of compds. to synthetic tau aggregates and tau-rich AD brain homogenates was detd. by satn. and competition binding assays.  The binding selectivity of compds. to tau pathol. was evaluated by autoradiog. of AD brain sections.  The pharmacokinetics of compds. were assessed in biodistribution studies in normal mice.  A 14-d toxicity study with i.v. administration of compds. was performed using rats and mice.  Results: In vitro binding assays demonstrated higher binding affinity of THK-5105 and THK-5117 than THK-523 to tau protein aggregates and tau-rich AD brain homogenates.  Autoradiog. analyses of AD brain sections showed that these radiotracers preferentially bound to neurofibrillary tangles and neuropil threads, which colocalized with Gallyas-pos. and immunoreactive tau protein deposits.  The distribution of this radiotracer binding in AD brain sections was completely different from that of 11C-Pittsburgh compd. B, showing preferential binding to amyloid plaques.  Furthermore, these derivs. demonstrated abundant initial brain uptake and faster clearance in normal mice than 18F-THK-523 and other reported 18F-labeled radiotracers.  THK-5105 and THK-5117 showed no toxic effects related to the administration of these compds. in mice and rats and no significant binding for various neuroreceptors, ion channels, and transporters at 1-μM concns.  Conclusion: 18F-labeled THK-5105 and THK-5117 are promising candidates as PET tau imaging radiotracers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLmleWUvjowbVg90H21EOLACvtfcHk0ljbqfdC-2275A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVejsr7L&md5=58ac191b3581c5e4896b999343b6a193</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.112.117341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.112.117341%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DAkatsu%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DNovel%252018F-labeled%2520arylquinoline%2520derivatives%2520for%2520noninvasive%2520imaging%2520of%2520tau%2520pathology%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D1420%26epage%3D1427%26doi%3D10.2967%2Fjnumed.112.117341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shidahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">[<sup>18</sup>F]-THK-5117 PET for assessing neurofibrillary pathology in Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1052</span><span class="NLM_x">–</span> <span class="NLM_lpage">1061</span><span class="refDoi"> DOI: 10.1007/s00259-015-3035-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1007%2Fs00259-015-3035-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=25792456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVKhs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=1052-1061&author=R.+Haradaauthor=N.+Okamuraauthor=S.+Furumotoauthor=K.+Furukawaauthor=A.+Ishikiauthor=N.+Tomitaauthor=K.+Hiraokaauthor=S.+Watanukiauthor=M.+Shidaharaauthor=M.+Miyakeauthor=Y.+Ishikawaauthor=R.+Matsudaauthor=A.+Inamiauthor=T.+Yoshikawaauthor=T.+Tagoauthor=Y.+Funakiauthor=R.+Iwataauthor=M.+Tashiroauthor=K.+Yanaiauthor=H.+Araiauthor=Y.+Kudo&title=%5B18F%5D-THK-5117+PET+for+assessing+neurofibrillary+pathology+in+Alzheimer%E2%80%99s+disease&doi=10.1007%2Fs00259-015-3035-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">[18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease</span></div><div class="casAuthors">Harada, Ryuichi; Okamura, Nobuyuki; Furumoto, Shozo; Furukawa, Katsutoshi; Ishiki, Aiko; Tomita, Naoki; Hiraoka, Kotaro; Watanuki, Shoichi; Shidahara, Miho; Miyake, Masayasu; Ishikawa, Yoichi; Matsuda, Rin; Inami, Akie; Yoshikawa, Takeo; Tago, Tetsuro; Funaki, Yoshihito; Iwata, Ren; Tashiro, Manabu; Yanai, Kazuhiko; Arai, Hiroyuki; Kudo, Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1052-1061</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Visualization of the spatial distribution of neurofibrillary tangles would help in the diagnosis, prevention and treatment of dementia.  The purpose of the study was to evaluate the clin. utility of [18F]THK-5117 as a highly selective tau imaging radiotracer.  Methods: We initially evaluated in vitro binding of [3H]THK-5117 in post-mortem brain tissues from patients with Alzheimer's disease (AD).  In clin. PET studies, [18F]THK-5117 retention in eight patients with AD was compared with that in six healthy elderly controls.  Ten subjects underwent an addnl. [11C]PiB PET scan within 2 wk.  Results: In post-mortem brain samples, THK-5117 bound selectively to neurofibrillary deposits, which differed from the binding target of PiB.  In clin. PET studies, [18F]THK-5117 binding in the temporal lobe clearly distinguished patients with AD from healthy elderly subjects.  Compared with [11C]PiB, [18F]THK-5117 retention was higher in the medial temporal cortex.  Conclusion: These findings suggest that [18F]THK-5117 provides regional information on neurofibrillary pathol. in living subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotZcAg2f1webVg90H21EOLACvtfcHk0liJ2awJs2Grpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVKhs7Y%253D&md5=4c35d238f7026cb33833f28549e760d5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs00259-015-3035-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-015-3035-4%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DIshiki%26aufirst%3DA.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DHiraoka%26aufirst%3DK.%26aulast%3DWatanuki%26aufirst%3DS.%26aulast%3DShidahara%26aufirst%3DM.%26aulast%3DMiyake%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DR.%26aulast%3DInami%26aufirst%3DA.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DFunaki%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DTashiro%26aufirst%3DM.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3D%255B18F%255D-THK-5117%2520PET%2520for%2520assessing%2520neurofibrillary%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2015%26volume%3D42%26spage%3D1052%26epage%3D1061%26doi%3D10.1007%2Fs00259-015-3035-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Ishiki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span> </span><span class="NLM_article-title">Longitudinal assessment of tau pathology in patients with Alzheimer’s disease using [<sup>18</sup>F]-THK-5117 Positron Emission Tomography</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span><span class="refDoi"> DOI: 10.1371/journal.pone.0140311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1371%2Fjournal.pone.0140311" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1-9&author=A.+Ishikiauthor=N.+Okamuraauthor=K.+Furukawaauthor=S.+Furumotoauthor=R.+Haradaauthor=N.+Tomitaauthor=K.+Hiraokaauthor=S.+Watanukiauthor=Y.+Ishikawaauthor=T.+Tagoauthor=Y.+Funakiauthor=R.+Iwataauthor=M.+Tashiroauthor=K.+Yanaiauthor=Y.+Kudoauthor=H.+Arai&title=Longitudinal+assessment+of+tau+pathology+in+patients+with+Alzheimer%E2%80%99s+disease+using+%5B18F%5D-THK-5117+Positron+Emission+Tomography&doi=10.1371%2Fjournal.pone.0140311"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0140311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0140311%26sid%3Dliteratum%253Aachs%26aulast%3DIshiki%26aufirst%3DA.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DHiraoka%26aufirst%3DK.%26aulast%3DWatanuki%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DFunaki%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DTashiro%26aufirst%3DM.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DArai%26aufirst%3DH.%26atitle%3DLongitudinal%2520assessment%2520of%2520tau%2520pathology%2520in%2520patients%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520using%2520%255B18F%255D-THK-5117%2520Positron%2520Emission%2520Tomography%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3D1%26epage%3D9%26doi%3D10.1371%2Fjournal.pone.0140311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiraoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shidahara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F-THK-5351: a novel PET radiotracer for imaging neurofibrillary pathology in Alzheimer’s disease</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span><span class="refDoi"> DOI: 10.2967/jnumed.115.164848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2967%2Fjnumed.115.164848" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=208-214&author=R.+Haradaauthor=N.+Okamuraauthor=S.+Furumotoauthor=K.+Furukawaauthor=A.+Ishikiauthor=N.+Tomitaauthor=T.+Tagoauthor=K.+Hiraokaauthor=S.+Watanukiauthor=S.+Shidaharaauthor=M.+Miyakeauthor=Y.+Ishikawaauthor=R.+Matsudaauthor=A.+Inamiauthor=T.+Yoshikawaauthor=Y.+Funakiauthor=R.+Iwataauthor=M.+Tashiroauthor=K.+Yanaiauthor=H.+Araiauthor=Y.+Kudo&title=18F-THK-5351%3A+a+novel+PET+radiotracer+for+imaging+neurofibrillary+pathology+in+Alzheimer%E2%80%99s+disease&doi=10.2967%2Fjnumed.115.164848"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.164848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.164848%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DIshiki%26aufirst%3DA.%26aulast%3DTomita%26aufirst%3DN.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DHiraoka%26aufirst%3DK.%26aulast%3DWatanuki%26aufirst%3DS.%26aulast%3DShidahara%26aufirst%3DS.%26aulast%3DMiyake%26aufirst%3DM.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DR.%26aulast%3DInami%26aufirst%3DA.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DFunaki%26aufirst%3DY.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DTashiro%26aufirst%3DM.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3D18F-THK-5351%253A%2520a%2520novel%2520PET%2520radiotracer%2520for%2520imaging%2520neurofibrillary%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D208%26epage%3D214%26doi%3D10.2967%2Fjnumed.115.164848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Xia, C.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharmath, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocharla, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">[<sup>18</sup>F]-T807, a novel tau positron emission tomography imaging agent for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span><span class="refDoi"> DOI: 10.1016/j.jalz.2012.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.jalz.2012.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=23411393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=666-676&author=C.-F.+Xiaauthor=J.+Arteagaauthor=G.+Chenauthor=U.+Gangadharmathauthor=L.+F.+Gomezauthor=D.+Kasiauthor=C.+Lamauthor=Q.+Liangauthor=C.+Liuauthor=V.+P.+Mocharlaauthor=F.+Muauthor=A.+Sinhaauthor=H.+Suauthor=A.+K.+Szardeningsauthor=J.+C.+Walshauthor=E.+Wangauthor=C.+Yuauthor=W.+Zhangauthor=T.+Zhaoauthor=H.+C.+Kolb&title=%5B18F%5D-T807%2C+a+novel+tau+positron+emission+tomography+imaging+agent+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.jalz.2012.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease</span></div><div class="casAuthors">Xia Chun-Fang; Arteaga Janna; Chen Gang; Gangadharmath Umesh; Gomez Luis F; Kasi Dhanalakshmi; Lam Chung; Liang Qianwa; Liu Changhui; Mocharla Vani P; Mu Fanrong; Sinha Anjana; Su Helen; Szardenings A Katrin; Walsh Joseph C; Wang Eric; Yu Chul; Zhang Wei; Zhao Tieming; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">666-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  We wished to develop a highly selective positron emission tomography (PET) imaging agent targeting PHF-tau in human Alzheimer's disease (AD) brains.  METHODS:  To screen potential tau binders, human AD brain sections were used as a source of native paired helical filament (PHF)-tau and Aβ rather than synthetic tau aggregates or Aβ fibrils generated in vitro to measure the affinity and selectivity of [(18)F]T807 to tau and Aβ.  Brain uptake and biodistribution of [(18)F]T807 in mice were also tested.  RESULTS:  In vitro autoradiography results show that [(18)F]T807 exhibits strong binding to PHF-tau-positive human brain sections.  A dissociation constant (Kd) of [(18)F]T807 (14.6 nM) was measured using brain sections from the frontal lobe of AD patients.  A comparison of autoradiography and double immunohistochemical staining of PHF-tau and Aβ on adjacent sections demonstrated that [(18)F]T807 binding colocalized with immunoreactive PHF-tau pathology, but did not highlight Aβ plaques.  In vivo studies in mice demonstrated that [(18)F]T807 was able to cross the blood-brain barrier and washed out quickly.  CONCLUSIONS:  [(18)F]T807 demonstrates high affinity and selectivity to PHF-tau as well as favorable in vivo properties, making this a promising candidate as an imaging agent for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2ZgjLtot9A50d-O_J5C0AfW6udTcc2eazUMd8CersJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D&md5=1fccbc6c3ffe8e57fdd6f64ec450b1d7</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DC.-F.%26aulast%3DArteaga%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGangadharmath%26aufirst%3DU.%26aulast%3DGomez%26aufirst%3DL.%2BF.%26aulast%3DKasi%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3D%255B18F%255D-T807%252C%2520a%2520novel%2520tau%2520positron%2520emission%2520tomography%2520imaging%2520agent%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3D666%26epage%3D676%26doi%3D10.1016%2Fj.jalz.2012.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Chien, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Early clinical PET imaging results with the novel PHF-tau radioligand [<sup>18</sup>F]-T807</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.3233/JAD-122059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.3233%2FJAD-122059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=23234879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlWlsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=457-468&author=D.+T.+Chienauthor=S.+Bahriauthor=A.+K.+Szardeningsauthor=J.+C.+Walshauthor=F.+Muauthor=M.-Y.+Suauthor=W.+R.+Shankleauthor=A.+Elizarovauthor=H.+C.+Kolb&title=Early+clinical+PET+imaging+results+with+the+novel+PHF-tau+radioligand+%5B18F%5D-T807&doi=10.3233%2FJAD-122059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807</span></div><div class="casAuthors">Chien, David T.; Bahri, Shadfar; Szardenings, A. Katrin; Walsh, Joseph C.; Mu, Fanrong; Su, Min-Ying; Shankle, William R.; Elizarov, Arkadij; Kolb, Hartmuth C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-468</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease.  We have developed a novel PHF-tau targeting positron emission tomog. imaging agent, [F-18]-T807, which may be useful for imaging Alzheimer's disease and other tauopathies.  Here in, we describe the first human brain images with [F-18]-T807.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofLFkBPeoi47Vg90H21EOLACvtfcHk0lgSf2YIPCOmvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlWlsbk%253D&md5=578173de3104c8e470381f0812ce6356</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3233%2FJAD-122059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-122059%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DD.%2BT.%26aulast%3DBahri%26aufirst%3DS.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSu%26aufirst%3DM.-Y.%26aulast%3DShankle%26aufirst%3DW.%2BR.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DEarly%2520clinical%2520PET%2520imaging%2520results%2520with%2520the%2520novel%2520PHF-tau%2520radioligand%2520%255B18F%255D-T807%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D34%26spage%3D457%26epage%3D468%26doi%3D10.3233%2FJAD-122059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Mintun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shcherbinin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontecorvo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skovronsky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Exploratory analyses of regional human brain distribution of the PET tau tracer F18-labeled T807 (AV-1541) in subjects with normal cognitive function or cognitive impairment thought to be due to AD</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">P842</span><span class="refDoi"> DOI: 10.1016/j.jalz.2013.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.jalz.2013.08.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=P842&author=M.+Mintunauthor=A.+Schwarzauthor=A.+Joshiauthor=S.+Shcherbininauthor=D.+Chienauthor=A.+Elizarovauthor=M.-Y.+Suauthor=W.+Shankleauthor=M.+Pontecorvoauthor=J.+Tauscherauthor=D.+Skovronskyauthor=H.+C.+Kolb&title=Exploratory+analyses+of+regional+human+brain+distribution+of+the+PET+tau+tracer+F18-labeled+T807+%28AV-1541%29+in+subjects+with+normal+cognitive+function+or+cognitive+impairment+thought+to+be+due+to+AD&doi=10.1016%2Fj.jalz.2013.08.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2013.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2013.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DMintun%26aufirst%3DM.%26aulast%3DSchwarz%26aufirst%3DA.%26aulast%3DJoshi%26aufirst%3DA.%26aulast%3DShcherbinin%26aufirst%3DS.%26aulast%3DChien%26aufirst%3DD.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DM.-Y.%26aulast%3DShankle%26aufirst%3DW.%26aulast%3DPontecorvo%26aufirst%3DM.%26aulast%3DTauscher%26aufirst%3DJ.%26aulast%3DSkovronsky%26aufirst%3DD.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DExploratory%2520analyses%2520of%2520regional%2520human%2520brain%2520distribution%2520of%2520the%2520PET%2520tau%2520tracer%2520F18-labeled%2520T807%2520%2528AV-1541%2529%2520in%2520subjects%2520with%2520normal%2520cognitive%2520function%2520or%2520cognitive%2520impairment%2520thought%2520to%2520be%2520due%2520to%2520AD%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3DP842%26doi%3D10.1016%2Fj.jalz.2013.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Mintun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devous, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shcherbinin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siderowf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontecorvo, M.</span><span> </span><span class="NLM_article-title">Potential utility of the tau deposit tracer [<sup>18</sup>F]T807 (aka [<sup>18</sup>F]AV-1451) as a PET biomarker for neurodegeneration in clinical trials</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">S207</span><span class="NLM_x">–</span> <span class="NLM_lpage">S208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=S207-S208&author=M.+Mintunauthor=M.+Devousauthor=G.+Attardoauthor=A.+Joshiauthor=A.+Schwarzauthor=S.+Shcherbininauthor=A.+Siderowfauthor=Y.+G.+Linauthor=Q.+W.+Liangauthor=K.+Conwayauthor=F.+Gomezauthor=M.+Pontecorvo&title=Potential+utility+of+the+tau+deposit+tracer+%5B18F%5DT807+%28aka+%5B18F%5DAV-1451%29+as+a+PET+biomarker+for+neurodegeneration+in+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMintun%26aufirst%3DM.%26aulast%3DDevous%26aufirst%3DM.%26aulast%3DAttardo%26aufirst%3DG.%26aulast%3DJoshi%26aufirst%3DA.%26aulast%3DSchwarz%26aufirst%3DA.%26aulast%3DShcherbinin%26aufirst%3DS.%26aulast%3DSiderowf%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DY.%2BG.%26aulast%3DLiang%26aufirst%3DQ.%2BW.%26aulast%3DConway%26aufirst%3DK.%26aulast%3DGomez%26aufirst%3DF.%26aulast%3DPontecorvo%26aufirst%3DM.%26atitle%3DPotential%2520utility%2520of%2520the%2520tau%2520deposit%2520tracer%2520%255B18F%255DT807%2520%2528aka%2520%255B18F%255DAV-1451%2529%2520as%2520a%2520PET%2520biomarker%2520for%2520neurodegeneration%2520in%2520clinical%2520trials%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3DS207%26epage%3DS208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span>9th Annual Human Amyloid Imaging (HAI) Conference, Miami Beach, Florida, January 14–16, 2015. Alzforum News. <a href="http://www.alzforum.org/news/conference-coverage/human-amyloid-imaging-meeting-was-abuzz-talk-tau" class="extLink">http://www.alzforum.org/news/conference-coverage/human-amyloid-imaging-meeting-was-abuzz-talk-tau</a> (accessed August 3,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=9th+Annual+Human+Amyloid+Imaging+%28HAI%29+Conference%2C+Miami+Beach%2C+Florida%2C+January+14%E2%80%9316%2C+2015.+Alzforum+News.+http%3A%2F%2Fwww.alzforum.org%2Fnews%2Fconference-coverage%2Fhuman-amyloid-imaging-meeting-was-abuzz-talk-tau+%28accessed+August+3%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Chien, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katrin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span><span class="refDoi"> DOI: 10.3233/JAD-130098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.3233%2FJAD-130098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=23948934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADC%252BC3sbgsVyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=171-184&author=D.+T.+Chienauthor=A.+Katrinauthor=S.+Bahriauthor=J.+C.+Walshauthor=F.+Muauthor=C.+Xiaauthor=W.+R.+Shankleauthor=A.+J.+Lernerauthor=M.-Y.+Suauthor=A.+Elizarovauthor=H.+C.+Kolb&title=Early+clinical+PET+imaging+results+with+the+novel+PHF-tau+radioligand+%5BF18%5D-T808&doi=10.3233%2FJAD-130098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808</span></div><div class="casAuthors">Chien David T; Szardenings A Katrin; Bahri Shadfar; Walsh Joseph C; Mu Fanrong; Xia Chunfang; Shankle William R; Lerner Alan J; Su Min-Ying; Elizarov Arkadij; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">171-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease.  We have recently reported early clinical results of a novel PHF-tau targeting PET imaging agent, [F18]-T807.  Since then, we have investigated a second novel PHF-tau targeting PET imaging agent, [F18]-T808, with different pharmacokinetic characteristics, which may be favorable for imaging Alzheimer's disease and other tauopathies.  Here, we describe the first human brain images with [F18]-T808.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvVIddGtbpMLqxQ2mb9Pu8fW6udTcc2eaIhI6XjG3Pw7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbgsVyjtQ%253D%253D&md5=757aaefcfe18524fdd4404c0cb351850</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3233%2FJAD-130098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-130098%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DD.%2BT.%26aulast%3DKatrin%26aufirst%3DA.%26aulast%3DBahri%26aufirst%3DS.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DShankle%26aufirst%3DW.%2BR.%26aulast%3DLerner%26aufirst%3DA.%2BJ.%26aulast%3DSu%26aufirst%3DM.-Y.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DEarly%2520clinical%2520PET%2520imaging%2520results%2520with%2520the%2520novel%2520PHF-tau%2520radioligand%2520%255BF18%255D-T808%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2014%26volume%3D38%26spage%3D171%26epage%3D184%26doi%3D10.3233%2FJAD-130098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Kimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichise, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikoma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinotoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higuchi, M.</span><span> </span><span class="NLM_article-title">PET quantification of tau pathology in human brain with <sup>11</sup>C-PBB3</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1365</span><span class="refDoi"> DOI: 10.2967/jnumed.115.160127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2967%2Fjnumed.115.160127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=26182966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSmsbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=1359-1365&author=Y.+Kimuraauthor=M.+Ichiseauthor=H.+Itoauthor=H.+Shimadaauthor=Y.+Ikomaauthor=C.+Sekiauthor=H.+Takanoauthor=S.+Kitamuraauthor=H.+Shinotohauthor=K.+Kawamuraauthor=M.-R.+Zhangauthor=N.+Saharaauthor=T.+Suharaauthor=M.+Higuchi&title=PET+quantification+of+tau+pathology+in+human+brain+with+11C-PBB3&doi=10.2967%2Fjnumed.115.160127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">PET quantification of tau pathology in human brain with 11C-PBB3</span></div><div class="casAuthors">Kimura, Yasuyuki; Ichise, Masanori; Ito, Hiroshi; Shimada, Hitoshi; Ikoma, Yoko; Seki, Chie; Takano, Harumasa; Kitamura, Soichiro; Shinotoh, Hitoshi; Kawamura, Kazunori; Zhang, Ming-Rong; Sahara, Naruhiko; Suhara, Tetsuya; Higuchi, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1359-1365</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">Tau accumulation in the brain is a pathol. hallmark of Alzheimer disease and other tauopathies.  Quant. visualization of tau pathol. in humans can be a powerful method as a diagnostic aid and for monitoring potential therapeutic interventions.  We established methods of PET quantification of tau pathol. with 11C-PBB3 (2-((1E,3E)-4-(6-(11C-methylamino)pyridin-3-yl)buta-1,3-dienyl) benzo[d]thiazol-6-ol), considering its radiometabolite entering the brain.  Methods: Seven Alzheimer disease patients and 7 healthy subjects underwent dynamic 11C-PBB3 PET scanning.  Arterial blood was sampled to obtain the parent and metabolite input functions.  Quantification of 11C-PBB3 binding was performed using dual-input models that take the brain metabolite activity into consideration, traditional single-input models without such considerations, and the ref. tissue model (MRTMO) and standardized uptake value ratio (SUVR).  The cerebellar cortex was used as the ref. tissue for all methods.  Results: The dual-input graphical models estd. binding parameter (BP*ND)stably (∼0.36 in high-binding regions).  The MRTMO BP*ND matched the corresponding BP*ND by the dual-input graphical model (r2 = 1.00).  SUVR minus 1 correlated well with MRTMO BP*ND (r2 > 0.97).  However, BPND by the single-input models did not correlate with BP*ND by the dual-input graphical model (r2 = 0.04).  Conclusion: The dual-input graphical model BP*ND is consistent with the ref. tissue BP*ND and SUVR-1, suggesting that these parameters can accurately quantify binding of 11C-PBB3 despite the entry of its radiometabolites into the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrePH11hC48FLVg90H21EOLACvtfcHk0ljCTtOR-SaeEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSmsbfL&md5=72358922f07ecea6110ad217202c039c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.160127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.160127%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DIchise%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DIkoma%26aufirst%3DY.%26aulast%3DSeki%26aufirst%3DC.%26aulast%3DTakano%26aufirst%3DH.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DShinotoh%26aufirst%3DH.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DM.-R.%26aulast%3DSahara%26aufirst%3DN.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DHiguchi%26aufirst%3DM.%26atitle%3DPET%2520quantification%2520of%2520tau%2520pathology%2520in%2520human%2520brain%2520with%252011C-PBB3%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2015%26volume%3D56%26spage%3D1359%26epage%3D1365%26doi%3D10.2967%2Fjnumed.115.160127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Q.-H.</span><span> </span><span class="NLM_article-title">Synthesis of a PET tau tracer [<sup>11</sup>C]PBB3 for imaging of Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4587</span><span class="NLM_x">–</span> <span class="NLM_lpage">4592</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.08.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.bmcl.2015.08.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4587-4592&author=M.+Wangauthor=M.+Gaoauthor=Z.+Xuauthor=Q.-H.+Zheng&title=Synthesis+of+a+PET+tau+tracer+%5B11C%5DPBB3+for+imaging+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2015.08.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.08.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.08.053%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DQ.-H.%26atitle%3DSynthesis%2520of%2520a%2520PET%2520tau%2520tracer%2520%255B11C%255DPBB3%2520for%2520imaging%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4587%26epage%3D4592%26doi%3D10.1016%2Fj.bmcl.2015.08.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Walji, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostetler, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennacef, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salinas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gantert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holahan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purcell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riffel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balsells, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OBrien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melquist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Della Rocca, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schachter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Struyk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babaoglu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohith, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evelhoch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span> </span><span class="NLM_article-title">Discovery of 6-(fluoro-<sup>18</sup>F)-3-(1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-1-yl)isoquinolin-5-amine ([<sup>18</sup>F]-MK-6240): a positron emission tomography (PET) imaging agent for quantification of neurofibrillary tangles (NFTs)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">4778</span><span class="NLM_x">–</span> <span class="NLM_lpage">4789</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00166</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00166" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtF2ls70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4778-4789&author=A.+M.+Waljiauthor=E.+D.+Hostetlerauthor=H.+Selnickauthor=Z.+Zengauthor=P.+Millerauthor=I.+Bennacefauthor=C.+Salinasauthor=B.+Connollyauthor=L.+Gantertauthor=M.+Holahanauthor=S.+O%E2%80%99Malleyauthor=M.+Purcellauthor=K.+Riffelauthor=J.+Liauthor=J.+Balsellsauthor=J.+A.+OBrienauthor=S.+Melquistauthor=A.+Sorianoauthor=X.+Zhangauthor=A.+Ogawaauthor=S.+Xuauthor=E.+Joshiauthor=J.+Della+Roccaauthor=F.+J.+Hessauthor=J.+Schachterauthor=D.+Heskauthor=D.+Schenkauthor=A.+Struykauthor=K.+Babaogluauthor=T.+G.+Lohithauthor=Y.+Wangauthor=K.+Yangauthor=J.+Fuauthor=J.+L.+Evelhochauthor=P.+J.+Coleman&title=Discovery+of+6-%28fluoro-18F%29-3-%281H-pyrrolo%5B2%2C3-c%5Dpyridin-1-yl%29isoquinolin-5-amine+%28%5B18F%5D-MK-6240%29%3A+a+positron+emission+tomography+%28PET%29+imaging+agent+for+quantification+of+neurofibrillary+tangles+%28NFTs%29&doi=10.1021%2Facs.jmedchem.6b00166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)</span></div><div class="casAuthors">Walji, Abbas M.; Hostetler, Eric D.; Selnick, Harold; Zeng, Zhizhen; Miller, Patricia; Bennacef, Idriss; Salinas, Cristian; Connolly, Brett; Gantert, Liza; Holahan, Marie; O'Malley, Stacey; Purcell, Mona; Riffel, Kerry; Li, Jing; Balsells, Jaume; OBrien, Julie A.; Melquist, Stacey; Soriano, Aileen; Zhang, Xiaoping; Ogawa, Aimie; Xu, Serena; Joshi, Elizabeth; Della Rocca, Joseph; Hess, Fred J.; Schachter, Joel; Hesk, David; Schenk, David; Struyk, Arie; Babaoglu, Kerim; Lohith, Talakad G.; Wang, Yaode; Yang, Kun; Fu, Jianmin; Evelhoch, Jeffrey L.; Coleman, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4778-4789</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurofibrillary tangles (NFTs) made up of aggregated tau protein have been identified as the pathol. hallmark of several neurodegenerative diseases including Alzheimer's disease.  In vivo detection of NFTs using PET imaging represents a unique opportunity to develop a pharmacodynamic tool to accelerate the discovery of new disease modifying therapeutics targeting tau pathol.  Herein, we present the discovery of 6-(fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine, 6 ([18F]-MK-6240), as a novel PET tracer for detecting NFTs. 6 exhibits high specificity and selectivity for binding to NFTs, with suitable physicochem. properties and in vivo pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTkJBwXYLQ4LVg90H21EOLACvtfcHk0lgB-slfZAIvyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtF2ls70%253D&md5=7155752a95bc279765280108b794a758</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00166%26sid%3Dliteratum%253Aachs%26aulast%3DWalji%26aufirst%3DA.%2BM.%26aulast%3DHostetler%26aufirst%3DE.%2BD.%26aulast%3DSelnick%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DMiller%26aufirst%3DP.%26aulast%3DBennacef%26aufirst%3DI.%26aulast%3DSalinas%26aufirst%3DC.%26aulast%3DConnolly%26aufirst%3DB.%26aulast%3DGantert%26aufirst%3DL.%26aulast%3DHolahan%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%26aulast%3DPurcell%26aufirst%3DM.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DBalsells%26aufirst%3DJ.%26aulast%3DOBrien%26aufirst%3DJ.%2BA.%26aulast%3DMelquist%26aufirst%3DS.%26aulast%3DSoriano%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DOgawa%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DE.%26aulast%3DDella%2BRocca%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DF.%2BJ.%26aulast%3DSchachter%26aufirst%3DJ.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DStruyk%26aufirst%3DA.%26aulast%3DBabaoglu%26aufirst%3DK.%26aulast%3DLohith%26aufirst%3DT.%2BG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DFu%26aufirst%3DJ.%26aulast%3DEvelhoch%26aufirst%3DJ.%2BL.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%25206-%2528fluoro-18F%2529-3-%25281H-pyrrolo%255B2%252C3-c%255Dpyridin-1-yl%2529isoquinolin-5-amine%2520%2528%255B18F%255D-MK-6240%2529%253A%2520a%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%2520agent%2520for%2520quantification%2520of%2520neurofibrillary%2520tangles%2520%2528NFTs%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4778%26epage%3D4789%26doi%3D10.1021%2Facs.jmedchem.6b00166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span>Alzheimer’s Association International Conference (AAIC), Washington, D.C., July 18–23, 2015. Alzforum News. <a href="http://www.alzforum.org/news/conference-coverage/new-imaging-data-tells-story-travelling-tau" class="extLink">http://www.alzforum.org/news/conference-coverage/new-imaging-data-tells-story-travelling-tau</a> (accessed August 3,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%E2%80%99s+Association+International+Conference+%28AAIC%29%2C+Washington%2C+D.C.%2C+July+18%E2%80%9323%2C+2015.+Alzforum+News.+http%3A%2F%2Fwww.alzforum.org%2Fnews%2Fconference-coverage%2Fnew-imaging-data-tells-story-travelling-tau+%28accessed+August+3%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Marquie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normandin, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderburg, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costantino, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bien, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rycyna, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikonomovic, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasdev, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomperts, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Growdon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frosch, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Isla, T.</span><span> </span><span class="NLM_article-title">Validating novel tau positron emission tomography tracer [<sup>18</sup>F]-AV-1451 (T807) on postmortem brain tissue</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span><span class="refDoi"> DOI: 10.1002/ana.24517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1002%2Fana.24517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=26344059" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKlt73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2015&pages=787-800&author=M.+Marquieauthor=M.+D.+Normandinauthor=C.+R.+Vanderburgauthor=I.+M.+Costantinoauthor=E.+A.+Bienauthor=L.+G.+Rycynaauthor=W.+E.+Klunkauthor=C.+A.+Mathisauthor=M.+D.+Ikonomovicauthor=M.+L.+Debnathauthor=N.+Vasdevauthor=B.+C.+Dickersonauthor=S.+N.+Gompertsauthor=J.+H.+Growdonauthor=K.+A.+Johnsonauthor=M.+P.+Froschauthor=B.+T.+Hymanauthor=T.+Gomez-Isla&title=Validating+novel+tau+positron+emission+tomography+tracer+%5B18F%5D-AV-1451+%28T807%29+on+postmortem+brain+tissue&doi=10.1002%2Fana.24517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue</span></div><div class="casAuthors">Marquie, Marta; Normandin, Marc D.; Vanderburg, Charles R.; Costantino, Isabel M.; Bien, Elizabeth A.; Rycyna, Lisa G.; Klunk, William E.; Mathis, Chester A.; Ikonomovic, Milos D.; Debnath, Manik L.; Vasdev, Neil; Dickerson, Bradford C.; Gomperts, Stephen N.; Growdon, John H.; Johnson, Keith A.; Frosch, Matthew P.; Hyman, Bradley T.; Gomez-Isla, Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">787-800</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : To examine region- and substrate-specific autoradiog. and in vitro binding patterns of positron emission tomog. tracer [F-18]-AV-1451 (previously known as T807), tailored to allow in vivo detection of paired helical filament-tau-contg. lesions, and to det. whether there is off-target binding to other amyloid/non-amyloid proteins.  Methods : We applied [F-18]-AV-1451 phosphor screen autoradiog., [F-18]-AV-1451 nuclear emulsion autoradiog., and [H-3]-AV-1451 in vitro binding assays to the study of postmortem samples from patients with a definite pathol. diagnosis of Alzheimer disease, frontotemporal lobar degeneration-tau, frontotemporal lobar degeneration-transactive response DNA binding protein 43 (TDP-43), progressive supranuclear palsy, corticobasal degeneration, dementia with Lewy bodies, multiple system atrophy, cerebral amyloid angiopathy and elderly controls free of pathol.  Results : Our data suggest that [F-18]-AV-1451 strongly binds to tau lesions primarily made of paired helical filaments in Alzheimer brains (eg, intraneuronal and extraneuronal tangles and dystrophic neurites), but does not seem to bind to a significant extent to neuronal and glial inclusions mainly composed of straight tau filaments in non-Alzheimer tauopathy brains or to lesions contg. β-amyloid, α-synuclein, or TDP-43.  [F-18]-AV-1451 off-target binding to neuromelanin- and melanin-contg. cells and, to a lesser extent, to brain hemorrhagic lesions was identified.  Interpretation : Our data suggest that [F-18]-AV-1451 holds promise as a surrogate marker for the detection of brain tau pathol. in the form of tangles and paired helical filament-tau-contg. neurites in Alzheimer brains but also point to its relatively lower affinity for lesions primarily made of straight tau filaments in non-Alzheimer tauopathy cases and to the existence of some [F-18]-AV-1451 off-target binding.  These findings provide important insights for interpreting in vivo patterns of [F-18]-AV-1451 retention.  Ann Neurol 2015 Ann Neurol 2015;78:Ann Neurol 2015;78:679-696.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgyGhMPNpa_bVg90H21EOLACvtfcHk0lgB-slfZAIvyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKlt73P&md5=a913e3c291117ad0a6020939d9cb8f80</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fana.24517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24517%26sid%3Dliteratum%253Aachs%26aulast%3DMarquie%26aufirst%3DM.%26aulast%3DNormandin%26aufirst%3DM.%2BD.%26aulast%3DVanderburg%26aufirst%3DC.%2BR.%26aulast%3DCostantino%26aufirst%3DI.%2BM.%26aulast%3DBien%26aufirst%3DE.%2BA.%26aulast%3DRycyna%26aufirst%3DL.%2BG.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DIkonomovic%26aufirst%3DM.%2BD.%26aulast%3DDebnath%26aufirst%3DM.%2BL.%26aulast%3DVasdev%26aufirst%3DN.%26aulast%3DDickerson%26aufirst%3DB.%2BC.%26aulast%3DGomperts%26aufirst%3DS.%2BN.%26aulast%3DGrowdon%26aufirst%3DJ.%2BH.%26aulast%3DJohnson%26aufirst%3DK.%2BA.%26aulast%3DFrosch%26aufirst%3DM.%2BP.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DGomez-Isla%26aufirst%3DT.%26atitle%3DValidating%2520novel%2520tau%2520positron%2520emission%2520tomography%2520tracer%2520%255B18F%255D-AV-1451%2520%2528T807%2529%2520on%2520postmortem%2520brain%2520tissue%26jtitle%3DAnn.%2520Neurol.%26date%3D2015%26volume%3D78%26spage%3D787%26epage%3D800%26doi%3D10.1002%2Fana.24517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Vermeiren, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viot, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mairet-Coello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannestad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courade, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, M.</span><span> </span><span class="NLM_article-title">T807, a reported selective tau tracer, binds with nanomolar affinity to monoamine oxidase A</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="refDoi"> DOI: 10.1016/j.jalz.2015.07.381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.jalz.2015.07.381" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=283&author=C.+Vermeirenauthor=J.+Mercierauthor=D.+Viotauthor=G.+Mairet-Coelloauthor=J.+Hannestadauthor=J.-P.+Couradeauthor=M.+Citronauthor=M.+Gillard&title=T807%2C+a+reported+selective+tau+tracer%2C+binds+with+nanomolar+affinity+to+monoamine+oxidase+A&doi=10.1016%2Fj.jalz.2015.07.381"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2015.07.381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2015.07.381%26sid%3Dliteratum%253Aachs%26aulast%3DVermeiren%26aufirst%3DC.%26aulast%3DMercier%26aufirst%3DJ.%26aulast%3DViot%26aufirst%3DD.%26aulast%3DMairet-Coello%26aufirst%3DG.%26aulast%3DHannestad%26aufirst%3DJ.%26aulast%3DCourade%26aufirst%3DJ.-P.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DGillard%26aufirst%3DM.%26atitle%3DT807%252C%2520a%2520reported%2520selective%2520tau%2520tracer%252C%2520binds%2520with%2520nanomolar%2520affinity%2520to%2520monoamine%2520oxidase%2520A%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2015%26volume%3D11%26spage%3D283%26doi%3D10.1016%2Fj.jalz.2015.07.381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Shcherbinin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navitsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flitter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devous, M. D.,  Sr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintun, M. A.</span><span> </span><span class="NLM_article-title">Kinetics of the tau PET tracer <sup>18</sup>F-AV-1451 (T807) in subjects with normal cognitive function, mild cognitive impairment and Alzheimer’s disease</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">1535</span><span class="NLM_x">–</span> <span class="NLM_lpage">1542</span><span class="refDoi"> DOI: 10.2967/jnumed.115.170027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2967%2Fjnumed.115.170027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=1535-1542&author=S.+Shcherbininauthor=A.+J.+Schwarzauthor=A.+D.+Joshiauthor=M.+Navitskyauthor=M.+Flitterauthor=W.+R.+Shankleauthor=M.+D.+Devousauthor=M.+A.+Mintun&title=Kinetics+of+the+tau+PET+tracer+18F-AV-1451+%28T807%29+in+subjects+with+normal+cognitive+function%2C+mild+cognitive+impairment+and+Alzheimer%E2%80%99s+disease&doi=10.2967%2Fjnumed.115.170027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.170027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.170027%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbinin%26aufirst%3DS.%26aulast%3DSchwarz%26aufirst%3DA.%2BJ.%26aulast%3DJoshi%26aufirst%3DA.%2BD.%26aulast%3DNavitsky%26aufirst%3DM.%26aulast%3DFlitter%26aufirst%3DM.%26aulast%3DShankle%26aufirst%3DW.%2BR.%26aulast%3DDevous%26aufirst%3DM.%2BD.%26aulast%3DMintun%26aufirst%3DM.%2BA.%26atitle%3DKinetics%2520of%2520the%2520tau%2520PET%2520tracer%252018F-AV-1451%2520%2528T807%2529%2520in%2520subjects%2520with%2520normal%2520cognitive%2520function%252C%2520mild%2520cognitive%2520impairment%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D1535%26epage%3D1542%26doi%3D10.2967%2Fjnumed.115.170027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Rogers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, M.</span><span> </span><span class="NLM_article-title">Extended-connectivity fingerprints</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span><span class="refDoi"> DOI: 10.1021/ci100050t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci100050t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=742-754&author=D.+Rogersauthor=M.+Hahn&title=Extended-connectivity+fingerprints&doi=10.1021%2Fci100050t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Extended-Connectivity Fingerprints</span></div><div class="casAuthors">Rogers, David; Hahn, Mathew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">742-754</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Extended-connectivity fingerprints (ECFPs) are a novel class of topol. fingerprints for mol. characterization.  Historically, topol. fingerprints were developed for substructure and similarity searching.  ECFPs were developed specifically for structure-activity modeling.  ECFPs are circular fingerprints with a no. of useful qualities: they can be very rapidly calcd.; they are not predefined and can represent an essentially infinite no. of different mol. features (including stereochem. information); their features represent the presence of particular substructures, allowing easier interpretation of anal. results; and the ECFP algorithm can be tailored to generate different types of circular fingerprints, optimized for different uses.  While the use of ECFPs has been widely adopted and validated, a description of their implementation has not previously been presented in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra43orI-Y7lbVg90H21EOLACvtfcHk0liEEq9017iwSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D&md5=cd6c736cd7a3d280b67f5316acce8006</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fci100050t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100050t%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DD.%26aulast%3DHahn%26aufirst%3DM.%26atitle%3DExtended-connectivity%2520fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D742%26epage%3D754%26doi%3D10.1021%2Fci100050t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span>FastROCS, version <span class="NLM_edition">1.4</span>; <span class="NLM_publisher-name">OpenEye Scientific Software Inc.</span> (<span class="NLM_publisher-loc">9 Bisbee Court, Suite D, Santa Fe, NM 87508, U.S.</span>); <a href="http://www.eyesopen.com" class="extLink">www.eyesopen.com</a> (accessed August 1,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FastROCS%2C+version+1.4%3B+OpenEye+Scientific+Software+Inc.+%289+Bisbee+Court%2C+Suite+D%2C+Santa+Fe%2C+NM+87508%2C+U.S.%29%3B+www.eyesopen.com+%28accessed+August+1%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DFastROCS%26pub%3DOpenEye%2520Scientific%2520Software%2520Inc%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rojo, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alzate-Morales, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedra, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccioni, R. B.</span><span> </span><span class="NLM_article-title">Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span><span class="refDoi"> DOI: 10.3233/JAD-2010-1262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.3233%2FJAD-2010-1262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=20110603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Slt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=573-589&author=L.+E.+Rojoauthor=J.+Alzate-Moralesauthor=I.+N.+Saavedraauthor=P.+Daviesauthor=R.+B.+Maccioni&title=Selective+interaction+of+lansoprazole+and+astemizole+with+tau+polymers%3A+potential+new+clinical+use+in+diagnosis+of+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-2010-1262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49aR"><div class="casContent"><span class="casTitleNuber">49a</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Interaction of Lansoprazole and Astemizole with Tau Polymers: Potential New Clinical Use in Diagnosis of Alzheimer's Disease</span></div><div class="casAuthors">Rojo, Leonel E.; Alzate-Morales, Jans; Saavedra, Ivan N.; Davies, Peter; Maccioni, Ricardo B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">573-589</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">We describe the interactions of two benzimidazole derivs., astemizole (AST) and lansoprazole (LNS), with anomalous aggregates of tau protein (neurofibrillary tangles).  Interestingly, these compds., with important medical applications in the treatment of allergies and gastrointestinal disorders resp., specifically bind to aggregated variants of tau protein and to paired helical filaments isolated from brains of Alzheimer's disease (AD) patients.  These ligands appear to be a powerful tool to tag brain-isolated tau-aggregates and heparin-induced polymers of recombinant tau.  The interactions of AST and LNS with tau aggregates were assessed by classical radioligand assays, surface plasmon resonance, and bioinformatic approaches.  The affinity of AST and LNS for tau aggregates was comparatively higher than that for amyloid-β polymers according to our data.  This is relevant since senile plaques are also abundant but are not pathognomonic in AD patients.  Immunochem. studies on paired helical filaments from brains of AD patients and surface plasmon resonance studies confirm these findings.  The capacity of these drugs to penetrate the blood-brain barrier was evaluated: (i) in vitro by parallel artificial membrane permeability assay followed by exptl. Log P detns.; and (ii) in vivo by pharmacokinetic studies comparing distribution profiles in blood and brain of mice using HPLC/UV.  Importantly, our studies indicate that the brain/blood concn. ratios for these compds. were suitable for their use as PET radiotracers.  Since neurofibrillary tangles are pos. correlated with cognitive impairment, we concluded that LNS and AST have a great potential in PET neuroimaing for in vivo early detection of AD and in reducing the formation of neurofibrillary tangles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJZHJBdFsZE7Vg90H21EOLACvtfcHk0liEEq9017iwSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Slt7s%253D&md5=db44a10a6d6cf5665e71e10537aaf12f</span></div><a href="/servlet/linkout?suffix=cit49a&amp;dbid=16384&amp;doi=10.3233%2FJAD-2010-1262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2010-1262%26sid%3Dliteratum%253Aachs%26aulast%3DRojo%26aufirst%3DL.%2BE.%26aulast%3DAlzate-Morales%26aufirst%3DJ.%26aulast%3DSaavedra%26aufirst%3DI.%2BN.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DMaccioni%26aufirst%3DR.%2BB.%26atitle%3DSelective%2520interaction%2520of%2520lansoprazole%2520and%2520astemizole%2520with%2520tau%2520polymers%253A%2520potential%2520new%2520clinical%2520use%2520in%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2010%26volume%3D19%26spage%3D573%26epage%3D589%26doi%3D10.3233%2FJAD-2010-1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit49b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Riss, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brichard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aigbirhio, F. I.</span><span> </span><span class="NLM_article-title">Radiosynthesis and characterization of astemizole derivatives as lead compounds toward PET imaging of τ-pathology</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">852</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span><span class="refDoi"> DOI: 10.1039/c3md00017f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1039%2Fc3md00017f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=852-855&author=P.+J.+Rissauthor=L.+Brichardauthor=V.+Ferrariauthor=D.+J.+Williamsonauthor=T.+D.+Fryerauthor=Y.+T.+Hongauthor=J.-C.+Baronauthor=F.+I.+Aigbirhio&title=Radiosynthesis+and+characterization+of+astemizole+derivatives+as+lead+compounds+toward+PET+imaging+of+%CF%84-pathology&doi=10.1039%2Fc3md00017f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49b&amp;dbid=16384&amp;doi=10.1039%2Fc3md00017f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00017f%26sid%3Dliteratum%253Aachs%26aulast%3DRiss%26aufirst%3DP.%2BJ.%26aulast%3DBrichard%26aufirst%3DL.%26aulast%3DFerrari%26aufirst%3DV.%26aulast%3DWilliamson%26aufirst%3DD.%2BJ.%26aulast%3DFryer%26aufirst%3DT.%2BD.%26aulast%3DHong%26aufirst%3DY.%2BT.%26aulast%3DBaron%26aufirst%3DJ.-C.%26aulast%3DAigbirhio%26aufirst%3DF.%2BI.%26atitle%3DRadiosynthesis%2520and%2520characterization%2520of%2520astemizole%2520derivatives%2520as%2520lead%2520compounds%2520toward%2520PET%2520imaging%2520of%2520%25CF%2584-pathology%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D852%26epage%3D855%26doi%3D10.1039%2Fc3md00017f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Hawkins, P. C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skillman, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholls, A.</span><span> </span><span class="NLM_article-title">Comparison of shape-matching and docking as virtual screening tools</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1021/jm0603365</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0603365" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlansb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=74-82&author=P.+C.+D.+Hawkinsauthor=A.+G.+Skillmanauthor=A.+Nicholls&title=Comparison+of+shape-matching+and+docking+as+virtual+screening+tools&doi=10.1021%2Fjm0603365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Shape-Matching and Docking as Virtual Screening Tools</span></div><div class="casAuthors">Hawkins, Paul C. D.; Skillman, A. Geoffrey; Nicholls, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-82</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ligand docking is a widely used approach in virtual screening.  In recent years a large no. of publications have appeared in which docking tools are compared and evaluated for their effectiveness in virtual screening against a wide variety of protein targets.  These studies have shown that the effectiveness of docking in virtual screening is highly variable due to a large no. of possible confounding factors.  Another class of method that has shown promise in virtual screening is the shape-based, ligand-centric approach.  Several direct comparisons of docking with the shape-based tool ROCS have been conducted using data sets from some of these recent docking publications.  The results show that a shape-based, ligand-centric approach is more consistent than, and often superior to, the protein-centric approach taken by docking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe0IKOly7zibVg90H21EOLACvtfcHk0lgTbGA6Bq7AKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlansb%252FF&md5=6f97f5c0cc092b4e225f7c2656c1bcf6</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm0603365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603365%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DP.%2BC.%2BD.%26aulast%3DSkillman%26aufirst%3DA.%2BG.%26aulast%3DNicholls%26aufirst%3DA.%26atitle%3DComparison%2520of%2520shape-matching%2520and%2520docking%2520as%2520virtual%2520screening%2520tools%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D74%26epage%3D82%26doi%3D10.1021%2Fjm0603365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, E.</span><span> </span><span class="NLM_article-title">Neuropathological stageing of Alzheimer-related changes</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span><span class="refDoi"> DOI: 10.1007/BF00308809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1007%2FBF00308809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1759558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1991&pages=239-259&author=H.+Braakauthor=E.+Braak&title=Neuropathological+stageing+of+Alzheimer-related+changes&doi=10.1007%2FBF00308809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathological stageing of Alzheimer-related changes</span></div><div class="casAuthors">Braak H; Braak E</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">239-59</span>
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    </div><div class="casAbstract">Eighty-three brains obtained at autopsy from nondemented and demented individuals were examined for extracellular amyloid deposits and intraneuronal neurofibrillary changes.  The distribution pattern and packing density of amyloid deposits turned out to be of limited significance for differentiation of neuropathological stages.  Neurofibrillary changes occurred in the form of neuritic plaques, neurofibrillary tangles and neuropil threads.  The distribution of neuritic plaques varied widely not only within architectonic units but also from one individual to another.  Neurofibrillary tangles and neuropil threads, in contrast, exhibited a characteristic distribution pattern permitting the differentiation of six stages.  The first two stages were characterized by an either mild or severe alteration of the transentorhinal layer Pre-alpha (transentorhinal stages I-II).  The two forms of limbic stages (stages III-IV) were marked by a conspicuous affection of layer Pre-alpha in both transentorhinal region and proper entorhinal cortex.  In addition, there was mild involvement of the first Ammon's horn sector.  The hallmark of the two isocortical stages (stages V-VI) was the destruction of virtually all isocortical association areas.  The investigation showed that recognition of the six stages required qualitative evaluation of only a few key preparations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIZP19xbDelK_dlEzl_fBafW6udTcc2ebhu0Aw6detNbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D&md5=b3e2663c943c202f121efeb65527a280</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1007%2FBF00308809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00308809%26sid%3Dliteratum%253Aachs%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DBraak%26aufirst%3DE.%26atitle%3DNeuropathological%2520stageing%2520of%2520Alzheimer-related%2520changes%26jtitle%3DActa%2520Neuropathol.%26date%3D1991%26volume%3D82%26spage%3D239%26epage%3D259%26doi%3D10.1007%2FBF00308809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><div class="note"><p class="first last">Online early access:</p></div><span class="NLM_contrib-group">Declercq, L.; Celen, S.; Lecina, J.; Ahamed, M.; Tousseyn, T.; Moechars, D.; Alcazar, J.; Ariza, M.; Fierens, K.; Bottelbergs, A.; Marien, J.; Vandenberghe, R.; Andres, I. J.; Van Laere, K.; Verbruggen, A.; Bormans, G.</span><span> </span><span class="NLM_article-title">Preclinical evaluation of 18F-JNJ64349311, a novel PET tracer for tau imaging</span>.  <span class="citation_source-journal">J. Nucl. Med.</span> [Online early access]. DOI: <span class="refDoi"> DOI: 10.2967/jnumed.116.185199</span> . Published Online: February 16, 2017.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2967%2Fjnumed.116.185199" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Online+early+access%3ADeclercq%2C+L.%3B+Celen%2C+S.%3B+Lecina%2C+J.%3B+Ahamed%2C+M.%3B+Tousseyn%2C+T.%3B+Moechars%2C+D.%3B+Alcazar%2C+J.%3B+Ariza%2C+M.%3B+Fierens%2C+K.%3B+Bottelbergs%2C+A.%3B+Marien%2C+J.%3B+Vandenberghe%2C+R.%3B+Andres%2C+I.+J.%3B+Van+Laere%2C+K.%3B+Verbruggen%2C+A.%3B+Bormans%2C+G.+Preclinical+evaluation+of+18F-JNJ64349311%2C+a+novel+PET+tracer+for+tau+imaging.+J.+Nucl.+Med.+%5BOnline+early+access%5D.+DOI%3A+10.2967%2Fjnumed.116.185199.+Published+Online%3A+February+16%2C+2017."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.116.185199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.116.185199%26sid%3Dliteratum%253Aachs%26aulast%3DDeclercq%26aufirst%3DL.%26atitle%3DPreclinical%2520evaluation%2520of%252018F-JNJ64349311%252C%2520a%2520novel%2520PET%2520tracer%2520for%2520tau%2520imaging%26jtitle%3DJ.%2520Nucl.%2520Med.%26doi%3D10.2967%2Fjnumed.116.185199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span>ADMET Predictor, version <span class="NLM_edition">7</span>; <span class="NLM_publisher-name">Simulations Plus, Inc.</span> (<span class="NLM_publisher-loc">42505 10th Street West, Lancaster, CA 93534-7059, U.S.</span>); <a href="http://www.simulations-plus.com/" class="extLink">http://www.simulations-plus.com/</a> (accessed August 3,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ADMET+Predictor%2C+version+7%3B+Simulations+Plus%2C+Inc.+%2842505+10th+Street+West%2C+Lancaster%2C+CA+93534-7059%2C+U.S.%29%3B+http%3A%2F%2Fwww.simulations-plus.com%2F+%28accessed+August+3%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DADMET%2520Predictor%26pub%3DSimulations%2520Plus%252C%2520Inc%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Bleickardt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazdoba, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, N. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R. A.</span><span> </span><span class="NLM_article-title">Antagonism of the adenosine A2A receptor attenuates akathisia-like behavior induced with MP-10 or aripiprazole in a novel non-human primate model</span> <span class="citation_source-journal">Pharmacol., Biochem. Behav.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.1016/j.pbb.2013.10.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1016%2Fj.pbb.2013.10.030" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2014&pages=36-45&author=C.+J.+Bleickardtauthor=T.+M.+Kazdobaauthor=N.+T.+Jonesauthor=J.+C.+Hunterauthor=R.+A.+Hodgson&title=Antagonism+of+the+adenosine+A2A+receptor+attenuates+akathisia-like+behavior+induced+with+MP-10+or+aripiprazole+in+a+novel+non-human+primate+model&doi=10.1016%2Fj.pbb.2013.10.030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.pbb.2013.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pbb.2013.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DBleickardt%26aufirst%3DC.%2BJ.%26aulast%3DKazdoba%26aufirst%3DT.%2BM.%26aulast%3DJones%26aufirst%3DN.%2BT.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26atitle%3DAntagonism%2520of%2520the%2520adenosine%2520A2A%2520receptor%2520attenuates%2520akathisia-like%2520behavior%2520induced%2520with%2520MP-10%2520or%2520aripiprazole%2520in%2520a%2520novel%2520non-human%2520primate%2520model%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D2014%26volume%3D118%26spage%3D36%26epage%3D45%26doi%3D10.1016%2Fj.pbb.2013.10.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Dounay, A. B.; Tuttle, J. B.; Verhoest, P. R.</span><span> </span><span class="NLM_article-title">Preparation of tricyclic compds. as KAT II inhibitors for treatment of neurol. disorders and other diseases</span>, WO2013186666, Dec 19,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+B.+Dounay&author=J.+B.+Tuttle&author=P.+R.+Verhoest&title=Preparation+of+tricyclic+compds.+as+KAT+II+inhibitors+for+treatment+of+neurol.+disorders+and+other+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDounay%26aufirst%3DA.%2BB.%26atitle%3DPreparation%2520of%2520tricyclic%2520compds.%2520as%2520KAT%2520II%2520inhibitors%2520for%2520treatment%2520of%2520neurol.%2520disorders%2520and%2520other%2520diseases%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Aldous, S. C.; Fennie, M. W.; Jiang, J. Z.; Lan Mu, S. J.; Pedgrift, B.; Pribish, J. R.; Rauckman, B.; Sabol, J. S.; Stoklosa, G. T.; Thurairatnam, S.; Vandeusen, C. L.</span><span> </span><span class="NLM_article-title">Pyrimidine hydrazide compounds as PGDS inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases</span>, WO2008121670, Oct 9,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+C.+Aldous&author=M.+W.+Fennie&author=J.+Z.+Jiang&author=S.+J.+Lan+Mu&author=B.+Pedgrift&author=J.+R.+Pribish&author=B.+Rauckman&author=J.+S.+Sabol&author=G.+T.+Stoklosa&author=S.+Thurairatnam&author=C.+L.+Vandeusen&title=Pyrimidine+hydrazide+compounds+as+PGDS+inhibitors+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAldous%26aufirst%3DS.%2BC.%26atitle%3DPyrimidine%2520hydrazide%2520compounds%2520as%2520PGDS%2520inhibitors%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520diseases%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span> </span><span class="NLM_article-title">A One-pot diazotation-fluorodediazoniation reaction and fluorine gas for the production of fluoronaphthyridines</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">993</span><span class="NLM_x">–</span> <span class="NLM_lpage">1001</span><span class="refDoi"> DOI: 10.1021/op500100b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/op500100b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=993-1001&author=S.+Abeleauthor=G.+Schmidtauthor=M.+J.+Flemingauthor=H.+Steiner&title=A+One-pot+diazotation-fluorodediazoniation+reaction+and+fluorine+gas+for+the+production+of+fluoronaphthyridines&doi=10.1021%2Fop500100b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fop500100b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop500100b%26sid%3Dliteratum%253Aachs%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DFleming%26aufirst%3DM.%2BJ.%26aulast%3DSteiner%26aufirst%3DH.%26atitle%3DA%2520One-pot%2520diazotation-fluorodediazoniation%2520reaction%2520and%2520fluorine%2520gas%2520for%2520the%2520production%2520of%2520fluoronaphthyridines%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2014%26volume%3D18%26spage%3D993%26epage%3D1001%26doi%3D10.1021%2Fop500100b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Xiong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoye, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horchler, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attardo, G.</span><span> </span><span class="NLM_article-title">Facile route to 2-fluoropyridines via 2-pyridyltrialkylammonium salts prepared from pyridine N-oxides and application to <sup>18</sup>F-labeling</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3726</span><span class="NLM_x">–</span> <span class="NLM_lpage">3729</span><span class="refDoi"> DOI: 10.1021/acs.orglett.5b01703</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.5b01703" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2ltrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=3726-3729&author=H.+Xiongauthor=A.+T.+Hoyeauthor=K.+H.+Fanauthor=X.+Liauthor=J.+Clemensauthor=C.+L.+Horchlerauthor=N.+C.+Limauthor=G.+Attardo&title=Facile+route+to+2-fluoropyridines+via+2-pyridyltrialkylammonium+salts+prepared+from+pyridine+N-oxides+and+application+to+18F-labeling&doi=10.1021%2Facs.orglett.5b01703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Facile Route to 2-Fluoropyridines via 2-Pyridyltrialkylammonium Salts Prepared from Pyridine N-Oxides and Application to 18F-Labeling</span></div><div class="casAuthors">Xiong, Hui; Hoye, Adam T.; Fan, Kuo-Hsien; Li, Ximin; Clemens, Jennifer; Horchler, Carey L.; Lim, Nathaniel C.; Attardo, Giorgio</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3726-3729</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Among known precursors for 2-[18F]fluoropyridines, pyridyltrialkylammonium salts have shown excellent reactivity; however, their broader utility has been limited because synthetic methods for their prepn. suffer from poor functional group compatibility.  In this paper, we demonstrate the regioselective conversion of readily available pyridine N-oxides into 2-pyridyltrialkylammonium salts under mild and metal-free conditions.  These isolable intermediates serve as effective precursors to structurally diverse 2-fluoropyridines, including mols. relevant to PET imaging.  In addn. to providing access to nonradioactive analogs, this method has been successfully applied to 18F-labeling in the radiosynthesis of [18F]AV-1451 ([18F]T807), a PET tracer currently under development for imaging tau.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVTE6KPqgCdLVg90H21EOLACvtfcHk0lgHhNparnYD0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2ltrbM&md5=ee36c30d7305c50722e912ad257cd90e</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.5b01703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.5b01703%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DH.%26aulast%3DHoye%26aufirst%3DA.%2BT.%26aulast%3DFan%26aufirst%3DK.%2BH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DClemens%26aufirst%3DJ.%26aulast%3DHorchler%26aufirst%3DC.%2BL.%26aulast%3DLim%26aufirst%3DN.%2BC.%26aulast%3DAttardo%26aufirst%3DG.%26atitle%3DFacile%2520route%2520to%25202-fluoropyridines%2520via%25202-pyridyltrialkylammonium%2520salts%2520prepared%2520from%2520pyridine%2520N-oxides%2520and%2520application%2520to%252018F-labeling%26jtitle%3DOrg.%2520Lett.%26date%3D2015%26volume%3D17%26spage%3D3726%26epage%3D3729%26doi%3D10.1021%2Facs.orglett.5b01703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="note"><p class="first last">Please note that in the SAR discussion tau and Aβ denote specifically the aggregated form of these proteins.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">CNS drug design: balancing physicochemical properties for optimal brain exposure</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2584</span><span class="NLM_x">–</span> <span class="NLM_lpage">2608</span><span class="refDoi"> DOI: 10.1021/jm501535r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501535r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2584-2608&author=Z.+Rankovic&title=CNS+drug+design%3A+balancing+physicochemical+properties+for+optimal+brain+exposure&doi=10.1021%2Fjm501535r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure</span></div><div class="casAuthors">Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2584-2608</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The human brain is a uniquely complex organ, which has evolved a sophisticated protection system to prevent injury from external insults and toxins.  Designing mols. that can overcome this protection system and achieve optimal concn. at the desired therapeutic target in the brain is a specific and major challenge for medicinal chemists working in CNS drug discovery.  Analogous to the now widely accepted rule of 5 in the design of oral drugs, the physicochem. properties required for optimal brain exposure have been extensively studied in an attempt to similarly define the attributes of successful CNS drugs and drug candidates.  This body of work is systematically reviewed here, with a particular emphasis on the interplay between the most crit. physicochem. and pharmacokinetic parameters of CNS drugs as well as their impact on medicinal chem. strategies toward mols. with optimal brain exposure.  A summary of modern CNS pharmacokinetic concepts and methods is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8V0N1j49uuLVg90H21EOLACvtfcHk0lgHhNparnYD0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrrP&md5=f01e3f2dc4e2eff7b0618124277a5cf8</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501535r%26sid%3Dliteratum%253Aachs%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DCNS%2520drug%2520design%253A%2520balancing%2520physicochemical%2520properties%2520for%2520optimal%2520brain%2520exposure%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2584%26epage%3D2608%26doi%3D10.1021%2Fjm501535r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span>All in vivo experimental procedures were performed according to the applicable European Communities Council Directive of November 24,<span class="NLM_x"> </span><span class="NLM_year">1986</span><span class="NLM_x">, </span>(86/609/EEC) and approved by the Animal Care and Use Committee of Janssen Pharmaceutical Companies of Johnson & Johnson and by the local ethical committee.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=All+in+vivo+experimental+procedures+were+performed+according+to+the+applicable+European+Communities+Council+Directive+of+November+24%2C+1986%2C+%2886%2F609%2FEEC%29+and+approved+by+the+Animal+Care+and+Use+Committee+of+Janssen+Pharmaceutical+Companies+of+Johnson+%26+Johnson+and+by+the+local+ethical+committee."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D1986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span>Eurofins Cerep SA, Le Bois l’Evêque, 86600 Celle L’Evescault, France. <a href="http://www.cerep.fr/" class="extLink">http://www.cerep.fr/</a> (accessed August 3,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Eurofins+Cerep+SA%2C+Le+Bois+l%E2%80%99Ev%C3%AAque%2C+86600+Celle+L%E2%80%99Evescault%2C+France.+http%3A%2F%2Fwww.cerep.fr%2F+%28accessed+August+3%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span>This is a competition binding assay:  <span class="citation_source-book">KINOMEscan Assay Platform</span>; <span class="NLM_publisher-name">KINOMEscan, a Division of DiscoverX</span> (<span class="NLM_publisher-loc">1180 Roselle Street, Suite D, San Diego, CA 92121, U.S.</span>); <a href="https://www.discoverx.com" class="extLink">https://www.discoverx.com</a> (accessed August 3,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=This+is+a+competition+binding+assay%3A+KINOMEscan+Assay+Platform%3B+KINOMEscan%2C+a+Division+of+DiscoverX+%281180+Roselle+Street%2C+Suite+D%2C+San+Diego%2C+CA+92121%2C+U.S.%29%3B+https%3A%2F%2Fwww.discoverx.com+%28accessed+August+3%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DKINOMEscan%2520Assay%2520Platform%26pub%3DKINOMEscan%252C%2520a%2520Division%2520of%2520DiscoverX%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Bonhaus, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeSouza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salazar, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuppan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eglen, R. M.</span><span> </span><span class="NLM_article-title">The pharmacology and distribution of human 5-hydroxytryptamine<sub>2B</sub> (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">622</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.1995.tb14977.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.1111%2Fj.1476-5381.1995.tb14977.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=7582481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADyaK2MXmtlOht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1995&pages=622-628&author=D.+W.+Bonhausauthor=C.+Bachauthor=A.+DeSouzaauthor=F.+H.+Salazarauthor=B.+D.+Matsuokaauthor=P.+Zuppanauthor=H.+W.+Chanauthor=R.+M.+Eglen&title=The+pharmacology+and+distribution+of+human+5-hydroxytryptamine2B+%285-HT2B%29+receptor+gene+products%3A+comparison+with+5-HT2A+and+5-HT2C+receptors&doi=10.1111%2Fj.1476-5381.1995.tb14977.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors</span></div><div class="casAuthors">Bonhaus, Douglas W.; Bach, Chinh; DeSouza, Andrea; Salazar, R. H. Rick; Matsuoka, Barbara D.; Zuppan, Patricia; Chan, Hardy W.; Eglen, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">622-8</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Scientific & Medical Division</span>)
        </div><div class="casAbstract">Full length clones of the human 5-HT2B receptor were isolated from human liver, kidney and pancreas.  The cloned human 5-HT2B receptors had a high degree of homol. (∼80%) with the rat and mouse 5-HT2B receptors.  PCR amplification was used to det. the tissue distribution of human 5-HT2B receptor mRNA.  MRNA encoding the 5-HT2B receptor was expressed with greatest abundance in human liver and kidney.  Lower levels of expression were detected in cerebral cortex, whole brain, pancreas and spleen.  Expression was not detected in heart.  Northern blot anal. confirmed the presence of 5-HT2B receptor mRNA (a 2.4 kB sized band) in pancreas, liver and kidney.  An addnl. 3.2 kB sized band of hybridization was detected in liver and kidney.  This raises the possibility of a splice variant of the receptor or the presence of an addnl. homologous receptor.  The human 5-HT2B receptor was expressed in Cos-7 cells and its ligand binding characteristics were compared to similarly expressed human 5-HT2A and 5-HT2C receptors.  The ligand specificity of the human 5-HT2B receptor (5-HT > ritanserin > SB 204741 > spiperone) was distinct from that of the human 5-HT2A (ritanserin > spiperone > 5-HT > SB 204741) and 5-HT2C (ritanserin > 5-HT > spiperone = SB 204741) receptors.  On the basis of a higher affinity for ketanserin and a lower affinity for yohimbine the human 5-HT2B receptor also appeared to differ from the rat 5-HT2B receptor.  These findings confirm the sequence of the human 5-HT2B receptor and they demonstrate that the receptor has a widespread tissue distribution.  In addn., these data suggest that there are differences in ligand affinities between different species homologues of the receptor.  Finally, the finding of two distinct bands on the Northern blots of liver and kidney raises the possibility of splice variants or subtypes of 5-HT2B receptors, within these tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo79mR3s8H2nLVg90H21EOLACvtfcHk0lhgEoncfSOGZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmtlOht7k%253D&md5=55752ff530149d3ac96e5d9082c3e5d6</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1995.tb14977.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1995.tb14977.x%26sid%3Dliteratum%253Aachs%26aulast%3DBonhaus%26aufirst%3DD.%2BW.%26aulast%3DBach%26aufirst%3DC.%26aulast%3DDeSouza%26aufirst%3DA.%26aulast%3DSalazar%26aufirst%3DF.%2BH.%26aulast%3DMatsuoka%26aufirst%3DB.%2BD.%26aulast%3DZuppan%26aufirst%3DP.%26aulast%3DChan%26aufirst%3DH.%2BW.%26aulast%3DEglen%26aufirst%3DR.%2BM.%26atitle%3DThe%2520pharmacology%2520and%2520distribution%2520of%2520human%25205-hydroxytryptamine2B%2520%25285-HT2B%2529%2520receptor%2520gene%2520products%253A%2520comparison%2520with%25205-HT2A%2520and%25205-HT2C%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D115%26spage%3D622%26epage%3D628%26doi%3D10.1111%2Fj.1476-5381.1995.tb14977.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Declercq, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rombouts, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koole, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fierens, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariën, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanduffel, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tousseyn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberghe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span> </span><span class="NLM_article-title">Preclinical evaluation of <sup>18</sup>F-JNJ64349311, a novel PET tracer for tau imaging</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_fpage">in press</span><span class="refDoi"> DOI: 10.2967/jnumed.116.185199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=10.2967%2Fjnumed.116.185199" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=in+press&author=L.+Declercqauthor=F.+Romboutsauthor=M.+Kooleauthor=K.+Fierensauthor=J.+Mari%C3%ABnauthor=X.+Langloisauthor=J.-I.+Andr%C3%A9sauthor=M.+Schmidtauthor=G.+Macdonaldauthor=D.+Moecharsauthor=W.+Vanduffelauthor=T.+Tousseynauthor=R.+Vandenbergheauthor=K.+Van+Laereauthor=A.+Verbruggenauthor=G.+Bormans&title=Preclinical+evaluation+of+18F-JNJ64349311%2C+a+novel+PET+tracer+for+tau+imaging&doi=10.2967%2Fjnumed.116.185199"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.116.185199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.116.185199%26sid%3Dliteratum%253Aachs%26aulast%3DDeclercq%26aufirst%3DL.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DFierens%26aufirst%3DK.%26aulast%3DMari%25C3%25ABn%26aufirst%3DJ.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.-I.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DVanduffel%26aufirst%3DW.%26aulast%3DTousseyn%26aufirst%3DT.%26aulast%3DVandenberghe%26aufirst%3DR.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DPreclinical%2520evaluation%2520of%252018F-JNJ64349311%252C%2520a%2520novel%2520PET%2520tracer%2520for%2520tau%2520imaging%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2017%26spage%3Din%2520press%26doi%3D10.2967%2Fjnumed.116.185199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span>Sirius Analytical Ltd., Forest Row Business Park, Station Road, Forest Row, East Sussex. RH18 5DW, U.K. <a href="http://www.sirius-analytical.com/" class="extLink">http://www.sirius-analytical.com/</a> (accessed August 3,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sirius+Analytical+Ltd.%2C+Forest+Row+Business+Park%2C+Station+Road%2C+Forest+Row%2C+East+Sussex.+RH18+5DW%2C+U.K.+http%3A%2F%2Fwww.sirius-analytical.com%2F+%28accessed+August+3%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Hoaq, B. P.; Kondakov, D. Y.; Conley, S. R.; Owczarczyk, Z. R.; Brown, C. T.</span><span> </span><span class="NLM_article-title">Organic element for electroluminescent devices</span>. EP 2003-75445, Nov 30,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=B.+P.+Hoaq&author=D.+Y.+Kondakov&author=S.+R.+Conley&author=Z.+R.+Owczarczyk&author=C.+T.+Brown&title=Organic+element+for+electroluminescent+devices"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHoaq%26aufirst%3DB.%2BP.%26atitle%3DOrganic%2520element%2520for%2520electroluminescent%2520devices%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Barlaam, B.; Ducray, R.</span><span> </span><span class="NLM_article-title">2,4-Diaminopyrimidine derivatives as EphB4 kinase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of proliferative diseases</span>, WO2009010794, Jan 22,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=B.+Barlaam&author=R.+Ducray&title=2%2C4-Diaminopyrimidine+derivatives+as+EphB4+kinase+inhibitors+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+proliferative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarlaam%26aufirst%3DB.%26atitle%3D2%252C4-Diaminopyrimidine%2520derivatives%2520as%2520EphB4%2520kinase%2520inhibitors%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520proliferative%2520diseases%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Heitman, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goblyos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweemer, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bakker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulder-Krieger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Veldhoven, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vries, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brussee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">A series of 2,4-disubstituted quinolines as a new class of allosteric enhancers of the adenosine A3 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">926</span><span class="NLM_x">–</span> <span class="NLM_lpage">931</span><span class="refDoi"> DOI: 10.1021/jm8014052</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8014052" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=926-931&author=L.+H.+Heitmanauthor=A.+Goblyosauthor=A.+M.+Zweemerauthor=R.+Bakkerauthor=T.+Mulder-Kriegerauthor=J.+P.+van+Veldhovenauthor=H.+de+Vriesauthor=J.+Brusseeauthor=A.+P.+Ijzerman&title=A+series+of+2%2C4-disubstituted+quinolines+as+a+new+class+of+allosteric+enhancers+of+the+adenosine+A3+receptor&doi=10.1021%2Fjm8014052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm8014052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8014052%26sid%3Dliteratum%253Aachs%26aulast%3DHeitman%26aufirst%3DL.%2BH.%26aulast%3DGoblyos%26aufirst%3DA.%26aulast%3DZweemer%26aufirst%3DA.%2BM.%26aulast%3DBakker%26aufirst%3DR.%26aulast%3DMulder-Krieger%26aufirst%3DT.%26aulast%3Dvan%2BVeldhoven%26aufirst%3DJ.%2BP.%26aulast%3Dde%2BVries%26aufirst%3DH.%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DA%2520series%2520of%25202%252C4-disubstituted%2520quinolines%2520as%2520a%2520new%2520class%2520of%2520allosteric%2520enhancers%2520of%2520the%2520adenosine%2520A3%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D926%26epage%3D931%26doi%3D10.1021%2Fjm8014052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Aldous, S. C.; Fennie, M. W.; Jiang, J. Z.; John, S.; Mu, L.; Pedgrift, B.; Pribish, J. R.; Rauckman, B.; Sabol, J. S.; Stoklosa, G. T.; Thurairatnam, S.; Vandeusen, C. L.</span><span> </span><span class="NLM_article-title">Pyrimidine hydrazide compounds as PGDS inhibitors</span>. WO 2008121670, Oct 9,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+C.+Aldous&author=M.+W.+Fennie&author=J.+Z.+Jiang&author=S.+John&author=L.+Mu&author=B.+Pedgrift&author=J.+R.+Pribish&author=B.+Rauckman&author=J.+S.+Sabol&author=G.+T.+Stoklosa&author=S.+Thurairatnam&author=C.+L.+Vandeusen&title=Pyrimidine+hydrazide+compounds+as+PGDS+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAldous%26aufirst%3DS.%2BC.%26atitle%3DPyrimidine%2520hydrazide%2520compounds%2520as%2520PGDS%2520inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span>Specs and Biospecs, Bleiswijkseweg 55, 2712 PB, Zoetermeer, The Netherlands. <a href="http://www.specs.net/" class="extLink">http://www.specs.net/</a> (accessed August 3,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Specs+and+Biospecs%2C+Bleiswijkseweg+55%2C+2712+PB%2C+Zoetermeer%2C+The+Netherlands.+http%3A%2F%2Fwww.specs.net%2F+%28accessed+August+3%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Profft, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, H.</span><span> </span><span class="NLM_article-title">Addition of formaldehyde to 4-bromo-2-picoline</span> <span class="citation_source-journal">Wiss. Z. Tech. Hochsch. Chem. "Carl Schorlemmer" Leuna-Merseburg</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;key=1%3ACAS%3A528%3ADyaF3cXls1Cltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1960&pages=85&author=E.+Profftauthor=H.+Richter&title=Addition+of+formaldehyde+to+4-bromo-2-picoline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Addition of formaldehyde to 4-bromo-2-picoline</span></div><div class="casAuthors">Profft, Elmar; Richter, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Wissenschaftliche Zeitschrift der Technischen Hochschule fuer Chemie "Carl Schorlemmer" Leuna-Merseburg</span>
        (<span class="NLM_cas:date">1960</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85</span>CODEN:
                <span class="NLM_cas:coden">WZTLA3</span>;
        ISSN:<span class="NLM_cas:issn">0043-6909</span>.
    </div><div class="casAbstract">4-Bromo-2-picoline (I) (43 g.), 25 ml. 30% HCHO, and 3-5 drops AcOH heated in a glass autoclave 15 hrs. at 120°, the resulting black mixt. treated with 5 ml. 10% NaOH, extd. with CHCl3, and distd. yielded 15% I, b14 74-80°, and 9% 2-(4-bromo-2-pyridyl)ethanol (II), b14 95-8°, m. 54.5° (ligroine).  The aq. phase acidified with HCl, evapd. to dryness, and digested with 100 ml. of EtOH yielded a soln. that with 150 ml. C6H6 gave a ppt.(black gum); an addnl. 100 ml. C6H6 pptd. 0.6 g. (1%) 2-(4-hydroxy-2-pyridyl)ethanol-HCl, m. 128°.  Picrate of II m. 157°; II reineckate m. 148°.  4-Bromo-2(β-hydroxyethyl)-1-methylpyridinium iodide, from II and MeI in C6H6, m. 242° (HCONMe2-Et2O).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7iDwcNICBgbVg90H21EOLACvtfcHk0ljuUcUvGoo1eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3cXls1Cltw%253D%253D&md5=f5727e46f35801f726368ec9c2008a5f</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DProfft%26aufirst%3DE.%26aulast%3DRichter%26aufirst%3DH.%26atitle%3DAddition%2520of%2520formaldehyde%2520to%25204-bromo-2-picoline%26jtitle%3DWiss.%2520Z.%2520Tech.%2520Hochsch.%2520Chem.%2520%2522Carl%2520Schorlemmer%2522%2520Leuna-Merseburg%26date%3D1960%26volume%3D2%26spage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i88"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01173">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_47584"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01173">10.1021/acs.jmedchem.6b01173</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Metabolic pathways for <b>60</b> in human and mouse liver microsomes, <i>K</i><sub>d</sub> and <i>B</i><sub>max</sub> determination for [<sup>3</sup>H]<b>7</b> and [<sup>3</sup>H]<b>39</b>, and CEREP and KINOMEscan data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01173/suppl_file/jm6b01173_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01173/suppl_file/jm6b01173_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01173/suppl_file/jm6b01173_si_001.pdf">jm6b01173_si_001.pdf (696.22 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01173/suppl_file/jm6b01173_si_002.csv">jm6b01173_si_002.csv (1.44 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01173&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-4%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01173%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01173" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67993b1a2ec223b0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
